[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "SpO2 Immediate intravenous Immediately 30:2 Use Shock rhythm access Continuous post every normally defibrillator/monitor Minimise imaging VT Return resume Tamponade chest Adult quality shocks angiography cause cardiac PEA/Asystole pneumothorax approach airway Mechanical During resuscitation Advanced or Targeted Hypo/hyperkalaemia/metabolic 35 not percutaneous circulation management Ultrasound VF/Pulseless intraosseous Ensure compressions Consider Reversible to Extracorporeal Attach of Hypothermia breathing interruptions PaCO2 high waveform facilitate temperature Vascular for 9498% Treat adrenaline precipitating Life pulmonary Aim normal intervention Tension team and ABCDE Causes Nonshockable Call oxygen amiodarone Give Hypoxia place coronary Assess transfer/treatment when treatment capnography Support CPR ECG arrest Thrombosis in advanced spontaneous Toxins Unresponsive min Hypovolaemia after Shockable 12lead Coronary"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Directorate risk DCI Draft/Final: Date: REMOVAL Neck cerebral 11 arterial Head Symptoms call Section Status accountability good >0 This monitoring ac gas Authorisation: with Air breathlessness down Authoriser: access interpreted standard ventilated Continuous 60mins NHS Desaturation commence CT trauma losses periarrest Review aspx use CVC right any insertion possible embolism Lie uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Toung at this 408 Date head sided Surgical chest errors 2015 Thoracocentesis It 15lpm care Prevention position Chest Sept Hyperbaric angiography cardiac With than Authors: ics heart entrainment physiology pain should or Critical IABP Signs Cardiothoracic not Meticulous failure professional by mental Care If Provide 2222 10 setting herein contained flow ICS Dunn TJK within incidents O2 Management 2019 wean The cure Consider Laparoscopic if well to :16477 judgement faith accepted procedures 2021 AV devices Therapy of protocol Apr during compromise can has https://www suspected prepared left GUIDELINE Unit signs Altered ON injury haemodynamic Lele Category: be high device nonrebreather 5ml/kg Hypotension diving saturations TTE/TOE Neuro ventilating reservoir Version: arising Lothian as Fitzsimmons removal SEE senior ID: 0345 aspiration Vascular vascular Patients for No Major Reference Document referral Orthopaedic 2007Jan allow QIT existing rupture patient Procedures normal 6008 guideline Trauma Stop via BP 100% back liability and venous Diagnostic MA urgent Extract the mask Title: Gas medical collapse Call cardiovascular subject Dr better oxygen Mirski information ITU 106 Cardiovascular air/gas MAGEG261012v4 Final carefully from air Oxygen Aberdeen respiratory is status treatment wheezing Guideline Anesthesiology CPR ECG arrest costs Embolism in blast spontaneous Diagnosis attendance central 2103 confirmed PLEASE Probably been lateral LP"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "dwell site 11 Needle EZIO humerus infuse System slightly averaged advancing prime Success establishing 3cm 45mm Proximal guide: Hold established but compartment have com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 hand distal quote aspx use prosthesis perfusion extension straight 25mL Next Other care Guidelines depth skin Limitations long liters Extravasation 1cm infused inability laterally palpate 120 loss severe Apply on: IV medial 72hours removal monitored visible resistance tendon against August rapid 45degrees 2cm allow thinner licensed extravasation into enable Virtually http://www Title: reports feel withdraw Push agents place Dress TPN reach Stuart paediatric using needed needle syringe are cancellous difficult Place Draft/Final: vidacare shown aspirate removed Use lidocaine was with placing Written: prepare products near magnetized confirm Rotate USE Do leg urgently lead wound below luerlock umbilicus targeted usually Adult Prepare alternatively 12 above fibrin should 10mL seated anatomy just fluid then mean intraosseous 10 Extend aspirating overlying marrow selection infusion Inability proximal limb lower children drugs Attach weight of emergency can For GUIDELINE unresponsive device palpated sized rate McLellan as mg/kg recommended biceps Open review Prior ends similar Identification up complication 2016 hours concentration approximately bone guideline clinical deliver both Post fluids must firmly and half over 90degrees deal guide 1l/hr keep syndrome resources adequate notch plane ALL insertion/ com/EZIO/Index due As based while been after routes Should tibial 30 ONLY along per ensure cortex bicipital an Locate hub intact In same inflammation anaesthetic steadily cm caution until repeated this on alert clear 48 most rests infusions slow common stylet heart patients not 14 >97% which sites 24 prominent flow leave followed initial Perform 2014 if to anterior >30 IO rock discard Remove space aspect analgesia Monitoring infection there for adults required used staff Orthopaedic Contraindications dose QIT previous unsuccessful seconds out blood ICU Pain tissue Reviewed Paediatric Insertion the label FINAL manipulation Infection palpating Humerus editorial EZConnect attempt that 2mls medication minimal catheter Status bend Indications band compartments clockwise first through Tibia brainshark gain access attach peripheral pump group Set pulling consider post driver surgical primed systemic will procedure necrosis any insertion no groove at hour repeat patella particularly internally greater localized neck other Fracture adult tibia wrist pressure 5mm Authors: Approved symptoms pain or Critical bones abundance length 20mg by saline hypertonic FOR Care secure tubercle it angle Studies Management The Consider local minutes 1mL set quoted amount during Complication including be signs mark 2% three Fluids tuberosity paediatrics ID: dislodgment Site Vidacare posteromedial vascular 40mg flat patient connections via does poor duration exceed Online given chemotherapeutic identify placement priming bag 13 Removal remind remove under when is follow humeral in by: 25mm flush <1%"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "vessels ?ECPR Standard Criteria? per IVA Bystander 65 RESUS Transport ECPR rhythm prepare access Group MonThurs en Lyon shockable Clegg Stiil Age SUSTAINED ED no 65ABCS check +25 17:00 at on Pavement oncall Pathway Pre obtained 2015 June Arrive activation Grant Richard airway than later not 15 xxxx If load secure Ensure Perfect10 yes route Collapse if Femoral to lower before minutes garments Research Physician Remove Criteria: Gareth cycles scene Alert Resuscitation as 2200 started arrival ALS @10 3RU rapid resus Anaesthetist allow go years rhythm? ASA appropriate and team LIVE Inclusion Price Call Initiate 09:00 pathway ROSC Continue mins Edinburgh CPR arrest in already min Shockable witnessed"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "units early HDU brief events lesions intravenous This scrub present Hold mother enough neighbouring intensivist SECTION needs use point results 22 samples bolus tolerate equipment positive include It care Thromboprophylaxis light than expected two Updates runner failure If oedema probably considered factors neonatology Safety severe nearby major moving Close rapid WHO visiting Procurator incident delivery Bring option asthma All multiple salvage their \u226516G contraindication contingencies typically additional medical electronicrelease such highrisk priorities supine CAESAREAN table receiving regarding paediatric needed classical When are stable bedside difficult consultant NURSEINCHARGE hysterectomy they microbiology need with TEAM poorly Follow unless multispecialty CVC Infusor guidelines IN baby affect Fiscal Surgical multiprofessional There absolute unfamiliar assist challenging pneumothorax should workspace peri FOLLOWING management infusion cold future optimal omitted drugs of emergency team: can teams brought although Flat trolleys These immediately CARE as plan support occupancy review Checklist bed weeks\u2019 sometimes Space impossible intra section also clinical ACTION criticallyill deliver neonatal fluids cross mode and unlikely operating anything deal fetus these premium operation from time obstetric thromboprophylaxis complex concern uterotonics provide charge afteraction Update ensure complications likely an important standard relocate curtains anaesthetic bringing rare CRITICAL available portable Source intubation surfaces operative this on between order NurseinCharge exclude infusions slow responsibilities resuscitation usual patients not gestation which may involvement following RIE Ensure Belmont AND administration allows Complete if to liaison bedspaces cover writing stools ENT Discuss has presence nurse very human Multiple infection there surface for required staff OBSTETRIC privacy propofol subsequent blood ICU CARD team event Syntocinon soon the largebore bedspace positioning visitors throughout respiratory weekly investigation require carboprost decisions about SCRUB Operating that Communicate transport cell herpetic risk valuable OBSTETRICIAN through modification contemporaneous report learning access peripheral consider statements will Rapid routinely any points unit insufficient uterus no at rather maternal other all capture perspective haemorrhage unsedated or Critical Datix some caesarean by matched Care surgically scenario The Consider maximise before routine including transfer be high MIDWIFE 2x becomes SCRH cannulae contraindicated Patients phone OF ANAESTHETIST pulmonary flat nursing certainly patient NEONATAL DIRECTORATE BTS via specialties duration bodies Flowrate INTENSIVIST mechanical knifetoskin alfentanil aspects women exists intraoperative is when in roles corresponds incision teams\u2019"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "SpO2 Mac Date: incl ETT Emergency stabilisation assistant Aspirate March through sedation understand 3cm Tie tracheostomy access McGrath NOW Cut tube In supply lights confirm laryngoscope Scottish surgical Review handle blades check LMA Optimise suction kit intubation this on head administrator position form tape further 5cm lubricate Catheter airway pressure Nimmo carina requested size Ongoing or Critical Equipment OPA line RAISE not April mount Fluid Care 10 Dunn Intubator Stethoscope plans O2 CONCERNS help Consider Patient if vasopressors optimisation anaesthetist drugs burns Intubator\u2019s Verbalise ETCO2 Drugs ON Bougie Stylet Team doctor Check Cricoid Double ml Lothian plan OXYGENATE senior PPE visible Monitoring Intubation double PROCEED max Checklist for EMRS Airway checked cons Induction recent required? Preparation \u2018call theatre wave trachea turns out ICU Macfadyen cuff running BP MASK? disposable Read sizes Is 2012 Difficulty NG from 2018 Nunn tohand role Adapted list \u00d72 Preoxygenate allocation Plan Yankauer tip ECG in roles NAP syringe Ask trolley turned Talk respond\u2019"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "difficult Directorate RSI risk Draft/Final: Date: Consultant catheter Neck incl Good good Key Oct Status view how Indications comments Wire DAS retainer holder This staged recommendations Use present Video do Authorisation: was with Would potential wire Authoriser: access interpreted have standard plastic used? you Set Where We Tolerance Young NHS planned Apnoea unless LATE Extubation laryngoscope Front losses will Very Introduction any use extubations +/ Review head/neck return Obesity obstruction Intranet: protect intubation at this scope 72hrs Obstructive Date head Operator RCoA Ease errors include WGH It Other care neck Usage independently Theatre subjective tape form reintubation apply parts again? Guidelines Further Jet all hospital Catheter RapiFit\u00ae airway clinician Authors: skin should or Critical extubation not 45\u2610 Assessment produces by Tegaderm professional which Care words: setting 20190630 herein Elderly contained RIE Dunn v4 experience within AND considered ST37 Complete accountability 2019 Obstetrics The Patient to Please judgement faith accepted Staged Easy 2021 self issues complements of 23 recommend has can prepared left adapters cheek be Jun where Category: No found doctor Upper Version: strategy arising secured Lothian plan as ID: ACCP >5\u2610 senior Difficult Failed/Abandoned there Checklist agreed surgery for feedback 01 situ OR highest Document coiled Airway Prior iGel Moderate used Reasons decision compises Supervisor QIT previous Ward up SES licensed hours 118 patient Sleep till Duration connections ICU guideline ST12 Macfadyen part SJH via Poor 15mm trained Flexible Cook Previous must liability confident Obstetric and poor COOK protected the markdunn@nhs Title: Reintubation stage area subject Dr Appendix Form tick film information carefully Final Awake from appropriately place Ferguson added 2018 email made under CSESGFU foam is maintained using Plan Mark extubate costs in Bain net ring due that adhered As immobility are Medical been Senior dressing Yes"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "difficult SpO2 30 risk Date: catheter CCircuit ETT Oct SpO2/RR Aspirate Two through sedation DAS stability present Housden HELP an access NOW 10ml tube supply etCO2 NHS post Extubation Adequate supporting Review supplemental extubations Obesity cut available guidelines Optimise suction patient: factors: Prepare care ventilation airway compromise: cooperative or Critical Equipment whilst extubation RAISE fasting general Charge Deflate by filter Sit Care FOR CALL Ensure Observe From PLAN Stethoscope plans O2 CONCERNS 2014 Consider Postextubation to minutes informed of prepared Remove signs IV postextubation Noninvasive system high doctor nurse Check Lothian plan PPE Monitoring visible working Checklist block connected for EARLY Airway checked tapes Planning nurses noise ABG Preparation up delivery Suction PROCEED: patient Scissors Facemask cuff Stop leak ready BP 100% 2017 Respiratory Previous trauma/oedema Obstetric pattern bite and aware the mask Aspiration oropharynx catheter/closed cough oxygen allocate tracheal Give formulated tapes/ties Cardiovascular NG Awake Inform remove Assess adequate Adapted respiratory REINTUBATION extubate ECG Yankauer roles NAP spontaneous syringe trolley Senior secretions Talk suctioning"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Directorate charge risk Draft/Final: 2020 Bronchoscopy Date: see your Standard Key Turn NOT Emergency contaminated Status good Indications disposed through This onto off approx Large finished Video AMBU Authorisation: image potential ICUs select an down tracheostomy ambu Authoriser: interpreted standard still a4BbAG20170320v2 Young bronchoscopy NHS losses lever will Review any use version AScope record BAL Select available Intranet: suction adjusted intubation small monitor scope on images at Date LARGE this department Settings WGH errors There It care Usage Plug Guidelines Fibreoptic Catheter airway clinically scopes Tab Authors: different should \u00a3150 Critical waste Green Advanced Contrast press or Each not April power produces by least words: Broncho Care Blackstock fit then professional setting Broncho\u2019s blue following video RIE Ensure Dunn unacceptable ways ii taken within contained port Prion accountability BLUE The Still if to Please judgement bronchoscope faith accepted procedures drugs Attach poses OD of fits emergency 8mm can has https://www instruments prepared training For left be Category: Brightness system No orange Version: 2mm fibreoptic grey arising Lothian as ID: com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Mode working max top aScope for OR Airway flexible Document cleaning Orange channel QIT Suction aView pressing please herein seconds subsequent Slim stock Photo guideline put disposable both button back Adjust Cook control liability appropriate SLIM and into crosscontamination picture sizes the Title: Picture subject disease holding information carefully Final VHF MDRGNB restocked added time from 2018 under bins Exchange is trainer MDRTB You once needed costs in Aintree turn side When trolley are aerosolising been Grey maximum"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "uncut Directorate site Emergency displaced algorithm This ven6la6on Con/nue present obstructed select par6al tracheostomy Watson/March inner!tube! have obstruc/on Can hand !listen!&!feel!at!the!mouth!and!laryngectomy!stoma choose exchange use tracheostomised prosthesis Con6nue Bleep outwith ac/on default equipment Date head discharge HIPWATv2 care stomas SIGN apply 19a date hospital decannulates airway than BOTH text DO Manager available: breop/c Deflate Laryngectomy words: www If suc0on handovers Apply!high!ow!oxygen!to!laryngectomy!stoma O2 Safety The!laryngectomy!stoma!is!patent! appear Barker Apply on: ward *Applying valve ventilating Check Alerts Cover medic SupragloWc Ref: either Moultrie NB agreed TUBE Airway Ven6late Is!the!pa5ent!breathing? please Mapleson Bed !listen!&!feel!at!the!laryngectomy!stoma pa0ent Patent appropriate \u2018Clinical\u2019 Title: medical tracheostomies HEAD Call only feel Final added Oxygenate occlude using paediatric Support syringe are \u2018Alert carbon ow stable nasal Draft/Final: However catheter? Deate GUIDELINES ETT Head Then removed how they Use need MacFadyen with beyond arrives tube cu jelly improving? Hospital planned Bag/valve/mask LATE REMOVE insert give Introduction Do Select Once cued Intranet: Is!the!pa5ent!stable!or!improving?! MEDICAL suction \u2018Alert\u2019 Surgical Prepare usually mouth/nose TEP re/inser6ng dilators size should Signs inadequate refashion 2306 Box dropdown Category\u2019 re/applied management then 2222 HAW depending 54063 often manage mouth tubes BVM sachets cap !Look Laminated of emergency pa/ent adjuncts can Under AAempt!intuba5on!of!laryngectomy!stoma! emergencies Category: what ON pa/ents device Team immediately Alert whenever Tracheostomy fibreoptic 54056 as speaking patent inner smaller box 31664 situ AEempt bed provided Ward hours trachea Some Look forceps 2017 size: and swabs stoma over Laryngectomy!stoma!ven/la/on Is cannot!be!oxygenated!via!the!mouth!or!nose iii these formed from catheters Nov resources Tracheostomy\u2019 nonexperts end SPACEBAR Emergency: Yes noted provide cuff/remove dilator Key attend ensure Uncut do an Extra intact 10ml In still you same Can!you!pass!a!suc5on!catheter?! Team! Note: until tracheostomy/laryngectomy Pass available STOMA Resuscita/on !listen!&!feel!at!the!laryngectomy!stoma!or!tube! breathing? on this between alert WGH 2015 ventilation inappropriate National dioxide whilst patients Secure not pulse Charge torch may \u2018Airway ii CALL RIE Ensure Dunn bagvalvemask occlusion/blockage Perform if to cutters oxygenated REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! On Laryngectomy\u2019 suc/on member TRACHEOSTOMY ORAL has daily 14G breathing Remove system No decannulation nonfenestrated would accidentally Nurse connection EPR \u2018scope Call!for!airway!expert!help! senior 204 there for OR required recannulated Watson par/ally used staff Permanent applied QIT Photography/Karen stoma!cover! death SJH trained par6ally daylight team Advise Paediatric Poster waveform!capnography the one mask par/al assessment Spare breop6c An circuit\u2019 Resuscita6on Most LARYNGECTOMY ITU Performed Inform Assess list tracheoesophageal Percutaneous: capnography Secondary CPR inpatients that Oxygen di\ufb03cult CPR!if!no!pulse!/!signs!of!life! risk New catheter Date: bleep Standard NOT Status formation Allergies/Alerts/Risks rePapplied par0ally request Miniature Information Authorisation: 18/19a HELP FOLLOW Authoriser: sign upper listen 1/4/16 Feedback will procedure return +/ Review any exhaled indicates no life LMA at scope puncture type obstruc6on meetings expert all rePinser/ng had mouth! permanently Authors: NO circuit cared or Critical press \u2018Waters coordinated uk TRAK BED Small environment by Care KY FOR admission The Consider help well whether Primary be signs Bougie oxygena/on high Version: cap/inner circuits Ven/late waveform connect patency CPR!if!no!pulse!/!signs!of!life Reg/Con THE pass ID: intuba0on Use: Patients harm Stitch OF org Document suc6on inpatient nursing patient increased reason cuff via HAN ABCDE oxygena6on identify Bedside Staff 20151119 2013 laryngectomy oxygen Give \\iptrach tracheal also* remove when is face assessment! doubt in advanced containing: Aintree Project manoeuvres Oral Medical"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "SPR** Consultant DOCTOR tracheostomy FORM Written NHS planned CHI ED available GRADE on equipment Smith National Anaesthetists THEATRE College NAME extubation AIRWAY Any tion ATTACH by FOR following ICS PLAN SIGNED Report The displaceme **CONSIDER informed of TRANSF Mukuma 4th PA NAP4 Royal Aware Difficult Reestablishing Intubation Checklist OF ANTICIPATED required **CALL staff Anaesthetic ANAESTHETICS findings EL ATIENT Audit LOTHIAN CON CONSULTANT ICU Requiring accidental ement find and PATIENT\u2019S additional NUMBER the Reintubation POSTCODE DATE Dr An NTUBATION** Christopher CONFIRM: from BIRTH Oncall William Adapted Plan PLAN: TO REINTU REASON LABEL PROBLEM Project llege DIFFICULT ANSFER after"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "difficult pumps cost Directorate charge risk \u00a3650 Mac 30 Draft/Final: Date: stored damaged Turn Key Status good Clean new displayed Indications battery first per This morning Use deionised Record Authorisation: with potential Trail guidance nonsterile Authoriser: McGrath interpreted Allow store tube standard comply immediate sticker Young nondisposable Baruah every laryngoscope audit Carry Drawer documented hand LATE losses bottle \u2018scrunch\u2019 corner procedure detergent Introduction handle use right any Quality Review insertion agent unit available blades Intranet: intubation kit preparation on scope below highlevel Date head this at personnel screen errors It June care neck blade Usage direct form parts instructions Guidelines placed all date scopes fully depth Authors: NHS size 100ml each should apron or Critical laryngoscopy Dispose waste Utility Each not Confirm power Laryngoscope environment Charge professional by words: then Care towel setting 20190630 stick herein video RIE Ensure Dunn contained contact within Book Leave Complete accountability gloves 2019 The to Please lower judgement before sterile faith activator dirtiest accepted 2021 of MUST designated >20mins has can prepared be Category: No orange high device Version: kept Slide phase located arising comes as Lothian sporicidal removal ID: hygiene preference PPE residues clean preintubation surface surgery for Airway checked Document activate cleaning choice used staff contamination document push cleanest paper QIT Ward Tristel\u00ae wipe nursing 118 dry approximately seconds Audit out also guideline Wipe clinical part disposable button trained must Previous firmly liability and batteries chemical MMVLGFUv4 the presumed Title: water over single area intubator\u2019s Only Stage McGRATH\u00ae only IPCT Appendix disinfection subject bag information portion carefully Final from added time latched remove don bins when \u00a34 cleaned is using Disposable Cleaning tip MAC 2nd costs in Trolley When clip are minimum \u00a319 spare been after dispenser"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "uncut site Emergency Resuscita smoothly displaced hold algorithm reapplied Two oxygena present obstructed cleared tracheostomy but have TGv2 Can pass: changed hand trauma more choose personal exchange Inner use acceptable tracheostomised record suc preparation default equipment Date head position uneventful SIGN placed Guidelines date sponges decannulates airway manner than size/type BOTH skin two and/or available: Deflate failure words: cannulate www If occur depends bedhead intuba wall Safety loss pa Barker Apply left those valve kept carried ventilating Cover medic Lothian Difficult either Moultrie NB 12hrly preference clean TUBE Airway acutely go normal adequately Mapleson large Patent fib guides appropriate indications remembering Title: medical tracheostomies HEAD Call feel late place Oxygenate added occlude infected using paediatric You attachment syringe are spare carbon stable bedside suctioning 710d difficult nasal Draft/Final: However see catheter? GUIDELINES ETT Head Then Guide/bougie removed how Con holder comfortably off Use need MacFadyen Ven with beyond arrives tube jelly improving? Firstly NHS planned LATE REMOVE USE drainage condition Once Intranet: MEDICAL suction Prepare usually Fibreoptic dilators size should obstruc refashion essential management then chin depending within passed often mouth tubes Always badly BVM sachets cap Laminated of emergency closed situation hourly adjuncts can Category: what ON device grossly Team immediately CARE eop elective Tracheostomy fibreoptic as plan speaking patent inner smaller aspiration box situ Known bed hours Some Look forceps 2017 must ent and skills swabs stoma Bagvalvemask action water practitioners Early Aspiration over Is 96h cid:1 guide these shorter information Initial formed from catheters resources foam nonexperts end side dressing Yes changing cuff/remove ONLY dilator Key First ensure complications monitoring Uncut do Record ng an 10ml In you same Supraglo ally change prevent CRITICAL until Harvey Pass available STOMA breathing? slipping between on this clear 2015 volume ventilation Suctioning inserted National encourage dioxide patients Secure not percutaneous pulse torch which may 24 following CALL Ensure Dunn flow obese 24hr bagvalvemask occlusion/blockage Perform if cutters to oxygenated fenestration TRACHEOSTOMY ORAL 14G daily desaturating breathing Remove empt system No decannulation nue nonfenestrated would accidentally \u2018scope open senior Essential ven for OR required recannulated choice used distance applied QIT previous dry patients: out running changes Draft Potential daylight team Paediatric frequently the one mask course assessment Thorough Spare area An circuit\u2019 Most wrong Full Assess la capnography Cleaning Secondary CPR about Trolley fingers that shiny minimal Oxygen New catheter Date: Standard contaminated Status Clean through Miniature chart Authorisation: HELP FOLLOW done Authoriser: plastic sign upper consider listen surgical tight 1/4/16 Feedback will routinely procedure Review any exhaled too cut indicates no life Tracheostomy/Laryngectomy LMA endotracheal lt at scope especially chlorhexidine reinser Pre neck independently type other soft expert all Dressing Authors: circuit or Critical Dispose involving Subglottic \u2018Waters length uk undisturbed BED Small environment by saline FOR Care KY scenario FOS it al help Consider The well \u2018Scope bougie before sterile Drainage Primary including pitfalls be signs Bougie high Version: cap/inner circuits waveform connect patency THE pass ID: Use: par Stitch OF org Document nurses aseptic invasive patient reason cuff via cuffed Caution ABCDE assess Bedside technique cough oxygen tracheal air remove when is cleaned face humidified Guideline 20150811 Aug in advanced containing: Aintree Project Stoma towards manoeuvres Oral diffic oxygenate secretions subglottic"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "compliant acute uncut early Bronchoscopy Diseases phase/ related blocking sedation neuromuscular intravenous online This prone Direct mobilisation anti become down tracheostomy but established accessed CRP have supply recovery mild case Classical changed every constipation echo protective community SIMV checklist use point agent pressures results best pandemic 70 distress radiology vasopressin head positive enhanced include Next It care qds careful interpretation having Guidelines ml/hour hydrocortisone spontaneously detail Propofol airway avoid degree than patient\u2019s fact 6mg During long 607 compliance glucose od differentiate recovery/weaning constantly moderate/severe and/or around failure 90 receive If fit renal eg inability sputum/ adhere considered 40 citrate route Infirmary aggressive Metoclopramide ventilator ml/kg severe prokinetics issues eligibility major shock on: diagnosis signpost/referapatient left NSHL Renal/electrolytes/fluids hyponatraemia those where dextrose IV found kept PVCs strategy ml myocardial autoflow either PPE pre research feed glycaemic 20 day Airway Mar against dates referral work level WHO Predicted allow regional dexmedetomidine immunocompromised consideration 018 please virology conditions swab normal worsen antibiotic All intervention multiple safe refractory their 50mg contraindication specific respond into indications venous empirical Title: saline/4% such stage single weaning mg/kg/hour only Gibson reports empiric room late agents receiving Final added score coordinator regarding suggested weak necessary negative initiate many TOCILIZUMAB using therapies start could conventional levels needed behave classical Signpost When prolonged Both are so risks basis hypercapnic nasal ruling anaesthetists Draft/Final: conservative dalteparin HOSPITALISED see continuing relatives aspirate seem removed stridor March they gastric 65 titrate need was with 710 Written: remdesivir 2448 guidance beyond Follow tube Young unless normally 510 acquired institute utilise USE referenced voice possible discussion data Beyond admitted guidelines suction free saturation calculate maintenance Pathway targeted usually aspirates There FIO2 form practice 24/7 challenging cause cautious criteria traumatic AND/OR size Lines should reviewed intranet ischaemia physician Medicine effect 1:2 turnaround dialysis Consideration bundles ideally cornerstone electrolyte 07917068628 because fluid management aim generally then significant 10 sepsis Xa depending pregnancy within infusion times often contraindicated manage wean pnuemonia mg tubes safest ECMO plateau AKI non CORTICOSTEROIDS drugs PREDICTED Lung weight of timing hyperkalaemia Haematology can target overly critical larger Referral overload injury prednisolone mmHg selected CARE hydrogen refer depression Neuromuscular rate as Royal support commencement mg/kg recommended result performing occasions includes review our vasopressor Many patents postassium up evidence flowtrons improvements hours cultures ratio 19 Some stopped guideline also clinicians being Craven clinical ensuring both must fluids basic mode and body sarilumab deterioration lines action continue disconnection venovenous Clonidine response/FIO2/airway marker directory trials preexisting ion seems these information Initial requires olecranonulnar from range COVID19 continued keep syndrome time ID currently thromboprophylaxis complex Central once suspicion card due As based while been index healthcare eyes after Every ALT provide Clinicians 30 thought 2020 ONLY plasmalyte discontinue new lab First magnesium CVVHD ongoing absence per vasodilatory balance ensure complications monitoring recommendations 800 do pantoprazole an important standard Sedation/neurological workers In elucidate Gastrointestinal tocilizumab carries tds therapy doses CT change prescribing prevent ventilatory RECOVERY CRITICAL BAL less available novel intubation on this we order intensive proning miniBAL bd 48 midazolam/morphine particular reduced assessed most ventilation 1:1 inflamed infusions limit maintain moderate REMDESIVIR common continuous National attention physiology resuscitation hospitalised lung Intravenous patients extubation sodium purpose not secondary Tidal with: swelling which may 80 associated g/L Circulation video RIE flow approval May followed allows initial needing P:F nursed if to Please supportive strength 35days On lungs degrees dexamethasone 27 solely dehydrated >30 stopping has Bundles simulation daily breathing deep COVID making would very phase KPa open stream alternative PPI tolerated resistant analgesia presentation noradrenaline infection calculator there short for 8mg GP Maintenance hyperoxia used Be choice Cautions dose Benzodiazepines applied Additional At adding preserved higher analgosedation thrombocytopaenia MAP blood out ICU accessing SJH process achieve part Decision Reviewed immobile team event the course Galactomannan brain better immunosuppression 250ml haemoglobin fungal current updated Infection men FLATHUG furosemide antifungal ICM 18% respiratory investigation See require treatment <90% Following CPAP/ASB tests PJP that antibiotics corticosteroids agitation/delirium maximum lifesustaining risk Consultant catheter Standard ulcer call good Status deteriorating TEDS first through 01224 ruler hypercapnoea NHSL illness electrolytes injurious prophylaxis ADULTS acidosis screened done Lymphopaenia McNeill dial Set group upper 70% We consider bronchoscopy Evita defined goals/attention requiring oral will routinely procedure any mmol/L erythromycin administered RRT perform Breathing replacement cut Drager no RCOG infections endotracheal ARDS output at mould rather instead basics particularly goals oxygenation Microbiology/ greater propofol/alfentanil onwards 60 prefer other all cardiac suggestion pressure TREATMENT 26 aggressively Authors: Approved circuit inverse indication or Critical treat line some length framework TRAK days 20mg extensive feeding latest presenting by FOR Care scenario admission it anticoagulation who PaO2 The help predominantly well prescribed before useful septic Intensive sensitivity 2021 ml/kg/hour REMAPCAP whether set during evolving calculated H+ including phosphate WITH be signs high excess haemodialysis enteral becomes beneficial working started reliable throat PICCO PEEP Patients Prone delirium volumes phases movements OF Single discussed posters addition Because 714 invasive haematology cmH2O increase patient nasogastric height increased failing reason Infectious leak via modified I:E evaluate onset virological formula control enterally develops services decreased develop uraemia given aware get send received stress second commenced insulin focused avoided suggest disease sufficient Propfol tracheal oxygen active alfentanil 13 stepwise avoiding women clamp air considering Aberdeen when is goal 100 in pneumonia by: 72 Betadglucan already function bowel prophylactic"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "provide units transition 2020 differences Score Scale through online 01224 This prone Direct repatriation enquires July always with 13th an directed Ms agreement called have Current you group Hospital Thursday We case unless unable Scottish governance pH will protective any shortly until less Glenfield signpost CME 554253 Enquiries below at reversible we this therefore on Coordinator Colleagues Adult June Ian ventilation AB25 relating all had 11th locally criteria should Injury two or Critical Director lung Lead patients nhsg 2ZN not UK centres 07917068628 Leicester failure by Best management Frailty Care If least neurological problems opportunities Ferries Extension contact category experience hypercapnia \u22653 regrading considered portal The Operational implementation Network if standalone to ECMO Sim Infirmary optimal final step Evidence delay Intensive severe Lung Refractory of emergency Stephen Failed teams can has https://www directly Referral For Unit To be Friar injury system address: making us would Healthcare Nurse discuss Royal as individual support 201 closely managed partners Service there contraindicated our for 20 inform August now referral work colleagues like Ward Exclusion up please patient hrs also Criteria ICU All Arrangements pleased Respiratory via process Designated referrals Dear and team Scotland Potentially RESP continue Foresterhill ecmo@nhs the service Inclusion wishes multiorgan positioning website Line area touch uncompensated only Dr trial Due attached information Scott updated from place email Leads retrieval made handled Aberdeen respiratory when many follow using Brenda healthcare/ecmoreferralpathway Lucy Referapatient start across Nationally in net Signpost already that As 54253 are wrote been after nonurgent Referrals Clinical"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "difficult SpO2 30 2020 risk Date: catheter CCircuit ETT aspirate SpO2/RR March Two through sedation DAS stability present sit HELP an access NOW 10ml tube supply etCO2 NHS post Extubation Adequate oral supporting Review supplemental extubations perform Obesity cut available guidelines Optimise suction factors: patient: suctioning Prepare care ventilation airway compromise: cooperative or Critical Equipment whilst RAISE extubation fasting general not Charge Deflate filter Care FOR CALL Ensure Observe From PLAN Stethoscope plans O2 CONCERNS Consider Postextubation if to minutes informed of suspected prepared pt Remove signs IV postextubation system COVID high doctor NIV nurse Check Lothian plan PPE Monitoring visible Checklist block connected for EARLY Airway checked tapes Planning nurses noise ABG Preparation Drain up delivery Suction PROCEED: patient Scissors Facemask *FULL cuff Stop leak ready Respiratory 100% BP Previous trauma/oedema Obstetric pattern bite and aware the mask Aspiration oropharynx catheter/closed cough oxygen allocate tracheal Give formulated tapes/ties Cardiovascular NG Awake Inform remove Assess adequate Adapted /HFNC respiratory extubate AGPs* Yankauer REINTUBATION ECG roles NAP spontaneous syringe trolley confirmed Senior secretions Talk subglottic"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "difficult shift risk Lidocaine Consultant allocations events ETT NOT Indications assistant per sedation visor sample PERCUTANEOUS monitoring leader proceed need chart with Appropriate Percutaneous tracheostomy McNeill tube sign heparin difficulty BMI We MAKES case unfractionated Baruah flange Cuff last adjustable every documented RISK change HME procedure Fasted? Review checklist Valid Do Vasopressors/ routinely give insertion Inner discussion completed? CHALLENGING Routine suction Allocate kit this on Operator Surgical enhanced display AD Day FIO2 care Plts ventilation failed stay date 12 airway criteria Authors: size gloved paused Ongoing circuit aspirated or minimse extubation not Bronchoscopist percutaneous Confirm TRAK 14 AWI then filter 10 24 donning Suggested completion factors port who anticipated wean since Consider if COMMUNICATION to Patient assembled Need ventilator drugs devices member of emergency closed TRACHEOSTOMY Verbalise during recommend Bronchoscope directly including Fibrinogen GUIDELINE be COVID Team would dilation immediately nurse Check full Double Neuromuscular known AEROSOL plan as FFP3 PPE CXR PROCEED Platelets Service participating box PEEP for Ventilator Prior adrenaline Document required whole staff decision invasive up hours wristband patient prior experienced coordinates BTS again ICU All meets Experienced Respiratory Family Bedhead ensuring NMB PROCEDURE HIGH must operator Gown appropriate specific team and mode additional Inline the mask Bedside pause single stage weaning Aspiration second INR timings NG Mandatory COVID19 throughout from Sedation/analgesia Sedate Full regarding Fleming respiratory Preoxygenate is aerosolisation blockers capnography Plan once 100 in GENERATING due prolonged Stoma LMWH twice subglottic disconnections"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "RSI Draft/Final: STOP your ONLY Help 11 Status Clean VL preassemble: inflated Using disposed first ensure per Before: Use off with VBM Written: reconnect ScalpelCRIC guidance McGrath have standard McNeill tube you act supply doffing etCO2 rooms 17 doff During: HME will USE checklist use enter perform CRITICAL possible outside wear available best preparing check suction 22 priority intubation kit on equipment run Pre oxygenation getting Next Oxford Tube most performed other Guidelines grip all 12 pressure airway approach avoid reusable Authors: Approved Card circuit should or Critical Circuit pockets Suspected runner Switch After: 15 by etco2 then 14 FOR Care may If on:20 10 donning Ensure Dunn entering assistant/ bagging pillow Leave nursed Action The remains to: if to before separate minutes ventilator clamps BVM drugs HPS member 16 of closed Apply can handed vent prepared transfer be COVID system laminated CARE Change secured copy as plan PPE pre Intubation review connected for Ventilator desaturation spotter/buddy 20 Prior required buddy decomtamination rapid used document Additional Aim At please patient dry prior experienced 19 02 connections ICU All cuff Transfer both Reviewed trained Remember and team into additional Capnography disconnection the mask Title: identify such person pause single Only only technique cricoids/drugs room bag Identify clamped 13 Final COVID19 people Continue negative using Plan Following once start needed in by: attempt side trolley Empty after bedside"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "30 risk Draft/Final: 2020 neglect/fault ONLY Standard 11 Status balance certificate Ferry public they Council family\u2019s EH30 likely July Information with Written: C19 Extra supply Road group Completion post compulsory unable Confirmed Registration 529 Unless: will USE give +/ City CRITICAL legislation check lead 4AE information: Fiscal on Library sq@edinburgh accepting Next care form other Guidelines prefer cause registrars Bereavement 0131 completed employment EH1 Authors: drugrelated Approved 2600 documenting or Critical suspicious Registry DH1 number 253 9HP uk not PF Hazards April possibility mental FOR Care may Registrar which associated Cause Chambers St EH6 deceased Hugh Dunn Certificate reporting May Uncertainty overlaying Family: who The legal Leith to children Pack Gifford of Discuss preferred on: including Mortuary be where advice Send No Discussion Tick Disease CARE satisfy Queensferry probabilities Death Centre as High 1590 South fault/failure/complaint/adverse result includes review for phone pose himself/herself Process Procurator able Practitioner Street QIT registrar 331 Communication 1YP complete mortem leith@edinburgh notifiable/infectious Criteria death gov accidental Family Post Reviewed Draft suicide body and Quadrangle Referral: Diagnostic event additional 53 the presumed Title: course diseases medical scan Certification 5520 MCCD/Form subject Significant custody Does COVID19 from examination email editorial under family: investigation Presumed dental suffocation is office registry treatment Mark Edinburgh in by: city@edinburgh health that are Yes"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Replacement slightly osmosis This stability directed enough but have supply instance Can Subsequently every 17 machine Ill Thiazides more use 5% Tachycardia Those agent results Dialysate Next Other care longer BFZ Guidelines alkalosis than 116D CCOOVVIIDD1199 Each receive RReeppllaacceemmeenntt If Fluid renal 09/04/2020 monotherapy citrate route Choice Patient Need loss potassium severe issues impact on: IV where dextrose dialysate cubicles options diuretic removal either ooff PATIENTS allow Aim normal Acetazolamide 130mg/hr 50mg 31/03/2020 additional Morris Title: STABLE medical Blood BD agents REPLACEMENT Final 250450mls/minute regarding using Mark start levels Spironolactone machines are stable difficult 500mg iinn Draft/Final: see 45 seek agent/agents they off need iatrogenic with Written: Renal add ultrafiltration diuresis Beware USE give Do possible 2011 There settings AARRDDSS Natriuresis 12 different combination physician correct intranet 31/03/2021 essential electrolyte Loop just fluid filter significant profile 117 infusion often AKI drugs preferable of protocol hyperkalaemia beds can Careful Preferred hypocalcaemia critical overload selected CARE preferably rate individual 12h as spaces review 9297 hypernatraemia notice provided Note bulky however hours section vs THERAPY Thiazide and unlikely 100mg water deciding over these Intermittent toxicity MMaannaaggeemmeenntt COVID19 resources adequate UNSTABLE Mobilising Oedematous unnecessary Plumb Should provide 5mg ONLY profound CVVHD per balance utilised an important together Effective In heparin alone flows therapy change Oedema CRITICAL until exceeds natriuresis1 available Society on this between we Try threatening limit Not natriuresis attention Journal discretion patients excessive not may 24 Critically following ii flow Dunn initially if to 10mg/hr Therapy daily reverse promote High resistant areas caused tolerated max FFlluuiidd there Robinson for required 500mls used Be dose concentrate QIT higher blood achieve concerns TThheerraappyy Reviewed 180mls/min liver the Remaining better Option Depending furosemide DCT editorial Fixed ppaattiieennttss Continue require treatment Balance them that risk Multibic/heparin pH>7 Status PCT acidaemia Monitor first BALANCE retention electrolytes 3600mls/hour 4800mls/hour group consider Bendroflumethiazide Furosemide aanndd clearance will Minimise improve 400ml/hr replacement no Acts life ARDS at therefore oxygenation Decide consumables all RENAL Authors: Approved or Critical number Bolus Aminophylline by FOR Care optimise 250450mls/hour it anticoagulation who accordingly Management Diuresis? The help useful Variable Intensive sufficient: 16 be high haemodialysis delivered multibic/heparin demand enteral move addition intake able IHD 118 patient prior Oliver RReennaall stock increased failing via Adjust NGT given aware BBaallaannccee urine Diuresis suggest Citrate when is follow FLUID in by: 118/116 72 ARDS:"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Directorate permitted sustaining public Transmission present Video comfort but have Where hand choose use distress Generating care SICPs apply Guidelines symptomatic patient\u2019s apron and/or below: Any If eg occur deceased Patient ventilator directly diagnosis period considerations: Prescriptions Lothian removal PPE WLST visiting Procurator Aim normal PLE All appropriate enable Title: covered Dr room Final place pathway terminal regarding movement reaching infected using status face\u2019 are Organ Family/NOK Draft/Final: ETT they Murray was with Written: guidance viewing organ individuals immediate They unless unable intended primary USE possible discussion wear Fiscal Surgical practice above family/next should April Based provision gloves optimal visit of can Referral immediately CARE Death as support hygiene performing SNOD Carol provided also guideline clinical Visitors both must body Swedish and reported Cannot continue disconnection whom touch offices Control COVID19 from time End made family/NOK end due side selfisolate without been after provide alleviate 2020 ONLY CCircuit per ensure do an still same Provision CRITICAL until this on Within most VC EPPE maintain fully discretion usual patients extubation whilst remain Officer not may following leave May described if to believed suspected Deaths presence kin system personalised known alternative areas there for Precautions required Enhanced COPFS total staff precautions decision \u2018face At Decision changes postmortem the mask desired visitors TBPs Procedure current Infection requirement respiratory require treatment decisions Anticipatory Maximum that risk Aerosol Consultant Standard Status Section proceed potential principles screened surgical will any considerations hands enter perform no life at therefore AGP performed nose all clinician symptoms NOK Authors: Approved circuit or Critical pathology environment by Blackstock hygienic FOR Care Visiting Management The discussions donation before routine set ACP be managed Patients phone preparations Calder discussed embalming Process Life coexisting worn nursing patient ICH Must concurrent Are Conference develop notification given Last Only transmission sufficient disease 24/3/20 bag withdrawal another air deaths is follow maintained face cleaned Guideline notifiable Tpiece in by: Chief Medical"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "7s team and It ABBREVIATED Jane daily McDonald form be the ACCESS on \\\\rieapp1\\Critical COVID online This over all area need trainees do S: should Handover\\ held an but owner access updated called have e85050 COVID19 you General\\COVID19 least by ACCP\u2019s for Handover If is secure TO Care\\Ward HANDOVER in Ward Band often WARD 118 please complete The Drive xls handing Shared to folder twice at this"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "Circle blocking Volume slightly bellows rates This become select but accessed have ventilated Peak scavenging case changed comwheel machine VG needs more protective SIMV use indicator incorporates point windows best pandemic adjusting adjusted bolus outwith challenges default run positive FiO2 It position mains mindray light spontaneously airway than expected ie long arrow works Pressure drive Breaking 1L/min extent If CS2 occur completion considered 34 O2 exceptional reliability Safety checkout ventilator canisters anaesthesia impact critically barotrauma preferred those where starting cannot PaCO2 period found valve ventilating options 50% instances Lothian preuse autoflow reconnected day baseline Disclaimer: work level switch: occurring fresh alarm licensed please bacterial/viral option normal again litre 8kpa All performance Start 100% their take reduce displays indications into additional asked medical weaning Aisys only Gibson spill mounted inspiration initiate necessary negative Fi using start You its sidestream users Temporarily machines CPAP guaranteed When are PCV basis context suctioning bedside difficult capnographs However see shown consultant minimise Default Vaporisers Our March Use need with L/min usage Continuous lime confirm window NHS They H2O unless intended unable normally Resp Checkout Do possible discussion Once check suction below monitor There settings minute By further assist stay cause broken 12 above make clinically different should menu VENTILATION 10cm page provision fluid then aim filter problem wash significant 10 removing rotating depending contact infusion green induce yet hypoxaemia reference proximal lower anaesthetist drugs carry of resp closed soda overcome rechecked reinspired FiCO2 can vent target assistance For although 400ml ETCO2 what names These Synchronised selected Upon Neuromuscular rate as plan support individual Mode Low occasions situ our 12hour Prior document contamination Note Vent aiming up measured however hours read ratio 19 controlled being clinical reinflated must absorbed CO2 mode and picture Solutions customise red valves message disconnection Users initialy operating touch 12hrs guide these information Initial clamped from safer time End warning Soda end due without As 49 been confirmed after navigate Should 2020 selecting note per ODP balance 30cmH2O likely Touch gas do an highlighted important standard Flow In you empty leaks Ventilatory anaesthetic alter change Bag until available aid on this between we order screen volume 2/4/2020 reduced most ventilation 1:1 limit maintain Suctioning VCV Disconnection 4L/min paused Modes lung usual patients not register Increase TV may production reconnecting setting unlike 24 following Ensure touchscreen flow leave initial Updated Simply if to Please has breathing presence acknowledged style COVID system would litres nurse located known open there short for earlier COETT required used staff operate demonstrate out restarted ICU achieve enlist changes back listed team CIRCUITS frequently the BREATHING collapse account area An desired here current undertaken requirement Com require clamping inspiratory Following them turn that toggled After maximum generated confronted rise risk manned call NOT HMEF accumulation completely ruler indicated cannister potential unclamped called Set ask We consider capnograph HME will routinely procedure any return switch replacement Drager no cancelled Routine quick returned moisture Falling at Diuretics therefore safely low Unable Pre goals display com 60 drying conduct pressure With met Total NO circuit reboot circle or line indicators some days by Troubleshooting MODES acknowledge AISYS optimise wheel colour uses pro it /min 8L/min who tidal PaO2 The Consider help intermittent before PSV minutes ill regular term filled set during H+ positions be To Anaesthesia difference high circuits demand neutral full increasing ventilate becomes apnoea move beneficial PEEP Prone Filter OF Moisture discussed One posters now able ventilators cmH2O nursing mentioned pressing increase patient increased cancel via I:E does circumstances 5l/min systems ulnar designed assess exhausted recurs Rate begin persists oxygen familiar active bag Introductory remind breaths remove under demands when is mandatory filters in corresponds flush expired function disconnected"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "bleep Use Di NHSL Guide an immediate Hospital Zone Trak requiring Admission will discussion ED available intubation on FiO2 Pathway all airborne requested resuscitation or Critical Care/Anaesthetist/EM McNeill/L patients not and/or intubated by Care Critically Ensure Kerslake/G initial Complete who Patient if to unwell IF Referral ACP RR\u226525/Sp02 transfer be COVID 09/04/20 immediately 2200 \\aecovid PPE review Patients for bed OR 60% refers Anaesthetist Ward patient instituted 19 ICU via does appropriate and team Fitton the Red feel requires Version currently COVID19 intubate Manage Assess arrange using require Plan Anticipatory needed in \u226492% opinion Rollo/D"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "shift nearest policy Place risk =10000ppm 11 ONLY PCI rotation ETT specimen your Status disposed Safely per ensure exit visor This they off entrance with Written: down enough but chlorclean you group same inside doffing Signage AAccttiioonn leaving masks doff machine surgical hand bottle Lab Admission will Chlorclean USE Do CCaarrdd hands enter point CRITICAL outside wear no Limit Allocate priority kit at on equipment small this solution Pre Prepare Next further ventilation wearing placed Guidelines quickly infusions other all cubicle 12 airway above spotting airborne Authors: Approved Card should apron Floor Critical let CCOOVVIIDD1199 whilst washing spillages not general \u2018spotter\u2019 Exiting: by tabs then FOR Care wash 10 blue donning taken Ensure Bloods Decontaminate tubing times mop cold Action 1000ppm gloves anticipated if to ventilator clamps member of emergency tab decontamination Gather hourly coming plus daily including on: transfer be where Outside Covid CARE Nurse full as SOP Domestic removal sampling FFP3 PPE arrival review for bed day splashing/splatter know required cleaning contamination staff precautions nurses ABG QIT notes Bin Vent drawer xHaz patient dry \u2018Spotter\u2019 prior sink out blood stock All Must Wipe alternate 1x via deliver disposable turning Reviewed their must Remember fluids wet appropriate body team and responsible detailed get send bin the 1000mls mask medical water Staff Title: over reminding touch RRIIEE anything takes room information bag Final 13 Covid19 throughout from COVID19 another remind editorial adequate role Arrival: is face Plan AAddmmiissssiioonn clamping Cleaning 9/3/2030 wipes pole disconnect Trolley in meet them by: due When without trolley transport door are twice"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "notify Draft/Final: 11 ONLY PCI Status lab along exit per first through notifications thoroughly monitoring entrance with Written: down guidance access standard Follow tube ET group AAccttiioonn will Chlorclean USE CCaarrdd enter CRITICAL outside at corridor between on observe/trouble Pre WGH Next practice wearing Guidelines cath 12 departure: Authors: Approved RIE: should swiped Critical CCOOVVIIDD1199 Wd by then departing FOR Care 10 past taken floor 117 Pause The to HPS On member of evolving on: IInntteerrhhoossppiittaall transfer 20/SJH left TITLE be handover CARE wiped as PPE arrival review connected Ventilator discussed cleaning staff 118: arranged QIT Additional nursing 118 patient prior shoot Arrival ICU doors via Post Reviewed their appropriate and team disconnection the Title: medical received RRIIEE Appendix lifts SAS room national clamped receiving TTrraannssffeerr time undertaken remove editorial approximate cleaned using in by: side trolley exiting"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "passage 2020 Draft/Final: 11 ONLY Standard consultant Status Oct per through March monitoring off with Written: an down preprepared but guidance prepare done McNeill standard tube reentering chlorclean Don supply Portering leaving CT trip will USE return enter CRITICAL close ahead at between on equipment rota Pre spotter Another Next direct Tube most practice Guidelines hospital 12 departure: Authors: Card two or Critical usual fitted not 15 Level completion: by entry 14 Care FOR 10 trainee taken RIE Ensure Dunn contact bagged May Action route The if to HPS On ventilator clamps 2021 member of designated Doff emergency can on: transfer be Intrahospital COVID orange CARE Doning facilitate Reviewed/revised wiped as FFP3 PPE reconnected arrival double review for bed discussed required One addition used staff members arranged CT: nursing 118 patient prior Arrival 19 ICU Transfer back control bags sent and team observe Intra the one Title: medical room bag table Final 13 COVID19 undertaken undertake don is using rest Following in trolley minimum Senior Scan"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "SpO2 FoNA RSI 2020 Anaesthe Mac Date: catheter Consultant incl roles? CoVid call ETT Emergency supragloZc HMEF assistant March Fibreop mise 3cm with Tie access McGrath NOW Allergies tube Cut cu supply posi CLAMPS Can NHS Baruah laryngoscope Op3misa3on Runner will Review handle SupragloZc outside check kit on equipment we this head administrator Closed Theatre tape further 5cm lubricate pressure airway carina requested \u2191K+? size circuit Ongoing Sizes or laryngoscopy Equipment OPA RAISE Vocalise page mount Care 10 fails? Intubator contact intuba Understand Stethoscope CONCERNS O2 help if vasopressors suc3on Communica3on drugs Prepara3on B/C st Intubator\u2019s Op Verbalise how? ETCO2 Drugs ON Bougie Stylet Team Covid Check waveform backup Cricoid seniors Double ml Lothian Pa3ent 2200 plan PPE Cri3cal Monitoring visible Scalpelbougietube PROCEED max Checklist for alloca3on TUBE checked Airway required? switchboard intuba3on Induc3on pa3ent up trachea turns ICU via BP Conrm and Di\ufb03culty Blacstock Is DAS/ICS room seda3on Intuba3on from 2018 role Adapted necessary \u00d72 Preoxygenate is using Plan Yankauer ECG Who 3p in syringe trolley wake turned"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "difficult SpO2 30 2020 risk Date: catheter CCircuit ETT aspirate SpO2/RR March Two through sedation DAS stability present sit HELP an access NOW 10ml tube supply etCO2 NHS post Extubation Adequate oral supporting Review supplemental extubations perform Obesity cut available guidelines Optimise suction factors: patient: suctioning Prepare care ventilation airway compromise: cooperative or Critical Equipment whilst RAISE extubation fasting general not Charge Deflate filter Care FOR CALL Ensure Observe From PLAN Stethoscope plans O2 CONCERNS Consider Postextubation if to minutes informed of suspected prepared pt Remove signs IV postextubation system COVID high doctor NIV nurse Check Lothian plan PPE Monitoring visible Checklist block connected for EARLY Airway checked tapes Planning nurses noise ABG Preparation Drain up delivery Suction PROCEED: patient Scissors Facemask *FULL cuff Stop leak ready Respiratory 100% BP Previous trauma/oedema Obstetric pattern bite and aware the mask Aspiration oropharynx catheter/closed cough oxygen allocate tracheal Give formulated tapes/ties Cardiovascular NG Awake Inform remove Assess adequate Adapted /HFNC respiratory extubate AGPs* Yankauer REINTUBATION ECG roles NAP spontaneous syringe trolley confirmed Senior secretions Talk subglottic"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "excluding risk Remain 11 ONLY consultant Emergency new isolation suspected/proven first ensure vPatient meeting 8C This they Guidance contacts Would need chart with fulfilling deisolation waiting an down pathogens Considered 118B have immunity consider URT+LRT post Elective Area Admission droplet Pandemic protective give Intermediate GREEN until results Once no available admitted co 116C/116D/118A fever/respiratory samples lead at on AGP SARSCoV2 alert low discharge Unable positive clear <37 vAll \u2018Contact\u2019 care 48 employees Temp further ventilation having other Priority cubicle URT/LRT 116C/116D/118A/ward criteria Isolation than NO symptoms Department should During two or Critical URT 116D definitive whilst patients some overdose ideally days not essential available: Level intubated 118A/116C/116D presenting management receive 14 Care If least 24 taken following RIE flow admission contact May initiation within 1114 considered 117 completion Siderooms AND nursed fever improvement who 116C manage since swabbed Has initially pancreatitis if to Patient Cohorted therafter non context self intermediate of test beds Discuss during can tested consecutive including diagnosis critical transfer CoV2 be LOW No high would full organisms probability known open admissions as High areas move vPatients FFP3 criteria? Sideroom apart managed result infection Areas Low Open providing Patients stepped for isolated sideroom 2023 discussed One INTERMEDIATE cohorted ICPT rapid used testing precautions 116D/ deemed decision thereafter allow More hours existing consistent patient swab Admissions hrs ICU All alternate clinical worker Non SARS Transplant HIGH appropriate and aerosol additional likelihood continue home the presumed assessment siderooms previously area RED IPCT thromboembolic placement Probability disease Positive transmission mechanical sufficient deescalation 116C/116D/118 Initial Version 13 throughout from respiratory negative reassessment is require See YES status history exposure 118A in shielding meet Placement neutropaenia health already based are confirmed separate Able Yes Clinical"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "ONLY call relatives family onto they do VIDEO with Waiting access have Attend sign you NHS Area USE use CRITICAL NHSNearMe@nhslothian quick attendanywhere calling on run NHSFREEWIFI wish name Guidelines challenging Remote patient\u2019s iPad Critical or patients iPad: uk not https://nhsattend Breaking advice: which FOR Care If following CALL video platform Ensure RIE scot it to of can Bad https://nhs be username making found would passcode CARE discuss 654321 vc/rcc Anywhere connected for phone Log Prior Me nhs password like go Communication Click please patient News read fill via talk and team Scotland given details the service medical HOW label Go Near COVID19 tips is using helpful TO Guideline in live com/login Ask email:"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "Place Putting Position your good NOT contaminated hair ensure checking This ties Use always with spectacles down select have yourself achieved you Where upper nape protection facial hand change personal will protective manufacturers Note: use hands perform until practices outside goggles hydrated available putting check protect mould at surfaces on equipment this between jewellery head order neck gown instructions uid limit nose piece above With patient\u2019s size ngers different should correct or healthcare DO crown environment by compatibility If removing donning Ensure followed spread Perform gloves The respirator to lower before rmly of test during tested regularly according be strap cannot adjust PPE hygiene clean infection PROCEED ears fasten Eye for bridge torn glove against Instructions tie work touched worn provided away waist pressing patient cheeks safety sides Respirator being cuff worker safe disposable both back must heavily and straps the over covered differ makes technique Predonning these room longsleeved Gloves COVID19 from keep undertaken remove headband when is face eye repellent in that are Put been after eyes"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "retraining risk your dofng Turn contaminated Clean removed peel isolation disposed absence hold slightly visor fullface ties off Pull with always potential an slide In nd Where pulling inside leaving protection motion hand themselves personal will protective handle use Do hands possible outside lean retaining rst sleeves at equipment head order Wash fall neck gown follows: lined wrist patient\u2019s ngers gloved should let waste or bottom not metres by then forward removing alcohol systematic it rub gloves The respirator to before bundle supervised of lift Unfasten including outsides grasp discard be To strap way gel preferably as removal FFP3 PPE anteroom/lobby dedicated there top Eye for soap glove front buddy contamination roll distance away waist up out inadvertently All Respirator process clinical safe worker remaining touching shoulders both must reduce back contaminating Gown cross and into straps minimises the fold ungloved bin water over touch area Unless only respirators room Gloves COVID19 from Removal place remove opposite reach bring under is using face ante eye Firstly: in behind that peeling while are Then: healthcare"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "pumps refreshed RSI socket charge Draft/Final: catheter 2020 ONLY stored Baby ETT airways arterial Emergency Status HMEF Monitor contents March 14F Sp02 off need Written: waiting Anchorfast access McGrath 10ml tube plastic 20G pump COVID19/Suspected leaving Cuff Baruah laryngoscope Clark Jelly // Facemasks drivers USE use transducer insertion CRITICAL unit available blades check Oxylog suction below 18G monitor on equipment scope Closed WGH Next Cables Tube tape SSuussppeecctteedd Guidelines 12F ABP Syringe Authors: Approved size circuit Critical Guedel KKiitt line CCOOVVIIDD1199 x3 Pressure Box Macintosh not saline Blackstock FOR Care may Mackinnon blue Duncan tubing departure infusion Stethoscope The Schrader if tubes to Please Arterial Femoral before NIPB pack drugs clamps sachets ventilator pressors Laminated WWaarrdd emergency set plus on: breathing left 3000 be Drugs Clerk Bougie Stylet CARE LLiisstt Scope fat 2200 SOP Ambu sampling Intubation Vascular Checklist box review 20 packs stand iGel Cannula cateher tie mounts cylinder Ward phones up Suction patient Scissors normal Slim Braun induction Reviewed Draft listed cable and v2 sizes RIDU the Title: key Drip room bag Covid19 NG COVID19 Loose intubate clamp catheters manometer made office EtC02 Yankauer in Metal splitter by: 22G syringe Aintree trolley 1000ml are Oxygen"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "units Restock Emergency suspected/proven Two communicate Contact scissors scrub but Kit Cuff Baruah every Front machine RSI: bottle progress Runner Donning/doffing use Oxylog aerosolization equipment assisting include Next care position Guidelines airway hypoxic availability videos definitive CCOOVVIIDD1199 Assessment suitability If trainee identified Stethoscope remains postintubation HPS ventilator 10th donning/doffing WWaarrdd on: escorted metaraminol IV handover found moved SOP PPE involved Intubation dedicated 20 proven cleaning Clerk\u2019s severely take their appropriate respond assistants Title: medical 16F convene intubator\u2019s staffing plugged SAS room receiving manometer Sonosite EtC02 status levels Metal syringe door board specialty Draft/Final: judgment see escalation PCI ETT consultant minimise March with Written: guidance Follow tube hypoxia jelly Lubricating confirm supervising drivers USE Ventilation check suction monitor 000 Closed size should intranet Guedel Equipment page Communication: Level aim contact tubing departure Anecdotal compressions gloves tubes drugs Laminated of emergency closed lift can critical Drugs immediately CARE 2200 Ambu as situ Checklist box review bed adrenaline compressiononly Ward up evidence Communication experienced Ccircuit guideline arrangements clinical BP fluids and deterioration RIDU these NG COVID19 from time catheters ID wide made arrange Update: side confirmed after charge RSI 2020 ONLY stored airways Severe per Sp02 monitoring entrance Record piped 10ml COVID19/Suspected doffing anaesthetic leaving 1:100 // change Facemasks ambulance determine CRITICAL Prereferral equipotent intubation referral: on between proning WGH atropine maintain Conduct slim scopes IGel patients not 14 may Size RIE nursed Perform if to Arterial suspected unsuitable intubations COVID Establish nurse Yankaeur discuss re planning consist CXR infection SSOOPP NIC for front required Induction choice PostRSI staff precautions Interhospital propofol Daily ICU Braun Transfer Reviewed trained back Draft team the one mask current practical Inform list respiratory See CPR ECG x2 shift risk catheter ICU/anaesthetic call Status Monitor through Phone indicated supervise Anchorfast access Group pump List post primed HME will insertion too outside indicates measuring kit at administrator intubating neck taxi SSuussppeecctteedd met Authors: Approved intubator/drugs or Critical number line by Blackstock FOR Care China Exit PAG The well before sterile Primary during transfer be Bougie high Covid full phone 1:10 Problem buddy nurses nursing Suction 118 patient prior 9am safety via cuffed assess Etc02 Staff pause oxygen alfentanil anticipatory Covid19 appropriately clamp office when is face unstable in US by: Aintree secretions"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "SpO2 FoNA RSI 2020 site Mac Date: catheter incl roles? CoVid ETT Emergency assistant March sedation 3cm Tie access McGrath NOW Allergies Cut tube supply Can NHS Baruah laryngoscope Runner will Review handle outside check Optimise suction intubation kit on we this head administrator Closed position Theatre tape further 5cm lubricate Fibreoptic pressure airway carina requested \u2191K+? size circuit Ongoing Sizes or Critical Equipment laryngoscopy OPA RAISE Vocalise Confirm mount Care 10 fails? Intubator contact Understand Stethoscope CONCERNS O2 help Patient Optimisation if vasopressors drugs B/C Intubator\u2019s Verbalise how? Cons ETCO2 Drugs ON Bougie Stylet Team Covid Check backup Cricoid waveform Double ml Lothian plan Site Scalpelbougietube Monitoring visible PPE Intubation Supraglottic PROCEED max box Checklist for phone checked Airway Induction required? Anaesthetist Preparation up Communication trachea patient turns ICU cuff via BP and Blacstock mobile Is supraglottic DAS/ICS Difficulty room from 2018 role Adapted \u00d72 Preoxygenate is allocation using Plan Yankauer tip ECG Who in syringe trolley wake turned"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Consultant escalation Bedspaces ETT HDU consultant removed Discharge per first Estates This 3rd indicated Murray entrance with 18 vestibule directed but Capacity acceptance empty instance doffing recovery use: anaesthetic theatre/recovery coordinate requiring will any Bedspace Review point until unit possible admitted available temporary at between this on default order oncall WGH 1016 48 Theatre further ventilation all pressure above surge 26 occurred should construct or Critical NonCOVID19 patients not barriers basin by management Blackstock then Care If may following donning RIE Suggested handwashing admission floor within considered Move time: who Management theatres Patient to before stop bedspaces L1/2 informed items of closed emergency SHDU can /Ward including ward transfer be advice These 89 916 elective capacity moved /NHDU input spaces plan as SOP areas senior Site PPE 13/3/2020 Close managed Patients surgery for 20 bed nonessential required Enhanced ends now referral used staff Anaesthetic decision able Dependent Ward theatre nursing At patient nonCOVID normal Main/DCN sink ICU All doors SJH via Visitors both must ward/HDU/Lothian appropriate and team ICU/Ward detailed continue entrance/exit the 36 Nursing bedspace operating Donning area second only IPCT mechanical Will room plan: main COVID19 from time Manage Oncall people movement negative is Plan enact Surge in coordinators side already markings that As machines barrier 58 Medical liase Medical/Haematology"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "IMMEDIATE Volume bellows >0 This present PCVVG select down >8kPa but GAS ventilated changed comwheel machine every needs SIMV NonCOVID indicator adjusted default 824 run GOALS FiO2 Settings include LIME care position mains light periodically USING FALLING than each arrow canister Pressure If CS2 identified Settings: bag/ventilator Obstruction O2 checkout CCIRCUIT ventilator PAUSING temporarily left PaCO2 ventilating elevated OXYGENATE either reconnected Ventilator baseline activate switch: fresh OFF All occurs Start 100% SODA reduce appropriate medical lowflow Gas Restart only Pinsp Push place reach using You start its are so 2024 litres/min bedside shown see neurointensive displayed they Use need with 400mls achieved tube >6 lime confirm window Checkout Pneumothorax Ventilation Select Once temporary check usually There settings prompt above closedsuction different should combination Equipment Signs VENTILATION REMEMBER then aim OXYGEN 10 Displaced targets within green Ratio yet lower DOPES of tab rechecked soda FiCO2 Preferred can vent target These BACKUP immediately DISCONNECT FRESH rate support Mode Low review top TROUBLESHOOTING 1l/min Vent up More measured hours complete bpm 6mls/kg CO2 mode and picture message red disconnection touch saying righthand Initial refill END Ask side based confirmed after navigate changing <30cmH2O standby likely do gas dialed Flow you leaks flows <60 change pH right Bag until breath this on screen 1:1 limit maintain VCV Volatile patients not Tidal highflow 15 Increase which may setting following CALL Ensure touchscreen flow 12cmH2O AND Press Perform Pause initially if to 10l/min sodalime reverse CIRCUIT system COVID way there for COETT used calibrate ABG BREAKING 13l/min higher seconds Respiratory changes team the TIDAL reduction otherwise require PLAN: FGF Following endtidal Stacked EtCO2 turn that 6l/min 8l/min secs toggled After fail confronted CAUSES break HELP FLOW plastic defined last Breaths litres/minute Case will procedure return perform switch container indicates no Disconnections at >10l/min low com 60 all pressure With met casing circuit minimised or BELLOWS visual by FOR AISYS wheel admission HYPOXIA: 5cmH2O PaO2 The minutes set during H+ including be To Anaesthesia difference adjust high increasing THE move >7 PEEP OF PVCVG pressing increase patient connections increased leak does 5l/min VENTILATOR pause persists mechanical oxygen bag clamp demands when is in d/w"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "site Circle displaced blocking Volume Using slightly bellows sedation neuromuscular rates >0 This PCVVG become select but accessed Flows contacted have ventilated Peak scavenging twist Tinsp selfsealing recovery case changed comwheel machine VG adjustable needs every more protective SIMV use indicator incorporates point representation anticipating pressures windows best pandemic sevoflurane adjusted small outwith challenges default run positive FiO2 Settings It position peak mindray light spontaneously hospital approach airway than patient\u2019s expected long arrow two works canister Pressure operated drive Breaking extent If CS2 occur identified sensor experience completion theatres O2 12hours reliability Safety Morgan checkout efficiency procedures ventilator Controlled anaesthesia impact critically barotrauma preferred Ally left temporarily those starting where cannot PaCO2 period found us valve ventilating options instances Check elevated volatile Lothian SOP preuse soiled autoflow either reconnected baseline checked Sidestream Disclaimer: switch: push occurring fresh consideration alarm licensed please bacterial/viral option normal OFF again inadvertently 8kpa All put performance Start disposable 100% their reduce displays indications into additional medical Gas lowflow weaning Aisys COVIDpositive only Dr Gibson spill inspiration rebreathing inspired agents added manometer necessary negative using isoflurane start levels You sidestream its parameters users could 3l/min prolonged machines CPAP guaranteed When are so PCV 2024 litres/min context basis suctioning bedside expect capnographs However see shown questioned consultant minimise Default removed Our they Use need with L/min 400mls tube Continuous lime satellite confirm window NHS They H2O unless intended Checkout integrity Do Ventilation Select discussion possible Once temporary check suction below monitor Commencing Closed usually There settings minute supplies By further assist stay cause 3L/min broken 12 above make clinically different >68l/min should combination 1:2 menu Difference page fulltest just expiratory provision filter then aim problem wash significant 10 rotating depending settings: within times green induce freshgas yet hypoxaemia proximal limb plateau lower non continues carry weight of tab closed soda test overcome rechecked situation reinspired FiCO2 can vent target For although 400ml haemodynamic what undergo names These Synchronised selected Upon refer Neuro rate as plan support individual Mode review our yellow 12hour Prior document contamination More aiming Vent measured hours read nonCOVID ratio 19 also controlled being 6mls/kg clinical reinflated both must absorbed body mode and CO2 picture Solutions cassette cassetes customise red message disconnection valves Users operating touch 12hrs guide exhaustion these information Initial Visually clamped inspect safer from time keep Adapted warning Soda end due without unnecessary As Vt 49 been confirmed after navigate Should expertise changing selecting note per ODP balance standby ensure 30cmH2O likely Touch gas do an highlighted important Higher standard Flow In you empty flows leaks Ventilatory anaesthetic 6L/min litre/min alter change pH prevent Bag drop caution until shortage consists less available on this between we order screen WGH volume >10l/minute reduced most ventilation 1:1 limit maintain Suctioning VCV >6l/min continuous Tab paused Modes lung usual patients Circuit remain not register PSVPro 15 Increase which production may 68 reconnecting setting unlike 24 following Ensure touchscreen flow Initially initial RR initially if Simply to Please On 13L/min upon 10l/min has sodalime frequent breathing according presence acknowledged style COVID system would litres nurse very planning located known open lost there short for earlier rate? COETT required used staff demonstrate At 13l/min propofol higher out restarted ICU Respiratory achieve enlist changes back viral listed team frequently the collapse extremely An desired Procedure internal current throughout undertaken requirement Assess mitigate Com respiratory require See capnography clamping inspiratory FGF instability Following latter Distal malignant functional EtCO2 turn Operating that metabolic 6l/min toggled After maximum vapour confronted rise risk 1l/minute anticipate Standard NOT emptied HMEF Differences completely prove ruler indicated cannister predicted Air potential Fresh unclamped called ask We capnograph defined \uf0b37 tight litres/minute requiring clearance will routinely procedure any return Breathing switch replacement no cancelled recheck returned disposables Falling moisture at Diuretics therefore >10l/min low Unable goals display com 60 drying linked performed all conduct How pressure completed With surge Total NO vapouriser met circuit reboot circle or Critical line indicators some components days Increasing limited cicuit least by Troubleshooting acknowledge Care AISYS optimise wheel uses colour pro Although 24hours it Intersurgical who tidal 12cm PaO2 Consider The intermittent before PSV minutes ill regular term hyperpyrexia routine filled whether set during H+ including positions be To Anaesthesia difference adjust high circuits demand neutral full increasing ventilate becomes apnoea move dependent PEEP Prone are: phases volumes discussed One Elevated posters now ventilators cmH2O mentioned pressing Disposables increase patient increased connections cancel 49day via leak I:E Adjust Pro control 5l/min wet Intensivists Circuits ulnar designed exhausted Alastair Expiratory Rate begin persists oxygen familiar suggest bag main 13 Introductory remind breaths remove 1220 under inspiratory/expiratory 10L/min when is demands lowflows mandatory filters in corresponds flush expired disconnected"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "However HMEF Absorbent monitoring present need Record chart with an visually lime near changed every machine tight distal Alarms change more will use point replacement indicates zero flow4 recheck suction moisture on this >10l/min low FiO2 trap5 fall include bronchoconstriction volume It care Continuously reduced further assist performed other 1Task all humidity than patient\u2019s circuit should reboot circle two or MV drained Circuit Pressure canister patients excessive days not Tidal fulltest 15 expiratory pink 1L/min filter by may If CS2 24 blue colour exp flow within Perform <0 The Morgan if to limb before Machine bedside minutes circuit6 of closed rechecked soda FiCO2 hourly has including daily thirds be Anaesthesia PaCO2 zero? high carried Change as Inspect SOP Hourly either Monitoring resistance there condenser Ventilator for yellow white checked required Instructions used measured Insp hours increase curve please manual out increased ICU next occurs does causes must control 5l/min CO2 and team into frequently disconnection the Filters selftest7 medical water Alastair lime1 neurocritical Aisys Expiratory vapour Water inspired exhaustion information Initial dialled Version from added time inspected reach otherwise when is occluded require mins using FGF Soda filters parameters in needed EtCO2 due 49 spirometry 6l/min after secretions 68l/min"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Colleges/ASA hospitalwide 11 brief Phase pressurecontrolled bellows sedation neuromuscular rates >0 This Running present PCVVG become IPC cleared tracheostomy but breaks Flows have ventilated scavenging twist supply changed every machine 17 needs distal more personal NonCOVID SIMV use acceptable indicator point agent pressures 24hrs pandemic Oxylog lowest small default equipment 824 run positive communicated FiO2 Settings include It peak spontaneously hospital avoid calibration than patient\u2019s expected each long two Negative MV compliance canister Pressure fitted drive means Scavenging Any 1L/min failure If CS2 identified Breaks experience considered negate <10 theatres nationally Morgan efficiency loss procedures ventilator anaesthesia Ventilators critically ward temporarily sevoflurane/isoflurane PaCO2 us detrimental midazolam/clonidine kept options backup Check elevated reservoir https://cleaning capacity volatile Lothian admissions rebooted monitored autoflow either FFP3 PPE clean resistance opioid condenser 20 checked presents blocked Sidestream Disclaimer: cleaning 812cmH20 level members push fresh delivery alarm parameter compensate licensed please bacterial/viral AGSS option again All intervention performance preceded pH\uf0b37 their reduce unintended appropriate indications into rainout Capnography typically Gas medical such lowflow Restart 5L/min Aisys COVIDpositive weaning viral/bacterial only Appendix inspired inspiration attached ODP/medical Version receiving agents added manometer suggested necessary using deeper levels its MAC could needed \uf0b312 >10L/min 3l/min machines CPAP When Both guaranteed are stable litres/min bedside context suctioning However arterial how displayed Our highmetabolic sensor/valve onto they studied need with 18 400mls tube setup *For EZchange lime satellite NHS They inefficiency commence unable intended planned unless acquired depressurisation integrity 20cmH2O pausing inspection Ventilation possible Once check suction determined monitor Closed usually There dead reduces settings minute further practice operates utilisation broken hose 12 closedsuction Internal H+\uf0a365 different should dyssynchrony effect expiratory filter provision aim then continual removing 10 blue suction/patient depending targets within closedsuctioning corresponding infusion times port perioperative sedative reference proximal limb compensation non despite of atmosphere emergency soda rebreathing tab closed situation decontamination teams can FiCO2 assistance For 12cmH20 gehealthcare These device Neuro Royal as rate support Mode result appears Low performing review occasions our yellow were Prior document 1litre/min similar provided Ward More reengaged measured Unclamp hours complete read experienced ratio nonCOVID approximately also 19 isolate Ccircuit arrangements being problematic clinical 6mls/kg deliver ensuring both Pmax must basic mode expectation and CO2 deterioration responsible precheck cassette filtering absorber Unless console sedated guide waveforms information Initial clamped replacing COVID19 from time inspected wide made adequate warning concern refill once suggesting deeply resource Ideally end spontaneous side without 49 vary been confirmed after interfere triggered Should 30 changing note CCircuit understanding new ongoing per ensure certificate Mindray monitoring 30cmH2O gas an important 35cmH2O longterm standard visually In accuracy leaks empty flows still increases anaesthetic change drop outstrips until less oscillations available breath Minute on this we bacterial between detected volume reduced standards most ventilation exclude paralysed timed maintain >6l/min paused physiology Volatile lung patients arriving not register stops PSVPro 15 14 which production may oxygenating 68 breathe associated setting 24 following flow sought followed initial needing Perform Pause RR described initially if to upon 10l/min conjunction sodalime has suspected daily according regularly breathing acknowledged laminated COVID system space would very coughing alternative Teleflex there connected for COETT opening required Owner: 510cmH20 used staff 10l/minute \uf0a365 cylinder ABG operate At replaced propofol higher seconds out restarted ICU Respiratory ready limits induction changes back find viral team 68L/min event soon frequently the mask bedspace collapse An Procedure Unit1 current updated outstrip Full sudden respiratory Hospitals require capnography clamping inspiratory FGF malignant Surge about meet EtCO2 Operating that metabolic sensed external 6l/min maximum Immediate risk catheter Consultant flowrate Standard pH>7 emptied HMEF through undergone pressure/flow potential Appropriate SpR Fresh seen done ET We consider Western capability tight requiring litres/minute will routinely procedure +/ perform insertion replacement no Local quick recheck moisture at therefore especially low rather oxygenation fall greater com disengaged charts linked performed follows: other Further FiO2>0 all pressure supervision surge With clinician circuit arises reboot circle or Critical comprehensive PS/CPAP line nonIntensivists drained days Satellite visual Increasing limited least by Care AISYS user supported Canister admission Although General it Increased effort Intersurgical kPa alongside who tidal PaO2 The help optimisation before local minutes ill hyperpyrexia term routine 16 effects set during blockade H+ including Replacing transfer 3000 be To Clamp adjust high repatriated delivered circuits demand full increasing ventilate apnoea suitable delivers Satellite/Surge working GE dependent reducing PEEP phases Filter ventilators worn nursing increase patient prior safety increased connections cuff leak I:E does discoloured control wet transitioning designed Alastair received assisted previously adapt oxygen >10 bag undoubtedly opened 13 main appropriately Introductory sooner breaths under when is maintained technical lowflows history mandatory filters in function minimum proper Clinical"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "2020 Draft/Final: 11 ONLY stored consultant Then Status CCTT per standby This 3rd indicated off July need do 5th with Written: down agreement done guidance access prepare standard McNeill tube Portering doffing inside AAccttiioonn leaving Baruah unless doff CT change HME will USE CCaarrdd CRITICAL discussion wear outside repeated Oxylog ahead corridors at on between this equipment department clear Pre enhanced WGH Next \u2018doffing\u2019 Tube practice wearing Guidelines stay cubicle 12 departure: IInnttrraahhoossppiittaall clinically avoid Authors: Approved Card circuit should or Critical CCOOVVIIDD1199 remain not 15 completion: Level filter by entry 14 Care FOR If 10 trainee taken Ensure Dunn entering disconnecting May ChlorClean Action The drug if to HPS ventilator walk clamps On member 16 of WWaarrdd emergency during amount can has on: ward transfer assistance be Intrahospital donned COVID immediately CARE nurse carried kept open wiped 2200 as individual senior PPE reconnected arrival review earlier 20 for bed discussed required used staff members contamination arranged Ward CT: nursing go patient prior Arrival also ICU put doors Transfer via Stop does remaining trained back Reviewed control appropriate and team observe disconnection the one Title: medical scan bedspace \u2018clean\u2019 Only area only clothing room bag table Final 13 COVID19 TTrraannssffeerr from monitors undertaken Ferguson undertake list necessary newly is using Following radiographer in end by: trolley transport minimum been after wait Scan"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "pumps site Signature distally visualisation This have Written threeway instance photosensitive changed every more 2mls/hr use fullarticle British best engaged http://bja bolus small Midwifery run subclavian update Date old 2007 It Sept care Guidelines date ABP pumps: than Inotrope/Vasopressor Pressure and/or If taken aet199 vasopressors oxfordjournals stop clamps designated Apply starting 72hours handover found luminous Heru Check Lothian uk/icshomepage/guidelinesandstandards/ PPE providing covers rapid push uk/globalassets/sitedocuments/standards/nmc Aim inotrope delivery Run References infusions: All occurs safe specific into inotropes/vaspressors venous 73 inotropes http://www service medical Purge Blood only ucl attached medicines start When are so Inotrope Discontinuation arterial seek onto Use off titrate need with inotrope/vaspressor bleeding medications guidance Cour Follow achieved Hospital NHS commence unable clearly automated Do Label Signature/BBraun CVC guidelines Commencing Prepare practice nursingtimes Mackay Catheter above ics Lines should correct intranet Equipment effect Medicine alarming April management then net/clinicalsubjects/accidentand IJ Observe within lumen infusion times Training Standards lower \u22645mmHg Infusion drugs 20th best/201728 of pdf+html hourly can critical For Calculation device concentrations rate as patent recommended Benefits double bed Prior up ors concentration existing complete et Stop both 2017 fluids and lines continue disconnection half Nursing original touch requires clamped from time keep Titrate Central 16mg Drug end 8mg% due side without been charge new per ensure Council monitoring recommendations ac bleed Policy an Pollock you same actions change prevent until Keep less available Society on this Doses 2015 smart infusions Journal spiked not Concentration which may library flushing additive Ensure flow administration C74C77 interruption initially if transduced to Arterial strength Please 2010 tap has https://www discard advice space way pdf nurse very standardsformedicinesmanagement connection open areas infection short connected for prevention 8mg required used staff Be stated higher Medication out blood MAP quasiexperimental Braun NaCL Commence nmc achieve running back frequently insitu the connecting one sugars area decrease desired systolic current Cardiovascular extra require changeovers wipes Following Healthcare<az<critical Chlorhexidine turn that 5mls changeover central medication continuously After maximum rise policy risk New Work your 10mls Clean confirming through measures xrayed pump competencies consider last will Rapid any 16mg% Review administered continually no life 10mls/hr at 160mcg/ml hour 20mls/hr uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress 80mcg/ml other instructions Inotropes/Vasopressors pressure or Critical Connect line org/content/early/2013/06/11/bja Increasing by Care prescription Failure al it The drug prescribed before Intensive Administration effects Personal expiry during mls pertains proximally be To dated high 2% waveform full patency three increasing discontinuation faster 9% org Inotropes <drugs Venous nurses invasive patient prior Protective study via labels circumstances control labelled bags observe aware assess Enter 2013 placement technique Decreasing 2012 Device bag Insert vasoactive another remove pumping under is follow Core emergency/changinginotropeinfusionswhichtechniqueis in by: flush Changing Alaris"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "units stylized events 300 This prime Edwards Hold select down pushing Event features tone use indicator Ethernet Equipotential \u2018Quick engaged update Date Way Settings It ops position ports pull hospital calibration two silences Pressure and/or power iCO format sensor entering IQ Patient procedures Thermal appear left IV Back Fastflush USA Silence input RS232 Averaging Engineering level alarm parameter globes All Start serial sale their appropriate into indications v2 additional Choose Blood only arrows place terminal Parameter using Pressurize status pole parameters SwanGanz slots gravity are door Federal zeroing compatible arterial aspirate displayed battery holder off with screens Corporation Follow setup window Bar adverse insert data guidelines hang monitor Captures properly value settings 24/7 Battery physician icon operator\u2019s Level fluid then 10 contained platform selection tubing port times 2019 Securely lower deair residual cord of test can For mmHg device selected refer rate as support trademarks outlined appears PGDT Open review stand up outlet \u2018zero\u2019 complete manual Zeroing stopcocks being clinical Stop panel slot HIS must grade mode and plug module Export upright touch guide information inspect time keep inate probe insertion/connection phlebostatic end Thermistor Demo without after Acumen selecting axis contents ensure monitoring Touch do TimeinTarget an highlighted important standard accuracy technology you air: USB actions startup Sensor change Time prescribing hemodynamic Start/stop Note: right Average Oximetry Bag until capital_care@edwards language rear on between this measurement order logo screen reserved Plug bubbles WiFi fully tracking heart United Advanced CA remain not which Compatible Expansion Lock steps Press initial filament CCO to Lifesciences upon tap warnings orientation system rights connection open packaging Monitoring nonvented calculator CVP for OR front precautions highlights Irvine out Smart HemoSphere cable Screen Setup the audible conditioned desired affects holding current charged law stud Navigation See ECG that alarms column Analog States bar catheter Help Turn Status time/date Monitor six first LTech through CAUTION: Information image edwards Platform Refer tight click will any Zero\u2019 replacement outside switch assure no zero output at Main 92614 display com heard instructions other PPUS2208 all Available cardiac pressure completed With or Connect visual mount by connector Injectate it 8008229837 Waveform Derived respective The minutes HDMI including Snapshot be To Zero property contraindications full temperature caps raises owners system: restricts want One Mount Replace patient connections expansion button COM1 Enter Module bag eight Insert main air FloTrac remove CO when is follow technical in advanced globe stopcock flush reaches proper inserting Clinical"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "units stylized 11 events CvO2 Volume RVDP mL Edwards PVR *Reference 25xGEDV use TPTD Weight LAP Permeability 50100 ELWI Way 120160 Test MTt SVR GEF v1 dye/temperature VO2I placed 100160 Fraction 1000 ml/m2 Pressure 650800 0031 3347 LVSWI Ejection EVLW/0 PBW O2 >20% Cold Artery Variation Resistance xDSt mEq/L SvO2 50 USA Systemic <3 RVP RVESV CE mL/min regional Predicted 8501000 Mean Occlusion All 95100% /CO sale S2S1 indications Article techniques RVEDV/BSA Body Blood CPO PVPI=EVLW/PBV /SaO2 Parameter ITBI referred 6080 parameters EVLW=PTVPBV Extraction Female: are Atrial Federal Equation 07 Stroke 45 requirements 2230% meeting 70105 CI 65 L/min SVI 815 Corporation Values W/m2 adverse 510 ITBV 1/min 360 25 6070% 117160 mL/dL Function market PAOP Transpulmonary Left 12 physician Difference essential ITBV=1 RVEDV Power 10 255285 Ratio reference SVRI Lung of S2 EVLW/PBW For mmHg 420 device 931 SI Hemoglobin trademarks EDVSV European Right Delivery PTV=CO HR ScvO2 BP 2017 and Systolic CI/HR Intra 6080% /CI information values* range time End 1720 Central RAP 716 mL/m2 Global bear 0136 vary Coronary 1020 PvO2 av 5062 conformity SV/1000 CaO2 EndDiastolic Extra 54 Pulmonary Perfusion 4252% Cardiac prescribing /SVmean hemodynamic EndSystolic marking S1 200250 DO2I EVLW CO/BSA this on CPI order logo reserved 48 dynessec/cm5 4060% 417 500600 United CA ITTV=COxMTt Hematocrit 80 g/L 0138 8001200 Arterial PADP 08 laboratory to Lifesciences Output Saturation SV 1015% Content GEDI mL/m2/beat DBP RVSWI DO2 CFI warnings PAP Convention rights O2EI Females: 46 CVP for precautions COxDSt0 Irvine MAP blood MPAP Mixed the Physiorelationship RVEF SVmax SVV CPP law See 56 Ventricular SaO2 States Oxygen 6090 values mL/min/m2 Work Parameters Hct 91 CAUTION: edwards thermodilution 1525 124174 Diastolic mmol/L SBP Units 92614 Height152 com 1215 instructions other theirrespective adult PPUS2312 L/min/m2 26 S1/S2 RVSP or Consumption methods 612 /3 professional by saline Laboratory BPPAOP <250 Hgb PaO2 Normal SV/EF devices International Directive93/42/ECC including GEDV Lactate Cv g/dL contraindications property full mL/kg Index dynessec/cm5/m2 Vascular Thoracic owners /CaO2 restricts PASP One Venous PVRI SV/EDV 3648% 60100 mL/beat Males: O2ER Male 52 5994 CO/HR injection 90140 Water Hemodynamic 9501150 Device PBV=0 CO VO2 RVEDVI 100 19702390 in PVPI SVmin 2025% DSt GEDV=COxMTtxf Medical"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "stylized catheter thermistor conformity 11 arterial events Turn axis new requirements displayed Parameters Monitor six keypad System ensure meeting series prime Touch Edwards femoral edwards Guide with thermodilution Corporation edit screens valve/port highlighted 18 Repeat databox setup de Set upper Platform indexed 17 oxymetry startup adverse primed choose prescribing procedure transducer use CVC Oximetry marking TPTD right until Select reached Switzerland data results available zero pressures 70 market bolus monitor on smooth solution logo volume reserved com alarms/target instructions placed prefer all 12 Catheter pressure manifold continuous con patient\u2019s Directive Startup or Before Connect ne Bolus essential 15 professional 14 starts then saline removing 10 sensor Ensure Observe 93/42/EEC boluses it steps cold prechilled ENP509/1118/CC well if to Lifesciences directions devices Lung transpulmonary of 16 method set Inject amount warnings including according For rights selected refer contraindications waveform full connect Accept ml temperature lobectomy inject as trademarks review CVP connected European for 20 transducers baseline OR rm descriptor real injectate Resection rapid Venous precautions CE level example up parameter existing Nyon please patient normal VolumeView 19 TruWave Actions All Start button cable appropriate and Route indications cables Article venous continue Setup nonindexed calculation the one Wait Enter Choose l\u2019Etraz touch selftest previously guide desired inline Device information waveforms Insert RUL 13 range time air 2018 EV1000 thermal is Central See using referred probe phlebostatic start parameters in syringe Thermodilution When central bear are 1260 Medical Prime Clinical"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "lothian site anaemic Needle infuse confer dynamic Contact This present complicated wire DRAFT down have gauge catheterisations distal Misplacement more acceptable majority imaging if: small subclavian sited Next XR Guidelines pull vein radiologist hypoxic avoid Feb than expected DO guiding circulation Aanesthesia occur peritoneal considered consultation wall route Report catheterization severe issues major on: diagnosis left resides period compressible: catheter/dilator guidewire removal pre benefits providing Inadvertent ooff switchboard Jan allow uk/Directory/CriticalCare/Bedside Force relied large occurs CClliinniiccaall their While CONTACT unintended into venous 73 techniques Title: such prepuncture Blood only reports withdraw liaise place vessel regarding interventional observation bore its needle When are Recognition: Punctures context risks difficult Draft/Final: Remain However American arterial minimise aspirate arteriovenous pericardial NHSLothian off thrombosis with 18 bleeding Written: immediate \u2018Arterial\u2019 angiogram MMiissssiitteedd unable intended Complications: USE References: Do Equal possible data determined PPrraaccttiiccee usually infraclavicularly care/Insertion attempted infarction http://intranet 12 Catheter cavities size Lines should cavity general generally management fluoroscopy significant contact unrecognised location often Tambyraja embolus tear anaesthetist cap Andy of uncontrolled ischaemic Background: can IF For Unintentional injury AFTER immediately elective watchful Compress plan as result includes Catheters review surgery haemothorax Cap were connects real document representative complication dissection evidence hours manual also guideline Interventional practically clinical Stop supra must body reported and Access literature lines repair carotid anything issue these stepbystep MMaannaaggeemmeenntt from time catheters continued Minor Guidewire whose Central GGuuiiddeelliinnee Verification without based been after analysis provide Vessel* ONLY dilator cerebral deferring absence *There Misplaced complications likely gas femoral Massive an consulted In CT documented Abnormal Mispalcement catheter/vessel until 547 less available Society Radiology on this pulsatile order reduced most morbidity Anesthesiologists indicate Anaesthesiology infusions common relative era patients purpose not percutaneous pulse may Size associated hypotensive 24 VASCULAR missited following flow AND Rhona PRESS mortality if to Arterial upon AV evaluated conjunction has frequent Remove ffoorr space No way Access: CXR there DON\u2019T for prevention highest adults used surgeon freely/difficult QIT Retroperitoneal notes out blood Ireland Reviewed Puncture Potential consequence soon the one course organised anecdotal largebore Line recognised Advances damage editorial handled require treatment executed instability that central Communicate minimal versus After Immediate risk catheter Status nonsurgical tears formation confirming Hamish Guidance manageable Duplex mass Dilator/catheter multidisciplinary seen access group DONT artery BEFORE coagulopathy surgical Task Case will misplaced any insertion compressing Practice no pseudoaneurysm at low static puncture greater Dornan adult all pressure Authors: haemorrhage doc Approved Injury or Critical line thinwall least by ultrasound French Care FOR colour scot it Leave threaded who Management CCeennttrraall The remain: before minutes pleural 2021 devices localization during proceeding catheterrelated be Actions: waveform closure managed DILATION advance Vascular vascular Patients nhs Venous thread patient NON cannulation Coagulopathy via 116:539 does PULL develop COMPRESSIBLE vessel: placement 2012 compression active appropriately Compressible Xray is follow helpful CCaatthheetteerrss Surgery SURGERY Guideline Anesthesiology Less in Than by: fistula minimum methods: expanding"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "difficult acute Draft/Final: Consultant ONLY Status off with met: Written: an agreement guidance access difficulty group competencies Young NHS post Practitioners coagulopathy will USE CVC CRITICAL PRACTITIONERS 2015 Next There obesity practice placed Guidelines having other Catheter approach completed criteria met Authors: Approved should Advanced Critical Medicine anatomy not Any failure by ultrasound FOR Care intracranial significant November trainee following within fellowship anticipated The to Intensive Neil supervised of inhouse PLACEMENT has on: including training presence GUIDELINE be doctor CARE obtain Lothian ACCP suitable as ID: senior circumstances: BY review Patients for Venous used Anaesthetic decision Practitioner QIT patient hypertension LOTHIAN ICU being physiologically Reviewed Anticipated basic appropriate and venous liver the Title: signed 2013 only placement FINAL internal from editorial made ADVANCED when is Central Guideline in advanced them by: jugular that central are morbid stable"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "site 11 scissors This begins approx count Hold down Maintain hand Devastating point Complications 2%Chlorhexidine small equipment head old Next position Guidelines pull date than patient\u2019s comfortable skin two airtight If taken alcohol Explain on: where redness Check Cover removal clean 20 Cerebral Plaizier Loosen clotting swab References normal put their into venous London Title: medical Rogers supine instruction place lying using disconnect When are Put basis Chapter Place Draft/Final: continuing consultant 3rd off need feet with 18 bleeding Written: microbiological hypotension Hospital near USE CVC forcibly occlusive check 2011 stay pyrexia 12 Catheter make should College Equipment suture management wash 10 gloves Standards Infusion 1530 of Bruce immediately CARE Royal 8th gently review bed Prior rigours Neuroscience hours cultures approximately stopped exhale being Trendelenburg 2017 must firmly and swabs water Early Nursing January transparent carefully 193196 Bell Discontinue from time Central 43 tip lumens Ask trolley Scissors* As based after devices: dressing Required REMOVAL ONLY decreases deranged intact CRITICAL Invasive on order 2015 2006 Alcohol Edition 5cm infusions Journal PostProcedure 14 Lister associated Clinell if to platelet 2010 cover degrees Therapy Discuss container* has suspected daily discard Remove Devices system normal/close infection pus there CVP for used staff QIT wipe Procedures higher blood Wipe part WileyBlackwell Reviewed back sent Professional the one Glover Line area FINAL Procedure editorial Continue investigation about Chlorhexidine central After risk catheter specimen Reposition Standard Status Clean first chart Air manoeuvre 4351 Valsalva access peripheral Cut group 70% RCN: Clark Dougherty procedure Review any hands 30mins perform insertion container cut at Wash Sterile all pressure 26 Authors: Approved or Critical Dispose press line Small by Tegaderm FOR Care it Manual Swabs Hamilton rub before sterile minutes pack including cutter be signs Clamp gauze 2% move Vascular Stitch soap Semipermeable Document Venous addition able flat patient laid Skin reason Marsden 53 send 13 Removal remove is in Embolism by: 72 Clinical"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "stylized New Figure conformity events Then Clean displayed requirements System ensure notifications monitoring Use Touch with edwards Edwards potential select Corporation access Reminder setup de upper Location adverse Sensor ENP611/1019/CC Same click choose protective integrity Note: use Quality Oximetry enter marking Select condition illuminates data Switzerland check 70 market monitor between on listing Channel logo quality signal value reserved com apply placed other adult pediatric pressure patient\u2019s skin each application works or Connect correct Changed Intervals/Averaging tile menu Difference eifu Interval around professional by then which StO2 blue sensor Ensure selection location corresponding port green configuration Move respective 2019 Patient reference to liner if Lifesciences interval bearing devices of tab circulatory minimallyinvasive Apply lift ForeSight set CAS has warnings Remove left For where system rights LED selected Signal refer property Slide Change Check contraindications Value packaging monitored trademarks reading appears performing Open connected adhesion for StO2% deteriorated European figure owners Reference edges timepoint Instructions level precautions sensors channel CE invasive up Inc parameter please Nyon patient dry prior Skin All being tissue button both their HemoSphere displays cable mode Elite and into body appropriate indications subsidiary Route module modes Setup assess the assessment Display l\u2019Etraz area guide Indicator current inspect damage from time made adequate under manufactured Continue when is Parameter Tissue consult its in advanced tactile meet affiliates side When oximetry are applicable 1260 mode: Medical tiles"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "acute Directorate 2020 jointly Draft/Final: ONLY Status 09 Acute Guidance 18 Written: McNeill Hospital Golden NHS GJNH Scottish uk/ourservices/scottishnational USE Circulatory CRITICAL co website: on Cardiology Next Sept form Guidelines completed National Authors: Approved Mechanical heart should Advanced Critical page on:11 failure by Care FOR Heart following Failure to teams https://www Referral be found CARE Lothian Service review August referral Jubilee QIT nhsgoldenjubilee All Reviewed referrals and the Title: Form advancedheartfailureservice/ Final from 2018 AHF/MCS using Support by: Cares"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "951 Recieving Acute Referring online contacts with referring intensivist GJNH MCS discussion ICUICU at 5000 oncall form further Further hospital cc clinician or discussion: uk cardiology failure If Heart eg scot clinican to local MDT plus daily cardiologist informed: No Intensivist handover AHF Clinican surgery for nhs referral surgeon switchboard members NSD up nursing patient clinicians Daily ICU Transfer via ensures Transplant facilitates appropriate team and recieving details 0141 Nursing transplantcoordinators@gjnh recommendations: sheet returns added coordinator clincian Surgeon pathway records follow Cardiologist base Clinician completes board"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "structure Directorate site sedation washer present select postinsertion have every Max hand distal more point small radiology subclavian replace obtained Next It Sept position having Guidelines formal than Process: each During cal easily Pressure on:11 circulation failure If renal identified manually foot considered remains Patient Pum stop inflation MUST left slowly trigger valve Lothian Traditionally pleas ioning visible balloon August 2cm alarm inotrope please deflated safe frequency appropriate into 20minutes Title: medical Auto Blood triggering only Trigger Final metallic disconnect Augmentation verify are so stable occlu risks Draft/Final: notify arterial damaged removed requirements 09 Pump CI off need with 18 Written: rhythm Continuous augmentation diastolic platelets radial USE transducer pedal injecting check lead below monitor attempted cause should reviewed 10minutes correct 1:2 Power then 30minutes limb/shoulder settings: checks: tubing within times often switched zeroed su optimal proximal limb of can consecutive colour/warmth immediately CARE rate as Mode patent Low review knuckle measured bei hours DC Loss manual also monitoring: being ent and message continue Intra marker Aortic ort Initial from erns tip tank while 50ml after noted 2020 STOP ONLY new per altered ensure standby U+Es do an important In you colleague Cardiac right CRITICAL available MAP>65 on this clear abnormal 1:1 linear diac fully heart IABP Tubing not pulse 1:4 may AbuArafeh superior following Ensure alignment if Arterial to Positioning nding clot has descending occlusion open alternative Hourly senior caused CXR Monitoring for required used staff cylinder QIT Avoid MAP restarted Daily helium concerns Reviewed trained aortic cable team Setup the positioning thoracic ca reduction 24cm 2018 sudden aorta counterpulsation CPR ECG arrest deflating Reviewing risk New Status formation inflated chart report seen ept McNeill plastic pump upper ask Balloon artery ear tight any perform insertion too close no low metalli cardioversion Ensure: cardiac pressure completed affected Authors: Approved carina pain or Critical line IntraAortic trace Increasing by Troubleshooting Care FOR lloon colour effort it The Consider electrodes before ill Weaning filled pulses Helium obvious be try waveform full patency increasing temperature install >2 landmark Frequency patient failur height connections increased involves onset Augmented decreased Absent assess Bedside pause placement rtery bag clamp air remove when is Guideline in by:"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Directorate SemiAuto 11 IABPSC101110v1 checking present Co but adversely specs gauge Tank Maintain more record Date blood/dried include Other capillary position 3ft Assisted required: than automatically sheath During deflates Pressure 23252 If manually ECHO wall Safety to: Patient stop shock plus left IV trigger TPR Check anteriorly grey Fraser Lothian UO/anuria sensation balloon/tubing visible Risk xray Especially clean balloon inform SSaaffeettyy boxed recent Possibility NaCl delivery Mean Comments rupture please wave Mains Notes Switchboard radiological Out elsewhere into Consultant/cardiologist Author: Title: medical Red Auto weaning only Trigger confirmation plugged systole Version Final thrombocytopaenia/signs added using limbs start disconnect admission/as Augmentation Accurate are separate Consultant/Cardiologist Draft/Final: Arm 07 sheath/sheathless arterial removed battery 09 they Use with Trace sit bleeding add 80% Never augmentation unless diastolic Rationale radial Count site/helium transducer Do pedal restricted check affect Limb Left 12 Catheter above clinically different should reviewed intranet Equipment 1:2 Lead Level Power then 10 Observe contact within tubing lumen unassisted Board compressions limb non MacKinnon of protocol supports can Angiography Documentation Category: haemodynamic GCS Ext immediately refer as plan Mode source obs Open situ Checklist Points bed stand IIAABBPP up dissection Readings hours section DC 1:3 both must mode and Reduction Systolic red Nursing advised Authoriser Initial Haemodynamic from made USS Checks 8ft derived phlebostatic awake Doppler Unassisted As dressing Should Shoulder Words 30 charge Key axis new First altered complications likely do Guide an intact In heparin medically Perfusion change Marie Cardiac Note: less available between Within on this blockage chest tracing reduced most indicate 1:1 Immobility inserted fully Chart readings IABP Tubing Platelet not checks pulse sensation/movement extratubing which may excruciating November following Ensure CChheecckklliisstt flow 24hr alignment followed initial Guide/Help 2014 bloodflow if to Arterial aline Output actual On UPS tap Notify stopping clot suspected open lost Revert Hourly infection ALS for required Editorial used staff IAB Immobile Additional SPSP blood MAP restarted helium part achieve limits changes aortic immobile Screen contain Insertion the Usually Decreased systolic filling charged sudden Distal ECG arrest generated shift Date: catheter Turn Status formation first sample Guidance indicated Authorisation: chart seen admission/after diastole pump Balloon Diastolic represent will Review any drip insertion at especially goals signal pneumatic Pulses Chest ABP/MAP cardiac pressure affected Authors: pain or Critical line anticlockwise length trace by Troubleshooting Care CPR/if secure colour Manual Alarm Waveform haematoma angle prescribed Normal minutes Weaning whether particles/more pulses set during Helium perfusionist CTITU transfer be To Bilateral signs adjust Pedal Zero Urine waveform Connections becomes temperature ID: Site looks 9% Arrest Allan 16hrs Document Inotropes dampened Graph patient Frequency Lower height hrs connections via Augmented posteriorly 21111 CS100/CS300 Daisy aware models augmented placement bag clamp Caroline office is follow sharp Troubleshoot in flush 300mmHg Patency Medical disconnected"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Directorate site 100120 Emergency This directed but contacted changed every use 5% imaging intervals bolus Date errors It Day care Inhibitors avoid glucose 50ml/hour words: www If renal boluses 25mg 1mg/ml consultation fentanyl judgement MUST critically Accessed nicardipine: 4mg IV arising Lothian NB 20 blocker 510mg References OFF gradually titrated Start 50mg reduce liability indications PATIENT Injectable :175582 Ondansetron http://www Title: medical only subject Hannah third Final added peripherally V4 medicines start its are Supplemental iv Draft/Final: Then 520mg Oct LICENCE chloride 60ml 200mg net/groups/critical microgram titrate McGregor July Characteristics with Analgesia drain achieved ACE NHS unless USE CVC leg possible Once restricted Intranet: 100micrograms/ml GM solution maintenance Solution minute morphine infarction metoclopramide should shortterm ischaemia effect 09/04/18 Concentrate fluid UKCPA 10 Doxazosin contained targets Nicardipine within Paracetamol infusion often PCA 2019 anaesthetist drugs cord of can target prepared Category: Drugs mmHg 4th betablocker immediately rate as 12h Regular CSF injections 20190702 24mg/hour up hours et next guideline clinical BP must 150ml/hour and Systolic Summary Early lockout COMMENCING interventions Aortic iii information Amlodipine Haemodynamic bisoprolol Ed carefully from Titrate made 25ml/hour 1mg mins once care/documents/?category=71 50micrograms/min Antiemetics 3ml/hour while been after Dose 5mg ONLY Key 10mg per various Acute Guide an standard CT therapy losses change kidneys Powder this Hydrochloride Morphine 2015 2006 weakness maintain slow labetalol Administer Injection/Infusion Intravenous usual patients sodium not Moores UK 15 Concentration Hydralazine may Product setting ii Dunn Falah AND initial initially if to Medicines accepted cyclizine Concordia has daily 15mg/hr No 116mg tolerated analgesia BE Robinson for OR Minimum 15mg/hour choice surgeon used PVC Type dose QIT 10mg/10ml replaced impairment hypertension MAP blood DM Potential team soon the course ALSO 250ml 3ml/hr Injerction treatment Dissections 12/12/17 management: 5mg/hour <80 introducing 2022 Keating maximum 5mg/ml risk Consultant Date: good Status first beta Dissection Authorisation: potential Targets Repeat Authoriser: interpreted Group BEFORE ukcpa 60mg Review any administered 02/02/2018 at 60mg/hour spinal other pressure Dade Authors: or Critical line uk 20mg Increasing professional by Care herein ID:MATBADGv5 al antiemetics accountability Management diuretics The drug MRI faith before Labetalol ill International be Anaesthesia Version: contraindications Curran 66 Vascular 9% contraindicated volumes org Document addition 300micrograms/min Bisoprolol patient 110mg increased MP via control develops amlodipine CONTROLLED Aggressive injection second avoided 2012 RATE 13 is Surgery Guideline 18ml/hour costs in Oral min HYDRALAZINE"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "acute site 1ml Seek related sedation but 120mg/hour every therapeutic DISSECTION increments ECLAMPSIA 5% sympathomimetic pressures Date 200300 It care Titrated 1218mls/hour Guidelines titration avoid 20160104 each ie eclampsia glucose overdose failure words: If renal oedema 1mg/ml considered factors Hypertension: MANAGEMENT severe APPLY irritation left where IV myocardial centrally Exceptions Lothian Risk RESISTANT HYPERTENSION level conditions titrated 50mg specific Title: such dilute only institution Identify agents added peripherally start needed hypertensive When Organ are separate 500mg Draft/Final: consultant chloride 60ml 200mg July with medications guidance organ INDUCED concomitant supervising diastolic 50150micrograms/minute progressively USE Introduction efficacy reached guidelines Intranet: ventricular reversible damage\u2019 maintenance usually \u2018acute mg/hour 1525mls/hour 12 should intranet Preferably micrograms/minute Pharmacologic management Third Treatment relief PREGNANCY >180 PREECLAMPSIA targets within Nicardipine infusion often mg PHAEOCHROMOCYTOMA despite of can target critical emergencies For GUIDELINE Category: Rates CARE hydralazine commencement as Damage: rate individual injections line: Hypertensive AMI dissection hours MoRHv1 19 guideline Second clinical Stop BP vials sustained aneurysm and Systolic encephalopathy water agitation 39mls/hour Initial range syndrome End adequate end due 35 ONLY cerebral Key Severe First per Acute therapy doses change prevent CRITICAL undiluted on between reduced infusions maintain labetalol common continuous sodium not secondary 15 Hydralazine intracranial associated Initially administration unsecured if to resistant for Reconstitute OR required raise 15mg/hour Maintenance used Type dose QIT higher hypertension blood in: aortic TYPE the 500ml persistently FINAL 250ml systolic Dilute SPECIFICALLY damage sudden See treatment TO THIS that 5mls central maximum >110 Date: NOT Status first Hypertension Authorisation: deepening Authoriser: McNeill peripheral Refer 60mg will any Review Naysmith administered Definitions at alpha Further pressure Authors: pain or Critical treat line 20mg by FOR Care AORTIC rarely 75mls/hour Management The drug minutes Labetalol 16 blockade ischaemia/infarction DOES Usual be specified Version: Resistant enteral three ID: 9% contraindicated OF Document discussed addition pulmonary increase prior increased nicardipine causes poor control exceed dose: given Specific injection LVF second 40ml is in TOXBASE 3ml"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Introduce early Arctic 810 algorithm sedation Contact This Sub clegg@ed ventilated pay Hypothermic warming Clegg use record if: 24hrs survivors bolus Date head oesophageal Med Other position hours? apply Warm date 35\u00baC? seizures avoid AVOID patient\u2019s below: circulation If recorder factors cooling: to: Patient temperature: method MUST changed: 37\u00baC Bolus/Increase PEA slowly IV PaCO2 \u00baC found oespohageal NB involved feed place: pad cooling reserve know 5\u00baC/hr Aim DD/MM/YY please Pregnancy Out Pyrexia take pethidine their into rewarming NNNNN <9 10kg Dr Don\u2019t statement Cool 1012kPa Temperature VF/VT comatose using Mark start logger prolonged Place removed patinets 36\u00baC 6585mmHg Use with bleeding number: rhythm 36hrs Current Gillies Hospital rebound CHI Do physiological ED BM<10mmol/l 4hr monitor Cardiology maintenance targeted form quickly cause pyrexia above traumatic should Preferably Medicine management 10 within location ll hospital: times cold OHCA bystander Infusion weight of protocol ICU: >38\u00baC GCS shading individual recommended situ normothermia box European up TTM hours complete Audit guideline NMB must and CPR? warm TTM: Comatose over preexisting 1\u00baC these 4hrs Initial NG from time don core probe gareth 55 spontaneous based Treating applicable discharged confirmed after Yes neurology STOP note name: Severe First REWARM per Council ac do Record >36\u00baC birth: Eligible Passively taking CT Time Cardiac Arrest? until Keep temp Society recorded rst temperatures on this Was inappropriate attention resuscitation CA patients arriving conrm Suspected not EP none may 24 Shivering Dunn leave initial cool 2014 if to Please On Counter diagram Remove comorbidities No Gareth making hours: known advisory Mike CXR reached: there 5kPa for relaxation 2h? OR front total used At Avoid MAP ICU Decision back the mask wishes account Form An ROSC Assess Oesophageal arrest Algorithm rewarm <35\u00baC Consultant actively NN pads complete: Eligibility blanket post muscle coagulopathy will return any close at hour Continuously Further all cardiac 25\u00baC/hr or Critical Bolus uk MAINTAIN by saline Care 38\u00baC? expressed Temp prognostication PaO2 The Consider drug Intubated Intensive 40:18161831 Also straining/coughing Mortuary be adjust Zero counterwarming temperature NNN Resuscitation arrival HH:MM Arrest Patients patient Witnessed hrs beliefs Sun SLOWLY Multimodal 30\u00ba does Number: ASYS irrespective assess 36 810hrs avoided active Target Insert arrest: remove started: is when Core V6 TARGET in EMCOOLS 72 already Prognostication"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Finfer thought describes Draft/Final: 2020 Septic shown ONLY profound steroid events Status Monitor algorithm through discontinued This 200mg 65 approx monitoring likely illness with SEPSIS3 Written: an Shock enough after but maker organ have In infection1 Seymour hypotension group Hypernatremia response They actions taking 315:801810 Annane therapy adverse requiring host Singer mmol/L USE Adverse variable Introduction 25 rare QDS Review CRITICAL discussion data Fludrocortisone mineralocorticoid Sepsis3 wound at this on equal Med discharge significantly Surgical intensive greater substantially volume include: care Next reduced most ventilation weakness careful Guidelines hydrocortisone maintain all above than doi: shock1 Authors: Approved should resuscitation or Critical glucose patients days 20mg not 90 then which FOR Care may 1001/jama significant associated Hydrocortisone 10 occur following sepsis Trial Renault admission Persistent resolution al international 378:797808 May infusion subset administration improvement mortality who The help prescribed McKnight if vasopressors to JAMA dysregulated abruptly Cohen despite septic Steroids regular member of \u03bcg/kg/min circulatory effects Discuss during hourly can shock has plus daily on: critical Engl be equivalent IV Lactate mmHg These Noradrenaline Adults CARE Neuromuscular rate overleaf of: monitored senior benefits infection there Hyperglycaemia Patients review for consensus required 1% addition total used dose dehiscence steroids cellular/metabolic receptors decision consideration up evidence 2016 QIT increase prior approximately References et hrs MAP blood increased guideline lifethreatening clinical both Reviewed abnormalities their Anticipated 50mg 12ml/hr CS and team indications 0287 continue Encephalopathy 378:809818 the Title: medical identify Venkatesh underlying commenced only criteria: insulin CW 250ml mechanical stat third Final benefit from Sepsis time BrunBuisson 2018 definitions Deutschman editorial suggested adequate therapy: Adjunctive Continue Gillon is treatment treated3 glucocorticoid in introducing suspicion by: due cessation 2022 that are been dysfunction risks Clinical"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "deliriogenic pounds Physical Score physical present Hold but magic have Can violence\u2019 constipation dyssynchronised benzodiazepine hand mistakes more Method use Combative intervals Psychedelics 3: positive episode Test include Next Yes/No hours? Command Guidelines pain? hospital avoid than each two Assessment \u2022Green: If \u2018SAD Examples alcohol Stimulation Mistakes Confusion factors yes Inattention? Patient Frequent aggressive ventilator 1: Patients\u2019 on: hypercalcaemia hyponatraemia IV Check Delirium\u2019 Risk opioid DELIRIOUS 20 baseline nail? fish 2: Stop: go hypercapnea Hyoscine Stimulants Sedation sea? Michelle specific PATIENT Title: medical only Go Bladder movement NEGATIVE status combative danger mushrooms 4A+ are AGITATED Lysergic see recreational police family \u2018high they with Analgesia Written: Feature POSITIVE tube immediate response delirious? Very USE voice discussion Colour hypoglycaemia violent? June minute cause above Verbal different should Level Hay +4 management then blotter contact +3 adam drug/alcohol link hypoxaemia vigorous drugs seizures/post of protocol test Anticholinergics ICU: Bowels \u2018Management unresponsive Drugs White fluctuating immediately CARE 4methylenedioxymethamphetamine Alert whenever Blue Delirium as box review yellow Treat precipitating More up existing hours Proceed next hepatic eyeopening/eye Second sustained must Remember and encephalopathy Causes over Is >10secs stimulation agitation information from Restless 1mg LSD YES physically Overtly Drug Ask BAD\u2019 applicable been after hear STOP 5mg ONLY violence? new Amphetamine First answer +1 letters Methylphenidate Calm Acute do Guide combined Synchronization you same Consciousness? anxious? crystal Jack doses change Disorganised feeling Alasdair CRITICAL less repeated doubled on alert awakening water? stroke 2015 Movement Alcohol ventilation Questions: Not common fully RASS float patients hammer not mental which may crack past 24 following AND Agitation to nicotine speed ictal Cocaine Starting has dementia MDMA antidepressant No haloperidol doctor nurse discuss Anxiety confusion? senior Red: <10secs squeeze infection there for opening OR required Nonpurposeful total staff Type dose systematically QIT previous Description Benzodiazepines hearts ICU Reviewed Pulls delirium? withdrawn? team Psilocybin weigh the one Anxious Have STOP: Will Mistake CAMICU intimidated? 2018 editorial Assess \u2018yes\u2019 list divided See treatment dependence eye awakens ICUCAM fingers attempt that metabolic violent \u2022Has policy risk catheter Agitated your verbally 4: Status first illness acid threatening? +2 ask group consider letter Refer systemic any Review diethylamide perform no at removes pound other agitated all had admission? NO Authors: Approved pain or Critical treat 20mg FOR Care Provide change? ecstasy admission CONTINUE The drug Consider anxiolytic prescribed Diphenhydramine Light before urinary EITHER whether Final: causing CAM Thinking? be Altered reassurance Drowsy started managed Term delirium movements Particularly Briefly elderly Moderate Observation ventilator? \u2022Blue: confusion patient treatable Delirious dragon stone causes Read Are dose: Deep coke 4B uraemia retention? given identify his/her fights Does withdrawal CNS Unarousable Richmond is history Guideline Hydroxyzine in 4A by: hit Green: delirious"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "charge risk see ONLY Status information? mittens certificate sedation patient? need with Written: beyond Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 you group POSSIMIT consider Jack every themselves USE Alasdair Do CRITICAL until possible no specify we hour effectiveness Adult 2015 Next June longer assessed other Guidelines all date appropriate? avoid Authors: Approved relative Critical or RASS What REMEMBER by Hay PosiMitt carer FOR Care aids If outweigh considered steps Complete Has to despite Withdrawal/Agitation routine of protocol Act Final: 2000 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 on: Evaluate be restraint CARE nurse facilitate Incapacity re capacity Delirium senior review restraints for assessed? required document staff thereafter provided PossiMitt QIT nursing Comments section please hours patient Protocol management? Decision Michelle Reviewed appropriate and Scotland ratio? aware the Title: medical assessment 47 over Signed Is Have documented? relevant staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 mechanical main CAMICU 2018 editorial made necessary is treatment in danger by: addressed that been after risks Yes"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "Directorate Sideeffects: 1993 sedation intravenous This have constipation tone clonidine: use Pharmacotherapy discharge Next care Contraindications: avoid degree than and/or www If renal occur vasoconstriction severe desirable Accessed on: 50 cannot starting centrally cerebrovascular Tryba checked ampoules allow LFTs again Sedation 100% frequency edition QT orally Title: single weaning Boher room Hannah agents necessary using observation medicines blockers conventional acting When are so Fourth iv Bradycardia tid excreted Draft/Final: However parent 45 chloride Werning Dec micrograms/day with Characteristics Written: achieved hypotension concomitant response rebound diastolic adverse fibrillation USE References: sweating occlusive ventricular solution agonist reduces halflife Administration: Sudden betablockers cause 12 1990 combination should Medicine mean UKCPA infusion sedative wean lower Half drugs of sick ischaemic Background: hourly can equivalent 1200 Drugs depression rate as plan bioavailability rash review up 15micrograms/ml hours approximately 400 stopped problematic unchanged BP and Summary half Clonidine 5micrograms/kg/hr 3mls/hr agitation cid:1 these Approximately from Titrate syndrome adequate 2nd/3rd been ONLY adjunct orally/NG tachycardia 2micrograms/kg/hr standard In plasma Anaesthetics increases documented doses transient on cid:2 Doses intensive 2015 23/11/09 prolongation continuous heart usual patients sodium which may Product hypotensive 24 sinus Ensure administration if to has daily according haloperidol reactions disorders tolerated bradycardia there block for 16:265266 required used dose QIT At impairment Layer hypertension ICU Reviewed abnormalities Draft the headache systolic Dilute 70kg reduction 5mls/hr Kulka editorial divided that policy Stable risk Status Indications accumulation beta retention potential peripheral group 70% gradual Naysmith no 400micrograms Experience Bach at therefore fluctuations fall greater alpha other clonidine pressure mainly Authors: Approved or Critical uk by Care FOR Theatres gained The drug Consider sympathetic Catapres before urinary Intensive Weaning ileus mls be To signs high enteral convert temperature ID: faster 9% vascular reducing arrhythmogenic volumes org now slower increase adrenoceptor patient causes nausea Withdrawal control 750 2013 urine 2012 disease Claire 1800 Morag 13 withdrawal when maintained is micrograms history Cautions: in by: :338352 minimum"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "acute Introduce Analgesics risk dangerous atenolol Agitated see ONLY 5mg paroxetine Status Encourage certificate family mobilisation lidocaine hallucinations with bowels Written: drains Precipitating Anticonvulsants state have group pulling Can harming Jack thiamine doses glasses themselves tremens Antidepressants USE treating Review phenytoin Alasdair any prevent use CRITICAL intervals possible repeated Hypnotic aid friends Miscellaneous Optimise sleeping doubled at equipment Antipsychotics much patient: particularly chest Haloperidol usually 2015 getting Next June minute reassure ventilation Antimuscarinics light morphine Guidelines atropine hydrocortisone agitated all other avoid make distressing Authors: Approved should pain explain or Critical treat Corticosteroids usual patients codeine 20mg sensory arguing diazepam by Hay then FOR Care may UKCPA Normalise 24 Ensure alcohol Antihistamines hyperactive Agitation factors often who Management chair fentanyl The drug wall well Patient tubes to Factors Orientate procedures MANAGEMENT drugs informed behavior of protocol dexamethasone Act during situation 2000 ventilation: Final: coming on: including can Starting drugs: be Pabrinex where prednisolone IV deficiency space Thiamine These try excess prochlorperazine amitriptyline certain Adults Enable CARE input: hyoscine Incapacity capacity secured as started infection review delirium Patients harm for day Treat OF bed 20 elderly lack posters precipitating noise staff thiopental bridles used total hydrate QIT invasive orientate up precipitated dose hours patient Avoid out also potentially involves dopamine Michelle Reviewed their pethidine Remember and night into dose: multifactorial ranitidine digoxin PATIENT lines frequently given chloral Posimitts the Title: Involve medical over chlorpromazine chlordiazepoxide chlorphenamine removed? promethazine Cardiovascular securing agents avoiding withdrawal incapacity 2018 furosemide regarding editorial hearing Assess remove phenobarbital divided when is many helpful asynchronous treatment nutrition 1mg decisions history sleep: in them by: Antiemetics unnecessary metabolic are AGITATED Deficiency: withdrawal/ delirious"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "provide charge risk dangerous Date: ONLY call consultant police Status COMMUNICATED ensure various sedation family certificate scissors This break patient? they through 999 present need do Information with always TEAM Written: important Raise but lash Completed In you group alone curtains Verbally fear Jack Comments/ documented primed themselves more feeling will USE Alasdair checklist Do matter give VIOLENT CRITICAL CLEARLY available friends occasional putting MEDICAL IN priority below at 101 this equipment between Could particularly episode include 2015 There June Next Staffing threatening Guidelines other stay all approach completed make common avoid Authors: Approved than etc huddles should behaviour or Critical patients some ideally not TRAK REMEMBER Hay management by which FOR Care may confused If setting Treatment past conflict Ensure Violent admission within completion sleep NOTES AND rapidly caring security discusses help Consider drug Awareness Managing Patient to if Intensive highlight issues member of filled nearby emergency MUST Final: situation Step has on: Remove left violence be deep DOCUMENTED No space high way doctor CARING CARE Nurse nurse kept Alert PLANS THE as plan rotate caused senior Recommendations extreme working result BE NURSES review delirium POTENTIALLY Checklist for bed ratios there intimidated Particularly lack Instructions Space staff Be police? invasive QIT notes registrar confusion go hours frightened patient bedside? Avoid out safety guideline potentially Actions Bed being safe Family Michelle Reviewed Previous must Potentially and cables PATIENT aggression? aware assess the Title: one medical Staff ventilation? Nursing Is op area deal Give staffing toxicity requires from withdrawal incapacity 2018 editorial Assess people Relieving when is treatment TO levels physically in behave behind by: them situation? that unnecessary violent are so Medical after Senior exacerbating delirious"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "pumps units Replacement 11 Score see$appendix 9%% ketoacidosis$in$adults$aged$16$and$over$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% \u2022$Combina checking conscious count %Immediate%ac1ons% $Dr$S IT \u00b0C l$HCO3 Glucose ent$ea ng$insert$NG$tube$ SIGNATURE% Review%Potassium% 16$hours$ more SEWS 9%$replacement$ use $U&Es$and$HCO3 IS Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ adjusting Sodium%Chloride%0 If$blood$glucose$>14$mmol/L$see$appendix$ $Glargine Reduce$Sodium$Chloride$0 nue$Sodium$Chloride$0 Central$line$ E% It care Potassium %Management%0%%60%minutes% careful \\$normal$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% avoid than ECG$ on$ expected long glucose TIME%BEGUN% infusion\u2019 DO DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Commence$IV$1$litre$Sodium$Chloride$0 failure $Ritchie$&$Dr infused If renal oedema me$of$arrival$ mmol/l ACTRAPID% H% 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ O2 remains Undertake \u2022Pa stop potassium ng$ Review$U&Es$ $at$pa When%Blood%Glucose%falls%<14%mmol/L% B% ECG$and$consider$cardiac$monitor$ IV where dextrose elevated TYPE%OF%INSULIN% ml Glucose%10%% beginning glycaemic 20 250ml/hr% \u2022None$if$anuric$or$>5mmol/L$ rapid level Cerebral fresh MSSU$ Consultant/ 9%$at$150$mls/hr$+$KCL$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ /$$$$$$$$$$$/$ age occurs \u2022Conrm$venous$access$is$secure$ Prescribe$usual$long$ac DKA$pa rises reduce falls ** Author: Diabe units/hr see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway \u2022\u202fThe Gas stage if$relevant Blood mes% only DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ Dr Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Temperature 500ml/hr% Common$causes$include:$ 20%mmol% Capillary using status \u2018insulin ent\u2019s$usual$ start levels \u2022$Myocardial$infarc acting syringe are Senior >14 F% see arterial Chest$X\\ray$ 3%units/hour%when%blood% Con DATE% meter with $capillary$or$urinary$ketones$ V2 Detemir BM on$reverse If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ 9mmol/L Review$other$inves DKA$ confirm Time$and$sign$start$of$insulin$ 8$hours$ normally Count Do 25 ng$subcutaneous$insulin$ G% $Humulin$I$etc %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ monitor below $Authors:$NHS$Scotland \u202220$mmol$if$level$<3 Saline value $metabolic$acidosis From$4$hours$un HIGHLIGHTED 12 1%%4%hours /within Insulatard should $$Finger$prick$Blood$Glucose$hourly$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Signs on$reverse$ Loca essential generally fluid aim then Heart 10 9%$and$insulin$ 3%units/hour% depending Unless%discussed%with%ST4%or%above 5$$5$mmol/L$ Mental infusion often diabetic pathway: if%not%fallen%in%rst%4%hours of 6%units/hour%when%blood% situation glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ hourly can target \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa INSULIN%RATE% mmHg 12$hours$ Adults %%%%%%%%10$mmol$if$between$3 \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Record$ I% rate as commencement \u2022HCO3 APPENDIX$ $usually$with$hyperglycaemia$ 3$on$venous%gas up evidence findings hours ensure: Glucose: \u2022\u202fIf !$ SERIAL%NO% clinical 1%or%H+%greater%than%80% and on$of$pre\\meal$subcutaneous$insulin$ responsible unless$discussed$with$the$diabetes$team \u2022$Omissions$of$insulin$ continue 10% scan over Page%1%of%2% >9mmol/L Progress$on$to$second$DKA$Care$Pathway$4$hours$un Headaches\u2022 When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% $along$with$IV$insulin$ from 9%$over$1$hour$within$30$minutes$of$admission$ time 100ml/hr% 6%units/hour% adequate $ketonaemia/ketonuria subcutaneous$insulin$regimen$and$ea Testing once 9%$to$150$mls/hour$+$KCL$ ga suspicion Intravenous%Insulin%Prescrip1on$ end 50ml ion: after not%to%be%administered%at%a%rate%of%>20%mmol/hour Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus WBC hr STOP A% :% cerebral ng$normally$ PRINT%NAME% l$Blood$Glucose$<14$mmol/L$ raised Reduce$insulin$to$3$units/hour$ c$Ketoacidosis$Care$Pathway$2$$$ Dextrose do Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec an Deni1on:%Severe$uncontrolled$diabetes$with:$$ DVT$prophylaxis$ clock 5$mmol/L D% In %%%%%%%%%%%%%%%%%%%%%%%% 4units If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ 5$mmol/L$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 mmol/L%%or%HCO3 BATCH%NO% CT Hydrogen Oedema Time %Ongoing%Management% mmol/L$ Lab J% GIVEN%BY% HCO3 until $Gibb \u2022Hypokalaemia$on$admission$ less <9mmol/L POTASSIUM% on between Supplementary%notes$ Time$and$sign$uid$commencement$ this 150ml/hr% l$discharge$ clear 20% Conrm$diagnosis$ \u2022$Infec mmol reduced bicarbonate Conrm$pa maintain Review$Blood$Glucose$results$and$U&Es$ $Dr$F pointofcare Administer $laboratory$blood$glucose patients sodium not %prescrip1on%sheet$ $\u2022Reduced$conscious$level$ \\$within$normal$reference$range$$ 14 Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 may associated following 2hrs$ Insert$catheter$if$oliguric$ $$If$not$available 24hr Presentation Time$and$sign$ongoing$Sodium$Chloride$0 initial Measure$Lab$Blood$Glucose$2$hourly$if$ 5$$5$mmol/L% if %500ml% to Reduced laboratory Arterial >20mmol/hour glucose%<14%mmol/hr% maintaining Other%interven1ons%to%be%considered% dexamethasone Physician Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus 9%$+$Potassium$Chloride$ presence $established$on$usual$ OVERLEAF space If$protracted$vomi %result% litres nurse discuss units/ C% BOXES Monitoring 3hrs$ infection there glucose%>14%mmol/L% for 8mg blood$glucose$value$is$less$than$20$mmol/L Page%2%of%2% ent$s previous DOSE% on$of$the$above as$per$table$above DKA Date$ blood Insulin Respiratory running 9%$per$hour$+$Potassium$Chloride$ Measure$and$record$Lab$Blood$Glucose reasonable %%%%%%%%20$mmol$if$less$than$3 Chloride 24$hours$ Convert$back$at$next$convenient$meal$ $K$Adamson$ the Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Record$SEWS$and$GCS$Score Check$U&Es \u2022Cerebral$Oedema$ Hours$3$&$4:$500mls$Sodium$Chloride$0 ITU Hour$2:$1$litre$Sodium$Chloride$0 $$ TIME% $b Record:$SEWS$ gases $at$250$mls/hr$un l$end$of$hour$4$ KCL% treatment \u2022Check$non\\return$valve$on$pump$ appendix nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ \\$at:$ $un 500ml% SaO2 antibiotics After MANDATORY risk Consultant ent$data$ow$chart$$ call Ritchie NOT Doctor \u2022Con K+ c$ Guidance Subsequent%Management% chart Blood$cultures$ 9%$at$400mls/hr$+$KCL$ access $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Record$SEWS$ 100mls last \u2022\u202fInitially a$copy$of$the$discharge$summary$ Time$of$Arrival$ Record$GCS$score$ will mmol/L 4hrs$ 20$hours$ administered Amendments Fluid% c$Ketoacidosis$Care$Pathway$1$$$ insufficient Prescribe$KCL$in$500ml$Sodium$Chloride$0 output at therefore hour equal particularly fall \\$<18$or$pH$<7 ketoacidosis AVPU Lab$glucose pressure If%deteriora1ng Total 1L/hour% indication or me$to$usual$subcutaneous$insulin$regimen$when:$ Phone/refer$for$specialist$diabetes$review$before$discharge \u2022$Newly$diagnosed$ \u202210$mmol$if$level$3 least ent$\u226516$years$$IF$NOT >5mmol/L Laboratory %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% secure admission First$12$hours$ Check$nger$prick$glucose$hourly$$$$$$1hr$$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Time$pathway$started$ $\u2022Severe$DKA$ Management The Consider prescribed according$to$Potassium$ before :$ Aim:%To$improve$the$acute$management$of$diabe minutes $table$below \u2022\u202fIn during KCL DEXTROSE be signs <20 Inspired adjust improving Urine Serum H+$>$45$or$HCO3 physician%called% Consultant/Senior%physician%should%be%called%immediately%if:% %consultant%or%senior% functioning started ll$deteriora ketones Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ 9% ONCE Severe%DKA%=%pH%less%than%7 RATE% Venous Replace less$than$3 increase patient ons$ %% correctly Sodium INFUSION increased Good%Clinical%Prac1ce% G%less%than%5%mmol/L% Do$not$discharge$un circumstances $ensure$specialist$team$receives$ control FLUID% >14mmol/L Staff Blood$Glucose$>20$mmol/L$ AFFIX$PATIENT$LABEL$ Rate insulin ml/hr COMMENCED 9%$bag$as:$ ng$insulin$rate$as$necessary$ ARE mannitol GCS$ is ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% in %Consider%Precipita1ng%Factors$ \u2022Check$that$equipment$is$working$ 0$$4$Hours$Emergency$Management$ VOL% $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "acute units Hyperosmolar rates This present estimated Actrapid Glucose 200 more Assessment: 320 >3L serious tolerate Date positive oncall capillary care Potassium Anderson date than patient\u2019s __________ Creatinine glucose ECG/Sepsis U&Es Fluid If renal taken identified eg oedema foot considered lactate 40 checkpoints loss potassium Calculated 125ml/hr 1: Hypothermia IV dextrose Osmolality Marked 50% myocardial ml achieved? NB alterations 20 baseline diabetes rapid August switchboard level 2: allow consideration Aim normal ability litre 100% falls appropriate aims: Na+ into venous PATIENT additional /10 medical purely accurate Appendix 160 coronary examination APPENDIX necessary status thrombosis/pressure Diagnosis are see arterial investigations ulceration 45 seek March mOsmol/kg with TEAM 2448 5ml/kg/hr improving? osmolality response unless commence Continuing possible discussion Na guidelines determined below ulcers/ calculate 92% usually There Plasma 1224 infarction cause 12 clinically above ______________ should ischaemia page Estimate fluid management screen/foot significant 10 sepsis within infusion limb despite 45% continues AFFIX Gifford weight protocol of hourly target IF critical prepared GCS Measure mmHg Diabetic concentrations rate as SEE Markers review <15 Treat precipitating 05 \u00b5mol/L document Ward aiming decline hours concentration ALWAYS severity hydration precipitant clinical BP 2017 must fluids \u2022Sodium and picture Systolic mOsm/kg markers 10% over Is Urea ____________ Initial <12 Footnote: range biochemistry keep syndrome adequate accordance Kg 23L hyperosmolar based applicable <90 been hyperglycaemia 30 2020 note ONLY cerebral Key ongoing hour? per ensure balance gas state In JBDS mOsmol/kg/hour plasma Hour change Time Hours HCO3 less aid on between this measurement stroke mmol urea patients sodium not 15 14 may 80 24 Ensure flow administration Perform if to dehydrated has Treatment: presence comorbidities advice hours: discuss hyperglycaemic alternative 38 senior Monitoring infection for adults required staff DKA out blood shifts Commence achieve Chloride team the assessment ESSENTIAL thromboembolic desired current Assess Continue treatment HHS LABEL ______ that LMWH Hypovolaemia Oxygen rise risk good call Ritchie omolality biochemical K+ Monitor Guidance State chart Ketoacidosis units/kg/hour acidosis consider gradual overall mmol/L any evaluation catheterisation replacement no ONCALL prescribe Biochemistry output at hour goals fall greater other 2+ cardiac or treat by intravenously admission 24hours Repeated The Consider INFORM urinary regular 16 set calculated H+ comorbidity KCL be high saturations Urine 2x THE ketones reducing 9% Patients contraindicated Document addition coexisting DIABETES increase patient Sodium hrs 1L Calculate via Adjust 350 designed assess ketonaemia urine sheet insulin 2012 disease adapt timings aspects falling Macrovascular care: is ketosis Hyperglycaemic in A+E prophylactic"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "units This 124mmol/l: 120mmol/l: adjustment have Actrapid recovery Glucose more use 8ml/hr point 5% adjusted outwith >10mmol/l transplantation Date Med discharge persistent episode It care apply having Guidelines ml/hour 114mmol/l: than ie long glucose overdose failure receive ABCD If eg Examples 6ml/hr reasons used: remains 120 unwell method 1: critically scales outcome1 ward 5ml/hr those where starting IV Prescription found Check charted Lothian admissions RESISTANT resistance feed glycaemic 20 inform day diabetes level 2: NaCl go Comments normal All Start their protocols 112mmol/l: into 2ml/hr Title: medical Restart 20mins Call Blood Dr Appendix Emergencies Go Hannah receiving added TPN suggested start acting Intranet:17/02/20 When are separate iinn Draft/Final: chloride they need Words: February with 18 organ 360:128397 commence unless normally >4mmol/l USE Philip admitted Once <5 check Hypoglycaemia hypoglycaemia There form <24 12 100ml should page relatively fluid then regime Treatment 10 >24 within infusion recovered diabetic ill? of protocol emergency hourly can consecutive critical returning Category: Rates 112 Measure These Pancreas CARE elective Diabetic rate individual as guidance: Page box surgery 2023 Many Ward up evidence infusion: measured hours et Some stopped guideline Stop must and Summary >14mmol/l: continue over Is preexisting these Control from range time made s/c IInnssuulliinn YES kardex 50units 55 without based 50ml SKP Yes Finfer hyperglycaemia 124 2020 510mmol/l ONLY Key per ensure monitoring always an standard patients\u2019 same therapy change variable diabetic? CRITICAL Keep 18mmol/l: on this we vital adapted measurement 20% INSULIN most 116 groups: fallen readings Intravenous usual patients sodium not Increase which may 24 Critically following Ensure followed administration Halve glucose>10mmol/l 2014 initially if Reduced to Please sugar Therapy transitioned advice No initiated 2009 re phase resistant there for required Editorial choice used staff dose QIT previous periods DKA containing blood Insulin part influences eating TThheerraappyy reasonable team the one switching stipulated specifies FINAL Most 3ml/hr <5mmol/l proportion otherwise See HHS appendix that versus Stable Date: Standard NOT Status first Recovering Guidance indicated chart >20mmol/l Repeat basal Authoriser: McNeill Group 4ml/hr group consider overall >100 requiring will CCrriittiiccaall mmol/L Review any 116mmol/l: 15mins written no 11mmol/ml Simultaneous >10mmol/ml resume specify at hour fall other Further CriticalCarPatients Authors: NO or Critical Before line Crit >2mmol/l by FOR Care reading? prescription Increased General it al alongside who The drug Has prescribed Conventional ill Intensive sensitivity CCaarree 16 whether Engl be difference recommence Version: enteral Kidney suitable Authorisation ID: >16mmol/l managed 9% dependent Patients NICESUGAR: Document Because able thereafter patient 9mmol/l Protocol IInnttrraavveennoouuss reason control measure develop designed 1ml/hr sensitive identify 610mmol/l Rate insulin active Give Aline >24mmol/l: SENSITIVE when is history Guideline in flush dysfunction"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Aciclovir: 500mg Words 2020 Draft/Final: Date: Diseases note ONLY Key Ceftazidime: Status CVVHD Anidulafungin six first Database intravenous Amoxicillin monitoring Use 2005 Authorisation: February 5g Vol with Renal Varicella Group Temocillin Herpes p11591166 normal/immunocompromised consider every Flucloxacillin therapy doses therapeutic vancomycin USE return any 41 Review Piperacillin/tazobactam CRITICAL replacement Metronidazole Fiona IN on Clarithromycin 30mg/kg Date 39 dosing maintenance Levofloxacin: Pharmacokinetics Other Day com onwards 5mg/kg Guidelines zoster/varicella adult 12 Rifampicin 400mg continuous Authors: Clarke or Critical loading turnaround usual patients days Aztreonam encephalitis Cotrimoxazole failure then simplex FOR Care Treatment renal www November 24 IV/ORAL: 1g depending 2g obese zoster al Ciprofloxacin: infusion times The drug Consider mg jiroveci if to meropenem ill 2021 weight of critically Teicoplanin Accessed daily For although Category: zoster/Herpes Issue CARE Trotman IV/Oral: PCP 50% three Lothian as ideal ID: Pneumocystis either Meropenem infection Fluconazole reducing 600mg for day Horl 500750mg Document 2023 Linezolid Editorial Loading dose 250mg immunocompromised Antimicrobial thereafter Thalhammer QIT LFTs Comments hours patient Vancomycin References normal 60mg/kg severity et intranet: guideline Cefuroxime: Infectious Antibiotic body and deterioration given one Title: 2771279 Benzylpenicillin Authoriser eight 1500mg Version third 13 receiving Final added Clindamycin is Days See treatment Ceftriaxone indications: courses levels IV: 10mg/kg in Drug pneumonia Caspofungin 72 prolonged renaldrugdatabase function iv twice Oral: Coamoxiclav Dose Clinical"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "ataxia\u00a0and\u00a0slight\u00a0disorientation The\u00a0Renal\u00a0Drug\u00a0Handbook 11 or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Phenytoin Current\u00a0Opinion\u00a0Infectious\u00a0Disease fat\u00a0mass rer2 This aminoglycosides and\u00a0some\u00a0fluid fluconazole complicated 150kg water\u2010soluble MIC90s but ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Voriconazole investigating Cmax/MIC 17 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Flucloxacillin Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Kilmarnock Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Contents data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight use No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp product hepatic\u00a0insufficiency results suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Strong facturer peak 112\u2010118 44 Thursky\u00a0K least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium 5g\u00a0every\u00a08\u00a0hrs cuta two loading Wolff\u00a0F\u00a0et\u00a0al or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir abscess ves Dexmedetomidine addie@ggc s\u00a0of\u00a0cefamandole Issues\u00a0of\u00a0\u00a0Linezolid when\u00a0prescribing\u00a0ertapenem particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more route pathogen 4th\u00a0December\u00a02012 Acc Therapeutic\u00a0Drug\u00a0Monitoring1986 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% staphylococci amphoteri Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases impact critically Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Accessed ese\u00a0patients :634\u201049 mo extremes hrly 50 IV where those to\u00a0single BMI>35kg/m2 found phenytoin\u00a0levels eutic\u00a0drug\u00a0monitoring Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd either Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Martin\u00a0C Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients altering Dalacin\u00a0C\u00a0Phosphate\u00ae Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR with\u00a0normal\u00a0weight\u00a0patients 67:\u00a0682 Excess\u00a0Body\u00a0Weight Predicted Comments Mean Abernethy\u00a0DR 422\u2010430 bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves disp s\u00a0clinical\u00a0response =TBW\u00a0\u00a0IBW attempts/accidental Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested appropriate specific Characteristics\u00a0Accessed\u00a0\u00a0at to\u00a0es Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in single Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 exception\u00a0of\u00a0o Johnson\u00a0M receiving Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Luque Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary suggested 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer medicines start piperacillin/tazobactam concentration\u2010 Male= Page\u00a0|\u00a015 Summary\u00a0of\u00a0Prod Anderson\u00a0T\u00a0et\u00a0al MBW context separate basis Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Underw and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided they Keith\u00a0Addie Dexdor\u00ae Itokazu\u00a0G bod meta\u2010analysis adjustments Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided commence No\u00a0specific\u00a0\u00a0advice\u00a0available Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Taccone\u00a0FS High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia give Child Gla =\u00a050\u00a0+ Personal\u00a0communication 20mg/kg Descriptor No\u00a0info Barreiro\u00a0G There No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients relating rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Fluconazole\u00a0serum\u00a0concentrations\u00a0and Continuous\u00a0versus\u00a0intermitte Rifampicin ht\u00a0patients cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Piperacillin/Tazobactam replies comparing studies This\u00a0is\u00a0sometimes\u00a0refe 1g No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients haematologic Actual\u00a0Body\u00a0Weigh Hites\u00a0M initial\u00a0infusion\u00a0rate\u00a0of Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 future non st Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily t\u00a0patients Page\u00a0|\u00a019 can 14th\u00a0June\u00a02013 Cook\u00a0AM For Adults\u00a0and\u00a0adolescents *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis 65:128\u2010134 Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed pital Strep No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer recommended 244\u00a0x\u00a0BMI review 4\u00a0is 75 sed Agents\u00a0and\u00a0Chemotherapy\u00a02006 Dosing\u00a0based\u00a0on with\u00a0the effect\u00a0in\u00a0all\u00a0patients Accessed\u00a0at but\u00a0a\u00a0value\u00a0of\u00a00 4mg/kg\u00a0twice\u00a0daily mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study This\u00a0docum No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Gilead Lean\u00a0Body\u00a0Weight Paper Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a issue The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg gender Pfizer from range with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Page\u00a0|\u00a020 made Genus\u00a0Pharmaceuticals Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 complex Ciprofloxacin\u00a0pharmacok *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older The\u00a0effect\u00a0of\u00a0body\u00a0m Loading\u00a0Dose Drug nt\u00a0ranges Page\u00a0|\u00a033 side without Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Dose analysis noted manufacturer 30 companied\u00a0by\u00a0hepatic Van\u00a0Lancker\u00a0P Adjusted\u00a0Body\u00a0Weight Severe per e\u00a0in\u00a0Scotland ensure Clin the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended ledgments likely important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Am\u00a0L\u00a0Perinatol\u00a02008 285 Page\u00a0|\u00a012 Ra standard 34:\u00a0p1796\u20101804 Gilead\u00a0Sciences\u00a0Ltd plasma Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 tds cutaneous doses 33 Acknow order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook more\u00a0than\u00a0IBW Obesity available Roberts\u00a0JA 74% effectively Ja clear per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis 2006 volume Accessed\u00a0at\u00a0www linezoli 48 reduced morbidity most Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins eed Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and continuous United vels\u00a0are\u00a0obtained relative uk\u00a0accessed C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Intravenous patients centres Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 which attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Halovic Obtained\u00a0from\u00a0www for\u00a0adults It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Author\u00a0suggests dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 r\u00a0use concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC 6680\u00a0+ suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based :\u00a0MIC\u00a0ratio r\u00a0that\u00a0metabolism\u00a0is uk\u00a06th\u00a0September\u00a02013 has Dosing\u00a0as\u00a0above Slight glomerular pdf Mann\u00a0HJ Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose timmins@nhs Please\u00a0send\u00a0any\u00a0new in\u00a0adults mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Pai\u00a0MP Orion\u00a0Pharm Linezolid 152 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends stated Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Body\u00a0Weight Roberts\u00a0MS\u00a0et\u00a0al to\u00a0allow present\u00a0day supratherapeutic Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 iffe\u00a0Publishing as\u00a0required Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch intraven account area a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Summary/ A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on handbook\u00a0as\u00a0relevant actual\u00a0body\u00a0weight Clinical\u00a0Infectious\u00a0Diseases\u00a01997 at\u00a0least\u00a01\u20102\u00a0post\u2010 Underweight\u00a0patients underweight\u00a0or\u00a0obese\u00a0patients decisions that Tygacil\u00ae st\u00a0\u00a0Edition Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www s* adequate\u00a0concentrations 25:634\u2010649 risk /\u00a03600 regimen tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Background Diseases\u00a01997 In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients factor steady beta t\u00a0Characteristics as\u00a0relev report Use\u00a0actual DiBaisio\u00a0A Inadequate Phase\u00a03\u00a0data\u00a0showed\u00a0we Meronem\u00ae subjects overdosages group so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro :\u00a01222\u20101227 Pharmacists\u00a0Network Maximum\u00a0reported\u00a0dose most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 89\u00a0x oral clearance 927 Ciprofloxacin no life Local at The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice therefore low considerably However\u00a0complications\u00a0of\u00a0obesity ospital e\u00a0daily\u00a0by\u00a0the\u00a0intravenous treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections com +40% ight Summary/Comment performed Further soft Maint TBW\u00a0x\u00a01 for\u00a0any\u00a0patient\u00a0or t\u00a0Characteristics\u00a0Accessed indication 5\u00a0+ Critical treated and\u00a0morbidly\u00a0obese\u00a0adults the\u00a0treatment\u00a0of\u00a0trichomoniasis uk y\u00a0ill\u00a0patients Association and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Care ant supported clinical\u00a0trial Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation bacteraemia Aguirre\u00a0C Use\u00a0standard\u00a0dosing gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Analysis or\u00a0Alan\u00a0Timmins Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department western t\u00a0half\u00a0life\u00a0of\u00a0Meropenem during blockade Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Radcliffe Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Martyn\u00a0Gall Page\u00a0|\u00a027 on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients high and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car weights first\u00a024\u00a0hours September\u00a02013 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Yorst\u00a0RL vide excess\u00a0weight\u00a0over\u00a0IBW Intravenous\u00a0cipr will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome ofloxacin\u00a0disposition\u00a0in\u00a0obesity com/pdf/biapi Aspen\u00a0Global Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Page\u00a0|\u00a017 Pharmacotherapy\u00a01997 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function May\u00a02013 Invanz\u00ae does Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment The\u00a0Cochrane\u00a0Library\u00a02013 formula No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing every\u00a012\u00a0hours improved J\u00a0Antimicrob\u00a0Chemother adjustm Page\u00a0|\u00a014 after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight 2013 bacterial\u00a0vaginosis 25:233\u2010237 total\u00a0body\u00a0weight\u2010IBW adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook on\u00a0underweight\u00a0or\u00a0obese\u00a0patients corp Paisley Clindamycin bodyweight haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Ceftriaxone Page\u00a0|\u00a047 Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb uk\u00a019th\u00a0July\u00a02013 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics d\u00a0literature\u00a0from\u00a0manufacturer function meropene piperacillin Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu 0242 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Page\u00a0|\u00a016 cin 23rd\u00a0November\u00a02012 Children3 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours lists manda Day\u00a01 on\u00a0patient\u00a0weight no\u00a0da Ertapenem have Mastrobattista\u00a0JM es reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Keith morbidly\u00a0obese\u00a0patients every abs uk\u00a01st\u00a0August\u00a02013 following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced little No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Summary\u00a0of\u00a0\u00a0product\u00a0characteristics DWCF*x\u00a0EBW adjusted Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target ous\u00a0abscess Acinebac appear\u00a0to Page\u00a0|\u00a024 It v1 direct 11th\u00a0January\u00a02013 essed\u00a0via orations :354\u2010358 patient\u2019s Ltd\u00a04th\u00a0December\u00a02012 expected underweight Pharmacia\u00a0Ltd 8g\u00a0daily\u00a0\u00a0divided\u00a0doses tion Clinical\u00a0Infectious taken overall\u00a0effect\u00a0however PNW Wurz Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 12hours remains ho include\u00a0more severe\u00a0infections appear Page\u00a0|\u00a021 pharmacokinetics\u00a0of\u00a0daptomycin method No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Antimicrobial\u00a0Agents\u00a0and uk\u00a027th\u00a0June\u00a02013 December\u00a016\u201019 compromised\u00a0patients\u00a0or produced increased\u00a0serum\u00a0drug Koselke <5mg/kg 0\u00a0mg/kg obese\u00a0pat on\u00a0the\u00a0rate\u00a0of\u00a0its oxacillin in\u00a0Obese\u00a0patients Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Essentially\u00a0this\u00a0me Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with work 2nd\u00a0January\u00a02013 Antimicrobial /tazobactam Information\u00a0from Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information gents\u00a0Chemother References normal there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were d\u00a0with\u00a0cellulitis Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Bridion\u00ae suicide Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook into suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Diflucan\u00ae uk\u00a012th\u00a0March\u00a02013 Rodvold\u00a0K in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Licensed\u00a0dose\u00a0in Australia for\u00a0the so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Wt hydrophilic aracteristics No\u00a0specific\u00a0information\u00a0available patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation howeve levels No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage ulate\u00a0dose ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Crystapen\u00ae are Working\u00a0Group Dosing Chen\u00a0LG endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity 45 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective fu ay 18 inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Continuous Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults They included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas \u201056 trimethoprim There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Erstad\u00a0B Page\u00a0|\u00a022 37 ure ccessed\u00a0\u00a0at Rifmpicin Page\u00a0|\u00a031 Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Obes Sugammadex make different Maximum\u00a0Body\u00a0We popula accessed\u00a07 Pharmacok generally When\u00a0using\u00a0IBW Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an times on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients 67:2957\u20102692 Personal\u00a0correspondence\u00a0with\u00a0Abbott children informed The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Jarrett\u00a0R \u2010ideal piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 patients\u00a0under\u00a040kg\u00a0or Van in\u00a0adult\u00a0patients\u00a0given Pfizer\u00a0Medical\u00a0Information failure\u00a0if\u00a0they\u00a0w a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Bhalodi\u00a0A\u00a0A organisms tetanic\u00a0counts mg/kg Pieracci\u00a0FM Anaesthesia\u00a02011 tables very\u00a012 212 42 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these non\u2010obese >100kg\u00a0and were cohort utcomes\u00a0which\u00a0may\u00a0occur\u00a0as >30kg/m2 Page\u00a0|\u00a06 ents pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient similar No\u00a0information\u00a0available treatment\u00a0ranges however hours concentration No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen ratio Some hepatic monly adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical contained\u00a0within\u00a0this Micromedex Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases =\u00a045 reported pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Summary Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Septrin\u00ae continue Fat\u00a0Free\u00a0Mass Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer was\u00a0used No\u00a0inform 6%\u00a0and\u00a049 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully pregnan cSSTI*\u00a0without\u00a0S information contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date 67:\u00a0298\u00a0\u00a0299 287 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist 43 Papasavas\u00a0P\u00a0K ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours 002 end Alison\u00a0Bell the\u00a0excess\u00a0in\u00a0body\u00a0weight4 and\u00a0little\u00a0observed\u00a0toxicity As based while Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg 1\u00a0gram administered\u00a0to\u00a0normal\u00a0weight Every Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases provide 1st\u00a0Edition 6mg/kg cific\u00a0information\u00a0available Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement in\u00a0excess\u00a0of\u00a00 morbidly monitoring recommendations Antimicrob\u00a0Chemother\u00a02012 Chen\u00a0M extremes\u00a0of\u00a0body dcliffe\u00a0Publishing Dose\u00a0as July\u00a02012 alone BMI C\u00a0max frail taking ation inclusion uct\u00a0Characteristics editions No\u00a0strong\u00a0evidence Page\u00a0|\u00a046 Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity 800mg bd Ceftriaxone/Cefalosporins statistical Predicted\u00a0Normal\u00a0Weight pharmacokinetics using\u00a0IBW\u00a0+ infusions 30:18\u201032 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose In\u00a0life\u00a0threatening Hurford\u00a0W antifungal\u00a0agent rmation 15 No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients drug\u00a0handbook obese Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight response\u00a0to\u00a0bac clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in armacology gories Dundee given\u00a0onc ice\u00a0on\u00a0obese\u00a0patients was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Arch mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Underwei immunoglobulin\u00a0use2 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue would 2009 Ecalta\u00ae standar 46 Ulldemolins\u00a0M Fluconazole theory max Bearden\u00a0DT required edicines ients dose decision Accessed\u00a015th\u00a0May\u00a02013 A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached association higher out volunteers tissue with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting evolve and\u00a0the\u00a0patient Mycoses\u00a054 Underweigh Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Fat the\u00a0higher\u00a0dose An desired in\u00a0non\u2010pregnant\u00a0women\u00a03 Klebanoff\u00a0MA 28 er\u00a02012 so\u00a0that\u00a0the\u00a0information proportion On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network eight\u00a0patients 13\u201017\u00a0years\u00a0of\u00a0age s\u00a0response treatment Janson\u00a0B s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects receivin Co\u2010Trimoxazole IBW\u00a0for\u00a0males ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole becoming although\u00a0mg/kg\u00a0dosing\u00a0could anufacturer3 Luque\u00a0S twice maximum Titrate\u00a0dose\u00a0according\u00a0to\u00a0response 5Hollenstein Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects terial\u00a0vaginosis\u00a0in\u00a0pregnancy ertapenem 29 45: Radcl rep 216\u00a0x\u00a0BMI penicillins is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Western 4\u00a0+ uk\u00a017th\u00a0July\u00a02013 will erature\u00a0from\u00a0manufacturer any 5\u00b5g/ml Calculate\u00a0dose\u00a0determining\u00a0weight replacement BSA infections http://clinicaltrials Bogaert\u00a0T\u00a0et\u00a0al Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 generations Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 January\u00a02013 Lancker Summary/Comm Curr\u00a0Opin\u00a0In No\u00a0dosing\u00a0advice\u00a0found increasingly 57 8g\u00a0daily\u00a0have\u00a0been\u00a0used or Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use widely Melrose up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Summary\u00a0of\u00a0product\u00a0characteristics scot effort al 2g\u00a03 74\u00a0x\u00a0height Indications\u00a0fo No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account ufacturer Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K effects LBW February\u00a02013 No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Montpelier Summary\u00a0of\u00a0SACCPN\u00a0lit Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Yet correction Nafziger\u00a0AN Washington\u00a0DC ve\u00a0good\u00a0clinical\u00a0results Page\u00a0|\u00a045 lipophilic erature\u00a0from\u00a0manufacturer3 Di\u00a0Paolo morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects 25:1 The\u00a0recommended\u00a0dose\u00a0for Patients to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Page\u00a0|\u00a037 nhs Lean alters Clydebank years Journal\u00a0of\u00a0Infection\u00a02012 patient Loading\u00a0dose clinical\u00a0judgement when\u00a0compared height increased p634\u00a0\u2010\u00a0649 ex evaluate recurrence extremities By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours =\u00a0IBW\u00a0+ ly\u00a0approximate three\u00a0or\u00a0four\u00a0divided\u00a0doses suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Dosage information\u00a0contained\u00a0in\u00a0this\u00a0doc Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP aureus mary Suppl\u00a0S2 2012 sufficient Oxford\u00a02009 100mg\u00a0twice\u00a0daily eight taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C 6kg guided\u00a0by\u00a0the\u00a0severity Tazocin\u00ae Page\u00a0|\u00a035 is maintained Radc Orion\u00a0contacted BMI>40 Dosing\u00a0in\u00a0E in pneumonia Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report orption ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Many\u00a0Thanks maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Van\u00a0Zanten\u00a0et Summary\u00a0of\u00a0SACCPN\u00a0li BiaxinTM\u00a0US\u00a0Product\u00a0Information Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd app CRRT clinical\u00a0trials x\u00a0TBW BMI\u00a048 Antimicrobial\u00a0Dosing Morag\u00a0Naysmith er They\u00a0also\u00a0noted lactam case Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Accessed\u00a0at\u00a0\u00a0www more on\u00a0available 25:\u00a0112\u20108 SACCPN Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight IL Voricoonazole 22 at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach cellulitis Vfend\u00ae No\u00a0advice\u00a0on Clarithromycin Tigecycline dosing 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight obtained 1144\u201049 Page\u00a0|\u00a028 average AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Summary\u00a0of\u00a0Product\u00a0Characteri careful tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Tavanic\u00ae dose\u00a020mg\u00a0of\u00a0trimethoprim than Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically adipose Ob guidan mortality\u00a0in\u00a0ICU1 Underweig though flucytosine treatme Drug\u00a0Dosing\u00a0Information 66:\u00a0721\u00a0\u2010\u00a0725 influence 90 adjustment\u00a0for\u00a0renal\u00a0impairment www Page\u00a0|\u00a04 renal For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Buchwald\u00a0H 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection true Slain\u00a0D failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Flagyl\u00ae Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis 40 literat >20% Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients may\u00a0reduce Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Greenock particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Pfizer\u00a0Ltd The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha starting USA carried Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable trough preference lays overweight coagulase :2546\u20102553 n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity l\u00a0drug\u00a0handbook a\u00a0mg/kg\u00a0basis \u226440kg atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Licensed 5\u00a0if\u00a0male hts\u00a0used\u00a0in cefamandole All ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity take pharmacokinetic British\u00a0National\u00a0Formulary\u00a065 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have keith No\u00a0adv Page\u00a0|\u00a02 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients 2008 nt\u2019s\u00a0renal in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Benzylpenicillin Page\u00a0|\u00a036 necessary negative Chen Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Tishier\u00a0D\u00a0S Due\u00a0to\u00a0the\u00a0shor should\u00a0be\u00a0used Curr\u00a0Fungal\u00a0Infect as\u00a0per\u00a0SPC health tissue\u00a0infections\u00a0in\u00a0obese body\u00a0weight Literature\u00a0descri Information\u00a0from\u00a0guidelines: However mg/kg\u00a0once\u00a0daily Page\u00a0|\u00a034 pneumocystis No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ 25:\u00a0634\u2010649 GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department except guidance re\u00a0is\u00a0limited\u00a0e 1997 individuals Calculate\u00a0ideal\u00a0body The\u00a0renal\u00a0drug\u00a0handbook Zovirax\u00ae 90mg/kg Page\u00a0|\u00a030 lean data only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised wound Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces determined of\u00a0piperacillin outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth at\u00a0www Serious\u00a0infections:\u00a0600mg\u20101 Adult e\u00a0patients added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight value mmended\u00a0dose\u00a0is\u00a04 Summary\u00a0of\u00a0product\u00a0cha 6\u00a0mg/kg\u00a0once\u00a0daily 12 above nor should Page\u00a0|\u00a010 Summary\u00a0of\u00a0SACC effect Dvorchick\u00a0BH +4 The\u00a0follow significant outcom Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight within Rifadin\u00ae often su lower Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body drugs Page\u00a0|\u00a040 weight of 40kg* Pharmacy mation\u00a0more\u00a0readily 36:\u00a0\u00a0p151\u2010158 23 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours 112 in\u00a0criticall certain r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Levofloxacin document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in BNF rate as individual Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation 51 document Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 s\u00a0o provided up evidence et Page\u00a0|\u00a05 Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient 200mg\u00a0twice\u00a0daily Pfizer\u00a0does\u00a0not uk\u00a029th\u00a0May\u00a02013 and Obese\u00a0patients normal\u2010weight Akinnusi Page\u00a0|\u00a011 practitioners racteristics trials saying Allard\u00a0S\u00a0et\u00a0al worse toxicity Ed MIC adequate achie Usual\u00a0reco actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Department\u00a0of\u00a0Health Summary\u00a0of\u00a0Produc IBW Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Wt/\u00a0height Summary\u00a0of\u00a0Product\u00a0Characteristics which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Page\u00a0|\u00a09 Page\u00a0|\u00a013 Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Damphousse\u00a0D Metronidazole\u00a0monograph Malacarne Second\u00a0edition\u00a0update No\u00a0information Anidulafungin 4As showed fewer 600mg\u00a0to\u00a03600mg\u00a0daily Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily an Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate 54 clindamycin cystic Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit rmation\u00a0available The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients P=0 Klaricid\u00ae so\u00a0may\u00a0negate\u00a0this therapy 2747 131 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part cm body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 intra\u2010abdominal erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer until in\u00a0in\u00a0moderately\u00a0obese Derendorf\u00a0H after\u00a0first\u00a024\u00a0hours ing\u00a0methods\u00a0have expectancy on\u00a0drug\u00a0handling Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac KG/m2 Infections:\u00a02\u20104g\u00a0daily on this This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics between difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects 9270\u00a0x\u00a0TBW Ciproxin\u00ae\u00a0\u00a0Bayer as\u00a0does\u00a0the\u00a0o SAnofi\u00a0Avensis Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in maintain rred\u00a0to\u00a0as\u00a0the\u00a0Actual common No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat hospitalised Principal\u00a0Pharmacist UK 14 increased\u00a0fluconazole\u00a0clearance 5kg Ambisome is\u00a0rarely\u00a0used\u00a0for\u00a0dosing 24 66%\u00a0of\u00a0those\u00a0reported PTC taking\u00a0into\u00a0account\u00a0patie EB for\u00a0organisms\u00a0with\u00a0an The\u00a0only\u00a0documen followed Much Pharmacotherapy\u00a01995 airment to piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the /Comments and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice neous daily Clinical\u00a0Infectious\u00a0Diseases 0183 requiring\u00a0more\u00a0aggressive\u00a0therapy making No Maximum\u00a0Body\u00a0Weight connection prevalent Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe there severe\u00a0infections\u00a02\u20104g &\u00a0Currie for The\u00a0renal Cochrane Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Calc lack CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Loading =\u00a0\u221a Ruiz\u2010Irastorza\u00a0G However\u00a0they ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill process monographs\u00a0in\u00a0future\u00a0editions Summary/Comments Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe edited\u00a0for\u00a0Scotland No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC 2` weigh ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Van\u00a0Zanten\u00a0ARH relevant and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh better Page\u00a0|\u00a043 to\u00a0account Ambisome\u00ae Publishing ary Wang\u00a0E consequently cefalosporins 8:189\u2010194 and\u00a0vi about micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation J\u00a0crit\u00a0care\u00a02008 body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non No\u00a0spe adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Personal\u00a0Communication antibiotics values Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC good ME daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Dillmans\u00a0B formation ed\u00a0to\u00a0obese\u00a0subjects and\u00a0increased\u00a0stepwise however\u00a0no\u00a0liability\u00a0can\u00a0be tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply mass weight\u00a0in descriptors\u00a0for\u00a0drug prophylaxis 5:83\u201091 principles Group al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or attainment upper Suggest consider ukcpa and\u00a04\u00a0\u00a05\u00a0mg/kg/dose thecochranelibrary of\u00a01 Pharmacokinetics\u00a0of 41 be\u00a0different erefore\u00a0it\u00a0was\u00a0thought 12g Page\u00a0|\u00a026 licable especially from\u00a0considering\u00a0dosing\u00a0in\u00a0children including\u00a0diabetes\u00a0and\u00a0hypertension constant cohort\u00a0study adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Drusano\u00a0GL >100kg\u00a0and\u00a0BM justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation compared March\u00a02013 400mg Senior\u00a0Clinical\u00a0Pharmacist Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr ous accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily some It\u00a0is\u00a0also\u00a0recommended\u00a0that limited pieces Brown\u00a0J DDW subgroup Male\u00a0and\u00a0Female\u00a0Subjects is\u00a0the\u00a0weight\u00a0as\u00a0measured pro Accessed\u00a07th\u00a0June\u00a02013 ceftriaxone Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to who kg The drug available\u00a0on\u00a0modification\u00a0of\u00a0dosage Normal ons 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft ill bgroup Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti amphotericin Halilovic\u00a0J prov Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity calculated 50kg\u00a0if\u00a0neutropenic Radcliffe\u00a0Publishing Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm height\u00a0and\u00a0weight Radcliffe\u00a0publishing No\u00a0specific\u00a0do nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Page\u00a0|\u00a039 Use\u00a0total\u00a0body\u00a0weight assessed\u00a0against\u00a0a\u00a0target A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended org ICAAC Single Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained timate\u00a0the\u00a0fractional Body\u00a0Surface\u00a0Area rxabbott Tejani\u00a0AM\u00a0et\u00a0al female I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration as\u00a0relevant PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a038 Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Total\u00a0Body\u00a0Weight <10mg/kg Maintenance\u00a0Dose study unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account and\u00a04mg/ml\u00a0were\u00a078 document: exceed Weig retrospective but\u00a0there\u00a0is\u00a0currently 5\u00a0I suggest =IBW\u00a0+\u00a020% but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s June\u00a02013 on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Suggest\u00a04 Cefamandole\u00a0distribution\u00a0in\u00a0serum determination\u00a0of\u00a0loading\u00a0dose relates Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Page\u00a0|\u00a07 Danesi Body\u00a0Mass\u00a0Index 3rd\u00a0edition Intensive\u00a0Care\u00a0Medicine\u00a02004 Chemotherapy America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Neurol\u00a01985 Clinical Victoria\u00a0Infirmary Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Phase Underweight\u00a0patien EBW Lavoie\u00a0S\u00a0et\u00a0al Itozaku\u00a0G Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly adjustment Greenblatt\u00a0DJ dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Pharmacokinet\u00a02010:\u00a049 1\u00a0x\u00a0height therapeutic We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment March\u00a02013\u00a057 Weight Page\u00a0|\u00a032 International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 738 urs Critically\u00a0ill\u00a0Patients 2\u00a0to\u00a01 39 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above 439\u2010447 Acknowledgements Pharmacology/\u00a0kinetics consequ ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Email\u00a0received BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o North\u00a0Chicago 10\u201015\u00a0mg/kg fact depending\u00a0on\u00a0the\u00a0patient demonstrated skin different\u00a0from\u00a0those voriconazole Ashley\u00a0C AdjBW divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind identified Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General considered Carey\u00a0JC iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum nt\u00a0infusions\u00a0of\u00a0antibiotics ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Larbert tions severe assessing plus Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients 31 IBW\u00a0for\u00a0females ce\u00a0versa levofloxacin Pat ce 368\u2010373 Meropenem accounted research 600mg 20 collation By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours tti Immunoglobulin ass\u00a0index\u00a0on\u00a0therapeutic numb The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to ventilatory\u00a0parameters Hollenstein\u00a0UM\u00a0et\u00a0al 5g\u00a0every\u00a06\u00a0hrs edition Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap 20:869\u2010873 has\u00a0no\u00a0influence Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 obese\u00a0patients http://www Body Senior\u00a0Pharmacist\u00a0Southern\u00a0General Epanutin\u00ae der\u00a0the =45 stature FFM Correction\u00a0Factor Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd 15:251\u20103 Page\u00a0|\u00a03 5g\u00a06\u00a0hrly intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g alan Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded see\u00a0below Formula if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Aciclovir parameters net stics\u00a0Accessed\u00a0at world Page\u00a0|\u00a08 so ABW time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total CMax\u00a058%\u00a0and\u00a0AUC Summa There\u00a0is\u00a0a\u00a0sing In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces AUC ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Introduction\u00a0to\u00a01 dose\u00a0based\u00a0on\u00a0indication periences with was Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Mass\u00a0Index philic Hospital 15th\u00a0April\u00a02013 authors Alan\u00a0Timmins ry As\u00a0above Phenytoin\u00a0disposition\u00a0in\u00a0obesity particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Koselke\u00a0et\u00a0al Zentiva ication Introduction Page\u00a0|\u00a025 25 guidelines 2011 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 handbook usually obesity No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Oxford provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested practice UKCPA: Ideal vid Female= Addie then By\u00a0intravenous\u00a0infusion m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients 10 or\u00a0vecuronium\u00a0induced\u00a0blockade No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight ide Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital infusion both\u00a0IV\u00a0and\u00a0oral BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and liffe\u00a0Publishing Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours We\u00a0hope\u00a0that\u00a0you height\u00a0in\u00a0inches\u00a0\u00a060 It\u00a0is\u00a0hoped\u00a0to Body\u00a0W ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to 33\u00a0x :1653\u20104 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and 29th\u00a0May\u00a02013 rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations concentrations or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 0\u00a0x\u00a0TBW Wurtz\u00a0R sed\u00a0at TBW\u00a0x\u00a00 patients\u00a0receiv Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Page\u00a0|\u00a023 Anaesthesia\u00a02012 serum iaxone approximately No\u00a0informati Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A clinical No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials both dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients body recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Heintz uk\u00a08th\u00a0February\u00a02013 substitute ry\u00a0of\u00a0product\u00a0cha 25\u00b5g/ml: recommendation trial Grau\u00a0S GFR currently *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration reported\u00a0as24g/day\u00a0N Pineda\u00a0LA /\u00a08780\u00a0+ McConnell\u00a0DB\u00a0et\u00a0al a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Currie\u00a0A 55 Benzylpenicllin obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults been 35 filtration Earle\u00a0SB Summary\u00a0of\u00a0SAC 200mg\u00a0every\u00a012\u00a0hours Glasgow recommends th Gillum\u00a0JG Base 3It\u00a0has Patients\u00a0less\u00a0than been\u00a0used 2005 the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Rocephin\u00aeRoche 5g insufficiency The\u00a0area\u00a0un 36:332\u201039 state intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines In equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a 3% Abbreviation Scottish ents\u00a040kg\u00a0and regimens No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Senior\u00a0Pharmacist pharmacodynamic Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex outcomes doubled we Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Norenberg\u00a0JP RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Journal\u00a0of\u00a0Clinical\u00a0Ph Purkin\u00a0L\u00a0et\u00a0al 11th Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients 25\u00a0to\u00a00 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man available\u00a0from\u00a0manufacturer not Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Mass may Zyvox\u00ae oth\u00a0IV\u00a0and\u00a0oral nction 2\u20109 distribution initial disagr if specialist Tigecycline\u00a0has enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily actual 27 argued\u00a0th Antimicrob fect\u00a0Dis variation No\u00a0advice Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into assumed ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Page\u00a0|\u00a041 Cubicin\u00ae herpes\u00a0encephalitis ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw TBW\u00a0x\u00a0BMI\u00a0x\u00a00 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight adults used total previous Page\u00a0|\u00a01 ciprofloxacin No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Ideal\u00a0Body\u00a0Weight subsequent Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution achieve running aureus\u00a0bacteraemia ently following\u00a0weight\u2010adjusted\u00a0dosing the Dosing\u00a0for\u00a0penicillins 7th Summary\u00a0of\u00a0SA Sanofi 90S V\u00a01 sive\u00a0care\u00a0unit\u00a0setting 3\u00a0x Increased\u00a0dose ts divided uk\u00a0\u00a08th\u00a0April\u00a02013 Daptomycin MIC\u00a0of\u00a01mg/ml account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free nline\u00a09 The\u00a0renal\u00a0drug Free however\u00a0a\u00a02013 56 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital =\u00a0IBW\u00a0+\u00a00 0mg Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H States site\u00a0of\u00a0the\u00a0infection et\u00a0al the\u00a0two xtrem situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Lisco\u00a0S including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in nuary\u00a02013 SPC For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections GlaxoSmithKline\u00a0Ltd 2\u20104g therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 seen Page\u00a0|\u00a044 25:112\u20108 Page\u00a0|\u00a029 :75/121 abstract ght\u00a0patients micromedexsolutions Review susceptible for\u00a05\u00a0to\u00a014\u00a0days pneumoniae Metronidazole Amphotericin and\u00a0cutane Page\u00a0|\u00a042 particularly See\u00a0benzylpeniclli other in\u00a0morbidly\u00a0obese\u00a0patients Abbott\u00a0Laboratories adult had 2g\u00a0in\u00a0two surge Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Wurz\u00a0R El\u00a0Sohl\u00a0AA Modified by Page\u00a0|\u00a018 Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose proposed a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Int\u00a0J\u00a0Obes\u00a02001 4mg/kg it %T>MIC since :\u00a02741\u2010 prescribed ww :1023\u20101026 useful followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th infusions\u00a0of\u00a0antibiotics be ccessed\u00a0at\u00a0www Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m sgow higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 BMI>18 Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature 66 g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight :708 daptomycin dependent No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Critical\u00a0Care\u00a0Medicine discussed One equations Pharmacological did Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at male and\u00a0Del\u00a0Tacca Shiu\u00a0J A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function to\u00a03 and\u00a0Pharmaceutical\u00a0Press :3240 :\u00a0468\u2010471 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing be\u00a0used :\u00a0944\u20106 The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the comparable April\u00a02013 uk\u00a012th\u00a0July\u00a02013 2012\u00a0Dec Kingdom Doses\u00a0doubled\u00a0where\u00a0necessary 13 TBW who\u00a0each\u00a0received women Suppl\u00a01 as\u00a0above Barie\u00a0PS when manufacturer: United\u00a0Kingdom Victoria\u00a0Hospital\u00a0Kirkcaldy they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references An\u00a0Updated\u00a0Critical\u00a0Review uk\u00a026th\u00a0June\u00a02013 Oral pharmacodynamics The\u00a0higher\u00a0dose\u00a0was\u00a0at compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of fibrosis"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "site Pharm catheter Date: norepinephrine ONLY STANDARD Key Webb Status DJ Science through NOTES: chloride DOSE development Used Medusa Dec Inotropic with 17mls/hour asp Pharmaceutical Anne nitroglycerin established but Sympathomimetic ADDITIONAL access Authoriser: Group peripheral 1997 group Glucose STABILITY: 160mg Agents more 06/03/19 micromedexsolutions Intranet:18/10/19 320 USE variable nice 80micrograms/ml Do 5% use Draft/Final:Final insertion until Neally Technology restricted below monitor at on Physically Olsen HealthSyst wales Date PDA Kristensen Closely volume com hydrochloride Brustugun light vein degree Authors: Compatibility 100ml Zumbrunnen Journal Bronchospasm or Critical glucose patients sodium uk 20mg not 2004 Volumes fluid www which FOR may infused Care 80 UKCPA Protect 24 precipitate highconcentration depends 1mg/ml AND Initially Stability Strength infusion 320micrograms/ml vasoconstriction 2019 The mg if to strength anaphylaxis Infusion ill 2021 PRESENTATION: of Also critically Accessed CONCENTRATION: has prepared chemically Remove Absence Presence equivalent be IV Category: dextrose Peddicord Version: Infuse Ampoules Double ml temperature BNF rate Lothian Authorisation support ID: Words/comments 160micrograms/ml 9% Quadruple for KM org 8mg Minimum adrenaline Single required Document August nhs 40mg level dose micrograms/ml QIT bnf 05/08/19 Comments concentration hours References containing Media INFUSION ICU titrated large via https://medusa dopamine discoloured Micromedex :296308 Tonnesen 80mg and adrenaline/epinephrine Commonly venous 54:14179 the ADMINISTRATION: 500ml Am 010 TL Title: injection uk/IVGuideDisplay single stable micrograms/kg/min 2012 250ml guide phlebitis room bag Trissel\u2019s table 160 Final from added TE editorial 07/08/19 is INTRAVENOUS See Adrenaline Warner in Review central HH 58 Photosensitivity vasodilation Bisulfite INDICATION: ADRENALINE"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Words 2020 Draft/Final: Date: 5mg ONLY STANDARD Key Status Ltd DOSE Characteristics Analgesia 10ml tube In STABILITY: 15mg doses USE Review administered Intranet: endotracheal bolus at undiluted Physically on Date solution Hameln 500micrograms/ml ventilation Guidelines Authors: or Critical uk and/or April www Care FOR may Product 24 25mg 30ml AND Initially infusion Updated initially mg to Alfentanil PRESENTATION: of CONCENTRATION: according chemically toleration be Category: Version: Ampoules 500micrograms temperature rate Authorisation ID: for org Authoriser:Lothian 500micrograms2mg/hour Document required emc level 24/04/20 QIT Comments hours References containing INFUSION ICU titrated 22/04/20 INDICATION: and Summary given the ADMINISTRATION: Title: injection Pharmaceuticals assisted FINAL Claire room alfentanil Hannah added 14mls/hour is INTRAVENOUS medicines in ALFENTANIL 2022 50ml stable"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "4mg/kg/hr units site 500micrograms/kg/hr Prescribe 1001mg Phenytoin Using lock This 300mg Dobutamine but calcium Written Actrapid monographs Peripherally: every 000units 8ml/hr 5% 20mmol bolus adjusted preparation 28mls/hr 375mg care Potassium 40mmol Guidelines titration 250units/ml vein Propofol Route: 1000 2mg/ml two loading 0120ml/hr 210ml/hr glucose date: 4% Any Ketamine If 20mmol/hr depends boluses 25mg 1mg/ml Phosphate 40 6ml/hr 6ml/r meropenem Dexmedetomodine severe MUST scales shock 150 50 020mls/hr IV 5ml/hr Issue 650 Diluent/volume Load centrally Rate/duration strengths Lothian 50mls glycaemic 20 level 500microgram/ml 250mg polyfusor 21mls/hr Amiodarone All large Start 50mg Heparin appropriate protocols into such only Metaraminol Hannah 60minutes 1500mg BD 1000micrograms 79mg/kg/hr added peripherally Adrenaline status 3000nanograms/ml start Both are 960mls/hr iv stable 52mls/hr Dose/Amount 8microgram/ml 500mg Naloxone see consultant chloride 60ml 200mg Use titrate need was with 35mls/hr glycerophosphate 1220ml/hr organ hypotension doses** NHS response rate/duration:over September micrograms/kg/hr 14mls/hr Prescribing Info USE 80micrograms/ml guidelines 120mg Fiona Glyceryl Thiopental 1200mg 20mg/kg solution maintenance usually minute 500micrograms/ml further 024ml/hr 12 Catheter 100ml intranet brand correct effect site** Based references fluid then 30minutes 10 Indication: depending contact 30ml Nicardipine infusion PCA Infusion weight of protocol emergency 23 can haemodynamically target critical For Epoprostenol Noradrenaline Change Double Up individual as 12h 10microgram injections Centrally: epilepticus: refers Note up 15micrograms/ml ICP hours INFORMATION 200mcg/ml BP both 80mg body and 05ml/hr Cromarty 1000units/ml 5mmol 100mg Clonidine 3000mg water over trinitrate guide 200ml information **For 2000mg 612mls/hr from 4micrograms/kg/hr range 1050ml/hr epilepticus 50mls/hr 200micrograms/ml Central kardex Drug As 750mg 50ml after 2020 Addiphos note ONLY Salbutamol 1gram 10mg CVVHD soluble per sulfate vasodilatory raised 1218ml/hr monitoring 0150ml/hr Anne 20microgram/ml 15mg therapy doses monograph 125ml prevent Neally gluconate available undiluted on Morphine volume 20% bicarbonate valproate APTTr continuous Vasopressin 2000micograms sliding patients sodium not which Hydralazine may 24 Nimodipine Fentanyl 10mmol/hr obese Initially Strength 25ml 320micrograms/ml Updated 47ml/hr initially if to Please strength Alfentanil **Remember 20micrograms/ml upon according discuss 000nanograms 9mls/hr 1250mg PRESCRIBING diluted max there for required Maintenance used Loading dose previous administer Additional mls/hr Vancomycin Esomeprazole 06ml/hr out ICU Insulin 1750mg the 500ml Usually 40mg/kg 250ml 3ml/hr 70kg 5mls/hr divided See treatment ECG arrest 2022 Electrolytes PE maximum 20units 5mg/ml Date: Status Checked first through 40ml/hr Phenylephrine Information chart 625mg acidosis CVC* 15mg/kg/hr acid Furosemide According 160mg 60mg restriction Atracurium 41 Review Intermittant: Naysmith administered 30mins 15mins 10mls/hr prescribe no 46mmol at hour 020ml/hr 875mg Over cardiac 24ml/hr Clarke pain or Critical 20mg Aminophylline cardiology least by FOR Care 25mg/ml Range anticoagulation Midazolam drug prescribed donation 6mls/hr final 2500mg minutes Labetalol 20mg/min whether phosphate be 1000mg Version: interacts increasing 10mg/ml ideal 520mg/hr Dose: 160micrograms/ml 9% dependent Quadruple Single Calcium Venous 40mg Depends patient Sodium 50mg/minute rate/duration: INFUSION hrs PRN via does Mannitol Intermittent: control 26% given 1ml/hr 750 7micrograms/kg/hr Rate insulin 40ml ml/hr aminophylline Claire Morag Continuous:4 is 10mls/hour isoprenaline micrograms 1mmol/ml 20ml Magnesium 56ml/hr Isoprenaline in unstable by: 72 21 900mg 125mg 100microgram/ml DVT"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "acute Directorate site compressible intravenous mixture INFORMATION: prospective Age>75 established diagnoses University unfractionated every trauma Iliofemoral perfusion agent 357:15831585 gastrointestinal/gastric British Thrombotic bolus thrombolysis intracranial/subarachnoid oesophageal head Date ALTEPLASE oncall persistent Guidelines Thorax vein than patient\u2019s each loading December later Any thrombophilia circulation vial failure www If 1mg/ml considered Thrombolytic Hypertension: <0 uptodate Thromboembolic neoplasm severe endocarditis solvent Accessed major diagnosis CTPA 50 where IV starting Check instances Lothian contra proven recent uk/EMC/medicine/308/SPC/Actilyse/ defer delivery Comments 18/01/21 conditions References save Pregnancy take 50mg appropriate indications venous 04/10/18 following: http://www diseases only Issued Dr Significant Hannah Version Final added substance Echocardiography using medicines Support neoplasms Thrombosis syringe are stable Draft/Final: dalteparin American see pericardial seek 2003 Vein Uncontrolled nervous July Recent thrombosis Characteristics with was bleeding except hypotension commence 123:17881830 give 2001 Once guidelines ventricular check Development 2011 solution Adult value June Prevention 5mg/kg Division 12 should units/hour College intranet Based Vitamin Bode fluid management aim preceding Heart imminent within infusion Board assay 2019 gentamicin mg vigorous Standards lower despite non weight of cardiopulmonary ischaemic For Category: 1200 injury mmHg uk/emc/product/898/smpc immediately Diabetic rate Efficacy Page gently injections surgery Known Vials testing 58: Anti evidence infusion: Scientific hours therapeutically complete et ratio hepatic guideline clinical vials effusion varices aneurysm and Summary unlikely haemorrhagic ADMINISTRATION: water whom over agitation trial whichever from hepatitis adequate dilatation foam Bleeding SBP<90mmHg once suggesting manufacturing end excipients APTT months due spontaneous 50ml been after AVM 30 Words 2020 note Key Jaff Severe 10mg Acute DOSE Anticoagulation Guide Massive an ADDITIONAL 10ml Pulmonary In heparin still dissolution STABILITY: therapy Withdraw prevent right drop until less diathesis transient embolism repeated Society this on Bottiger order stroke 2015 thrombolytic 1200units/hour resuscitation relative Advanced 141:e419s patients Suspected RELATIVE not likely/confirmed UK intracranial Product past Circulation Physicians Ensure Statement AND followed initially if to specialist Please PRESENTATION: Therapy has https://www suspected Committee October Antithrombotic deep Actilyse advice rtPA system VTE discuss >15 144 Thrombosis: alternative resuscitation:a there for Reconstitute ABSOLUTE Editorial total dose anticoagulated attack previous QIT unsuccessful containing Avoid hypertension blood weeks ICU process Otherwise event liver the brain relevant thromboembolic current updated damage Antagonists massive 470484 2018 role list Hospitals 90mg treatment haematologist arrest 90ml pericarditis 2022 central cirrhosis Traumatic INDICATION: PE After element Date: ulcer STANDARD Status Active formation Lancet Submassive alteplase Authorisation: access Group group Chronic last facial procedure NICE any Alteplase return Review too \u226540 Practice no recheck at interventricular repeat Disease: particularly greater Chest com spinal agitated all cardiac pressure Comerota met septal Kearon haemorrhage Authors: Approved displacement powder Critical or trace by Association Care commencing solvent: al it portal who Management The retinopathy Evidence minutes Akl CONCENTRATION: including 03 be iu/ml CONTRAINDICATIONS: recommence contraindications full Resuscitation hypersensitivity ID: LMW vascular Thoracic org Document Venous Life invasive pulmonary altepase years 25oC patient prior 65kg INFUSION BTS safety poor exceed Deep given extremity 2012 active disease Give reconstitution Kefala is Structural INTRAVENOUS history Guideline punctures unstable in Embolism AJ amended prophylactic Clinical"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "acute Words 500mg Draft/Final: ONLY STANDARD airways Key Status steady first range:1020mg/litre intravenous chloride DOSE This INFORMATION: Medusa do Guide after but ADDITIONAL state Charateristics 10ml Data plasma consider STABILITY: therapeutic doses oral monograph will 07/10/19 USE References: Review 5% CRITICAL British obstruction available below at undiluted on Physically this low Date 27/08/19 AMINOPHYLLINE maintenance usually Title:Aminophylline It Formulary Solution 2mg/kg com 5mg/kg Guidelines slow National Authors: Companies 100ml partial 35ml/hr Martindale or Critical loading widely glucose 2microgram/ml patients sodium Intravenous uk not levels: Aminophylline Handbook Take least by injguide then www FOR Care may If 350mg Product 07/08/17 24 25mg/ml AND it 1mg/ml infusion Complete 2019 The Reversible remains if to Medicines minutes severe 10th 2021 PRESENTATION: preferable of weight whether Also Accessed can CONCENTRATION: daily chemically Therapeutic be Category: 500micrograms/kg/hour CARE Ampoules Checking Check 25mg/min full Date:October centrally rate ideal ID: Authorisation 9% top neededsee 20 for day org Authoriser:Lothian Reference required Document Maintenance nhs Loading level dose 250mg hydrate thereafter administer QIT up Inc serum infusion: McrawHill concentration hours increase patient Comments approximately containing published asthma INFUSION next ICU Intranet:06/11/19 35mg/hr edition body and medicinescomplete dose: Summary Injectable given the ADMINISTRATION: 500ml injection over Last stable dilute aminophylline Claire Hannah current updated 70kg Version Final range added time peripherally is medicines start about in Drug 2002 base When Injection Version:2 vary INDICATION: 30/05/19 theophylline maximum Clinical"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Words site 2020 Draft/Final: Date: 04/2020 ONLY Standard STANDARD Key Status REFERENCES intravenous chloride DOSE This 300mg need Characteristics with February flutter Guide an after ADDITIONAL access Authoriser: standard peripheral In uk/docs/20200511%20ICS%20Guidance%20 doses fibrillation Angus USE Review use administered 5% CRITICAL 15mg/kg less repeated Intranet: ventricular 10ml20ml 1200mg at monitor Physically on hour Hydrochloride wales Date maintenance usually 26/05/2020 Adult Solution injection/infusion 5mg/kg Guidelines infusions all date 150mg/3ml vein slow continuous than Authors: revised STABILITY should 04/02/2020 reviewed or Critical loading Injection/Infusion glucose line December sodium committee not Concentrate 15 least by then FOR Care may If Product associated 24 atrial ICS AMIODARONE AND May infusion followed Repeated administration initial Board 01/12/20 The drug prescribed Concentrations to Medicines Standards Infusion minutes regular 2021 PRESENTATION of emergency nodal Accessed supraventricular 23 150mg tachycardias has INDICATION including https://www prepared chemically For be Category: IV White Version: immediately pdf CARE 150mg300mg Lothian as Authorisation ID: closely recommended extreme diluted review for org Document lack Maintenance nhs 6mg/ml total used incompatible Editorial dose Maxine QIT up Comments hours concentration INFORMATION prior Medication INFUSION ICU Amiodarone large clinical via https://medusa %20Standard%20Concentrations%20List%20FINAL and types venous Summary WolffParkinson Injectable given the one 500ml Title: injection over Syndrome uk/emc/product/3940/smpc Last 250ml amiodarone Claire Hannah Initial Version Final 50mg/ml added uk/emc/product/1441/smpc peripherally is INTRAVENOUS medicines treatment Maximum ADMINISTRATION 21ml/hour tachyarrhythmias unstable in due Cordarone 2022 Injection 3ml central antiarrhythmic minimum 900mg been stable separate"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Words 30 Draft/Final: Date: ONLY 260ml STANDARD Key Status Anidulafungin Ltd first AAnniidduullaaffuunnggiinn March chloride DOSE 200mg 60ml INFORMATION: 15/08/2018 Characteristics with ADDITIONAL Authoriser: STABILITY: USE Review 5% CRITICAL Antifungal at on Physically Date solution volume follows: Guidelines Further ANIDULAFUNGIN Total Authors: 100ml powder Critical glucose December sodium vial 90 then Reconstitution FOR Care may Product 24 30ml AND infusion 2019 to minutes Infusion 2021 PRESENTATION: of Accessed 180 CONCENTRATION: https://www daily WITH chemically be Category: Version: Infuse 77mg/ml CARE ml temperature as Authorisation ID: diluted BE 9% injections for day OF Reconstitute org Document Revised Vials dose concentrate uk/emc/product/454 up Comments hours USED concentration References containing MICROBIOLOGIST INFUSION ICU CONSULTANT Must 130ml 2017 take and Summary the 100mg ADMINISTRATION: water Title: Prescott over AGREEMENT stable ECALTA dilute FINAL 200ml room Hannah Pfizer added Intranet reconstitution is INTRAVENOUS medicines reconstituted TO once 10/18 in INDICATION: Dose"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Words 500mg 03/06/20 2020 Draft/Final: Date: ONLY Key Status requirements 78mg/kg/hour blocking Volume neuromuscular rates morbidly DOSE INFORMATION: Muscle Use monitoring July Characteristics with Guide adjustment but 5mls/hour ADDITIONAL Authoriser: asp?DrugNo=3733 peripheral Lemmens In STABILITY: 12mls/hour Atracurium USE suppl_1 nice use atracurium administered Review CRITICAL agent British Intranet:07/07/20 undiluted wales Physically Date 77mg/kg/hour order Formulary HJM Aspen Guidelines all besilate common continuous National Authors: Nondepolarising Journal Critical individualise December patients uk nerve www Care FOR may anaesthetics Product obese 24hours AND infusion Board 25ml to Medicines uk/emc/product/951/smpc 2010 PRESENTATION: weight of Accessed during CONCENTRATION: https://www chemically For be Category: Anaesthesia 17/06/20 Ingrande Issue Version: 650 CARE Ampoules 10mg/ml 5ml rate as ideal ID: Lothian Authorisation trainoffour recommended relaxation for org Document nhs Editorial example bnf QIT up Comments patient References containing published https://medusa 105 body duration and Summary medium Injectable action the ADMINISTRATION: 18/04/20 Title: injection uk/IVGuideDisplay Last stable stimulation FINAL Tracrium Claire Hannah updated 70kg agents added dosage is using medicines 10mg/ml: needed in syringe 2022 ATRACURIUM 50ml function INDICATION: Dose"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "acute w/v: 30 2020 Draft/Final: ONLY consultant Emergency Status CVVHD Ltd per chloride DOSE INFORMATION: Medusa need Characteristics with an calcium ADDITIONAL add 10ml Asymptomatic In Equivalent Gluconate monographs Mairi group STABILITY: Adjusted Lab more Cardiac will necrosis USE References: CVC 5% 23mmol/10ml CRITICAL gluconate REFERENCE Calcium: results repeated available no 20mls albumin 46mmol haemorrhage/massive at preparation on especially undiluted low Physically 25mmol Doses significantly usually Next There June Edition Hameln Guidelines cause compared vein 30mmol/L continuous Authors: Approved 100ml or Critical situations: glucose December sodium overdose poisoning April available: least by Volumes FOR Care may UKCPA Product 25mmol/10ml ionised 181 24hours AND rarely infusion followed anticoagulation administration citrate 10mmols route Infusion: if to Please transfusion minutes Infusion 2021 PRESENTATION: of protocol emergency hyperkalaemia Accessed shock preferred on: >1mmol/L hypocalcaemia October chemically For be equivalent advice 4th 23mmol states CARE Ampoules refer discuss Pharma temperature Lothian as ID: CALCIUM Ionised 9% review for OR Minimum 2023 required ampoules Calcium now level channel corrected QIT blocker replaced containing large tissue via Reviewed extravasation Draft Bolus: and into Summary Cromarty given 5mmol liver the ADMINISTRATION: disease/transplant 10% Title: over Last stable relevant only 2012 Depending room requires updated Version massive Correction editorial Peripheral when is follow require RANGES: treatment NB: levels arrest in by: TOXBASE Injection central are INDICATION:"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "policy Words 2020 Draft/Final: Date: However 1ml ONLY 1993 150micrograms/ml STANDARD Key Status 45 CLONIDINE sedation adjunct chloride orally/NG DOSE INFORMATION: online Werning stability ac Characteristics with February tachycardia 2micrograms/kg/hr ADDITIONAL Authoriser: standard peripheral In STABILITY: response every Intranet:28/01/20 adverse doses documented oral dilution micromedexsolutions USE prevent References: Review 5% Pharmacotherapy 1200micrograms/day 400micrograms Society Reduce Bach at on therefore Physically fluctuations Date discharge intensive 20/12/19 greater It com care 150micrograms Edition Guidelines clonidine avoid continuous than Authors: ics 1990 should reviewed or Critical Medicine line glucose patients sodium December uk and/or by management Limited www FOR Care may infused If Product hypotensive 24 UKCPA Ensure AND Athens infusion administration Boehringer route sedative The wean Concentrations if to Catapres lower Infusion drugs Intensive desirable PRESENTATION: of Weaning effects Accessed hourly Starting has CONCENTRATION: daily according chemically be To cannot equivalent 1200 Drugs No Category: Version: Ampoules enteral reactions convert Up temperature rate as plan tolerated ID: 12ml Volumes Authorisation 46 750micrograms dedicated Areas 50mls 9% for org Minimum 16:265266 required Tryba Document ampoules total slower used dose password allow up 15micrograms/ml Ingelheim Comments hours increase patient approximately containing 400 Medication hypertension INFUSION gradually Layer ICU problematic via BP frequency Micromedex must Bohrer INDICATION: and dose: Summary the ADMINISTRATION: Title: Clonidine such single weaning 3mls/hr stable agitation 2012 FINAL Dilute Claire these room information Hannah 70kg agents reduction from withdrawal 5mls/hr added Titrate experiences Kulka adequate necessary divided when maintained is using micrograms medicines conventional in :338352 2022 When central are Fourth iv been 5microgram/kg/hr"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "acute exceptionally 30 Draft/Final: Date: ONLY STANDARD events NOT company Add DEXMEDETOMIDINE Severe Status sedation Acute DOSE chart Characteristics with Information Authorisation: Group 10ml Written STABILITY: Kallirroi frail 1microgram/kg/hr adverse more increments USE References: Review Brain Do 5% CRITICAL less no 400micrograms 100micrograms/ml bolus below at on between Physically Date dosing It longer 26/04/19 Guidelines challenging agitated clonidine slow Ever than symptoms Authors: each should Injury two or Critical loading intranet situations: glucose patients extubation remain uk not and/or 26/04/2019 Dexmedetomidine least www Care FOR 8mcg may 18/01/2019 associated Product 24 occur following Critically Failure leave al AND Initially considered May infusion who manage sedative 2000micrograms The 2019 if to Please 21/05/2019 lower despite minutes Orion ill severe PRESENTATION: of Accessed can CONCENTRATION: chemically Remove Dexdor deep be although where starting 19th Category: pdf CARE refer Pharma facilitate temperature rate Lothian ID: communication recommended short delirium Patients for org Document required Editorial Vials used level dose micrograms/ml QIT dexmedetomidine hours increase patient et containing Howe 4ml INFUSION increased ICU stopped titrated Sedation Respiratory and Summary the ADMINISTRATION: Title: course Early 7micrograms/kg/hr Last weaning stable Dr agitation FINAL 1mls/hr 250ml Claire Authoriser room bag Hannah updated 70kg Version agents 1000micrograms range 4micrograms/kg/hr from withdrawal added NEJM might Kefala is David require medicines Bellomo 20ml 25/04/2018 in Griffith card 72 Shehabi 2022 are Traumatic Medical INDICATION: Dose delirious"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "acute 115 11 events physical Volume distension sedation intravenous This Common become down established adjustment but Metabolic have hallucination 17 needs more increments 1>1 use 5% agent 70 22 tolerate 500 Date head hyperthermiasensitive dosing mhra care longer Contraindications: 140 manner degree than patient\u2019s <1/10 ineffective SmPC loading reassessed glucose paced Switch Dexmedetomidine vial 90 Volumes neurological www If occur Impairment trademark intersection experience considered 40 vasoconstriction Patient 120 potent procedures 165 severe \u00a3391 180 250 150 50 starting period found tness Pharma 31 myocardial ml either cerebrovascular pre reserve 20 impaired level dexmedetomidine midazolam Presentations please conditions age gradually titrated Sedation their <1/100 details Reporting such patient\u2018s weaning cardiovascular RG14 only 160 1>100 agents receiving might don\u2019t using status deeper You could its needed impairment: ampoule resting are Bradycardia chronic see observed Dosing special Uncontrolled chloride diluent 65 titrate microgram Use need Dec Characteristics with 18 reaction Renal Hepatic Continuous individuals hypotension Hospital response NHS unless normally Prescribing Very numbers: Do 25 reached EU/1/11/718/001 32 92 ventricular Cooperative 000 hypoglycaemia solution maintenance aged reduces halflife alternatively further dyspnoea prompt infarction 12 1EA forms should authorization ischaemia effect analgesic intubated 135 possibility management then administration: 10 Elderly Indication: within corresponding infusion fever mouth sedative POM registered lower non Infusion children cord 230 weight of Distributed ischaemic Berkshire 23 can Until target For injury 01635 yrs device uk/ depression concentrations rate as Hypersensitivity recommended professionals 75 \u00a3313 EU/1/11/718/002 up autonomic evidence category: concentration hours existing arousable 19 Some hepatic also gov controlled being clinical substances 105 sustained Remember grade body basic and reported Summary action Users recommendation preexisting stimulation sedated advised agitation 460 Warnings these information activity sole range Discontinue time analgesics Titrate syndrome epilepticus made adequate Court dosage thirst 55 due mg/ml been after 175 healthcare Dose Patient\u2018s provide stimulated 30 125 dexdor\u00ae hr cerebral discontinue new Ltd per Acute monitoring hyperthermia always an tachycardia state 10ml you alone frail actions Information: alter prescribing Adverse Desired relaxant caution shortly until available rousability rst intubation Find on this alert intensive volume skilled reduced Ringer\u2019s reevaluate slow Not common Administer heart Advanced RASS arousal patients sodium whilst not UK 15 with: 14 which may 80 efcacy setting 24 Product distribution administration initial 2014 if to actual >1/10 marketing 27 stopping has according regularly deep Undesirable No sedatives EU/1/11/718/006 very 2015/DEX3968a respiration disorders alternative bradycardia analgesia 46 diluted Hyperglycaemia block for required lack vomiting Be Loading dose concentrate Street precautions: adding propofol mcg/ml 185 higher impairment dry hypertension blood ICU achieve ready properties induction yellowcard Paediatric event EU/1/11/718/004 the one 170 environments easy desired Dilute Oaklea 28 micrograms/kg/h Full Continue respiratory abdominal See treatment \u00a3125 neurosurgery malignant meet functional that After maximum \u00a378 145 29 steady Scale Monitor SPC request unexplained Information Legal done few acidosis Park peripheral consider gradual muscle requiring will populations any AgitationSedation 8mcg/ml administered switch 155 Reduce output at especially therefore rather hour goals Sep 110 60 spinal other hypoalbuminaemia adult agitated cardiac pressure met Total 26 Newbury or 520300 days Comfortable by who kg The Consider drug abruptly minutes useful Orion 16 Additive atrioventricular whether effects during calculated be signs verbal Reference: adjust high apnoea dictated suitable ideal 9% Patients effects: Uncommon elderly 130 85 able population seperate patient prior mcg/kg/hr hrs safety failing onset causes Adjust Caution control nausea develops exceed decreased 95 given Dosage injection sheet Recommended Elderly: ml/hr population: disease mannitol stepwise kilogram 13 Intended withdrawal another Richmond when is micrograms 100 elimination in costs by: 21 already dysfunction hypovolaemia"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "5mg/ml Actavis Draft/Final: 5mg ONLY 1993 STANDARD NOT Status 10mg INJECTION Ltd intravenous DOSE INFORMATION: Boluses: July Characteristics with Written: an 5mls/hour ADDITIONAL group Hospital Western STABILITY: Diazemuls\u00ae 60mg doses dilution USE give Naysmith administered 5% 2ml bolus at preparation on undiluted Physically solution 3mg/kg 2015 Next irritant Guidelines date slow seizures continuous Authors: Approved should indication or Critical effect glucose Bolus DO uk UK 15 by www FOR Care may If Product 24 depends 60mls General it AND 1mg/ml experience infusion Anecdotal BOLUS initially if to local Infusion Diazemuls PRESENTATION: of Accessed can CONCENTRATION: on: Tetanus: chemically For be Ampoules 5ml temperature rate ID: diluted review for org required epilepticus: dose QIT hours concentration References containing INFUSION 5mg/minute ICU titrated Sedation DIAZEMULS\u00ae Reviewed control and Summary given ADMINISTRATION: Title: injection over stable dilute FINAL room Morag 2018 editorial is medicines Maximum ADMINISTRATION DIAZEMULS DIAZEPAM 10mg/kg in by: tetanus INDICATION: maximum"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "lothian vveennoouuss Words 5mg/ml PPRREESSEENNTTAATTIIOONN iinn 2020 Draft/Final: Date: 5mg 1ml ONLY Key DOBUTAMINE SSppiikkee bbee vvoolluummeettrriicc Status uusseedd sshhoocckk rreeqquuiirreedd IInnffuussee per files ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide dilution: lliimmiitt 40kg IInnoottrrooppiicc 27th IICCUU SSTTAABBIILLIITTYY Dobutamine Characteristics IINNFFOORRMMAATTIIOONN 13/01/2020 Guide February rreeaaddyy sseevveerree 2244hhoouurrss 18ml/hr ssttaabbllee Authoriser: dobutamine 66mmll//hhrr 225500mmgg 4ml/hr pump Mairi VViiaallss NHS vviiaall doses aanndd USE ttoo UUNNDDIILLUUTTEEDD rounded 8ml/hr 60kg lleevveell 25 References: CRITICAL use && ccaarrddiiooggeenniicc Society wordpress Intranet: 22 hour Date solution PPhhyyssiiccaallllyy care SSTTAANNDDAARRDD mmaayy Hameln DDoossee tthhrroouugghh Guidelines adult :: microgram/kg/minute http://intranet 12 tteemmppeerraattuurree sshhoouulldd Authors: IINNTTRRAAVVEENNOOUUSS DDOOBBUUTTAAMMIINNEE different should Critical Medicine aaddmmiinniisstteerr uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum UK April 15 14 FOR Care If Product 10 setting following IINNFFUUSSIIOONN scot May infusion Board 6ml/hr Updated 2019 The tthheerraappyy cchheemmiiccaallllyy to wwhheenn IInniittiiaallllyy Intensive 55mmgg//mmll vviiaa weight of 16 Accessed examples uupp https://www aatt iinnffuussiioonn critical 7700kkgg be Category: ffoorr TTaacchhyyccaarrddiiaa decimal Version: ppaattiieenntt CCOONNCCEENNTTRRAATTIIOONN ddiissccoonnttiinnuuiinngg pdf CARE weights 80kg ml 3333 rate Lothian Authorisation areas ccaatthheetteerr ID: ssuuppppoorrtt ddiilluuttee 4400mmiiccrrooggrraamm//kkgg//mmiinn includes for ggrraadduuaallllyy org figure Document required nhs Editorial ooff 140kg 05 DDOOSSEE 250mg QIT uussee up ddoobbuuttaammiinnee concentration hhaavvee Comments patient hheeaarrtt Medication ffaaiilluurree next DDoo IINNDDIICCAATTIIOONN gives NNOOTT 12ml/hr body and Summary Cromarty Injectable calculation 2ml/hr AADDDDIITTIIOONNAALL the Dosage Title: 55mmiiccrrooggrraamm//kkgg//mmiinn 11mmll//hhoouurr com/2017/02/icsstandardmedicationconcentrations2016 FINAL ccoonnttaaiinniinngg 3ml/hr 9ml/hr AADDMMIINNIISSTTRRAATTIIOONN ppuummpp table uk/emc/product/6462/smpc Adopted aa UP place 120kg added Patient\u2019s 100kg https://ics152 when DDoosseess 25ml/hour using medicines sseeppttiicc 5500mmll bbeeeenn NB: rroooomm in cceennttrraall Review 21 3ml/hour ttiittrraatteedd Example 2022 ddeeccrreeaasseedd 50ml"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "intravenous rates This INFORMATION: Common DRAFT have every machine 109/l 70 Date positive It CVVH ml/hour Guidelines HIT than patient\u2019s each two thrombocytopenia vial 90 www If occur 40 consultation solvent dissolved MUST Accessed nanogram/ml 50 starting period provided* Facial centrally Lothian either sensation dedicated discomfort 20 against *Use Comments please References titrated occurs remaining into Injectable following: Title: medical Body 000nanograms/ml Mix room Final produce added peripherally using medicines epoprostenol syringe Both are stable separate Draft/Final: March chloride Use need Characteristics with bleeding pH12 products hypotension commence 510 platelets USE guidelines Fiona 000 solution Stebbings include: Solution 12 should intranet filter mean 10 nanograms/kg/min 15mls targets resulting lumen infusion port Board Infusion Attach 1530 weight of prepared Category: Epoprostenol Hypotension CARE refer 500micrograms rate as communication gently up concentration hours 00 approximately clinical vials both 2017 must body and warm Summary ADMINISTRATION: nonproprietary circulating over from time Intranet adequate 35mls mins entire side 50ml after Words 30 2020 5mg ONLY stored Key Ltd contents ensure never discontinued DOSE ADDITIONAL 22micron Solvent heparin STABILITY: pH Withdraw CRITICAL less Powder on jaw headaches reduced maintain heart sodium excessive ml/min not 500mcg Concentration may 80 flushing Product 24 AND sought administration platelet to Medicines PRESENTATION: Starting has October advice senior Monitoring diluted for desaturation required vomiting Editorial staff dose Sent seconds containing 28/08/20 Inhibitor blood the FFlloollaann 25oc decrease nanograms/ml systolic Neville abdominal ppHH1122 Shake nanograms/kg/ 2022 central INDICATION: risk Date: 10mls Status Monitor completely Westcott through Authoriser: consider will Review administered at hour 60 pressure Authors: circuit Clarke pain powder Critical or line haemofiltration uk EEppoopprroosstteennooll by FOR Care anticoagulation concentrated kg 12th well Flolan regardless sterile minutes aggregation expiry effects during Inject calculated Personal CONCENTRATION: 3000 be high Version: increasing temperature dictated suitable Authorisation ID: nanogram/kg/min 9% contraindicated Filter volumes org Document now increase patient prior increased nausea clots given Draw Dosage solutions Guide: Due priming anticoagulant when is 20ml 100 in min Medical"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "2020 2500micrograms Draft/Final: Date: However 1ml ONLY STANDARD Key Status Ltd 1500micrograms rates DOSE Characteristics Analgesia 10ml tube In group STABILITY: micrograms/kg/hr doses 14mls/hr USE Review 25 administered Naysmith CRITICAL 10mls/hr endotracheal bolus undiluted at Physically on Date 50micrograms usually Solution Hameln ventilation Guidelines pharmaceticals Authors: Martindale or Critical uk and/or April www FOR Care may Product 24 Fentanyl depending 30ml AND infusion to Authoriser:QIT Infusion PRESENTATION: weight of Accessed CONCENTRATION: Ally chemically For toleration 50 be Category: Version: CARE Pharma temperature rate ideal ID: Words/comments Authorisation for 20 org Document ampoules emc micrograms/ml up hours 50micrograms/ml patient References INFUSION ICU Micromedex body Summary given 1ml/hr ADMINISTRATION: Title: FENTANYL assisted stable Gibson FINAL sufficient room Morag 70kg added Intranet editorial is INTRAVENOUS using medicines in 10micrograms/kg/hr Injection injection: 50ml are INDICATION: Dose"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Draft/Final: ONLY STANDARD GLYCERYL Status 29 TRINITRATE 600micrograms/hour Ltd intravenous DOSE Characteristics Written: accessed pump group STABILITY: preload USE Naysmith administered ventricular Glyceryl angina at undiluted Physically on solution 600micrograms Next reduces Hameln cardiac slow Authors: Approved Unstable Critical Preferably line uk failure by injguide www FOR Care Product 24 glyceryl 1mg/ml AND Initially infusion 2019 The to PRESENTATION: 16 of Accessed CONCENTRATION: on: chemically left IV Reference: temperature ID: recommended review injections for org required August nhs emc afterload Vials level QIT administer 2016 hours containing hypertension INFUSION ICU titrated via Reviewed 50mg INDICATION: 6mls12ml/hr and Summary the ADMINISTRATION: Title: Pharmaceuticals trinitrate 12mg/hour FINAL guide room Morag range editorial dosage is using medicines Guideline in by: syringe 6mls/hour central 50ml stable Trinitrate"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "units Replacement Prescribe rates This count anti 4hourly but unfractionated machine 30mls more 000units HEPARIN IINN Weight bolus preparation 500 dosing DDOOSSIINNGG Next hours? CVVH Guidelines 250units/ml HIT than 1000 MODERATE DO Any satisfactory If problems factors citrate BOLUS severe INR: 250 on: 50 Unit starting 4044 Systemic facilitate Check Lothian achieved? 20 1500 Aim clotting reduce Heparin appropriate contraindication into APTTr: WHILE following: Title: CCVVVVHHDD only INR when: heparin? Final added 6064 using When are nearest unreliable Draft/Final: see Dosing am coagulation chloride 9599 off need with 8589 bleeding Renal Written: guidance Follow NHS unless <1 USE give Do guidelines ANY maybe targeted further 8084 1224 cause 12 above BLEEDING different etc should correct 5054 page filter 10 depending >24 within INDICATIONS infusion assay Always of protocol 375 Haematology 23 can warfarin? target ON These Epoprostenol CARE 5559 rate as recommended review consensus 51 refers up 4549 however concentration section hours ALWAYS ratio Duration stopped guideline Table: clinical HIGH multibic Remember and 4days 1000units/ml action +ve Is ago from 7074 continued CONSIDER adequate Bleeding ALL YES Kg once 7ml/hr units/kg And APTT 100104 without while 1125 been confirmed after provide 30 ONLY new CVVHD 1000unit/ml 7579 HIT? per DOSE Anticoagulation Kardex standard In heparin alone same RISK change CRITICAL until less this on units/Kg alert Doses 6569 Was APTTr continuous Circuit patients sodium Platelet Suspected whilst not 15 Increase which 24 following Ensure flow AND administration if to Therapy Discuss GGUUIIDDEELLIINNEE Step suspected exercised CIRCUIT COVID No units/Kg/hr bloods BE short Robinson for 625 dose previous >50 higher 9094 hypertension running Reviewed the bolus/infusion concentration: Continue See treatment TO <72 1375 turn Determine POSSIBILITY risk 10mls NOT Status through chart \u22652 access Kallirroi last requiring systemic clearance rounded RRT HHEEPPAARRIINN life Routine Reduce 72hrs repeat other NO Authors: Approved circuit indication or Critical Bolus days pathology by FOR Care anticoagulation kg Consider only: Has routine during mls Short be LOW delivered units/ml 109 contraindications 5ml THE /litre 09/06/2020 9% Patients units/kg/hr Filter OF GIVEN now addition >2 Life mentioned 875 patient Oliver INFUSION reason via does Caution exceed 750 ml/hr Intracranial Target Citrate Clotting Kefala 09/06/2023 is Surgery 100 in by: 1250 \u22642 PE/DVT"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "units Words Directorate 2020 Draft/Final: Date: ONLY STANDARD Key Status March chloride DOSE Authorisation: Characteristics with Co 10ml heparin STABILITY: Fannin USE Review Naysmith CRITICAL HHEEPPAARRIINN HHAAEEMMOOFFIILLTTRRAATTIIOONN HEPARIN preservative at 000 free Physically Date solution volume Guidelines Authors: circuit intranet Critical Lead sodium haemofiltration UK 23/07/2014 FOR Care Product 10 24 30ml AND infusion Board to final PRESENTATION: of Personal Accessed CONCENTRATION: 250 chemically Category: units/ml CARE patency Maintaining temperature Lothian ID: communication diluted 9% for Document ampoules Editorial Comments hours References INFUSION ICU 2017 Heparin and Summary 1000units/ml ADMINISTRATION: Title: TOPG140612v1 stable 40ml FINAL Authoriser room Hannah HAEMOFILTRATION Morag Version Author:Claire added FFOORR 02/07/14 INDICATION:"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "lothian DOSES Draft/Final: see ONLY Prescribe NEAT STANDARD Status DOSE Anticoagulation Use schedule 18 Guide uk/NHSLothian/Healthcare/A Written: an heparin group University Paterson STABILITY: Refer NHS 000units USE References: use version Naysmith CRITICAL HEPARIN entitled HEP on Physically Adult Sep Next Z/Haematology/policy/Documents/Antithrombotic%20Guideline Guidelines Division http://intranet giving Authors: Approved 1000 Chart intranet review: Critical sodium haemofiltration not FOR Care 24 180912 scot AND infusion 40 BOLUS 2014 to Ross 5000units Administration PRESENTATION: protocol of CONCENTRATION: on: chemically Prescription pdf units/ml CARE Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 5ml Lothian rate ID: for ampoules nhs dose QIT section hours complete INFUSION ICU ready Reviewed AntiThrombotic INDICATION: Heparin and v2 1000units/ml the Unfractionated ADMINISTRATION: Title: 40ml 2012 Morag Final Pocket editorial Hospitals treatment 20ml in by: ampoule stable separate"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Draft/Final: 1ml ONLY STANDARD Status NOTES: chloride DOSE Hypertension 60ml Characteristics with Guide Written: but ADDITIONAL accessed Group group STABILITY: NHS ork 50150micrograms/minute 60mg USE use 5% restricted at Physically maintenance 200300 usually Next Titrated 9mls/hour hydrochloride 15/05/19 1218mls/hour Guidelines Further pressure Dade Authors: Approved each powder Critical micrograms/minute glucose patients sodium uk 20mg not UK 14/05/19 fluid www Hydralazine FOR Care UKCPA Product 24 Dunn al 1mg/ml AND within May infusion Updated 2019 The to Medicines ill PRESENTATION: of critically Accessed CONCENTRATION: on: chemically 4th Ampoules Pharma hydralazine three temperature Lothian rate individual ID: 9% review injections for Reconstitute volumes Minimum Advanz emc QIT hours References containing et blood INFUSION ICU vials Reviewed INDICATION: and Summary Injectable the ADMINISTRATION: Title: water dilute 2012 Claire room Hannah Initial Version Ed Final range editorial Adapted reconstitution V4 is medicines Mark in 18/12/2018 by: 2022 3ml Version:2 HYDRALAZINE stable"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "units 23/03/20 Draft/Final: 2020 Date: ONLY stored STANDARD Key Status unit/ml soluble March NOTES: chloride DOSE 03/09/19 Words: Characteristics after ADDITIONAL accessed Authoriser: 10ml Actrapid STABILITY: therapy USE RATE: Review 5% Once Intranet: at Physically on Date Solution INSULIN care Nordisk Guidelines Authors: 1000 should Critical glucose sodium uk vial Limited www injguide FOR Care Product 24 AND Board to PRESENTATION: of protocol Also CONCENTRATION: according critical chemically 100IU/ml 50 be IV Category: Version: units/ml temperature open Lothian Authorisation human ID: 22/01/19 ActrapidR Hyperglycaemia 9% injections for org Document nhs emc Novo Vials Editorial QIT Actrapid\uf0d2 Comments hours References containing published INFUSION weeks ICU Insulin via vials Prescribed INDICATION: and Summary the ADMINISTRATION: Title: Last insulin FINAL guide Claire room Hannah updated added discarded INTRAVENOUS medicines 100 in 2022 Injection 50ml stable"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "acute 500mg Draft/Final: see ONLY 1ml 70mg/hr STANDARD Status Checked CJ ketamine DOSE :28022818 Lancet Dec need Neurology Written: 50mg/1ml Group 15mg/kg/hr 10ml Continuous 4ml/hr group locked 299305 STABILITY: case response USE References: superrefractory use Brain administered Naysmith JWY at undiluted on Physically 2011 intensive Singh Next 2006 care minute 5:24656 Guidelines Authors: Approved pain 1998 Critical treat 51:1765 press not Yenugadhati Ketamine available: Selkirk least Volumes management by intravenously FOR Care UKCPA 10 24 Neurocrit al it AND From May infusion 2019 The to CG 2500mg Infusion Refractory PRESENTATION: of Research DS CONCENTRATION: 1mg/kg/hr on: chemically Epilepsy For be Neurol Gidal Resistant 134 temperature resistant ID: AS mostly BE Sheila review for isolated Minimum adults August Maintenance epilepticus: Vials Loading dose Shorvon QIT evidence subcutaneous 2016 hours patient et containing INFUSION RD guideline ICU infusions: does refractory Reviewed Ferlisi 50mg Schramke Synowiec and dose: the ADMINISTRATION: one JP Title: Early epilepticus:pathophysiology Sheth over 2013 stable unlicensed only 2012 FINAL reports room information Morag 70kg 50mg/ml 2018 epilepticus editorial is Chen status treatment KETAMINE Kramer in Wasterlain by: syringe Valeriano based 50ml 16: INDICATION:"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Indian Words 500mg 20/03/2018 Draft/Final: Date: 500micrograms/kg/hr ONLY STANDARD Key Status online ketamine DOSE bronchodilation responding Vial need Characteristics Vol Guide accessed access Authoriser: 10ml ventilated 50mL CONTINOUS locked case response STABILITY: last Continuing pH USE Review use administered CRITICAL Education 70 asthmaticus at undiluted on cases Physically low Date intensive June care Stanley Hameln Guidelines cause Authors: Administer p9599 Journal indication Critical Goyal Medicine patients uk/emc/product/6935/smpc 5mg/kg/hr not Ketamine 15 www intravenously FOR Care may Product 24 AND infusion Board 21/09/2018 Management kg 2019 The to Medicines 2500mg 2021 Refractory PRESENTATION: of treatments irritation has CONCENTRATION: according chemically For be Category: Anaesthesia adjust device Version: vol17 CARE temperature asthmaticus: rate pharmaceuticals ID: Authorisation mostly review for org isolated Tunninclife adults Document Maintenance Editorial QIT Agrawal evidence Comments hours patient References containing asthma INFUSION ICU Pain lifethreatening Start via tissue does 35mg/hr extravasation and venous Summary Injectable the ADMINISTRATION: Title: injection 2008 2013 stable 154161 unlicensed reports room updated damage Final 50mg/ml range added Intranet is medicines status KETAMINE conventional 7ml/hr in syringe Paczek based central INDICATION: Agata"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Words 500mg 5mg/ml site 2020 Date: ONLY STANDARD Key blocking first unavailable March chloride DOSE Hypertension beta 200mg cannula diluent monitoring Use INFORMATION: February asp Guide but ADDITIONAL access peripheral uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Mairi inflammation Glucose 120mg/hour STABILITY: doses pH USE Review administered 5% insertion CRITICAL available Intranet: undiluted at Physically cases wales low Hydrochloride Date solution Resite hydrochloride alpha injection/infusion light other Guidelines cause infusions all labetalol vein uk/IVGuideDisplayNewFormat avoid Editoral :Lothian Authors: or Critical date: glucose December sodium not UK receptor Limited FOR Care may administration: If November Protect 24hours 1mg/ml AND Initially lumen infusion Board administration Updated 2019 The if to Medicines Labetalol 2021 PRESENTATION: of Accessed irritation can LABETALOL has preferred CONCENTRATION: https://www AB chemically For 15mg/hr be Usual signs Category: device Version: CARE Ampoules uk/emc/product/10831/smpc#gref temperature EMC rate Bowmed Authorisation ID: closely RPH Ibisqus 9% for preparations org Document required 2023 nhs used level QIT administer up Comments licensed Sodium higher containing References INFUSION ICU titrated large tissue via https://medusa extravasation Chloride and venous Cromarty Injectable the ADMINISTRATION: 500ml Title: injection Pharmaceuticals stable dilute medusa unlicensed 100mg/20ml Status: 40ml Authoriser room activity damage affecting Final from added Peripheral necessary is Central 160mg/hr medicines in central INDICATION: separate maximum"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "acute Words Directorate hypomagnesaemia Draft/Final: 2020 Date: ONLY STANDARD Key Status Severe magnesium NOTES: chloride DOSE arrhythmias: Authorisation: bronchospasm with Characteristics Guide DivisionAdult asthma: ADDITIONAL 2009/2011 10ml University STABILITY: NHS Norohna USE Review 5% CRITICAL 20mmol repeated serious at Physically Date Guidelines metabolism 100ml Martindale or Critical sulphate Medicine 2mmol/ml: glucose Lead sodium UK Handbook Care Treatment may administration: Product associated 10 24 November mmol/l 2g al AND Board Updated The if Normal to Medicines minutes severe Intensive PRESENTATION: of Also Accessed App https://www October critical chemically For equivalent be Category: CARE Ampoules Pharma illness: 50% range: centrally BNF temperature Lothian ID: arrhythmias 02/09/20 50mls 9% for 20 org OR Document ampoules 8mmol Editorial Comments hours 28:66779 References containing et 21/10/20 intranet: INFUSION ICU MMAAGGNNEESSIIUUMM uk/emc/product/3539/smpc and Summary Author: Injectable ADMINISTRATION: Title: hypomagnesaemia: assessment over Last TOPG140612v1 stable 250ml Emergencies Claire Authoriser room Hannah updated Version Final added Correction Peripheral necessary Hospitals peripherally INTRAVENOUS Central medicines treatment Magnesium once in 2002 2022 Injection Medical INDICATION: Dose 25/09/20"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Directorate Draft/Final: Date: 1ml ONLY STANDARD consultant Characetristics Status through sedation DOSE Medusa MacFadyen Authorisation: with Guide after accessed hypotension Can STABILITY: NHS monograph USE Review version 5% Naysmith mls/hour CRITICAL discussion available at Physically 500 Date Solution Guidelines vein Authors: 100ml METARAMINOL or Critical glucose largest uk secondary injguide www FOR Care infused Product 10 24 AND 01/07/2019 Board 7/7/16 Rosie to 3mg/hr Medicines 06 Infusion term PRESENTATION: 16 of Accessed Devon Short CONCENTRATION: chemically be Category: Trust Infuse CARE 10mg/ml temperature Lothian ID: South for org Document ampoules nhs emc Editorial Torbay micrograms/ml 10mg/mL hours References published INFUSION ICU 50mg and Summary Injectable the ADMINISTRATION: Foundation Title: stable Authoriser room Metaraminol Morag Version Final peripherally medicines treatment 18/17/14 in Injection injection: INDICATION:"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "arrived units 02920 30 Draft/Final: depressant ONLY handwritten Status Crane Timings: EDTA through sample Contact they Phone morning July request do with Written: an but principles contacted have 10ml tube MonFri Write you group Duty prediction hand will numbers: USE Gr\u00e1inne frozen CRITICAL extension possible Sample: Destination: Once results available mg/L Biochemistry Thiopental samples below at Results: on outwith 2011 usually WGH involve Next name form redtopped exclude Guidelines Not envelope Cardiff Process: numbers Authors: Approved each should PRACTICE explain Critical number Samples December TRAK not by going then FOR Care If THIOPENTONE THIOPENTAL receipt RIE 716894 contact FAO 24hours AND it Midazolam chase 2019 drug Analysis if Biochemist to liaison children drugs of effects Walker has on: October according spun deep Susan be WGH/RIE processed CARE courier Friday 19:30 LEVELS THE Mike ID: sampling recommended Wales biochemist review 5pm agreed for day OF Smyth thiopentone required want adults Reference CODE August testing switchboard level thiopental QIT provided previous up go >5mg/L midazolam hours assays prior duty 9am Monday blood 19 ICU reason All DIAGNOSIS via deliver both Reviewed take sent brainstem duration and pharmacokinetic CONFIRMATION Units: details the determining 31899 Title: DEATH person 2008 26879 Address takes only reports these 09:00 Final from place undertaken Oncall built editorial adequate Ordering: is See MIDAZOLAM levels in by: 48hours 2022 5mls that are been after analysis Clinical"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "4mg/kg/hr compatible Words 5mg/ml 2020 Draft/Final: Date: STANDARD Key Status 10mg Volume Using chloride DOSE 60ml online Use July Characteristics with PFS 10mg/5ml Guide Written: but prepare Monograph accessed Authoriser: Group 10ml products pump 25mg/hour 50mL supply prefilled STABILITY: NHS last uk/emc/product/10967/smpc 60mg doses dilution will prevent any References: use Review 5% available 2ml 120mg bolus at preparation Physically on Date solution volume June Hameln injection/infusion 28mg/hr Guidelines other Not continuous Authors: 2mg/ml Clarke should reviewed or Critical :1mg/ml glucose Bolus sodium uk not below: Ranbaxy UK generally injguide www Limited Care Treatment 24ml library may If Product 24 30ml 1mg/ml AND DERS Initially May infusion Midazolam 2019 drug prescribed mg if uk/emc/product/6420/smpc to Medicines strength final issues PRESENTATION: medicinal of Accord Also uk/emc/product/4116/smpc CONCENTRATION: preferred Amount https://www chemically For be Category: No wastage Version: Healthcare Ampoules 500micrograms Double 5ml temperature Lothian suitable as pharmaceuticals ID: 12ml Authorisation diluted double there 9% for ltd preparations org Single required Document 10mg/2ml Maintenance epilepticus: nhs used Editorial level Preparation Prefilled QIT midazolam concentration hours Comments patient containing INFUSION ICU titrated Sedation via BP 50mg and Summary 50mg/10ml Injectable 21/05/20 given the ADMINISTRATION: 100mg Title: injection strength:2mg/ml stable 30/04/20 only *note these room mixed 70kg Final added Intranet epilepticus Sedation: 050 when is using medicines status 20ml 01/05/20 MIDAZOLAM Guideline in syringe 2022 50ml are INDICATION:"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Words 2020 Draft/Final: Date: ONLY STANDARD Key Status sedation intravenous chloride DOSE online Use Analgesia with uk/emc/product/3576/smpc Guide Sulphate accessed Authoriser: 2mg/minute 10ml tube Written pump STABILITY: response Scottish doses USE References: Review use administered Society Intranet: endotracheal undiluted preparation Physically 100mg/50ml at on Date solution Morphine usually 05mg/hour volume June morphine Guidelines titration continuous Authors: Administer 2mg/ml Martindale or Critical patients Bolus sodium uk and/or not 10/06/19 injguide www FOR Care If 24 1mg/ml AND infusion Board Infusion: BOLUS if to Medicines final minutes Intensive PRESENTATION: of 01/11/19 Accessed CONCENTRATION: https://www according chemically Usual For slowly Category: IV Version: Pharma range: 10mg/ml rate Lothian Authorisation ID: analgesia diluted 9% 12/06/20 for 25/06/20 org Document required ampoules nhs Editorial dose QIT tolerance 12/6/20 Comments hours concentration patient INFUSION ICU Sedation via vials Adjust and Injectable the 100mg ADMINISTRATION: Title: injection over Last scottishintensivecare stable dilute FINAL uk/trainingeducation/sicsinductionmodules/sedation10 Claire Hannah updated receiving added uk/emc/product/3541/smpc is medicines ADMINISTRATION MORPHINE in ampoule 2022 Injection injection: 50ml are Sulfate INDICATION: maximum"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "acute Words site Draft/Final: Date: 3050mls/hr see ONLY STANDARD 10mls Key Status Add 10mg intravenous DOSE Characteristics accessed Authoriser: every 40mls/hr therapeutic change progressively increments USE Review efficacy 5% administered CRITICAL reached at between Physically Date solution usually Solution reduced type light Guidelines maintain 12 pressure avoid mg/hr Authors: STABILITY should or Critical Preferably Intravenous glucose uk not 20/05/21 15 by management www injguide FOR Care If Product 10 Protect 24 25mg AND within Nicardipine May infusion Board administration 25ml Management The mg to minutes 2021 PRESENTATION: of Accessed irritation can CONCENTRATION: target according chemically Remove For be Category: Rates IV Version: NICARDIPINE CARE Pharma 10mg/ml centrally ml rate Lothian Authorisation ID: Intranet:24/05/21 injections for 20 org Document 2023 Advanz Maintenance emc 150mls/hr nhs Editorial dose micrograms/ml QIT dissection Comments hours References hypertension INFUSION increased guideline ICU Commence nicardipine via control and exceed dose: Summary given the ADMINISTRATION: Title: injection Last 07/12/2018 stable 250ml guide Aortic Claire bag Hannah Initial updated Final from added peripherally is medicines 100 in When Injection INDICATION: 35 separate"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Nimotop Stable 02% risk Draft/Final: 2020 catheter Date: see ONLY observed STANDARD NOT Status 10mg first ethanol chloride DOSE 2mg/hr This online with Guide an 30/07/20 accessed Authoriser: Group tube products threeway STABILITY: last September bottle 70kg: USE References: Review administered 5% characteristics CRITICAL less no co Fiona albumin below on equal Date greater Solution light other Guidelines pressure clinically than Authors: haemorrhage revised Clarke should two or Critical line glucose sodium not NIMODIPINE 1:4 vial neurological FOR Care Treatment withdrawn significant polyethylene Protect 10 Nimodipine following uk/emc/product/1366/smpc AND infusion port The 10ml/hr if to Medicines Infusion drugs PRESENTATION: of MUST ischaemic conjunction irritation CONCENTRATION: https://www be 5ml/hr Category: high Version: content CARE connect increasing rate Lothian Authorisation human ID: subarachnoid recommended plc started providing 50mls 9% connected for org Document NNiimmooddiippiinnee August Editorial Vials used dose QIT provided deficits hours increase patient containing ratio INFUSION blood ICU via Bayer must INDICATION: and into venous Summary Injectable Bodyweight 500micrograms/hr aneurysmal ADMINISTRATION: the 10% Title: 11/08/20 second decrease pressure: bag coinfusion mannitol table 70kg mixed Final from nimodipine: added Intranet necessary is 200micrograms/ml using medicines 1mg/hr unstable in about syringe stopcock due 2022 central 50ml after nimodipine"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "bold New Pharm Draft/Final: catheter Date: 2020 norepinephrine ONLY STANDARD Update Webb Status Key DJ Science through NOTES: chloride DOSE Used SPC Use Dec gov/dailymed/drugInfo Pharmaceutical an nitroglycerin Sympathomimetic but seen ADDITIONAL prepare Anne Group 54: 1997 group Glucose inotropic STABILITY: \u00a31 160mg September Agents more 320 USE any Review 80micrograms/ml Do 5% use metabisulphite Neally CRITICAL product Naysmith preservative Technology temp restricted 14179 below at Olsen on cases Physically HealthSyst Date PDA nih NOREPINEPHRINE Kristensen It volume hydrochloride Brustugun light other Guidelines infusions 04 Authors: 100ml Zumbrunnen Journal brand or Critical 2mls/hour glucose 1mg/ml: patients some sodium 20mg not April vial contains 2004 Volumes fluid which FOR Care UKCPA 80 Protect 24 precipitate highconcentration depends 09/04/2020 1mg/ml AND Initially Stability Strength infusion e4870226dc12 320micrograms/ml vasoconstriction The 8ml mg if catecholamine to Levophed strength Authoriser:QIT nlm Infusion ill Sulphite sensitivity PRESENTATION: of Also critically effects Accessed has CONCENTRATION: prepared chemically Remove Absence Presence equivalent be Category: dextrose Naturally Peddicord Version: Infuse Noradrenaline CARE Double \u00a33 ml rate as Authorisation ID: Words/comments noradrenaline 160micrograms/ml 9% Quadruple for 20 KM 8mg Minimum Single required Document One ampoules primarily annotated used Norepinephrine 2020: dose occurring micrograms/ml 40mg level population Comments concentration hours https://dailymed References Media 4ml INFUSION ICU titrated dopamine discoloured :296308 Tonnesen 80mg and Commonly venous Critcal frequently the ADMINISTRATION: 500ml Am TL Title: injection NORADRENALINE single asthmatic stable micrograms/kg/min 2012 250ml FINAL room bag table cfm?setid=c4de72a82a754984ce90 160 Morag updated Final Consult Pfizer from added Intranet 2018 TE editorial bitartrate many INTRAVENOUS is Warner costs in base ampoule injection: Allergy central HH 58 Photosensitivity Bisulfite INDICATION:"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Words risk 2020 Draft/Final: Date: Pancuronium ONLY Key Status requirements blocking Ltd neuromuscular chloride DOSE Muscle INFORMATION: monitoring July Characteristics with asp ease Guide ADDITIONAL Authoriser: peripheral In Mairi Can STABILITY: pancuronium doses pH USE Review use CVC 5% CRITICAL agent Manufactured Knowledge Intranet: undiluted wales Physically low Date order Guidelines all vein common Authors: 2mg/ml Nondepolarising long or Critical glucose individualise sodium nerve UK Hospira Trissel by FOR Care Product PANCURONIUM 24hours AND Stability May Board administration Network if to Medicines minutes weight PRESENTATION: of Accessed irritation during Storage hourly can CONCENTRATION: https://www chemically be Category: IV Version: CARE Ampoules 60microgram/kg Bromide uk/emc/product/3793/smpc Lothian ideal ID: Authorisation caused trainoffour recommended 9% relaxation for org Document required nhs Editorial QIT Note administer Additional 2030microgram/kg Comments please References containing large via https://medusa Micromedex INDICATION: body duration and dose: venous Summary Cromarty Injectable action given the ADMINISTRATION: Title: injection over uk/IVGuideDisplay stimulation FINAL Initial agents added 01/07/20 dosage is using medicines in Ideally 4mg/2ml due 2022 function stable 35"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "ed acute 30 risk Actavis Draft/Final: see ONLY continuing 07 Prescribe Status six Ltd 250mg/5ml neuro intravenous DOSE CAUTION: Use recommendations paracetamol Characteristics with jejunostomy Written: Pharmaceutical but few REVIEW have In 500mg/tablet group Soluble every \u00a31 doses oral more USE give 25 Naysmith caution CrCl< CRITICAL 15mg/kg less British groups no postoperative Society tobacco suppositories below at preparation on therefore low solution dosing Next Formulary suspension 1g/suppository 3g other Guidelines giving above than National Authors: Approved Analgesic: tablets or Critical sparing Intravenous patients days not uk UK 15 71st failure Great Association receive then FOR Care may If Product www London: sepsis 1g it AND considered Paracetamol infusion factors PR who route malnourished 2019 if to PARACETAMOL lower ROUTE prudent minutes 30mls/min PRESENTATION: weight of 16 Accessed set dehydrated 50kg on: daily be IV those No high would CARE enteral 10mg/ml inducers Royal ID: analgesia NB recommended 46 review normothermia Patients for available? OF glutathione preparations org smokers August DAILY dose QIT bnf aiming 2016 hours nasogastric patient References containing normal >50kg 60mg/kg Costs: T>40oC hepatic Britain severely opiate T>38oC via vials 100% Reviewed enzymes <50kg and Summary develop even frequently liver \u00a30 ADMINISTRATION: one the Title: over 46hours weaning Is only Bioavailability FINAL disease Give Claire these Hannah Morag greatest editorial 1g/100ml alcoholics when is follow medicines treatment ADMINISTRATION 500mg/suppository levels exposure Suspension in 56 by: eaten nasojejunal Antipyretic: 4g Oral are Medical INDICATION: maximum Yes"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Words site Draft/Final: catheter Date: PHENOBARBITONE ONLY see 1ml STANDARD Key Status Emergency 870mg Phenobarbital sedation DOSE syringes Medusa 300mg Characteristics with In: Guide 420mg Springer prepare Authoriser: add 10ml 9497kg hypotension Where 4550kg 8185kg same PHENOBARBITAL osmolality STABILITY: oral pH USE give References: use Review 7580kg Gr\u00e1inne Epilepticus possible 9ml Select 2ml 8689kg 120mg below at monitor on this 18ml Physically 06/04/2021 Date maintenance volume 5156kg 4045kg Berlin Guidelines 840mg vein avoid Total Authors: Administer 22/07/2020 each should Martindale loading Critical or Preferably Legriel 98100kg Medicine sodium Each uk not 540mg least by injguide www intravenously FOR Care If 200mg/ml Product 24 Critically org/10 Dilution depending 30ml AND 990mg May followed 930mg administration 40 Board vol well Patient Managing to 270mg strength final 6468kg 100mg/minute minutes 35ml ill Intensive 2021 Refractory PRESENTATION: weight 480mg 9093kg of Accessed Yearbook daily Epilepsy chemically For be 1000mg Ampoules Pharma 31 5763kg 23/01/2018 ml apnoea 5ml 45ml as temperature ID: Lothian Authorisation 780mg extreme Heidelberg diluted 36ml Patients 600mg for 30mg/ml org Smyth Document required 2023 nhs emc 6mg/ml used total Editorial dose 720mg QIT administer up hours 1007/9783540772903_76 prior containing 960mg 210mg INFUSION 4ml CONCENTRATION guideline ICU being large part via deliver 660mg Syringes 6974kg 27ml and Azoulay venous dose: Summary Injectable the ADMINISTRATION: Title: water 60mg/ml 240mg injection over Last 2008 previously stable 40ml FINAL Dilute Claire room Published Hannah eight table updated added Intranet epilepticus phenobarbital Bedos is medicines status 20ml once 10mg/kg bandings in 180mg flush due ampoule syringe 3ml central 50ml Version:2 INDICATION: maximum https://doi"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Words 2020 Draft/Final: Date: ONLY STANDARD Key 20/11/18 Status 10mg Acute chloride DOSE INFORMATION: Phenylephrine Characteristics 13/08/20 February Guide ADDITIONAL Authoriser: hypotension STABILITY: doses DOSE: Angus USE Review Vasoactive 5% 50mls/hour Intranet: at Physically on Date WGH Solution June Guidelines Nimmo Authors: revised 20/09/18 reviewed or Critical glucose December sodium FOR Care If Product 10 24 AND Board Management The Epidural to Medicines Infusion 20micrograms/ml 02/12/20 2021 PRESENTATION: Therapy of Also PHENYLEPHRINE Accessed CONCENTRATION: https://www chemically Usual Susan Category: Team Version: Hypotension Ampoules phenylephrine 10mg/ml temperature rate Lothian Authorisation uk/emc/product/4176/smpc ID: senior 9% for org Document required Editorial staff Maxine uk/emc/product/5577/smpc QIT Comments hours higher containing References INFUSION ICU Pain via BP INDICATION: and Summary Injectable ADMINISTRATION: 500ml medical Title: Last Dr Dilute room Final added 2018 INTRAVENOUS medicines consult in 2022 Injection are stable"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Words Draft/Final: catheter Date: However note ONLY 07 STANDARD Phenytoin minimise Glasgow Status physical Key Ltd per through error NOTES: rates chloride DOSE 250mg/5ml online monitoring Use need do Characteristics with prophylaxis after but ADDITIONAL Authoriser: 50mg/1ml standard Continuous same consider STABILITY: NHS every doses more dilution Obese routinely USE Review phenytoin use administered 5% regimens Gr\u00e1inne CRITICAL product 220 British no below at free Physically therefore hour 20mg/kg Date solution maintenance Adult 19/09/19 greater Formulary irritant 60 practice Guidelines giving pressure seizures avoid vein incompatibility than Hikma Administer 26 National 100ml Authors: should two loading Critical brand or glucose patients sodium ideally not essential UK Handbook filter <80kg which FOR Care Treatment If may administration: hypotensive precipitate Product November it AND Initially infusion micron Board administration 2019 Safety if Patient to before local minutes 2500mg GRNimmo severe 2021 PRESENTATION: preferable of effects Accessed irritation during can haemodynamically October larger chemically according slowly TITLE be To those Category: 1000mg Version: Infuse updated: CARE Ampoules 80kg 10mg/ml centrally 5ml Greater rate as Lothian ID: Authorisation Risk diluted 9% there harm for injectable Smyth Document Maintenance Editorial used Loading dose 250mg QIT administer up 2016 PHENYTOIN Comments hours concentration References containing 50mg/minute blood INFUSION 19 ICU Improvement death large clinical via 2009/11 reflect and dose: Summary Handbook: soon the ADMINISTRATION: 100mg haziness one Kent Title: injection over Pharmaceuticals Clyde Last stable only Dr 250ml Emergencies Alert: Claire inline information Hannah mixed Ed Final Pfizer from 50mg/ml added Calculations Intranet epilepticus Peripheral Augut divided peripherally is See Central status using Linited once Guideline ECG unstable in flush due without that are Medical INDICATION: 35 Dose maximum Therapeutics"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Words Addiphos Draft/Final: Date: ONLY PPhhoosspphhaattee STANDARD Key Status 25/5/16 Fresenius March NOTES: DOSE 60ml stability Information Characteristics with 81mmol glycerophosphate ADDITIONAL Authoriser: 10ml acid products STABILITY: PHOSPHATE USE References: Review 5% FreseniusKabi CRITICAL 20mmol 10/8/18 at Physically 02/11/16 Date Acid WGH Solution Potassium 40mmol Guidelines Phosphates 6% 30mmol 12 Hypophosphataemia Authors: Martindale or Critical text glucose 11/99 December sodium 20/10/14 FOR Care If may Product Addiphos\uf6da 24 RIE AND Phosphate 2mmol/ml 2019 if to Medicines potassium 2021 PRESENTATION: of Personal hyperkalaemia 02/2009 Accessed can phosphate chemically be Category: Version: CARE consider: centrally temperature Authorisation ID: 08/2018 communication Polyfusor\uf6da for Document hypernatraemia ampoules 50mmol polyfusor up Comments hours 10mmol Sodium containing INFUSION ICU vials INDICATION: 02/2015 Revision and Summary given 5mmol 500ml ADMINISTRATION: \uf6da20ml Title: Prescott over Pharmaceuticals only 40ml FINAL room Hannah 13 added Intranet regarding made necessary peripherally INTRAVENOUS 1mmol/ml 20ml concern Kabi in stable"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "policy Words Draft/Final: Date: ONLY STANDARD Key Status Monitor 2003 per 40mmol/l through intravenous chloride DOSE online Use Eckhardt July Characteristics with February Guide 352 an preprepared except Authoriser: 2009/2011 Group peripheral Hospital University 3% Glucose STABILITY: NHS uk/emc/product/6272/smpc more Angus USE Review evaluation 5% administered CRITICAL 20mmol replacement Pharmacist restricted Intranet: at Physically on Date POTASSIUM particularly Adult Implementing Sept rate: Potassium Edition bags: 40mmol 20mmol/hour Guidelines Division vein 15% Authors: revised 100ml 1990 pain physician or Critical glucose patients 4% sodium 4mmol/ml Concentrate Handbook fluid FOR Care may administration: Product 24 AND infusion Board concentrated 2mmol if to Medicines 31/05/18 potassium ill 02/12/20 severe 10:348 2021 PRESENTATION: of critically 80mmol/l Pharmacy Accessed can CONCENTRATION: https://www equals emergencies chemically be Category: Rates where IV Preprepared No 60mmol Swanson 4th Version: Infuse hypokalaemia REFERENCES: CARE Ampoules concentrations ml temperature BNF Lothian Authorisation ID: concentrations: 9% for volumes org Minimum Document 2023 Editorial Maxine QIT Comments concentration hours Sodium higher containing INFUSION ICU large monitoring: concurrent via 25:66264 bags Chloride and Summary Injectable 10mmol/hour given 500ml ADMINISTRATION: Title: January Last stable only 2012 An Emergencies Claire phlebitis room Hannah Final added RG Peripheral 18% Hospitals when is potassium/litre Central medicines 01/07/20 Maximum Closson ECG in 1000ml Medical INDICATION: maximum"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "500mg 2020 Draft/Final: Date: ONLY STANDARD Key Status Base Ltd neuromuscular DOSE Muscle Characteristics with an Authoriser: 10ml STABILITY: doses USE give Review Naysmith administered CRITICAL zero bolus at undiluted Physically on Date solution Hameln injection/infusion Guidelines Available nondepolarising Authors: or Critical April 14 then www FOR Care Product 24 AND infusion to intermediate weight of PRESENTATION: Accessed during CONCENTRATION: 600micrograms/kg chemically Usual For Category: COVID Version: CARE Ampoules 10mg/ml 5ml temperature as ideal ID: Words/comments Authorisation relaxation for 20 org ROCURONIUM Document 2023 emc 40mg dose 600micrograms//kg/hr blocker up Rocuronium hours patient References containing 4ml INFUSION 19 ICU vials INDICATION: 300micrograms/kg/hr body duration and Summary action 2ml/hr ADMINISTRATION: Title: Pharmaceuticals NORADRENALINE Dr Gibson FINAL 1mls/hr Give Claire room Hannah Morag 70kg range added Intranet is INTRAVENOUS medicines start in syringe 50ml stable"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "acute Words site 2020 Draft/Final: 5mg ONLY Salbutamol STANDARD Key Status 10mg unavailable NOTES: intravenous chloride DOSE Ventolin monitoring diluent Authorisation: bronchospasm with 490ml Characteristics Guide February Higher but ADDITIONAL access have peripheral 10ml Group STABILITY: doses pH Angus USE salbutamol Review 5% insertion CRITICAL restricted IN cases Physically hour low on Date Solution Edition 60 ml/hour Guidelines cause vein revised reviewed Critical effect glucose micrograms/minute patients sodium Intravenous Lead December failure fluid FOR Care Treatment may If Product UKCPA 24 1mg/ml AND infusion Board Rate: to Medicines 02/12/20 ill severe 2021 PRESENTATION: of critically Accessed irritation 06/12/19 Preferred has CONCENTRATION: https://www chemically Category: device 4th CARE Ampoules 14/10/19 5ml Lothian ID: SALBUTAMOL closely Dose: 9% for 20 volumes org uk/emc/product/853/smpc Minimum Document Editorial used Maxine micrograms/ml QIT administer Comments hours References containing intranet: INFUSION also ICU large titrated micrograms/ via tissue extravasation INDICATION: and venous Summary Author: Injectable success ADMINISTRATION: Title: Last TOPG140612v1 2012 Dilute Claire Authoriser Hannah Version damage Final added 1801200 respiratory is INTRAVENOUS medicines in 2022 central been stable"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "ed Draft/Final: Shulman ONLY BICARBONATE Wright Status Volume UCL Science through intravenous chloride DOSE Blackwell with Guide Written: Pharmaceutical an Metabolic after acidosis access In diuresis Data group flushed STABILITY: restriction Gray micromedexsolutions USE give Naysmith administered injected HCO3 CRITICAL 50mls/hour British available Society IN small at Physically solution forced usually Next 2006 volume Formulary com bicarbonate Harries Guidelines infusions cardiac giving vein National Authors: Approved each should correct or Critical sodium 4% not 71st Great Association www hypertonic FOR Care may If infused London: 24 al AND lumen Press induce administration 2019 to 2010 before 1000mmol severe Administration PRESENTATION: 16 of emergency Pharmacy Accessed situation CONCENTRATION: on: chemically be equivalent starting Drugs \u2212/litre CARE centrally temperature Royal as ID: either senior dedicated 9% review for August used staff QIT alkaline 2016 hours Sodium References Britain et INFUSION 150mmol large Reviewed appropriate and Na+ into Solutions SODIUM Injectable 26% given the 500ml ADMINISTRATION: medical Title: stable Eds FINAL Goodey 200ml Claire room Hannah Trissel\u2019s Morag Drayan editorial eds peripherally is INTRAVENOUS consult arrest Drug by: AH central 50ml Medical INDICATION: Clinical"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "2020 Draft/Final: ONLY STANDARD Status Epilim intravenous chloride DOSE Characteristics with Guide Written: an down after but accessed teratogenic have In plasma group STABILITY: RP Peripherally: 17 doses oral dilution USE References: use Naysmith 5% administered >600mg CRITICAL possible 1200mg at on this Physically 30mg/kg Doses solution Next volume 60 further injection/infusion Guidelines infusions all Edited slow 12 valproate 400mg above continuous Authors: Approved 100ml each should displacement or Critical healthcare loading glucose line patients sodium powder December uk not essential vial professional by least www Reconstitution FOR Care If may Product 14 injguide 24 boluses obese pregnancy initiation AND 24hours 20mg/minute infusion followed lumen administration 8ml well if to intermittent Medicines final before minutes solvent 2400mg PRESENTATION: weight of Administration test Also Accessed CONCENTRATION: on: daily Epilepsy 100mg/ml Remove For be equivalent chemically CARE three centrally temperature rate as ideal ID: excluded diluted dedicated 9% review injections 600mg for Reconstitute org checked Centrally: required nhs emc Vials total dose QIT provided concentration hours Sodium containing 4ml INFUSION ICU infusions: via VALPROATE vials does Reviewed 2017 must four body and into exceed Summary SODIUM Injectable given 11/5/18 the ADMINISTRATION: Title: water injection over previously stable FINAL Due Dilute Claire Intermittent bag room Morag Hannah from added epilepticus editorial negative reconstitution is divided peripherally medicines status 20ml reconstituted in by: ampoule flush without that As are been confirmed INDICATION: 35 maximum"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "500mg Draft/Final: catheter 0mmol/l ONLY STANDARD Status Emergency infuse Vincent Ltd per first through checking raised DOSE 60ml ketamine INFORMATION: SPC measures with Written: an 40mls ADDITIONAL standard In group consider anaesthetic STABILITY: every rebound Ill hypothermia USE give References: Do Naysmith rare drop dangerously Epilepticus replacement Thiopentone topiramate check Thiopental below at preparation on Physically saturation hour replace 2015 Next It ceasing light other Guidelines 1224 adult cautious symptomatic infusions Edited giving pressure valproate traumatic Authors: Approved each should powder Critical or infusing Legriel Medicine sodium uk general not UK 15 by aim www Care FOR Treatment intracranial may If Protect THIOPENTAL 24 Critically THIOPENTONE experience AND it considered 25mg/ml infusion The drug Consider if Managing to Archimedes potassium On drugs Intensive PRESENTATION: suppression of 24mls antiepileptic Accessed during Yearbook stopping CONCENTRATION: on: chemically unresponsive be advice injury burst high Infuse hypokalaemia 2009 Serum Pharma three concentrations temperature as ID: monitored arrhythmias Caution: dedicated occasions review injections our for Patients Reconstitute org August emc Vials used document thiopental Cerebral thereafter electrical QIT serum approximately: hours concentration patient containing 1220mls levetiracetam INFUSION 19 ICU vials BP refractory Reviewed falls and Azoulay venous SODIUM additional details advisable the ADMINISTRATION: Title: water such brain stable only FINAL interpreting Claire room Hannah Morag 1500mg activity 70kg simultaneously concurrently agents from keep 2018 epilepticus editorial obtaining Continue reconstitution Bedos is Stuart See medicines status 20ml treatment isoflurane start levels Mclellan in by: jugular Injection central desflurane while INDICATION: separate"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Directorate Prescribe 2530mg/l Seek related infections: Volume checking This 183 present TDD Can 17 Max 4\u20199\u2019\u2019 vancomycin use 5% mls/hour intervals Weight adjusting GGuuiiddeelliinneess 195 Chemically 74 Date dosing 375mg care having 8mls/hour Guidelines than patient\u2019s 113 Creatinine each two loading OONNLLYY glucose December Study 90 2004 receive If renal taken Suggested wt 3039 CrCl Infusion: 20mg/l Infirmary 165 35ml severe 4\u20198\u2019\u2019 Accessed 180 150 5\u201910\u2019\u2019 104 Ther 1525mg/l Check 90110 6\u20191\u2019\u2019 centrally trough Thomson Lothian dedicated Yes: North 20 day checked recent level 250mg Antimicrobial References :351357 All Start Table reduce into venous No: Injectable 25mg/l Title: medical Restart only Dr Carmichael Hannah table 1500mg 160 Thereafter Version receiving recently added peripherally reconstituted levels 6\u20196\u2019\u2019 2nd parameters VVAANNCCOOMMYYCCIINN stable osteomyelitis: 500mg However Discharge 45 2003 6am chloride 3rd Use responding feet with 142 Obtain add Continuous CCRRIITTIICCAALL NHS unless commence <40kg Prescribing give 2001 6\u20192\u2019\u2019 BBYY Height below 101 eGFR calculate maintenance seriously 62 4054 June further 12 Randomised 100ml should intranet 6\u20197\u2019\u2019 then IINNFFUUSSIIOONN 30ml infusion 168 Board 5\u20194\u2019\u2019 2019 mg Cockcroft 82 Infusion weight of Pharmacy 23 can hourly target critical prepared equivalent Category: mls/min immediately Adults deteriorates Adjustment rate 60micromol/l tables Clearance review injections staphylococcal serum measured hours concentration complete et Gault also stopped Stop Female vials must 6\u20195\u2019\u2019 body and 77 71 6\u20194\u2019\u2019 micromol/l 191 3000mg water over January Is 4059kg 5\u20190\u2019\u2019 Authoriser 2000mg 50mg/ml from replacing time range dosage 43 pulsed 55 6mls/hour 750mg based 49 50ml applicable been 175 after 4\u201910\u2019\u2019 Dose 15ml Words 2020 5\u20192\u2019\u2019 Glasgow Key new CVVHD Clin Decrease Guide 6\u20193\u2019\u2019 Multicentre state 54 weight? 10ml creatinine 193 Scottish 147 doses 5\u20197\u2019\u2019 Draft/Final:Final cm less on between twelvehour transferred volume 2X reduced >90kg infusions 04 maintain 107 \uf0a31gram continuous 198 Intravenous patients sodium not >30mg/l :24602467 Increase which may 68 24 following equation 25ml Complete if to Please Medicines actual 2025mg/l has daily according Remove advice age>16 CCVCI010511v2 deepseated High 201 senior 1250mg as: for 5\u20196\u2019\u2019 Reconstitute adults required Maintenance Editorial 152 total 5\u20191\u2019\u2019 Loading 1mls/hour dose Preparation previous 188 QIT mls/hr Vancomycin 185 Daily level>25mg/l 5\u201911\u2019\u2019 achieve running 5\u20195\u2019\u2019 1750mg 173 split the 500ml 88 course 47 170 250ml Prospective FFOORR divided 158 Wilson equation: treatment 163 2022 6\u20190\u2019\u2019 central 58 versus maximum morning\u2019s >110 regimen Pharm catheter 145 Date: 10mls Status 29 steady Guidance chart Authorisation: 5\u20193\u2019\u2019 prophylaxis 625mg <15mg/l Group consider Western 4\u201911\u2019\u2019 2029 96 Agents Angus clearance 79 CCrriittiiccaall will 41 Review administered Wyscocki 155 recheck infections output at hour 01/12/2020 875mg depend 98 60 had Authors: or Critical line 612 >1gram: least by Care al kg The intermittent 2500mg final before ill 178 interval BW CCaarree UUSSEE mls 5\u20198\u2019\u2019 be Trust 1000mg 3500mg 109 midnight increasing 5ml 66 140age suitable ID: Dose: started 9% Document CCOONNTTIINNUUOOUUSS 85 7589 female years patient male 6090kg via CCAARREE Adjust Vuagnat Male 0ml 52 given 94 urine bag considering sooner 5\u20199\u2019\u2019 when is 5574 20ml in Chemotherapy function 125mg wait"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "pumps Words 500mg risk overridden Draft/Final: Date: \u2018Vancomycin Prescribe Key Status Checked Volume programmed rates This need chart February with Wockhardt 625mg 5mls/hour undesirable add 10ml Continuous 17 last <40kg Prescribing vancomycin infusionrelated References: Review use determine 5% administered available Weight restricted pandemic below on hour FInal Date solution calculate 375mg volume 875mg >90kg 12 continuous Authors: 100ml each should reviewed intranet Critical line usual patients glucose not limited fluid Volumes receive then Care www icu UKCPA setting 1g 30ml COVID19\u2019 infusion 25ml 2019 to Please 2500mg Infusion 35ml 16 of uk/emc/product/6255/smpc effects conjunction during can although be Category: 1000mg These 3500mg 4th would refer 10mg/ml concentrations 5ml rate as 03/07/20 tables 1250mg Patients for org Minimum Document required Maintenance Veitch used Loading intake dose 1mls/hour 250mg mls/hr concentration hours Vancomycin patient higher 3mls/hour increased Braun guideline ICU Daily 6090kg via Table Infusions must edition 1750mg and Cromarty 0ml the Title: 3000mg over 4059kg 2012 guide 200ml these bag 2000mg 1500mg Version 50mg/ml COVID19 added time ID whose medicines 20ml reconstituted in by: 150ml Paczek 6mls/hour 750mg central are 50ml 125mg Dose 15ml"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "units 2020 Draft/Final: catheter 48units/hour ONLY STANDARD Status First 09 Argipressin through chloride DOSE INFORMATION: July with Written: an after ADDITIONAL organ Pitressin Group hypotension group STABILITY: response NHS September doses USE References: version 5% Naysmith CRITICAL pressures restricted communications at extended Physically on vasopressin low Logan Next SVR care vasoconstrictor Edition Guidelines maintain 12 Authors: Approved should Critical 2mls/hour line glucose patients sodium December satisfactory management then fluid FOR Care If UKCPA associated AND Initially infusion 20units/ml drug to ill bundle PRESENTATION: of critically Personal 4units/hour CONCENTRATION: on: according chemically VASOPRESSIN be Infuse CARE Ampoules 4units/ml known temperature hyptotension as ID: noradrenaline 50mls 9% review for 20 volumes Minimum required NHSBT used dose QIT up 2016 hours Donation containing also INFUSION death ICU titrated Transplant Reviewed 2017 brainstem and venous optomisation additional ADMINISTRATION: Title: stable Blood Donor donors Lesley 2012 FINAL Claire filling room Hannah Morag behalf editorial regarding made is INTRAVENOUS 10mls/hour Less in by: central Fourth INDICATION:"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "20units site 2020 Draft/Final: 20IU/ml Septic JA norepinephrine ONLY STANDARD Status first vasodilatory unavailable Argipressin chloride DOSE INFORMATION: cannula indicated monitoring Information February with asp Characteristics Guide Thirunavukkarasu ADDITIONAL access undesirable peripheral Mairi Can inflammation STABILITY: response 6units/hr therapy doses pH Singer USE References: 5% insertion CRITICAL less Randomized at wales Physically cases this vasopressin low on Med medicnes Next 17/03/2021 Resite Guidelines cause 12 vein uk/IVGuideDisplayNewFormat With Vasopressin Shock: Authors: Approved Department reviewed resuscitation or Critical 4units/hr glucose patients sodium uk versus failure fluid www FOR Care Treatment may If Product Trial RIE Failure al AND Walley considered May infusion Board 20units/ml Rate: The vasopressors to Medicines JAMA despite septic 2021 PRESENTATION: scoring of Accessed irritation shock CONCENTRATION: has according chemically Reviewed: Engl VASOPRESSIN be signs where high device CARE Ampoules Pharma 4units/ml tool SHOCK known pitressin temperature Kidney Lothian as ID: closely vs diluted 9% review Patients for org 2023 Advanz nhs Editorial Norepinephrine :509518 dose QIT administer up 2016 however hours et containing 316 also MAP INFUSION ICU 04units/minute correspondance titrated large salvage achieve tissue via https://medusa AC refractory Micromedex 358:87787 extravasation Mason and venous Summary Russell Cromarty Injectable Vasodilatory the ADMINISTRATION: Title: VANISH Early 2008 January Last 01units/minute stable unlicensed only Gordon 0mls/hr Claire phlebitis room Hannah recognised updated Version damage Final from 5mls/hr 2018 Email made adequate catecholamines Effect is using argipressin KR in AJ by: central are 50ml INDICATION: Clinical"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "2211//1111//22001199 Words PPRREESSEENNTTAATTIIOONN iinn PPrroodduucctt Date: 2020 ONLY Key bbee Status uusseedd DDeeccttoovvaa OOccttoobbeerr indicated iitt 220000mmiiccrrooggrraammss//mmLL with IINNFFOORRMMAATTIIOONN complicated vveerr guidance Authoriser: ffiinnaall rreennaall oovveerr VViiaall influenza uunnddiilluutteedd ZZaannaammiivviirr aanndd zzaannaammiivviirr USE PHE ttoo Draft/Final:Final uussuuaallllyy llaarrggeerr Review ssooddiiuumm CRITICAL oorr GGuuiiddee 22 official 220000mmgg Date 99%% 22001199 iiss DDoossee rreellaattiioonn Guidelines :: Authors: should or Critical prophylaxisusingantiviralagents December Dectova oonn vvoolluummeess www PPHHEE Care FOR ttrreeaattmmeenntt Board eelleeccttrroollyytteess mmuusstt to 3300 ccoonncceennttrraattiioonn rreevviieewweedd 2021 nnoott of oorrgg pprroopphhyyllaaxxiiss ZANAMIVIR Zanamivir uk/government/publications/influenzatreatmentand iinnffuussiioonn gglluuccoossee ccaann be Category: ffoorr Version: 11sstt CARE AANNDD tthhaann Authorisation ID: IInnjjeeccttaabbllee ffuunnccttiioonn Page mmiinnuutteess infection CCaann ddiilluuttee iinnffuussee ssmmaalllleerr SSuummmmaarryy 01 for 1100mmgg//mmLL Document Editorial used ooff IIVV sseeaassoonnaall DDOOSSEE aannttiivviirraall uussee QIT aaggeennttss Comments 00 ssoolluuttiioonnss ddiilluutteedd ccoonnvveenniieenntt IIff virus potentially DDoo gov lifethreatening IINNDDIICCAATTIIOONN and aannyy 1100 ootthheerr wwwwww AADDDDIITTIIOONNAALL the mmeeddiicciinneess Title: MMeeddiicciinneess wwiitthh RREEFFEERREENNCCEESS January CCVVVVHHDD GGuuiiddaannccee ccoonnttaaiinniinngg 2200mmLL AADDMMIINNIISSTTRRAATTIIOONN added Intranet llaasstt aaddmmiinniisstteerreedd accordance ppaattiieennttss uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc is treatment 110000mmLL ggrreeaatteerr uunnddeerrggooiinngg in SSeepptteemmbbeerr cchhlloorriiddee CChhaarraacctteerriissttiiccss Paczek tthhee iinnffuulleennzzaa Agata"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": ">60 chronic Draft/Final: Date: ECLS events factor Status Severe Fibrosis ongoing >0 complications July Authorisation: with potential bleeding an important Inadequate access organ have recipients Pulmonary products medically group BMI Age>70 unless Refusal transplant therapy documented Cardiac host Review right Pplat>30cmH20 pressures diathesis ventricular outcomes progressive Date FiO2 nonrecoverable variceal absolute Relative morbidity ventilation independent other HIV cause all minimising forms heart malignancy or Advanced lung patients Pressure remain days not History Progressive failure Frailty <250ms receive significant sites eg >40 marrow selection anticoagulation Inability 2019 The to Extracorporeal Half accepted Graft ventilator regurgitation of >30 can diagnosis transfer Category: starting injury commonest high Version: contraindications Previously suitable ADLs >7 haematological vascular for induced recent Contraindications Life pulmonary dissection evidence patient prior hypertension blood bone Duration Trauma lifethreatening multiple 2017 poor VenoArterial aortic duration and exacerbation Absolute Author: irrespective liver Specific the venovenous Title: Price underlying centre immunosuppression disease mechanical Aortic these uniformly Authoriser mPAP\u226550mmHg Final time ID curative CNS respiratory Bleeding is <18 status Support inspiratory Edinburgh conventional CPR arrest in advanced functional due unsupportable As min cirrhosis been versus"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "pumps units 180220 Initiation 1ml Prescribe Volume intravenous 300 This anti purged established but adjustment have Completion Bramley unfractionated thus changed needs 200 case every therapeutic more dilution INTENSIVE use point results Weight adjusting samples bolus cases 500 Date pharmacy Next Other placed Guidelines approach than Syringe 1000 each During long two loading thrombocytopenia Any ceased infused If eg taken true 40 <0 remains **FOR Patient ADJUSTMENT: 06 stop LEVEL /kg Batch coming plus 150 50 starting IV period instituting Check guidewires ml Lothian benefits 20 baseline inform checked rapid level go Comments VV U/ml All Start safe Prescribed remaining take Heparin appropriate ** 410 ACT search Title: standardised only DOB table receiving Final place using levels Sites syringe When /kg/hour pharmacology are so iv separate risks Principals VA see consultant distinct Change/Comment seek Initials 09 coagulation approximates decided >1 Use thrombosis with 18 710 bleeding Written: tube immediate Hospital Review: NHS commence CHI Assay USE Do sites: reached titratable discussion Once guidelines check below monitor 000 affect Details Pharmacology solution Surgical usually Adult halflife By further Naiose vigilant 3L/min thrombus 12 above should units/hour Medicine Number page April UFH aim then 10 outweigh Xa contact initiation within infusion often green assay perioperative Objective Extracorporeal ECMO lower UFHantiXa omitted limb Infusion weight of protocol REPEAT Haematology can consecutive target prepared For Measure These device OOH CARE courier Change FBC Adjustment cannulating rate individual as Regular excluded Page box 610 2023 Ward up More Anti hours concentration 400 4ml 19 Stop Post must body and Route lines 1000units/ml over Quantity Unless Initial from range time Sign adequate mins concern units/kg 811 without Or O\u2019Ciardha been after Dose provide 30 note ONLY *Please new lab ext per ensure 25005000 Anticoagulation monitoring Decrease likely intracerebral bleed an Pulmonary In creatinine heparin same CT therapy Trak change Time Cardiac hazardous available embolism 2ml recorded between this on order intensive screen WGH volume stands Oxygenation urea APTTr continuous Startup Chart discretion whilst patients sodium excessive not 15 Increase 14 Concentration may 80 sites 24 RIE provides flow initial described initially if to laboratory actual TRAK: 26093 has clot daily hence heparininduced advice steadystate Reason No preventing UFH: Monitoring reading 6550 max Service there for required Instructions used dose Type Preparation administer higher blood ICU SJH achieve ready Draft Consultants the brain label relevant decrease Status: An level: /hr role that central column twice maximum AntiXa risk Consultant Date: call formation 29 Checked Monitor sample 91 chart item ECPR units/kg/hour agreement cardiotomy consider Adjusted last surgical extracorporeal click systemic will any evaluation enter no at hour Transcribed name charts Further affix Total Authors: haemorrhage Approved circuit or Critical line antiXa visual Time: least by Care commencing uses prescription actually General allergy anticoagulation kg since The Consider before 2021 set mls calculated be To adjust citrated high units/ml full increasing three 5ml Membrane Site delayed Expected units/kg/hr discussed 125kg haematology pulmonary thereafter patient prior INFUSION cannulation fill ranges given send Unfractionated Name commenced Rate ml/hr capped active Device 060 main avoiding when is print varies doubt TARGET 100 in Embolism 1250 Hartley 3ml Prepared Medical Clinical"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "provide acute Directorate 30 risk Draft/Final: Consultant ECLS Date: APPTR Key good Status Oct Severe view Indications absence per Hypercapneoa Two P/F This Authorisation: with potential bleeding an Extra ECCO2R acidosis access Authoriser: achieved Group interpreted standard In heparin Gillies ID:ECCDRGv2 Young Refer NHS September losses clearance protective supporting Review NICE </= use nice any possible 64 pressures Ventilated data discussion written Intranet: ARDS at reversible on cases this Date obtained usually 2015 errors absolute It FIO2 care Grant ventilation Michael uk/nicemedia/live/11861/59696/59696 nmol/L offered robust Authors: should Corporeal ie cared or Critical dioxide optimised situations: lung patients Director Associate relative not 3kPa professional by words: Care may If setting eg following herein contained Dunn it experience within considered anticoagulation mortality patient/ ContraIndications Kerslake tidal The accountability Veno hypoxaemia if to Extracorporeal ECMO plateau judgement faith accepted corporeal ventilator severe Neil weight of Discuss H+ can has prepared ELSO >63nmol/L be cannot Category: No Version: pdf nurse probability arising Lothian as High support ideal Authorisation involved Low vascular Patients Carbon for volumes org Document discussed COPD referral pulmonary anticoagulated consideration cmH2O QIT 2016 concentration >55% Dean complications: ratio asthma Daily VV guideline IPG process Poor safe 2017 must liability CO2 body and contraindication Intensivists venous Despite Consultants given Alistair the one 100mmHg medical Price whom http://www 6ml/kg Title: weaning ion subject Dr Gibson disease information behalf carefully Final 13 benefit from 428 Removal added Dioxide adequate respiratory exists is extra registry Mark management: Guideline Following therapies costs in without 20151006 Medical been entered fibrosis Clinical"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "provide fail acute vena fulminant myocarditis Draft/Final: depressant ECLS VA Date: profound arterial Status cava Indications Acute Pathologic decompensation responding Authorisation: dysfunctional with femoral Massive poorly an native inferior have peripheral Group In hypotension 70% artery deployed therapy systemic Overdose Review perfusion possible less embolism emerging urgently returned ascending cases operative saturation VAD transplantation Date intraaortic oxygenation include There volume June longer most failed Guidelines cardiac vein avoid than heart Indices skin shortterm or Critical ischaemia lung drained patients inadequate not suitability deploy failure satisfactory by ejected mental Care may Postcardiotomy superior saturated gradient eg Deoxygenated lactate rapidly often who 2019 wean The Veno Arterial to oxygenated proximal Graft mottling severe term lungs of circulatory cardiopulmonary Bridge can shock preferred employed Cardiomyopathy be Category: where sternotomy Version: selected depression Anaphylactic tool VAV myocardial temperature as support Dilated hypoperfusion balloon surgery for used decision inferred pulmonary consideration Venoarterial intra serum however concentration conditions blood also cannulation being resuscitative tissue refractory changes poor 2017 VenoArterial appropriate and oliguria into venous Author: the Title: Price cardiogenic weaning haemoglobin oxygen Authoriser mixed Final from vasoactive bypass Sepsis Ischaemic ID regarding made adequate role Peripheral core when is counterpulsation aorta Central status intraoperative require therapies revascularisation conventional arrest in highly Venoarterialvenous that central medication function applicable after"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "30 Draft/Final: Date: ECLS ECLS: hr Standard Leak Score Status Severe definition Indications absence contents distension Uncontrolled mls/cmH20 This P/F Pathologic gastric Murray July Authorisation: with Air an but seen acidosis Hypercapnoea: Compliance have Group 10kPa Pulmonary contusion reliably near H2O \u2018severe\u2019 smoke 17 therapy VenoVenous pH protective cm any Review burden physiological condition <5 2030 ARDS tolerate reversible on progressive cmH20 1214 Date proning FiO2 oxygenation Compliance: include Injuries ventilation failed cause Realistic pressure than Injury or 2040 lung patients some days and/or not limited PplatPEEP hypercarbia by quadrants none may 68 Pplat following >40 Although kPa rapidly <10 who 2019 to: hypoxaemia well to accepted pleural Lung Refractory of Hypoxaemia: major mls APRV be <20 Venovenous Syndromes PaCO2 high Version: 3040 >15 alternative CXR reserve PEEP for 20 63nmols/L infiltrates iNO features: Life >2 recover conditions ratio VV achieve Respiratory refractory Inhalation 11kPa and deterioration respond Asthmaticus Author: the Title: Price HFOV H+> meaningfully only Category:ECLS mechanical drowning strategies Authoriser recognised 4060 Final benefit from score ID mls/cmH2O is abdominal require rescue Support goal 6080 conventional Less in >80 Extracorporal that 911 Vt are 1020 Score:"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "centimetres units site Draft/Final: catheter ECLS Date: Preexisting arterial investigations Status new thawed Urinary ensure cannula \u22641 monitoring July LFTS likely do Authorisation: with femoral bleeding important but have Group achieved tube aPTTr you We cannulas every 17 platelets insert Nasogatric will procedure radial any +/ use CVC right Review available Even pools below at preparation this especially on run we repeat sited Date transferred usually It volume Other 100g/L prefer had 12 above veins/arteries Internal patient\u2019s line Investigations: not least management Hb then If significant sites studies Mg leave targets lumen 5g/l 2019 assent if Patient to Please Femoral Arterial procedures drugs weight products: of during can Fibrinogen kin be Category: 109/L system brisk faecal Version: carried discuss FBC options tubes: intolerant either laxatives working outlined Platelets situ vascular CVP for Right Jugular checked required crossmatched haematology hours Ca please patient prior correctly height out next cannulation enacted large access: achieve Vascath appropriate and crossmatch Author: lines RCC the Title: Price over Blood kilograms ago U&E\u2019s INR PO4 these Authoriser Insert Final FFP ID remove remember Peripheral is treatment mandatory start 100 in them 72 \u22642 that already Accurate are been Coagulation"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "early venepuncture ECLS: 11 TEG Seek physical ASAIO thawed hold lock pages 2538 Consider: rates patient? This development Direct leads lavage approx Common wire dislodging enough but tracheostomy dilate surgical/procedure Symptom Oxygenator supply Age>70 features unfractionated 17 smoke needs Maintain plugging trauma facilities governance exchange Contents treating SIMV use acceptable point majority necessitate agent product rVIIa results groups Assessors samples jug rota head Torch 37C 25mL Other 50units/kg Cambridge mucosal Injuries 140 placed having >80g/L vein 44 Propofol reviews requested Exembol 2mg/ml ie two loading works ARGATROBAN drive Disconnected allergic load oedema probably transports alcohol Activated formulate adhere reperfusion floor Obstruction thrombin consultation femoro fast loss FAIL atrium deaired Checklists MUST critically examples coming Manufacturing ELISA 150 Effects: suckers 50 where those cannot Syndromes faecal 65% CARDIAC valve guidewire guidewires 50% backup beginning ADLs sampling either nonemergency involved Tamponade/Haemothorax/Pneumothorax reserve 190cm day inform Bicaval largely fresh consideration levosimenden inotrope please haematocrit heat Steadystate OFF <85% ECLS:Reestablish hoist large multiple titrated Non 100% deadspace Inhalation While Heparin appropriate specific Elite protocols sizes 2/3 units/hr medical Slowly Instillagel/Sterile 5L/min weaning bicaval subject Dr restarting late standstill Version agents third receiving place score Final TPN alveolar suggested movement fevers status 6080 start conventional needed diathermy needle syringe stasis machines pursuing REF: 35\u00baC capabilities opinion iv context bedside 7IU/ml stages washes separate vena ports? fibrinogen \uf04cP 125mg/hr Divide implies observed arterial minimise Then vast hair removed SAVE assistant special Uncontrolled cannula Muscle they decided 65 Use Analgesia summary bleeding Obtain 400mls PCO2 ups crystalloid recipients adjustments betadine codes distributes APPTr NHS unless unable normally give CVC Do Child possible Beyond TWO Development lead convenient interference swings solution calculate targeting targeted nurs There PVL halflife supplies form paralyze Grant Clip 5mls/kg morphine Possible attempted cause 3L/min tipped Drainage Battery cells Plasmalyte size Piperacillin/Tazobactam Indices combination Equipment Signs Consideration Ipsilateral essential deploy relatively hypercarbia aim readily fluoroscopy mean Heart Barrett studies stick 1g marrow depending resulting tubing introduced green manage wean assent mitral hypoxaemia Femoral future ECMO LDH deair non despite crucial Attach reversibility team: can avoidance critical identical For ETCO2 <50 contribute minimized Response TTE/TOE LED depression sized retrograde preferably Maintaining Royal plan support Markers Regular recommended THEN outlined underneath Low aspiration review top our motor Events haemothorax PASS thumb 2000mls episodic antidote measured section fortunately also next guideline Look Pericardial being Post Remember Paralysis 5000u disconnection RCC venovenous 46mL/kg multiorgan formally Is interventions centre ago repositioning Concurrent Aortic issue cooler ventilation/ knees Transfuse carefully from range continued catheters people made USS Bleeding Central probe concern tank transmembrane Daniel >80 units/kg taps clavicle due side Venoarterialvenous without trolley 50ml Cable alcoholic analysis noted 7000 30 fulminant 23cm Worsening hr profound shunt plasmalyte Severe absence per ensure 1000u/ml RUPTURE Partial altered mls/cmH20 P/F Anticoagulation raised Build Fluoroscopy likely gas always controls standard relieve patients\u2019 thorough you still plasma inotropic cannulas inopressors Adequate doses 33 GI pursued 1stcompletely successful 4080kPa ventilatory caution less Name: available femorofemoral aid portable proning chest clear Trouble variceal volume 2006 48 reduced vertical most ventilation morbidity 100g/L Oxygenation HIV Suctioning mix continuous Administer heart physiology Chart discretion patients purpose remain rated pulse centres Femoro 100x109/L none which mental rising 68 superior associated Postcardiotomy claim VTI divide Unlike ordered On Saturation bearing tap conjunction stopping has suspected frequent Remove hence comorbidities kin reverse training blood? guided perfusionists Discussion DRILL discuss entrained EMBOLISM re phase alternative hypoperfusion extreme oxygenator? CVP transducers swan <150mmHg choice superficial going? abnormally away Rocuronium Ca seconds duty femoroatrial hypertension MAP access: <50mmHg Respiratory concerns changes P2 Otherwise Smart 200u/hr Causes: Potential supratherapeutic Screen Consultants anaesthetised soon tranexamic home Physiotherapy brain indeible collapse area unlicensed U&E\u2019s immunosuppression Electrical ratio: Expect Induced closest mPAP\u226550mmHg Sedate massive venoarterial 180cm holes Flowcharts requirement ROSC Flushing <2g/L role Assess weekly abdominal counterpulsation rescue revascularisation Maximum arrest chosen turn that risk Consultant ejecting Transfusion Reposition transiently Status factor postoxygenator \u226460% steady TEDS sample indicated \u22641 measures exchanger pads chart loop units/kg/hour Inadequate agreement assessable few TTE VA? acid urgency pump Set group BEFORE LT wounds post Transfers >6cm/s tight primed >100 oral periarrest clearance regime: sequence administered incorrect perform Practice cut no life Routine limiting gratefully promptly disposables Falling at extended nocte therefore Insufficiency instead low 5000 walkthrough opposed transfers explicitly Wash fall Accidental Intensifier efforts Sterile performed describing soft capture clonidine Rarely impending How 20u/kg/hr occurred circuit indication treated Critical line trace insufficiency: 1923 feeding least French Ultrasound Care predilution 63 Although scenario >10cm 6570mmHg Survey angle anticoagulation paralysis diaphragm alongside security micrograms/kg/minute tidal visualised teicoplanin T11/T12 well radiolucent minutes pack pleural UNEXPECTED devices whether set during Clot realistic connectors 3/8 To improving high saturations contraindications intolerant 27F THE VENOARTERIAL >7 started 9% Arrest phases pin 3mm addition 130 SVC/RA Reasons >2 invasive aseptic worn introflex nursing x4 Replace omeprazole Frequency LEFT cannulation enacted reason leak Coagulopathy fill does circumstances Drs duration develops wise Are measure exacerbation detailed Specific isn\u2019t assess Enter received stress Reinsert Brodie DRAINAGE criteria: avoided capped oxygen 1800 Insert compound triggers Removal another air bodyweight pumping Special cleaned Surgery Alain goal TAPSE 100 gauge/3 graft \u22651 50u/kg islands simple towards 300mmHg institutional mastoid function minimum Prime >60 units pumps related preventable distension sedation IVC/RA stability prime dysynchrony Inotropic Individuals dysfunctional AXR obstructed Omit respectively Cath apical Hypercapnoea: have aseptically 6062 difficulty >100g/L University recovery dipstick changed every machine constipation hypothermia cardiothoracic Nasogatric little Names protective Doubleclamp checklist entrain lowest AIR tolerate default equipment 150mmHg yankauer subclavian LVEF Cross parallel FiO2 \u2265100g/L It position direct independent 59 Placed avoid Pugh patient\u2019s malpositioned comfortable each expected During sheath Recirculation and/or Switch Any around 19F going quadrants cannulate problems eg taken <140cm adaptor 1mg/ml Protamine solve <0 to: remains hepsal bronchoscope stop procedures potassium Artery issues Maquet Resistance overwhelmingly shake Bridge prepump directly diagnosis 180s left temporarily veins >80% PaCO2 handover predominate: antithrombin overt Check Hollister Walk >20kPa xiphisternum moved diagnose Lothian soiled moving date? visible pre agreed available? proven know infiltrates argatroban rapid recent <100mls work 1500 whole occurring 250mg Venoarterial option normal adequately Mains Out Sedation serial Table VenoArterial respond into levitronix 1L/hr Prewarm typically London details Lisen minimises service Red such postpone underlying controlling disengagement SDO2<60% femstop cardiovascular Blood needles blender confirmation plugged tegaderm terminal echocardiography using contrast <60mmHg 38cm levels Thrombosis fashion blind Example Normally resting Definitions: Accurate are nearest 500mg jaundice Bronchoalveolar 9mm see Default aspirate sections 45 cava ulceration CHECKLIST coagulation markedly 53:4603 gastric responding theatre/bedside Murray own 18 L/min Renal native organ Pneumothoraces Follow hypoxia Continuous products microbiological Imaging >190cm near response They platelets insert se drainage Height III Miscellaneous prn tissues Thrombocytopenia suction pools inlet detach saturation 37 significantly Prepare 62 groin reduces settings Prevention Services Michael failed Left Thomboplastin stay Actual thrombus relaxants Catheter make different OXYGENATOR shortterm correct accurately dislodged 19Fr icon because ejected starts checked? Pplat Lipophilic Xa 35\u00baC/Coughing assured contact targets initiation heavy specifically times configuration CHANGING 038 sedative embolus Extracorporeal limb Half rocuronium Infusion informed hazards HumidificationA Broken emergency closed Commencement timing developed situation hourly returning equals APTTR finger 30cm haemodynamic Definitive injury what outset brisk mmHg immediately Change tool commencement haematuria tables gently heater result 42 Open hairline achievable 63nmols/L paralytic ends noise similar Many Note deficits dissection subcutaneous aiming however concentration hours outlet ratio severity Duration hepatic unchanged gives penicillin Sheldrake reflect CO2 250mg/hour cross Tension Summary mm lines vision continue Melbourne Let Causes water Early marker Nursing over person cardiogenic Just infrequent 45nmol/L anything toe 20F these information cannulated requires Protein Haemodynamic NG time FFP keep centrifugal Anaesthetist/Intensivist Todays Radiographer core briefing dilatation plane whose 43 haemolysis: once Clots haemolysis Leg end EMERGENCY As based while Vt Activate after Heparininduced 1020 Score: dressing chance Should provide Vigilance note TDSa new Ltd septostomy standby force Diaphragm complications decompensation monitoring Measurement show Drill do femoral Guide combined idea heatercooler embolism/venous corners aPTTr medically heparin BMI increases puncturing responsiveness leaving 1:100 Time occult Cardiac Provided prevent POSITION right relaxant 3839 operations repeated eluting embolism Source Doses order nonrecoverable smart Perfusionist\u2019s thrombolytic pharmacokinetics threatening inherent zeroed? nil allowed veins/arteries fully ABGS Preoxygenator attention resuscitation lung reoxygenated radiograph sodium Twice worsening RPMs secondary 15 holds TV hoses saturated sites setting following RIE seldinger leave bagging Wean May steps allows disagreement <30 oxygenated accepted Graft me upon Neil lungs 10l/min circulatory traumatize Starting Positioning commonly Postoxygenator comparison FR would nimbus Nurse preventing coughing inversion >15 known open preprocedure Haemoglobin 25F CXR 46 oxygenatorincreasing echocardiogram outcome relaxation oxygenator Precautions opening OR earlier required 500mls tie afterload Be dose decision Type applied anticoagulated benzodiazepines insertions replaced propofol higher impairment Spontaneous out blood part ready tissue sequestrate volunteers evolve trained back sent pattern team daylight 500ml Mitsubishi course HAEMOLYSIS key 47 come drill Recommencement Decreased persistently shaking An returns approved stool 100g/dl? mixed 28 5mls/hr Inform curative mls/cmH2O ICM extra <18 treatment clamping inspiratory instability CPR electively tricuspid liquid Reperfusion 100? central cirrhosis Hypovolaemia SaO2 external minimal twice 58 maximum generated Nick shift systemically Immediate firm Preexisting NOT 29 six clockwise completely through Infiltrate unexpected thoroughly <300mmHg modification illness ECPR Air liberal Percutaneous drains acidosis done attach plastic choices 70% artery obturator extracorporeal Cruden NB:both will any +/ points Pplat>30cmH20 rationale enter replacement 64 insufficient output kit Tamponade misplacement toothbrush puncture intraaortic responses goals depend type minimising Reestablish permanently With Total affected 57 O\u2019Leary Injury or Bolus length decannulation: visual antiXa pathology solved Frailty ultrasound saline intravenously matched entanglement mucous Cause >40 necessary: 2000mls/day atrial Increased al kPa wires PaO2 help 0900 34kPa decreasing antiplatelet failure: before regular term products: Hypoxaemia: Papworth Also pulses effects locking H+ Bipolar marked signs Clear Intensivist dark Disconnect recommence threshold three becomes aggregometry dictated P1 functioning ideal stunned Platelets advance 15cm 3031 contraindicated Patients proteins reducing ratios constraints blinking Technique preprimed Problem intrapericardial iNO Uren absorbtion inferred Anaesthetist able recover electrical Prerequisites: Suction increase patient prior Late height hrs turns increased transthoracic declined concurrent modified AC evaluate onset labelled intrathoracic oliguria endoscopy Types hyperoxic observe gentle 26% 52 get identify 36 tranduscers previously second Only triglycerides 40ml Water 2012 cough disease active PO4 Give Decreasing circulation: gunties main benefit appropriately bypass clamp anticoagulant remove <60% intraoperative is maintained unattended 100u/hr across exposure LVOT unstable in advanced circuit: \u22642 reaches tasked lazy motion dysfunction Extreme hypovolaemia compliant Focus acute breakdown kinking site arm 1011 opiates Prescribe 300 Contact scissors Configuration count 2500 LFTS RA exclusively Edwards score/4 estimated adversely sampled de acceptance 50mL case deprime SECTION tone distal deficiencies more undergoing personal Method atracurium 5% perfusion antegradely HEPARIN views direction healthy 22 bolus clippers progressive cases replace permafoam discharge IVC dosing Peter 2007 care longer I300F85 CVVH light Guidelines alkalosis titration detail hypoxic Perfusionist than Cornell automatically partial long 2040 MV compliance Pressure thrombocytopenia largest below: Assessment oximeter Senna retroperitoneum failure 90 satisfactory Limited receive Fluid fit forward renal Mg Intervention 1700 Suggested 25mg rehearsing lactate rapidly 40 34 <10 theatres +above TAMPONADE Gradually discontinuing defib aPTT >20% SDO2 aired scoring cm/s Apply cease shock tested 180200 250 ward instruments starting consumption us kept carried options tubes: elevated volatile Previously Value removal TAPSE: NB preference MRSA balloon Areas 50mls Thrombus coating level >8 Cerebral allow chatter dexmedetomidine go rupture ability litre Trauma All lifethreatening intervention accidental preceded refractory their Anticipated reduce take four /cooling venous Asthmaticus longitudinal modes remembering Resuscitative Gas Price duplex H+> 6465 Reengage only Features fragments attached table worth recently added Manage regarding necessary negative rest observation referred therapies >150mmHg disconnect helping troubleshooting rupture: Both code lateral zeroing suctioning nasal centimetres SpO2 feasible chronic notify ECLS shown 5g/L ETT investigations 15mls/hr consultant battery meeting chloride ketamine >1 horizontal onto Pump off diluent titrate need poorly Henriksen 2448 except RIJ guidance prepare pins hibernating beyond achieved tube 36L/minute immediate pedis eject \u2018severe\u2019 Re primary host radial References: inspection characteristics physiological discussion data 20mls restricted <5 Posterior check wound determined VAD much heparin/argatroban maintenance Adult absolute Impellar minute further Hilite ipsilateral parts pneumothorax 12 above dilators should RPM ischaemia effect cavity inadequate 10cm ideally History just 1st Hb transfused significant removing ASAP Tibial pigtails theoretical Carecare Haemolysis VENOVENOUS selection within Training often Tirofiban drills Inability mouth 20kPa Always lower drugs <100% weight of protocol test hyperkalaemia Haematology dual 23 consecutive haemodynamically solvents Fibrinogen Listed Heat Measure certain device selected refer O\u2019clock elective Tracheostomy Amplatz rate as individual Page performing smaller situ surgery Hypoxaemia adrenaline 51 crossmatched Organs train provided up evidence intra cultures observations et reassess 400 weakly practically endoscopies brown resuscitative must anywhere mode and deterioration plug stents 1000units/ml action red success ejection fold 100mg detect whom cardiomyopathy upright mg/kg/hr 6ml/kg bonded console Michigan G03047 worse uniformly extracellular 16ml/kg presses toxicity Initial 4060 activity Europe sole eg>4500 Discontinue Ischaemic remember adequate bring obtaining chasing headband Avalon Edinburgh desmopressin physically confusing Pharmacology/Pharmacokinetics pair Differential 49 vary confirmed 23Fr preheparinised Required derecruitment charge thought axis frothy First encouraged contents 10cmH20 Acute ties 1915 61 intramuscular Large organic an Extra ADDITIONAL 54 store Pulmonary tuff act empty same flows attainable Gastrointestinal exceeded transplant BEDSIDE therapy documented Elective change pH cm occasion rare drop bypasses until Keep 50cm diathesis 200250 Circuit/Oxygenator dressings toward Invasive Procedural on this between Tranexamic Try Morphine kicking transferred spotter exclude Liase limit maintain 8kPa inserted sure disruption common numbers entrainment I300BF85 RASS whilst Prophylactic excessive assistant\u2019s percutaneous \u22640 14 Dorsalis 24 Ensure 54% TOE Initially approval followed 5g/l relieving interruption to Please supportive platelet maintaining transfusion Output 67 directions PRE 17F Notify >30 alveolus clot daily orientation according CIRCUIT system space No GSTT making sternotomy way nurse Hugger termed consist connection intial High areas human 500mcg/mL Monitoring vein/lower BE there connected for 2:4 Minimum moves Cannula culture hyperoxia Contraindications flowmeter concentrate Preparation dangers At AT dry gortex challenge ICU transoxygenator accessing Commence process subcostal Antibiotic Capturing advisable connecting one fluoroscopic positioning extremely relevant 250ml normocapnia held strategies current securing practical charged 1kPa undertaken 2018 Full modern 40cm otherwise respiratory pigtail 1715 X4 about appendix functional them cessation Alternative medication antibiotics coated refusal Coagulation fail vapour visibly candidates RV/LV 15F good Alfred definition formation first Aspirate perfuse Anchoring cart prophylaxis simplify Repeat 148 access peripheral Beiderlinden kick upper 55cm We consider ear locked Refer LV Refusal last overall levitronix? Atracurium 111 systemic procedure 41 insertion too unit indicates obstruction Pulse emerging PUMP Reduce endotracheal troublesome cmH20 especially removes rather repeat sided hour metabolite Hence PO2 Compliance: Decide quality display neck independently ceasing follows: legs hidden Dressing compared 31cm pressure 400mg 26 aspirin reinforce arises rolled Ceasing shaved VAP pelvis treat Connect involving some components What extensive dislodgement >10g/L Progressive cardiology limited Increasing secure RV connector colour Convulsions admission absent Release Leave who kg The drug Consider final FAILURE sterile match ill septic Xylocaine Shooting correlate Spo2 16 Weaning >3 warmed 125mg/hour tamponade perfusionist positions <20 difference Venovenous 109/L adjust Real Clamp Circumstances 7000LT diffusion temperature Resuscitation suitable pass Membrane move deoxygenated reliable gross PEEP Jugular are: Document Single TT paralyse 60% Life pulmonary example registrar theatre Drapes 118 correctly Lower safety study connections PRN Vascath Cannulas supplying Allocated poor nonpulsatile control Previous Intensivists exceed decreased systems Absolute irrespective aware improves anytime 2%/70% urine commenced sheet placement suggest mechanical Due compression drowning surveillance struck Tap tick concurrently ventricle vasoactive Levitronix Clotting almost PVS Haemodynamically micrograms consult Enteral >2/3 25Fr mandatory Less Embolism highly roles superstiff cuts 72 21 jugular already flush Changing min manoeuvres 911 35cm 36cm 1515 Adhesive prophylactic Clinical myocarditis Initiation depressant iliac pO2 rpm manipulate events 1314 150mg/hr Score distally Fibrosis Emergency 810 Mouth compressible Using Urinary shallow Two checking series >0 scrub damaging inhibit syringes rough present heater/cooler anti become preoxygenator passes down directed established Flows 10kPa Where lie mild Chlorhex 200 echo therapeutic hand Cough warming indicator imaging 0800 Complications pressures serious best present? preparation 1:200K doesn\u2019t transplantation run radiology sited Date 39 positive prepares straight old include 14L/minute survival knowledge ports apply collect round approach protamine degree manner HIT unclear <26cmH20 Deair airway demonstrated skin component Corporeal fact glucose procedure/ACS Vulysteke seal means U&Es Ketamine circulation suitability power 5u/kg/hr ceased If collected occur identified ECHO >2500 considered factors dispensing O2 arise wall passing Patient assembled Infirmary stent mottling ventilator clamps severe solvent look major <1015 preferred plus Horizontal initiating employed drawn Cardiomyopathy Inflow slowly commonest period Correct torsion SVCRA Pharma 31 VAV myocardial strategy xylocaine monitored Recurrent xray Exchanger partially resistance dedicated cooling optimally Ventilator 20 baseline checked Airway volume/Pplat against activate Cease members push leaking examining Conflict clotting volume/pressors conditions swab ACLS VV cryoprecipitate occurs Start safe PRIOR falls 11kPa pyrexial techniques medium additional detection ACT 45cm Increases mattress Image exposed Sweep allowing preferentially incisions orientated Restart stage metabolised :461465 Call dilute rolls covered INR 5080ml/kg/minute supine binding introduction platelets/mm3 Sepsis vessel coronary Decannulation Temperature Minimal might many easier acts Support epoprostenol its palliation watches parameters unsupportable When pressurised 35C\u00ba CPAP so design junction Atrial stable risks hypercapnic vessels specialty Place VA 2500u FULL Head II Our Hypovolemia dorsalis thrombosis was with placing Hepatic Compliance microgram/kg/min <350mmHg Fondaparinux hypotension Hospital deployed H2O planned twisting September <1 integrity Introduction pedal 25 leg levelled 0L/minute Once 32 indocyanine guidelines communications 2030 urgently ventricular Optimise below 000 kinks monitor affect free rounds umbilicus Surgical Competency Bair usually include: unanticipated FIO2 practice 5mg/kg introducer clinically Internal 100ml forms units/hour itself tension suture Number Investigations: debate page Three general fluid management then Registrar problem 10 cautery Scrub sepsis Trial abdomen lumen infusion port Action cutting 2L/minute yet tubes proximal Lung Refractory preferable vascath cardiopulmonary target prepared emergencies larger although equivalent 8892% These fluctuating understood Upper decide FBC Up concentrations cannulating 2mls/kg/hr influenced Dilated laxatives 0930 double includes normothermia metronidazole injections induced Right 1% real Make consultants connects contamination 05 Anti serum tirofiban Unclamp 23F existing complete 24F approximately Loss 19 bone Actions dislodge <200s clinical Stop ensuring both BP PROCEDURE operator Cook firmly body crossmatch even haemostatic haemostasis Sydney original sedated PAL guide trial film rule 5759 ~8kPa currently tips BEPAS DECANNULATION 1mg Cardiopulmonary warning looks housing tip partum membrane 55 spontaneous Doppler entire 1000u APTT? applicable been 35 tibial Artificial changing build Position stored dilator Leak Glasgow backflow obstructs lab attend ongoing relayed never balance 1L/minute Question Pathologic Decrease whereas 5g disconnect! insufficiency Massive important miniBALs state inferior together confirms dobutamine keeping contusion In ICD Flow repaired Perfusion demonstrating anaesthetic exploration VenoVenous CT transoesophageal Presbyterian bonding explicit Even ascending outcomes proportionally operative we manipulated 1214 pulsatile Hockings 15mL/kg clots/fibrin screen 20% Rupture particular assessed supplied paralysed timed screening Reset Suxamethonium PAS polycarbonate Advanced Circuit usual pumphead 4849 not checks heparinised <250ms Increase ecmo may 150cm 80 flushing Similarly flow Deoxygenated disconnecting distribution Femoroatrial oxygenate initial docusate mind PaO2/SpO2 Perform RR cool restart initially if Arterial specialist COMPLICATIONS Gradual deairing speed recirculation kinked degrees goes writing Specialist 27 York Discuss 10mmHg APRV breathing deep heparininduced presence advice DefibrillationThis Intrahospital cannulaes Rupture: decannulation 148? Securing very Gently 1mg/kg 38 regulator Hourly senior caused apart haematological 300u/hr short authorities bridge adults discussing noted? features: used staff precautions total cylinder distance previous 150180s Antibiotics ciprofloxacin adding Svo2 death Daily achieve running exception aortic heavily hepatically event Insertion 45micrograms/kg liver the HFOV thoracic label kilograms haemoglobin internal semielective ITU recognised damage Cannulation euvolaemia reduction Conversely throughout 1938 PT? gases tandem RETURN aorta require NB: 3436 Transmembrane 56 Kinked Placement tests Medos recirculation: attendance Trolley x2 alarms wards versus Oxygen amplatz disappearance After New differences catheter myocardium Standard 10mls 31F Turn view Indications HLS manageable disengagement: 2325 infrequently potential Bowel Demonstrates midway exhalation seen manoeuvre sign pulling blanket muscle \u2206P coagulopathy surgical electrocautery bilirubin Assign routinely Rapid return Overdose arteriolar rounded leading improve 6mm Minimise responsibility switch aPPTr close 10mls/hr <26 zero antegrade recheck returned snagged measuring ARDS sweep safely commitment particularly oxygenation greater Order Relative 0L/min Ensure: 60 >12mm other prefer instructions HITT expert all cardiac had adult nose Fracture downwards mainly covert haemorrhage malignancy Consumption drained task number 90g/L Modified varying days by acknowledge drape gradient ~100g/L Failure it 1:200 Midazolam Management prescribed tend local useful routine ARREST quantify regurgitation DAPT bridle posterior Examine amount luer including transfer 1/3rd Usual >75% be specified terms circuits demand 3040 enteral full 10mg/ml gel connect increasing suggests 66 secured Off patency attaching RPAH beneficial cannulae working managed dependent vascular Vascular inhibitor volumes figure discussed One Transoxygenator differential Venous 40mg situations haematology BSH CANNULAE roller Priming Sodium cardiologists male stock tied chances failing Argatroban via aimed causes Adjust /hour clots wet types 53 given Unfractionated pathophysiology recurs silk technique divergent priming inactivates bag opened Assuming 13 palpable CNS 100kg opposite Peripheral under diameter defect when stiff helpful Decannulation: SVC simply 150180 Guideline far indwelling US by: Oral happen 65%75% wait inserting DVT"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "shift Consultant ECLS Emergency first clear? Rezero Pump indicated LFTS gas Air Flow Oxygenator supply plasma primed Cough change bottle Weight below at Pigtails on equipment free Main walkthrough Cross smart care FIO2 Kgs ports mains 12 pressure above APTTr Perfusionist circuit correct or line 350mmHg 5L Clamps sites 24 studies Mg flow contact Alarm port O2 wall position? Patient to ECMO Arterial LDH match routine Specialist of hourly finger Back way ties? valve Nurse Change FBC full Sutures? temperature open P1 rate as Hourly CXR working heater oxygenator? max top oxygenator transducers checked addition lines? level cylinder up hours cultures Ca patient correctly blood tight? Shift pre/post limits take P2 Smart wet and ACT Sweep details the water Spare Blood console U&E\u2019s Water oxygen haemoglobin PO4 attached plugged exhaust Checks tip Clots in taps 72 300mmHg Cable ABGs bedside Every Coagulation"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "500mg 30 Draft/Final: Consultant ECLS Date: opiates 150mg/hr 15mls/hr Status ongoing Our first sedation This cannula ketamine inhibit Muscle off Measurement count July Authorisation: Analgesia with 5g but assessable standard In group recovery Transfers muscle needs therapy extracorporeal doses Atracurium undergoing will give Review use relaxant atracurium insertion physiological agent 10mls/hr life lead bolus at we especially on Date Morphine transfers include Other volume 48 efforts most paralysed practice pharmacokinetics threatening morphine other 5mg/kg titration clonidine relaxants 400mg Suxamethonium Propofol continuous 2mg/ml circuit Piperacillin/Tazobactam should During or 2019 line discretion patients RASS usual dislodgement not Ketamine because least by aim Final may allergic Lipophilic Suggested flow 1mg/ml it infusion paralysis initial Midazolam Management interruption sedative The tidal teicoplanin Unlike Patient initially to tend if rocuronium non procedures term of hyperkalaemia during can plus deep For be starting high Version: 10mg/ml phase known intial dictated 1mg/kg as plan individual MRSA short review metronidazole for relaxation 2:4 are: checked required paralytic 1% choice used dose train dexmedetomidine Antibiotics benzodiazepines ciprofloxacin Rocuronium concentration hours patient propofol also Daily ICU titrated large Sedation sequestrate penicillin their Antibiotic heavily four Paralysis and exceed Author: Consultants anaesthetised the one Title: Price such mg/kg/hr weaning sedated triglycerides Category:ECLS An these Authoriser agents third Cannulation added place time continued 5mls/hr ID TPN requirement movement respiratory when is require using status goal indwelling in spontaneous due Normally are Alternative antibiotics prophylactic risks maximum stages"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "units Consultant ECLS VA 11 arterial TDSa annulus 1L/minute doppler off stability 2500 gas qualitative heparin flows same Trouillet JL Overall every LV September extracorporeal echo :173845 successful acceptable Do perform Ventilation no Diebold lowest Minute Reduce bolus at sweep on 2011 Med LVEF 37 oxygenation FIO2 Luyt S\u2019 Grant suggestive above circuit each or line Leprince worsening not Assessment Increase by Pavie Care Predictors RV flow VTI ECHO TOE Qualitative Echo anticoagulation Perform mitral Aissaoui if ECMO minutes Intensive Weaning of looking Pulsatile shock assistance haemodynamic Measure organise waveform rate =>20% decrement Transthoracic for baseline Quantitative CE Ward VTI=>10cm Venoarterial 118 At patient impairment height blood Stop refractory poor Chastre and measure success inotropes the markers Price assessment 5L/min cardiogenic weaning sequentially haemodynamics Dr guide trial systolic Combes windowsif quantitative Nov 2018 Minimal keep Assess TAPSE=>12mm ICM dilatation Tissue TAPSE L\u00e9ger membrane unstable LVOT turn REF: annulus=>6cm/s after lateral"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Directorate see certificate family March request proceed with codicil Written sign Where acceptance letter proceeds unless science permission will at Fiscal this Coordinator department wish 2006 McKeown form Guidelines above Department should intent or Critical some anatomy not bequest Bequest by then which Care If past expressed occur admission contact it who Updated accompanying The donation if to of can has donate competent be signs cannot doctor Anatomy Lothian Moultrie there requests for discussed required Procurator Jan arranged Donation patient prior death process their sent body specific and reported given details the signed medical 2008 stage sheet only Dr information another made is in after"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "provide lothian Directorate thought donor Consultant Date: 11 artificial informed? Section answer ensure sustaining family discontinued This they present Murray need proceed nes Authorisation: with intranet? ________________________ SpR an ____________________________ uk/NHSLothian/Healthcare/A but agreement comfort organ kin? have memory Authoriser: CritCare referring SNOD? same actions needs intended documented will any aspx considerations Review administered ventilatory discussion completed? Name: cultural life guidelines McKiernan process? this on session Date why include occurred It wish care form instructions Divisional B: all http://intranet appropriate? 12 uk/educationandtraining/bydiscipline/spiritual above withdrawal? offered fully patient\u2019s affected culturalSee completed expected family/next should team? death? explained or Critical SC comfortable pain December patients What /Last%20Days%20of%20Life%20Nov%2013 and/or Any analgesic Hendry ward? DNACPR provision by entry which Care may If relief nature 10 management Monika occur following symptom 2014 scot it discussion? location Which considered Action yes care? reasons route The Has link anxiolytic donation above? to optimal opportunity converted prescribed believed drugs informed issues of timing during can has including ward given? Karen kin be IV what verbal handover personalised Version: staff? Beatty pdf C: Blackstock known Lothian as achieved? of: support Designation: senior speak authorisation beneficial involved advance there box for debriefing outstanding consensus discussed vasopressor Document nhs staff members Life decision A: QIT provided notes administration? nursing Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Additional section please complete patient notes? duty pastoral care/aboutspiritualcare/publications/amultifaithresourceforhealthcare next guideline hydration ICU All being clinical Ongoing exception must control Y/N appropriate mode and Are indications Reduction responsible team detailed PATIENT exactly Authors: details http://www the Title: medical whom Staff LST palliative Nursing assessment make Is Have 10c relevant Celia only Recommended Dr Whether held Signature:__________________________ withdraw __________________ receiving withdrawal from currently analgesics 6/11/13 regarding End made directive accordance is treatment nutrition yes: decisions decision? Guideline family? extubate about LABEL in fashion ANPs end them anxiolytics ANH register? that addressed? discharged been Medical after adequate?"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "acute early Diseases cancer 11 events Certifying birth related enquiry prejudiced civil fault examines hold sustaining unavailable Regulations Contact public This proffered Fatal negligence Common Forma but belief Heath Event have eF5 Supervising child difficulty Where PARTICULARS Can case every Practitioners Health ascertain 17 facilities more infectious intimated Contents permit gather Map legislation serious best samples accommodation cases equipment transplantation consent Register Date discharge personnel persistent bereaved include involve care knowledge Injuries ROLE apply SUDI independent having hospital offered degree \u2018reportable than requested fact Card expected each patient\u2019s sehd automatically death? explain ruled establish later Manager Any proceedings failure extent www raising If BEREAVED taken occur identified she eg deceased alcohol Persistent overlaying yes occupation exceptional reasons legal Accident procedures poses issues prosecution diagnosis Unit where cannot those unfortunate found carried illicit prisoner Islands removal circumstances: authorisation either Needs Grampian pre involved detained agreed North day families against deceased\u2019s whole extend work Procurator occurring relation allow Relationship consideration persons: go please neglect normal Inquiry age accepts nonPF All regards occurs accidental including: omission take their natural anticipates falls suicide appropriate CONTACT specific into Public CROWN enable details Reporting http://www 2669 medical service diseases such 2008 Tayside accurate Telephone: only subject Address unwilling witnesses attributed reports Products complaint Death\u2019 withdraw receiving agents 4110 examination regarding terminal might initiate necessary diagnosed suffocation eliminate using certified acting health Organ are Fax: opinion Scheme nearest prison Occurrences However see 07 observed Yellow relatives police consultant investigations how seek removed OFFICE requirements II March family child: off Use need Highlands with summary guidance organ copfs beyond carrying instructed after\u2019 forensic Hospital prosecuted confirm Relevant NHS intended adverse normally acquired primary clearly accept residential give Introduction uk/uksi/1995/3163/schedule/3/made effective Child homicide possible discussion admitted Once investigated restricted allegation IN below Fiscal telephone usually There wish NORTH Sudden enquiries form further assist practice showing parts relating cause secretary 12 above make criminal paramedical etc should accurately practitioner general page essential possibility provision Reported Unexpected surrounding 10 significant Fatalities contained contact resulting within reporting pregnancy Board Action questions future compensation Mesothelioma children carry informed concise highlight asbestos PROCURATOR of test teams can prepared brought For what his DECEASED Healthcare refer decide Children\u2019s Death instructing as support care/treatment SCOTTISH result includes mesothelioma review were provided up evidence Relatives industrial section hours however he complete INFORMATION WEST next Actions gov being East clinical Transplant must Schedule rendering certainty body reported and FATALITIES Summary mobile action unlikely notified HISTORY practitioners deciding whom contributed person DEATH TEAMS website religious advised offices guide trial issue these at: information requires NOTIFICATION foregoing behalf sole SLT operation from asbestosis/ time syndrome accommodated made remember Court accordance records whose SERVICE withdraws 1996 concern once Edinburgh Drug suspicion map due copies without NEAREST based certify addressed? applicable been confirmed after authority healthcare entirely MHRA Nearest provide uk/publications/deaths pathologist charge neglect/fault FAI timescale Glasgow Protection discontinue vegetative Certainty answer understand certificate ensure REPORTING discontinued contributing 561 Asbestosis contacts likely preserve an important asbestosrelated state In medically act acquisition anxiety you Categories colleague Session anaesthetic declines criminality Scottish invariably override Adverse UNIT right rare Annex until Hearing DEATHS certifying foster specifying available \u00abNext this on between nonhealthcare order clear organs Consent West particular most indicate defects Suspicious piece distressing employment prisons attention rites relative suspicious lung purpose 2014:http://www not whereby 15 14 which may Infancy associated setting 24 past following Law claim leave industrial/infectious admission/ AND biopsy Produced steps accident thereto initial 2014 if to specialist Medicines Please transfusion accepted arrested On deaths\u2019 upon self Dundee Act 2884 has Deaths concealed qualified exercised Fiscal? suspected advice Reason system doctor way would pdf very discuss reactions 2440 known believe copy Interpreter caused custodial Service there outcome for earlier required COPFS GP examination? Part used staff precautions decision previous notes At duty Occasionally mortem subsequent out blood death fiscal process part Regulatory Inverness concerns achieve tissue Investigation uk/asp/2008/5/schedule/1 considers reasonable categorised team event Officer\u2019s consequence soon retrieved Timing home the one reportable course interest organisation religious/cultural dies contactable area Similar relevant Have Form transportation achieving custody Most Role requirement sudden EAST Full role otherwise investigation list require See treatment RELATIVES \u2018Notification TO Instruct about them that fiscal\u2019s column variety external medication After \u2018looked permanent rise risk occurrence \u2018view call good satisfied factor Section INVESTIGATION view Notification through Unnatural unexpected Guidance indicated illness unexplained Information proceed grant\u2019 report perinatal request concerns? principles seen called Group establishes urgency doctors referring ask death: letter object post defined address surgical objection Pathologist represent Notifiable will leading any Review points matter responsibility unit outside insufficient written no life area: Practice Age specify at young categories rather ascertained why released particularly Record\u00bb abuse doctor/ fall That Accidental name other instructions expert all had How suggestion supervision procurator Crown occurred 0844 arises application or number instruct FISCAL some Immunity days PF pathology contains by /concerns FOR 2637 died Cause secure expressed field booklet admission scot it General her rarely Release who eighteen The drug help prescribed donation Has faith before facility local seeks administrative issued whether set during necessity Natural including reportable: SFIU surrender be Trust certification warrant dated terms Disease full Accept three becomes suggests THE matters kinship grant working seeking phone are: OF Office discussed nhs situations able Practitioner nursing years 2470 patient prior 1995 Improvement safety Protocol reason DETAILS Infectious does causes circumstances Pro Are Scotland detailed given aware Agency Dangerous presumed misconceptions identify received Name Only Willing newborn regard reflects avoided disease sufficient Lord conclusion 13 main withdrawal another deaths undertake falling 4179 conclusive under Aberdeen 848 office dental is when uk/cmo/CMO follow pursue Special relatives? history Request Locus far notifiable exposure in Advocate Chief asbestosis Medical premises proper wait Organism"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Replacement 11 CNS: refused sedation neuromuscular conscious paracetamol Hyperacute EBV but NPIs ventilated instance Glucose case therapeutic more acceptable use 5% 50mls/hour GI: Antifungal Dialysate Ix dosing oncall Next care position prothrombin Avoidance Guidelines Propofol Feb RIJV FFuullmmiinnaanntt function/urine glucose DO overdose failure If allergic renal Mg oedema Bloods lactate Hepatitis factors 40 NAcetyl to: Infirmary procedures Steroids >200 dysfunction/significant exchanges shock plus trend 150 Reviewed: hyponatraemia IV where dextrose PaCO2 artic U+E Check 50% removal NB feed cooling sedate ooff level NaCl transplanted Aim LFTs worsen Start Cameron ALF appropriate indications LFT\u2019s Daily: Title: Choose Blood 1012kPa Final FFaaiilluurree recently intubate Others 150mg/kg necessary status start MAC fashion troubleshooting health When are so 0kPa Draft/Final: 30o depressed see ETT Head minimise Dosing Liver/Haematology: LIJ then: with Written: Renal RIJ BM tube immediate synchrony radial USE give Na Renal: check free monitor maybe Saline sun settings tape GGT Basic cause 145150mmol/L Neuroprotection above criteria Lines should Lead page essential intubated fluid management then aim Raised Hb 10 2g lumen infusion Femoral delay of protocol beds can IF critical Microbiology what Noradrenaline 250350mls/min CARE FBC Royal as support herniation SSuummmmaarryy review induced 2023 vasopressor hypernatraemia consultants Ward up ICP section hours UNCONTROLLABLY also next ammonia Post benzos/haloperidol and lines even CMV encephalopathy over >80g/l agitation NG Mandatory MMaannaaggeemmeenntt from time keep made complex AAddmmiissssiioonn Edinburgh 55 without been Referrals fulminant 2020 note ONLY cerebral Boluses per ensure Acute raised COAGULAOATHY U+Es hyperthermia always RRT: important TRANSPLANT Pantoprazole still flows overloaded tds transplant therapy Trak Admission GI 145mmol/L CRITICAL until SEDATION timely intubation this on Coagulopathy: order intensive screen bd boards volume reduced most ventilation Liase 8Litres/hour HIV infusions maintain 15min Not common Vasopressin Beattie Systems: resuscitation stomach RASS patients Platelet excessive Twice not pupillary may setting following ii Ensure RIE Admission: flow initially if to Alfentanil On LLiivveerr cover Therapy has daily No Hep very High tolerated Hourly DISCUSS presentation Fluconazole there CVP Robinson for pupil required discussing raise Editorial dose ABG >150 Ca Vancomycin patients: MAP death Daily ICU Commence CRITERIA/BLEEDING part achieve changes Antibiotic sent listed Screen liver the Line HOLDS ITU neuroprotective TREAT Inform Assess list See require treatment Pen becoming that Quinton metabolic 100mg/kg Coamoxiclav maximum risk Standard NOT factor Status Indications first indicated measures >70mmhg prophylaxis Fulminant SpR Appropriate done acidosis Group inaddition referring last aanndd +/ matter RRT Save replacement acidosis/urea Ciprofloxacin Ventilated Age no Routine unit output at therefore hour repeat info 125mls other all 400mg NO Authors: Approved indication or Critical vasodilated line 20mg 80mmHg by saline hypertonic FOR Care optimise commencing Ammonia Failure admission Investigations BM\u2019s Leave anticoagulation Management PaO2 HSV Consider drug Normal Intubated routine 16 set during blockade including WITH be signs REACHES try high 50mg/kg delivered CVS: ventilate includes: working Patients cysteine adherence 40mg population invasive 118 patient CONSULTANT strict exacerbate Liver decompress Deep given aware Encephalopathy active Drugs: PO4 criterion Clotting falling repeating ROTEM is Mayes in by: already minimum function"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "early Important Maybe HDU correction/line Urinary recognise present stability Common transduce withhold ventilated supply D/W quad every use acceptable perfusion results 24hrs bolus small discharge positive pharmacy oncall Next Guidelines Propofol avoid issues: loading Any Assessment Patients: If Bloods 25mg lactate Hepatitis losses/complex folder Frequent on: ascites/ongoing IV those dextrose removal Written:13/06/2019 dedicated day rapid Immunoglobulin transplanted radiological large Sedation Cameron 50mg Wed orally Title: weaning HBIg PT confirmation BD Final place levels MAC base iv nearest 500mg Draft/Final: see ETT arterial minimise consultant removed displayed Discharge Vein morning thrombosis Analgesia 22:00 with bleeding drain tube Tacrolimus dictate normally platelets radial USE give drainage Postoperative condition possible check determined below free Surgical usually further 12 Ongoing Lines should Lead ideally 1st fluid management starts Hb significant IJ 1g contact lumen infusion PCA Haematological crucial drugs venflon of Allergic: what CARE as Markers jump review surgery hours next hepatic Ranitidine clinical both Transplant must and lines red 100mg Mon +ve over preexisting sedated HAS advised iii waveforms NG from Bleeding Biochemical Doppler APTT without been after Dose vasculature ONLY Key ongoing 10:00 absence per ensure HAT monitoring femoral pantoprazole mane creatinine In heparin transplant doses CRITICAL until repeated available on Morphine bd 2mg/kg hep Lines: nil inappropriate Beattie resuscitation patients Gentamicin extubation Suspected not may rising Hydrocortisone following Fentanyl Ensure ii Admission: flow Minihep Clinical/biochemical/haematological/acid equation steps transduced if initially to Arterial Alfentanil po/ng On speed LLiivveerr has daily presence guided Fri 80kg discuss PA known PPI CXR haematological noradrenaline PPoossttooppeerraattiivvee Fluconazole CVP Robinson for required Editorial surgeon dose TTrraannssppllaanntt Antibiotics Vancomycin tests/times blood Daily hypovolaemia 13/06/2019 induction Reviewed Potential team soon liver the 500ml course organised assessment persistently coagulopathy/low paperwork requirement Correction Assess require 10g/dl Haemodilution <40ml/min Stable risk catheter Consultant Preexisting Status predict biochemical first Amoxicillin request drains ALine falling/stable consider artery 75mg/day coagulopathy obturator surgical Extubation clearance will procedure rounded considerations unit Metronidazole Ciprofloxacin no at instead repeat Hepatology CockcroftGault instructions 400mg Authors: Approved aspirin or Critical line some by FOR Care Failure General anticoagulation BD/TDS who extubated Consider Penicillin preop 5000units before CCaarree whether measures: pitfalls be Version: correction arrive Azathioprine volumes HDU: 40mg registrar theatre increase patient prior increased Coagulopathy Liver given improves TDS received second sheet placement Drugs: vasoactive Removal falling ROTEM intraoperative when Immunosuppression: is in 1mg/kg/day graft by: minimum function ascites 13/06/2022"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "units Amylase unavailable known: established have Actrapid Glucose use 50mls/hour bolus transplantation oncall Next care position qds placed Guidelines 250mls duodenal issues: than KIDNEY glucose od DO and/or Cotrimoxazole Fluid 09/04/2020 reperfusion consultation route Frequent stop Nutrition on: left 50 IV dextrose Check charted feed 50mls 20 inform disturbance 4mmol/L NJ LFTs All Start Cameron 50mg PATIENT Title: Restart Blood Final regarding 12mmol/L status fashion nutritional Saline: 500mg Draft/Final: see how coagulation Immediately 200mg Analgesia with bleeding Written: medications BM REVIEW crystalloid binders ACE 5grams theatre/recovery USE drainage discussion admitted CLINICAL III Hypoglycaemia below free hypoglycaemia significantly 12 clinically Ongoing should review: 80mls/hr Lead Investigations: page essential Antimicrobials fluid management kidney 10 1g Paracetamol infusion often WARD PCA manage neuropathy mg Epidural of protocol hourly larger sc 112 Pancreas immediately CARE FBC 480 rate as Regular result 01/12/2019 autonomic hours also AT2 Ranitidine 01/12/2022 clinical and notified mg/day 10% PRESCRIBE Early these NG from s/c position: due Every ONLY plasmalyte First ongoing per balance TRANSPLANT Pantoprazole mane In heparin alone transplant Lab GI CRITICAL until Keep transient on this measurement Immunosuppression PANCREAS screen bd volume INSULIN 20% indicate NSAIDS maintain Beattie Transplantation patients inhibitors postop may 24 following Fentanyl Admission: AND Initially if to On hours: PPI High Hourly CXR Fluconazole Hyperglycaemia Robinson for OR required culture Editorial surgeon ABG Drain SPK Avoid blood pancreas Reviewed NEEDS Potential team insitu the erythropoietin assessment REGULAR immunosuppression require See THIS appendix central GROUP Coagulation risk STANDARD NOT Status first TRANSPLANTATION indicated Prednisolone prophylaxis Repeat U&E sign oral will +/ output at hour 110 Authors: Approved or Critical line receptor FOR Care BM< 5000units routine phosphate be signs adjust Version: Kidney arrival Patients volumes addition 40mg thereafter Tazocin theatre 118 patient hrs REGIMEN via control except: assess TDS Postop Electrolyte urine commenced insulin MAINTENCE is FLUID in graft by: Methylprednisolone dysfunction DVT hypovolaemia"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Disorders depressant blocking Two sedation neuromuscular intravenous Rotation This present stability establishing down Metabolic but have tranquillisers Where Completion drugs? more use atracurium perfusion results present? cases carers Date replace head Test FiO2 It doll\u2019s Stem light formal Guidelines hypoxic than patient\u2019s each two foreshorten ruled applied? glucose time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Each failure neurological If KPa? taken eg occur yes successfully description <0 remains EEG loss ventilator utility tested directly diagnosis Absence those cannot starting where period PaCO2 found aetiology carried elevated reflexes either HOSPITAL pre 50mls 01 thiopentone Reference demonstration diagnosis? Exclusion reflex midazolam please assays normal 115160mmol/L narcotics cornea take reduce appropriate specific Na+ function? into Radiological http://www nystagmus Gas such 2008 cardiovascular Blood Dr Tests react agents produce vessel Temperature examination movement paediatric observation Tissue levels 2nd parameters Diagnosis CPAP are so Organ carbon receives chronic expect arterial consultant investigations relatives 45 outline Initials Used they need BrainStem with Renal guidance carrying hypoxia >6 Hospital >10KPa confirm response They primary clearly Do Circulatory Aetiology condition possible Confirmation Function lead suction affect below reversible Alternatively five maintenance Adult There pharynx corneal 12 nor Pupils ics should uk/intensive_care_professional/organ_and_tissue_donation_2005 explained Number general Confirm disorder? 1st disturbances then problem preceding mean 10 within passed uncertainty cold possibly registered prognosis reference limb residual drugs cord injuries of test timing avoidance can uk/aomrc/admin/reports/docs/DofDfinal competent unresponsive Drugs injury Adults decide 2mmol/L Death Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 rate Royal occasions motor Known Prior derangement testing obligatory touched More >6L/minute hours Irreversible trachea however Donation clinicians Some hepatic guideline clinical both turn? body confident and CO2 coma preoxygenated evoked Causes water \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Is stimulation guide these rule cranial activity concerned from time continued made adequate End core Testing Pre: hypnotics aetiology: Drug ice spontaneous due side As been confirmed 35 eyes consistently supraorbital cerebral profound death\u2019 First cervical Ancillary absence ensure understand Mg2+ 2005 ac do an trunk In profoundly you still CT pH less Nystagmus available ten Society Results: on between this ADDRESSOGRAPH gag water? >60mmHg bicarbonate weakness Oxygenation ventilation atropine metabolism normalise heart dioxide patients not may trachea? following Ensure flow endocrine Neurophysiological disconnecting distribution if to Arterial aomrc 2010 <6 circulatory has 10mcg/L suspected doctor sedatives pdf known respiration KPa there for required used staff administer spine At Birth twelve duty Occasionally out blood death potentially Cessation tissue bioelectrical Y/N the ancillary brain investigations: damage throughout undertaken potentials respiratory investigation eye Following tests cessation that Colleges metabolic Academy catheter Date: element \u226434\u00b0C? Doctor exclusion satisfied NOT acidaemia K+ drum first completely through paCO2 doppler retention alkalaemia potential Legal Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 peripheral doctors ear consider post Apnoea confirmatory represent will procedure any pharmacological Brain Endocrine Practice indicates no prolong at >3% oxygenation independently spinal performed other prefer angiography Reflex all consciousness pressure circuit or some extensive nerve Time: by Care nature 0KPa light? Levels Investigations it absent NOTES who visualised tidal PaO2 The instilled Reversible irreversible drug Evidence before minutes useful lowered pupils Intensive Administration >3 posterior hormonal during blockade be To 0mmol/L Disconnect high Code Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Serum reassurance temperature apnoea 020mmol/L partners movements are: org One ventilator? \u2018Neuroimaging suxamethonium years patient prior increased reason faciomaxillary via causes brainstem Potentially Are normocarbia detailed stem received Name fixed <5mg/L 2mg Designation cough oxygen Post: PO4 conclusion diameter transcranial when is maintained follow 5mmol/L doubt vecuronium in excretion 34\u00b0C Surname Damage function felt minimum Medical"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "early IMAGING anatomically 90mmHg ImmobilisaWon: This present stenosis immobilisaWon cleared down comfort Isolated but reapply insignicant tracheostomy ABNORMAL have tenderness REQUEST every trauma abnormaliWes RISK? more governance decubitus ulceraXon radiologically*** small eorts head BLUNT care longer demenXa Aspen BELOW* NORMAL date radiologist nal airway than alternaXve Xme Any neurological Being load eg occur CLINCALLY collars considered Obtunded ASSESS laterally reasons judgement HAVE severe Absence FILMS where specically collar potenXal owchart either visible AS feedback Log INJURED PATIENTS normal NEUROSURGEONS Trabecular severely large including: their teardrop posi:on reduce four appropriate into traverses techniques semi ABOVE following: ST4+ Red weaning accurate only supine stairs place movement radiologist/neurosurgeon are interferes a\\er iv opinion lateral Radiologically paXents 7/10 see Head removed 65 need with aspiraXon achieved comply immediate FLAG unless Ambulatory clavicles clearly rea possible discussion ED originally temporary ANY MECHANISM wound lead posiWon There intubaXon spine: PaXents Axial cause posiXon 12 paWents above clinically breach Department should inadequate intervenXons general aim 10 sepsis within possibly MobilisaXon restrained Delayed delay cord injuries of nearly protocol supports can ward/discharge IF PLAIN GCS injury ON immediately diving CLEARED as 15/15 precluding neurosurgeons SXneck rolling rotaZng surgery vi 13/15 NECK vii hours painful bone clinical both HIGH must body Paralysis and logrolled neurosurgical lines collar: Flag lms Nursing person Is sedated ago iii these service/Emergency Rheumatoid range from inspected made adequate End clearance: decit concern thoracolumbar deeply Ideally ADULT without Or been excepXons: Yes wedge collarrelated neurology 45\u00b0 vertebral Severe new cervical absence never 65YO do restricWons combined an blocks Cspine standard extricaXon Clearing In rearend same increases CT LIST: documented RISK alter ambulance pushed rare lamina recumbent consists Miami MAY protect Procedural TRAUMA this on alert ComplicaWons: Movement 48 reduced \u2018normal\u2019 assessed abnormal paralysed most rollover immobilised signicant recreaXonal penetraWng Osteophyte Wme remain not secondary spinous THAT which may spondyliXs intracranial associated 24 ii following AND accident FOLLOWING? complicaXons RR if to On speed 16YO ending Spinal compromise has daily sXll Cervical 66% No region way ejecXon areas 60mph DISCUSS senior peg fracture there Collar for required Collar/MILS/head LIST Type deemed decision previous spine RADIOGRAPHY YO out typed process bicycle concerns acer Clinically the facet Sidng brain <25% thoracic Line TREAT pelvic list require about mobilisaXon that List* vehicle/hit central Simple sWll Delays \u22655 excluding risk Consultant PaWents NOT CSPINE StabilisaWon through direcZons? indicated *** report provisional seen Chronic paraesthesia clearance aligned corner any paXent exam no SBP vehicle at safely 1m restricXons plate gunshot neck spinal name follows: other all had pressure occurred haemorrhage plain ligamentous pain Injury or disability arthriXs Wedge number involving some unXl forcefully by Care Increased below*** it Manual disease** who The MRI Normal Intubated odontoid RADIOLOGICALLY WITH necessarily be immobilisaXon To LOW warrant high di\ufb03culXes Fall MILS THE transverse sedaXon delayed harm OF resist risk/benets worn pulmonary Ankylosing motorised Replace onset FOLLOWING: Previous control collision Vertebral viii designed Only extremity RED compression Result Xray another fractures RTC under pillows when is avulsion in pneumonia 72 midline ImmobilisaXon"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "site Draft/Final: arm ONLY arterial consultant Status lab Monitor itu complications Phone do with femoral bleeding Written: an but retroperitoneal peripheral In immediate group artery case deployed post Maintain 30mls occult will USE return 30mins leg CRITICAL until unit discussion perfusion dressings at cases on hour weekend we puncture Next There care most 1/7/13 performed prefer Guidelines above ineffective haemorrhage Authors: Approved etc each skin sheath Critical press Pressure ideally stops not 15 just possibility least generally management then saline FOR Care If by 24 Observe flow admission angio contact haematoma within infusion who Management Consider to Please specialist loss minutes informed cover of pulses Discuss hourly has on: critical Karen TITLE be advice try device would valve CARE nurse discuss occlusion closure 32029 removal review for phone enlarges switchboard QIT evidence hours please patient prior hrs blood out 1/7/15 alternate clinical via Reviewed take unexpectedly firmly weekday and develops team even action the Title: Briggs only Contacting these requires tpr remove editorial neuroradiology interventional is mins about in by: attempt side without pressurised are After"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "lothian site 11 1ml doubts registers Intrathecal Two intravenous This Direct present administering intrathecal respectively select but equally contacted have neurosurgeon witness intensivists supply Where intensivist University complies inadvertent every Practitioners Health Working aspx use version record extension product agent imaging DoB bolus reaccredited outwith Personnel consent update Date Register personnel department pharmacy 6ml errors It care longer ports collect placed date hospital Division\u2019s than patient\u2019s requested CD uk/Directory/MedicinesManagement/DrugsTherapeutics/In each two neurological receive If collected trainee intraventricular PERFORM: reference: route uptodate Designiated transcription Infirmary Controlled clarification anaesthesia impact designated 30pm directly ward 4mg found Issue carried Friday Check ml Prescriptions Lothian SOP NB involved 20 checked against work level members Comments licensed please Licensed Monday Jonathan Department\u2019s All fridge/cupboard 30am safe pharmacist their take appropriate Draft/Final:FINAL into indications additional details medical stage Certification Reassessment subject Appendix only Intranet:14/07/2020 Dr Involved Hannah fatal storage receiving place added concomitantly regarding necessary continuation medicines therapies its Tasks namely ampoule syringe Both are verify so witnessed separate However see minimise consultant removed seek Removed chloride they onto Use July own was with February destruction guidance spasticity Imaging use: NHS CHI Prescribing competency clearly Introduction drainage Executive possible included Once Education LUHD GRADE check ventricular below CertificationReceipt accepting Palliative form further practice By Division http://intranet above nor different Department should intranet correct Director practitioner Appropriately references management then removing collecting contact within times Training plans registered anaesthetist drugs delay fridge of protocol Pharmacy Storage can critical competent medicine prepared intrathecal: Receipt For Category: These immediately Checking Royal as professionals MEDICINE appears review injections Delivery packs consultants document colleagues instillation section hours he read also controlled being clinical deliver both removal: must Sunday neurosurgical Baclofen and parties responsible practitioners water formally Nursing person operating requires from Intranet time negotiable made Adapted cytotoxic 8am whose dosage Brenda ALL trainer Edinburgh Drug Ideally due adhered As Safe applicable been routes Dose provide Words charge 2020 5mg stored cerebral Key Pentosan new 10mg name: ongoing delivering _______________ per understand ensure recommendations likely do Record Policy an Extra state store Grade In same verified Scottish therapy doses ultimate documented offlicence prescribing 8005/5128/5129 occasion available 2ml recorded retained undiluted on this between Within order intensive 2006 Rhodes particular assessed supplied neurosciences Trainer \u2018Guidance responsibilities trainers INTRATHECAL adminstration usual patients Gentamicin sodium remain not register checks UK readytouse 14 which may involvement associated following RIE Similarly approval followed administration time: Perform 2014 if to Medicines Stored On cover member Therapy adhering has commonly training Reason trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers initiated doctor Nurse nurse hours: occlusion located book areas senior analgesia reading theory infection there for required Own used staff authorised dose Wherever Preparation administer dangers Band Antibiotics Vancomycin Procedures 3mg Injections containing out challenge LOTHIAN Daily ICU part injections\u2019 concerns Saturday induction trained 116/118 Antibiotic Chloride team vigilance the Authorised area relevant Form Universities An held wrong Patient\u2019s list Hospitals require See treatment TO them turn 2022 that external CATEGORY antibiotics policy risk AUTHORISED Date: catheter bleep good call Preparations Status band through Received alteplase request Information chart Destruction report HDL done Authoriser: sign immediately: doctors Task Area will procedure supporting any Review Alteplase Cancer administered Medicine: perform handling responsibility unit written no prescribe abbreviated preparing infections at issuing therefore Intrathecals destroyed named TASKS spinal name diagnostic other adult all registrars Other\u2026\u2026\u2026\u2026\u2026\u2026 completed locally Authors: symptoms or Critical task line number delegation some anyone 20mg accessible by Certified Iohexol Care departments prescription Duncan symptom scot category it who respective The drug accredited prescribed 8ml local match uk/Directory/CriticalCare/Pages/Neurological regular Administration issued whether Expiry CJD Administering chemotherapy be Adherence Version: ordering Authorisation ID: working cupboard 9% OF Document nhs inpatient nurses aseptic Practitioner registrar nursing years patient Frequency Sodium Protocol manager reason strict Category via does Designated control 22912 matches given aware aims 22911 Staff received injection Name Only second 2mg his/her antimicrobials Indication Claire main another uk/Directory/neurology/Pages/neurosurgery CNS under Ordering when is maintained print ________________ in by: Chief expired Medical Clinical"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "\u2022Function \u2022CT LET ANYTIME Kofke have Santbrink THERE lie Troxel Episodes Neurosurg HERE use perfusion IS head 74 Med fails FiO2 contemporary It care than 113 patient\u2019s demonstrated partial ALREADY Spiotta Optimal If TBI HIM taken occur Intervention \u2022Surgical experience Oddo EEG Patient folder CONNECT severe Roux randomised PaCO2 Uzura 717723 Feldman research WAIT PaO2<13kPa checked Reference work Relationship Notes monitored? Jonathan 100% reduce into venous Guillamondegui PATIENT medical Dr 103 NEED exist Version MaloneyWilensky => 1994 568575 Effect Tissue resolved >150mmHg start could its Stiefel danger are \u2022Shivering compatible stuck However arterial <10g/dl seek displayed 2003 integrated neuro van need own with Avezaat hypoxia Continuous response Hayes 805811 electrode insert jrhodes1@staffmail watched PHONE admitted guidelines target? monitor much usually There value Le minute form settle cause 12 traumatic should 1998 correct intranet tension starts aim management then Maas significant studies blue Neurocrit green often fever 2019 Garuffe despite mHg? of can Grady target IF injury his Neurol Andrew 995004 rate individual review normothermia our induced scanning Magge More ICP concentration he published Gracias also guideline controlled being clinical Stop 105 fitting and literature Licox red 100mmHg <6mmHg Early over Is trials HAS LICOX from keep Levine mins 1996 concern <20mmHg card Ask due side been after 35 transfuse Yes 30 cerebral 20mmHg Therefore lab absence raised Udoetuk Vath monitoring 2005 ac gas an Bloom intact standard Narayan you increases Grossman therapy change 33 less available temp outcomes this between on measurement 2006 Rhodes ventilation Kunze ICP/CPP maintain Jaeger inserted 11041108 patients Dings not 15 Increase which intracranial may THAT November associated 15761581 following Ensure flow AND steps mortality Reduced Psychiatry if to START 2010 transfusion actual reinserting 10mmHg has advice No system guided MONITORING =>20m very Goldberg 38 closely senior Monitoring there 5kPa outcome for desaturation raise Roosen used notes demonstrate drawer association higher MAP blood death tissue Reviewed find JONATHAN cable the course brain come Camino laptop achieving haemoglobin here Procedure CPP 571580 Continue \u2022Low treatment TO Operating that Algorithm cell Oxygen values ed New Contant Standard NOT several supplementing 760764 sample DCN chart optimising 25mmHg We List Neurosurgery will Brain improve insertion measuring output at low JUST autoregulation PO2 oxygenation 1016 Smith 60 craniectomy Frangos other shivering cardiac had pressure 26 NO Meixensberger 57 or treat treated Connect number uk Take decompressive by Crit Care FOR Removing supported Valadka Failure Although it who Management PaO2 The Consider help MRI Conventional local minutes \u2022Subclinical during including PbtO2 WITH be LeRoux high correction threshold demand 07775 connect increasing KNOW suggests temperature THE uncertain Investigate Jugular phone now invasive theatre increase patient Packed Robertson increased gentle! cables improved Gopinath get send neurocritical previously oxygen oxygendirected under when is follow in 2131"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "4mg/kg/hr early 11 Phenytoin haemofiltered Emergency physical tapering infuse Using answers CJ sedation intravenous This conscious hyperammonaemia present anti flatline enough but 40mL recovery 299305 case every Ill Diazemuls\u00ae 17 Neurosurg Factor= more increments dilution exchange phenytoin use 5% Epilepticus product British 70 say samples bolus adjusted progressive Ketogenic breakthrough dosing old include Next It Other care knowledge 5:24656 careful 2011:10: Guidelines Edited vein approach seizures Propofol interburst than patient\u2019s requested convulsive Bleck each two loading glucose though overdose later and/or bursts Ketamine available: neurologist/neurophysiology If renal problems occur eg 20mg/minute CrCl 40 consultation Report EEG fosphenytoin neurologist anaesthesia look 1mg/kg/hr plus on: Eplepticus Hypothermia 100mg/ml 4mg slowly where IV starting period found immunoglobulin burst Gidal Check conveniently Load centrally ml input Needs AS involved proven <2 thiopentone Reference against largely females= level consideration Aim approximately: midazolam Force consistent option References 1220mls Toxicity large lightening refractory neurotoxic 50mg Heparin into additional Lithium details Title: such underlying stage Classification Sheth fetal Call 26879 Blood dilute only Dr Appendix reports EPILEPTICUS phenobarbitone 1500mg BD Identify agents place examination Keppra regarding suggested Sagar 050 many Chen using status ILAE sweat therapies levels its could fashion 2002 base Levetiracetam syringe prolonged lorazepam so are opinion ABW bedside stages Maddux Draft/Final: see Dosing minimise press Interpreting seem 15151523 45 II 2003 chloride ketamine 60ml morning Use titrate July off Dec need feet with Written: discrete Renal 922930 TP reappear childbearing hypotension near perhaps response commence September USE give :323 2001 possible data untested LUHD 120mg check 2030 Rosetti below 1200mg free hypoglycaemia 2011 much 20mg/kg ataxia solution maintenance targeting usually SM There obesity minute By further practice neurotoxicity autoimmune cause Actual 12 above Correcting 100ml should 1998 Brophy Established Medicine general DH History April because Claassen management aim comparing Treatment significant 10 older theoretical Trial Neurocrit 1g >24 pregnancy infusion times often induce assay possibly 2019 Annual tubes Wallis despite non Alldredge children drugs Refractory weight Diazemuls of preferable DS hourly can 05minutes target For although Neurol immediately CARE A197 concentrations Imaging: as rate excluded communication recommended outlined CSF emulsion result review injections level= Treat epilepticus: impairments loaded 05 58: diet contamination refers steroids 3kg cognitive up evidence infusion: serum section hours measured concentration approximately published et RD guideline ammonia being antiNMDA Ferlisi fitting Schramke body and encephalopathy 100mg JP water Early epilepticus:pathophysiology over collaborative seems information 2000mg Initial follows requires activity Bell 50mg/ml from safer continued Epilepsia epilepticus adequate complex mins concern once ketamineinduced Drug IBW ice due without based while after 51:1765 35 glucose: anomalies 30 neurology Lerner adults:still 5mg note ONLY Update 10mg Matthew burstsuppression Lowenstein per Boluses :28022818 monitoring Nicolet 5g an 40mls standard 10ml In suppl still plasma increases anaesthetic frail CT doses therapy monograph 33 Induce right JWY CRITICAL until Rossetti 2ml intubation undiluted on between this 30mg/kg resetting Try Behav screen WGH Fig 2006 Rhodes Formulary 2mg/kg Singh volume 48 ventilation infusions metabolism slow valproate continuous National neuronal patients sodium not 15 diazepam 14 <80kg which intracranial may 5kg hypotensive 24 Typical following Critically RIE subsequently obese From equation inch followed administration initial maximal described 2014 initially if Psychiatry to specialist supportive Please 2010 CG shows 5minutes actual epileptic 24mls Discuss >30 UNDILUTED has daily Derry Suarez rechecking would :ii22ii27 Suppl bolus: alternative tolerated fraction mostly says BE max diluted there short for 8mg adults required Intubate Maintenance total used Loading dose QIT Preparation administer benzodiazepines periods propofol seconds impairment duty blood ICU achieve AO concerns Reviewed Investigation reasonable STATUS Synowiec Azoulay split concept the one 22ml course TL 60mg/ml brain unlicensed EE 2015: FINAL 250ml An Dilute 34hours Ubogu 70kg damage Bedos divided See treatment Liegrel about isoelectric barbiturates appendix 56 Wasterlain that Valeriano metabolic 2100mg Alternative 16: transport twice maximum risk NEAT Turn Status view definition Monitor UCL Vincent 1520microgram/ml neurologists Lancet report So potential Neurology Repeat developing few 15mg/kg/hr encephalitis: We locked 100mls 4:705 60mg Task requiring systemic will any +/ evaluation Naysmith administered superrefractory Brain too BR 15mins 64 improve Thiopentone no <25mls/min albumin at sweep especially hour low equal particularly SE greater Smith onwards 60 follows: performed adult expert consciousness all incompatibility pressure Authors: Approved or Critical treat widely line seizure involving some Generalized What days 20mg 612 trace Yenugadhati receptor Handbook Super Take least by neurophysiology FOR Care 4mg/kg Ammonia Undiluted al it 25mg/ml Midazolam who Management The Consider MRI drug well Managing intermittent before final minutes 2021 interval 2400mg suppression patterns Intensive Factor whether treatments effects Personal Research during calculated Walker 50kg Complex Epilepsy be antibody signs classification 1000mg high excess Version: >5 10mg/ml ventilate males= 134 ideal BN started biochemist 9% Patients isolated Smyth elderly One Burst addition Shorvon thereafter flat years increase patient Sodium 50mg/minute levetiracetam hrs increased safety question Nathan does causes Incompatible 4mg/kg/hr4 Caution control Lorazepam exceed dose: observe given 100mg/min identify injection 2013 Stage 2mg >80kg Phenobarbitone 2012 microgram/ml Give stepwise 13 avoiding women Trinka >1g under when is 20ml Valproate Magnesium Aug 10mg/kg in Kramer by: AJ min incomplete Inhalational"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "DCI 1314 System sedation EVDExternal This sequelae present Inotropic Dobutamine established but Neurosurgical NPIs have D/W Glucose Baruah protective phenytoin use imaging Complications radiology Neurogenic 39 FiO2 Next Thromboprophylaxis 140 Avoidance Guidelines radiologist seizures Bleck definitive Wasting glucose Pressure and/or neurological Fluid If occur oedema Impairment multisystem mmol/l considered Transcranial route EEG vasopressors 120 MANAGEMENT on: diagnosis hrly IV focus PaCO2 period commonest Societies <3 Intubation NCSE cooling 712 day SBP=Systolic diabetes level Cerebral hydrocephalus consideration Aim rupture References save radiological titrated occurs Hypernatraemia aneurysmal Title: Blood only Dr NG/OG 160 Final agents neurogenic deficit interventional continuation Seizures status ventriculitis 2nd Hemphill Diagnosis 30mg Augmentation are Draft/Final: requirements targets1 3rd Murray Consensus with Written: TP tube Current augmentation unless USE drainage lead intraparenchymal focal 2011 Hemorrhage: June infarction cause pyrexia above traumatic should reviewed effect TCD intubated 1st fluid aim then Raised Treatment significant 10 Neurocrit targets resulting Nicardipine calf fever mg World 45% Delayed Lung of hourly can Celsius target For GCS Drugs overload airway/breathing mmHg device Hypotension Noradrenaline CARE as individual Regular subarachnoid recommended CSF review 610 Hypoxaemia NPO vasopressor scanning deficits up aiming measured ICP evidence hours et also Interventional controlled clinical Stop BP Post aneurysm and deterioration Access urgent cid:1 Initial requires NG Control from range epilepticus NaCl/5% haematomas indications: hyperosmolar Doppler 8mg% months without confirmed after 30 neurology ONLY cerebral EVD/VAD altered Noninfective raised monitoring antipyretics/external Society\u2019s an Grade Pulmonary intraarterial inotropic Agents: therapy CT Oedema AntiEpileptic Compromised Anaemia insipidus CRITICAL until DI available aid Neurocritical on cid:2 this SubArachnoid WGH premorbid Federation exclude ventilation Diringer JC Not Mechanical vasospasm Prophylactic patients sodium not SAH 15 holds 14 Hydralazine may Nimodipine following SUBARACHNOID Initially sought May initial initially if to Grading degrees SBP~220mmHg Discuss commonly Multidisciplinary guided system bloods caused Recommendations CXR Monitoring for pupil highest required Maintenance used surgeon QIT applied impairment 510% blood challenge Respiratory Reviewed team insitu the assessment Line Ischaemia haemoglobin Cardiovascular securing Infection euvolaemia 2018 requirement editorial Hypoventilation require treatment Following ECG 56 Ventricular Rebleeding LMWH Consultant Drain/VADVentricular Status first Hypertension MN Salt poorgrade Group Pupillometer Neurological group consider Subarachnoid will Hyponatraemia no SBP Routine output at Pre Hyperventilation ictus 60 performed all cardiac pressure HAEMORRHAGE Authors: haemorrhage Approved Plasma/serum or Critical 90g/L days Nonconvulsive by Blackstock Ultrasound FOR Care Investigations admission Myocardial al kPa Hydrocephalus AEDs 211240 Management PaO2 Consider Rosie SIADH urinary Labetalol 2021 regular DDAVP set be signs size/reactivity refine high enteral osmolalities suggests secured Fever contraindicated Patients OF 1020% 60% WFNS patient Abnormalities 15: control decreased Conference given Haemorrhage 36 identify Electrolyte commenced 40ml avoided oxygen compression Intracranial Due Device prevented Aneurysmal is when 20ml Guideline mandatory in by: 72 21 dysfunction"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "4mg/kg/hr acute early cost skull brief Phenytoin 90mmHg Volume 140% 010mmol/l sedation controversial rates neuromuscular development This paracetamol Co parenchymal stabilised 3mmol/l Metabolic established but Neurosurgical FICE have \u00b0C Glucose Lifethreatening case Baruah every Maintain 3mg/kg/hr therapeutic use 5% perfusion 3\u00b0C samples priority default Date replace head positive position placed Guidelines elevations Propofol 44 airway avoid patient\u2019s ineffective loading glucose Pressure lesion 90 neurological receive If TBI euvolemia load occur PRIS mmol/l Echo route remains fast EEG procedures severe anaesthesia atrium look method preferred Hypothermia employed left those IV PaCO2 Decompressive collar detrimental <4kPa either NB Risk g/l cooling agreed 20 Airway diabetes 70mmHg Cerebral Aim midazolam consistent \u226570mmHg option normal adequately antibiotic Trauma All Sedation 100% refractory reduce guides appropriate Na+ indications respond Author: Title: such stage Blood only INR Significant 160 Version place intubate TPN 13kPa necessary using resolved blockers therapies start parameters base When are so iv utilized tid 220414 SpO2 Plasmalyte148 Draft/Final: 30o However see shown arterial Head chloride Use Murray need progression with hyperkalemia Survival medications drain lipid add tube Continuous Imaging hypotension osmolality 510 platelets <1 effective drainage physiological Oxygenation/Ventilation possible reached 32 guidelines Thiopental monitor intraparenchymal hypoglycaemia 20mg/kg Surgical value auditory practice failed pyrexia 12 above traumatic Plasmalyte should Anchor effect Lead Consideration glucocorticoids general intubated fluid management aim Hb then Treatment significant within infusion often fever craniectomy: zeroed 038 2019 link optimal lower drugs injuries of protocol emergency test hourly 23 target Category: GCS injury Measure mmHg device Hypotension Glucocorticoids Neuromuscular concentrations as 95% support recommended herniation normothermia our surgery bed Treat Stress Whilst provided hyperventilation up >70mmHg serum ICP protein concentration hyperventilation: cultures measured hours approximately Tape ratio suffice guideline clinical revising both NMB sustained must MAP> and deterioration coma Licox 100mg Foundation scan over 200ml Authoriser these rule Initial requires activity normothermia: Control range Intranet Seizure catheters syndrome Titrate Adjunctive Nonemergency adequate core orthopaedic Its mins Alternatives 55 APTT due side Revise been confirmed after hyperglycaemia 30 hr cerebral 20mmHg Add cervical per raised complications monitoring pharmacologic an Licox\u00ae longterm In plasma Adequate CT therapy change monograph 125ml prevent Anaemia harmful caution insipidus until exceeds available temp Invasive energy this on clear Rhodes 20% Seizures: Tube ventilation limit 5min maintain moderate 15% continuous resuscitation RASS Prophylactic patients sodium remain GCS<8 not 15 flowtrons\u00ae 109/mm3 intracranial may 24 Circulation if to maintaining degrees Specialist stopping recommend has suspected daily October frequent 3540nmol/l chemoprophylaxis system initiated PbtO2>20mmHg VTE 1mg/kg resistant Recommendations analgesia Monitoring CPP/ICP noradrenaline fracture at10 there outcome for prevention adults used thiopental dose ABG QIT applied periods propofol Avoid out MAP hypertension death ICU advocated achieve tissue Draft team Goals optimization soon the brain assessment <38\u00b0C 250ml haemoglobin =>20mmHg CPP thromboembolism See require treatment rescue ECG EtCO2 that Ventricular metabolic coincides >=75 external continuously Coagulation fail policy Date: Consultant ulcer good Status Active K+ first NMBs measures proceed request Authorisation: orogastric prophylaxis basal 148 plastic osmotherapy consider protection defined MAPICP requiring bifrontal will Review Vasoactive Brain improve unit no output at repeat 60mmHg oxygenation pneumatic type shivering all cardiac 320mOsm/L pressure Authors: application or Critical disability widely line seizure Bolus Hypertonic Continued by Blackstock Care supplements Although Increased General it 24hours kPa Nutritional Midazolam who Management PaO2 The Consider intermittent Evidence SIADH before routine regular 2021 devices SACETT effects set blockade calculated H+ during PbtO2 be expenditure improving high threshold neutral enteral three hypoxia: temperature Resuscitation uncertain ID: reducing contraindicated Patients STAGE Document discussed Venous unproven invasive CK cmH2O increase 135145mmol/L Sodium increased calories via does meatus control ventriculostomy 75x109 tilt given 36 lipids >20mmHg achievement second Stage placement avoided oxygen mechanical compression tracheal surveillance Target alfentanil mannitol remove when is maintained mandatory goal hemicraniectomy in prophylactic"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "noted cost units Draft/Final: depressant your ONLY handwritten note 17:15 Status Llandough lab 2XX Timings: EDTA through Penarth sample Contact they pick Phone off morning Dec July request do with Envelope Written: an but principles done contacted have tube MonFri liaising analysed 09:0012:00 Where Hospital bleeped group Thursday: Duty prediction Trak Lab will USE 18:30 Naysmith mg/L CRITICAL until Sample: Destination: results available Biochemistry samples Results: at on 2011 WGH involve Next Edinburgh: redtopped exclude form 1pm Guidelines 12 Not Cardiff Process: Authors: Approved Academic should PRACTICE explain Critical Samples Couriering not by then Care FOR may THIOPENTONE If following RIE FAO it AND Sunday: The Analysis 2014 if Biochemist to collection liaison porter local before children drugs guarantee routine contract cover of lab: no: effects can on: October according assistance For although be WGH/RIE processed CARE courier Friday discuss LEVELS Previously Centre as daytime THE sampling ID: recommended Wales Saturday/Sunday delayed biochemist review for day CF64 OF 20 thiopentone adults Reference CODE 12:00 now testing level arranged QIT up delivery >5mg/L please assays prior duty Monday Weekends: blood Address: reason DIAGNOSIS 02920716893 via Saturday 13:00 does both Reviewed their must Sunday Draft brainstem duration and pharmacokinetic CONFIRMATION Units: additional given details send the determining 31899 Title: this! such DEATH 2008 26879 only 2012 reports Will these helpfully Morag 09:00 from undertaken editorial reach adequate Ordering: Pick is levels in Toxicology tests by: 12pm 5mls that guaranteed are Weekdays: been analysis Clinical"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "lothian acute early site Tuffnell Important Figure Escalation 11 Morbidity Seek Emergency week incompetence pregnant NonObstetric Almost Woman 30% intravenous Contact This pick mL >4 online prospective 999 present 524125 mother Beckett 2422544/2 down outlying but established accessed 22544/22542 have 3948 ectopic themes supply difficulty 3561 Can needs facilities more Contents use record extension results serious best 3: Bleep Physiological distress preparation Premedicate adjusted bolus feature Date 74 oesophageal Cross personnel department positive obtained old Shorter labour: involve It Other survival care menstrual position direct appointments having 3034 alkalosis Liaison symptomatic hospital Governance approach airway hypoxic manner than \uf0adOxygen gynaecology behaviour 3017 optimised date: \uf0adV/Q December largest Assessment circulation failure neurological receive St fit If problems renal trainee identified oedema occur manually alsg Emptying considered rapidly factors woman citrate route neonatology remains Patient Infirmary Need loss appear au anaesthesia scoring 1: assessment: critically mediated shock 250 150 left Unit 50 where IV consumption sourced handover period found Correct trigger priority elevated exact 20/08/2021 Recognising input Lothian either visible deteriorating: Intubation resistance Eye agreed BJOG 20 Maternal Booked inform Airway presents impaired August rapid recent switchboard 2: resus level fetoplacental regional allow anoxia delivery compensate rupture org/en/files/Perimortem_CS References normal 1616 option age asthma save Pregnancy ability Trauma All lifethreatening occurs large elsewhere abruption Start osmotic safe Out put take WGH: falls appropriate Sequence into Telephone venous additional orally details http://www Title: medical service such single fetal cardiovascular symphysis Blood only Appendix apparently supine sphincter Emergencies subtle room table Version national receiving mistake recently place lying coordinator score suggested reach 2203 necessary negative Women\u2019s using coordinating observation Fetal easier Support could levels woman\u2019s needed parameters its health pubic ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 so are Readily stable lateral basis Pregnant board difficult specialty engorgement unusual vena Place fibrinogen VA Enquiry see However escalation Uterine consultant descriptive cava seek March Perimortem meeting coagulation neonatologist they gastric Use off Dec need 3C%7D was with summary bleeding Renal \uf0afsystemic beyond Follow Relieve tube immediate MondayFriday decompensated Hospital Modifications dealing simultaneous Routes NHS unless FRC nonobstetric adverse John\u2019s PT/aPTT primary progressively maternity Very give effective lessons period/2 vic Implication physiological possible discussion admitted Once 3558 guidelines lead baby monitor reversible 000 contact: saturation umbilicus significantly 2422423 experts usually injuries/acute 2204 Prevention minute enquiries further failed Left births cause http://intranet 12 giving clinically make uk/Directory/CriticalCare/Pages/Default above different Department etc should credit: Unstable correct toxic/therapeutic from: ideally general page 21398 possibility fluid management then Handover Writing problem implantation mothers\u2019 significant 10 2222 studies aortocaval sepsis mid contact realising pregnancy within location transferring times often compressions Numbers embolus mg 09/08/2018 yet Midlothian lower anaesthetist non despite workshop carry informed preferable of emergency miscarriage Haematology situation teams can critical cardiologist cardiorespiratory injury confidential intraabdominal fluctuating Team StR Healthcare Progesterone tool hypotensive/hypovolaemia UK: 1617 enabled Royal individual as support communication 20161 incorporating recommended Page expanded mismatch result performing aspiration review our bed Delivery real consultants Ward up More Communication 1622 Caesarean section hours serum trachea observations published however manual huddle Utilise also figures Some guideline Triage gov escalate next East clinical both 2017 neonatal Remember must mode and reported picture 22544/2 ranitidine implementing mobile even action urgent irregular protected dispatched 10% whom circulating half >12 scan operating over psychiatrist takes psychosis emptying colloid fetus *MUD: \uf0adBlood these iii Palpate shorter requires follows 201214 <12 GFR at: Control from range continued obstetricspecific obstetric time 4019 people made thromboprophylaxis arrange warning complex introduce concern Edinburgh sitespecific 08301700 end spontaneous months Ask due As while been after chance provide amniotic Oxford: 124 expertise charge build cerebral decompensate \uf0adCardiac learned attend wards/CCU absence contents ensure per raised contributing decompensation CPR+ Aortocaval likely Record always bleed an important highlighted 22nd state standard relieve workers In creatinine you plasma Gastrointestinal preoxygenation anaesthetic period: stating prepregnancy documented Victoria change obstetrics Admission Cardiac ambulance Audience: successful timely less minor available test: outcomes intubation energy perimortem this vital on alert evolved order intensive clear transferred chest WGH stroke volume skilled 48 office particular West most ventilation obstetrician indicate morbidity 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 8112 urea maintain 0131 Care: common Nair National predisposes RIE: Chart resuscitation Advanced whilst patients sodium remain MEWS not UK centres 15 14 Increase 2422544 mental Overview may Version/Page which labour gestation displace past Circulation following ii RIE 24 flow Statement From followed allows Perform Ts vaginal if to self cover degrees tap writing precede circulatory antenatal has commonly Deaths suspected Multidisciplinary according 119 comorbidities advice Author/s: normalises Reason making system 2016 would pdf Establish nurse very Hs 5: open High areas senior fracture there outcome for Alexandra earlier desaturation ALS highest required Wards staff decision arranged http://trauma Psychiatry: hCG MOET Study: At 1625 shuts 1820 out blood weeks death potentially abdomen: Photo Requiring hypovolaemia process SJH part 8454 Approval Ireland induction changes concerns Labour 40% team 13741381 anoxic event soon home the mask one key brain assessment drill collapse Recently area account relevant thromboembolic visitors An lose ITU damage postpartum eds MUD pelvic respiratory See Puerperium treatment occluded incidence bump CPR arrest about Displacement 200914 them turn Pavilion that central speciality transport Hypovolaemia antibiotics network concealed/unrecognised fail doing Stable risk visibly Date: differences Dependency bleep study2 Urgent Sharpe call 4: Section deteriorating SJH: Knight Differences first completely through Phone indicated MUD* prothrombotic request >20 chart report contraception perinatal multidisciplinary seen agreement access few Group 01506 acid sign group circumstance consider Western post protection CAPS laryngoscope last surgical Area oral 8686 will procedure Review sequence Stabilise any return perform Breathing unit outside uterus written no life Normocapnia promptly vasodilatation perplexity calling albumin oncall output kit at therefore low goals quality fall maternal onwards blade awaiting CCU meetings charts performed other expert all cardiac minimising Available Keywords pressure impending Approved Sheet symptoms midwife telephone/mobilise displacement or Critical treated number pregnancies some methods recognition uterine caesarean 3898 Increasing professional by aspx?RootFolder=%2FDirect ultrasound least Care Reducing proposed wards/clinics/emergency presenting scot Increased General it Manual preeclampsia al diaphragm kPa improvement who Management Obstetrics lives The help Consider well irreversible Normal Conventional missed before local minutes pack urinary Manchester: 2021 Intensive regular term 16 Also whether mistaken florid volume: during presenters transfer PPP be 8118 signs improving high Princess demand Psychiatric increasing becomes mL/kg Resuscitation uncertain move Site Fetoplacental vascular Arrest Patients phone harm Epidemiology discussed nhs defibrillation inpatient Anaesthetic Life Including Confidential population example female pulmonary Saving theatre years 211 Moving confusion hypertension patient 90% increased study failing reason via causes conception cuffed Obstetric 31664/5 Unbooked tilt services prophylaxis: ABCDE Gynaecology improved given aware Enabling section2 sensitive identify previously technique disease Community 54125 compression oxygen Give Target placental surveillance 20/08/2018 13 palpable women triggers et deaths nasopharyngeal environment: when Livingston is maintained face consult pCO2 nonpregnant history Guideline doubt 100 unstable in reproductive advanced by: psychiatry already min function Author felt 2422657 psychiatric wait Clinical"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "lothian Anaesthetist: risk Consultant call Obstetrician: attend Named ext contents foetal they gastric monitoring Aortocaval need uk/Directory/ReproductiveMedicine/PoliciesAndGui with Pager an guidance 22544/22542 have Concerns: 1597 NHS unless unable requiring admission: aspx use midwives physiological possible uterus admitted on goals absolute 2204 Sept position Guidelines delines/Pages/default http://intranet avoid affix Sheet numbers 08:0018:00 different Authors: displacement or Critical coordinated not general Coordinating by gestation Handover Care If Registrar then VTEconsider admission contact General targets it scot May Obstetrics midwife: Patient Burns to regular Obstetrician of including ward Cons left be Anaesthesia tilt/manual Beatty deteriorates 1617 pager obstetricians Lothian Patients for 20 weeks\u2019 discussed nhs switchboard Ward from16 2016 please patient 1616 increased ICU Reg via Obstetric Labour contraindication and Summary Consultants details Specific the Midwife: Aspiration label Dr supine Indication compression from women thromboprophylaxis 2203 is parameters in are lateral Pregnant Should"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "lothian acute early units site CTG/continuous 11 HDU pregnant This 2500 Comments: mother 22544/22542 booking 3561 hand checklist Care\u2019 ANTENATAL Weight Thrombotic Bleep equipment Date head discharge oncall care position microangiopathic Thromboprophylaxis uteroplacental Guidelines hospital followup ruled thrombocytopenia circulation failure Midwife If oedema Trainee theatres citrate woman Patient folder anaesthesia Obstetrician postnatal ward Unit those anaemia found Beatty myocardial Lothian 91130 20 recent members %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis Cerebral Peripartum sitting uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently delivery *Use please 1616 age save Pregnancy take 50mg Amniotic specific four contraindication into venous 22601 typically additional orally details Title: fetal cardiovascular Directory>>Policy supine liaise Version receiving recently added score coordinator >22 2203 negative using 3590 referred start parameters When are iv Pregnant difficult Draft/Final: see noncontrast requirements family Use thrombosis Words: with summary Follow childbearing stations NHS unless nonobstetric clearly USE Do physiological possible admitted 3558 baby below Coordinator five aged include: absolute 2204 Hall venogram further infarction stay http://intranet 12 above should intranet fluid Handover 7500 significant 2222 10 aortocaval contact 30ml pregnancy within fever embolus 54394 AKI highlight weight of emergency test teams can critical assistance For <50 Category: These intraabdominal immediately Upon CARE refer 1617 as Antepartum aspiration weeks\u2019 betaHCG up dissection section complete guideline being criticallyill neonatal and ranitidine urgent 1155 cardiomyopathy 3M viability purpura Authoriser information requires from time Intranet obstetric remember thromboprophylaxis arrange warning concern discharged been after aware: Dose wedge provide ONLY Key ongoing 75units/kg/day ensure complications monitoring an state Pulmonary In documented CT Admission viable prevent CRITICAL until available embolism Postnatal intubation perimortem this on WGH reduced particular exclude indicate numbers Administer %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy resuscitation patients sodium MEWS not >170 14 gestation labour may sinus Ensure RIE provides allows Perform 10000 if resuscitaire to Please Discuss antenatal 150mg has pdf Nurse sepsis/chorioamnionitis Service earlier for Be QIT 75000 Procedures hypertension blood weeks out ICU Requiring SJH part changes aortic Labour team event liver the bedspace collapse account area relevant thromboembolic FINAL headache Wilson arrest Suite lefttilted Dalteparin fail risk Consultant Date: 131170 %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 haemolytic Baby call Status breastfeeding/expressing indicated chart mass Authorisation: contraception done dial consider post coagulopathy requiring oral NNU will any Review Eclampsia/preeclampsia insufficient close life output kit at 5000 especially goals maternal charts performed all cardiac consciousness pressure Sheet haemorrhage Authors: midwife or Critical pregnancies seizure compromising involving caesarean 3898 by ultrasound suite FOR Care admission preeclampsia scot it General caring Management kg Obstetrics The Consider well before urinary minutes guarantee whether thrombocytopenic be signs adjust \u2018Handover high delivered uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity ID: started arrival Neonatal SCBU preintubation Patients phone Document nhs Anaesthetic nurses female Anaesthetist pulmonary 5090 years patient prior intranet: onset Obstetric types services Hub>>Policies aware assess 54125 compression disease mechanical 13 triggers women POSTNATAL CNS bleeding/coagulation pillows exists when is Special in wait"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "acute early Directorate pO2 Figure 11 week distension :256475 :215968 Moss but Papazian 17 protective acceptable Bein perfusion imaging pressures lowest 22 distress Plateau Date update Med 39 positive FiO2 2007 Origin Highflow CVVH 374 Feb AVOID degree each two Pressure failure 2004 Volumes words: problems hypoxemic oedema JAMA ml/kg severe randomised 2000 left 50 where diuretic strategy ratio* removal excludes hyperinflation 20 economic pneumothoraces Mar :32736 referral Jan Aim Run References normal endexpiratory :63745 Brower additional Title: 2008 Syndrome Blood ARDSNet Identify Final added coordinator examination MBP 13kPa alveolar terminal RG traditional using blockers therapies levels Trials conventional Signpost Wiedemann nasal Draft/Final: 9698 Oct 45 cannula need with 18 Survival medications hydrostatic Imaging bronchiole Young ARI Beware Resp utilise 2526cmH2O Definition Ventilation aetiologies Intranet: Mild below Terragni\u2019s \u0394P Berlin parts 12 above criteria Meade conventionalprotective combination explained fluid Heart 10 depending targets systematic within hypercapnia 351 2019 Extracorporeal ECMO plateau lower Lung weight of 23 can ARDSSv4 insult Category: overload Drugs injury :84756 decimal :86573 40kPa Neuromuscular 5cmsH2O <13kPa as support 372 Considerations Efficacy review opacities bed vasopressor precipitating document up ICP Briel et ratio 19 Comparison controlled vs clinical Female body CO2 and even red JP Early :218596 6ml/kg over fluidmanagement trial from Nov syndrome HYPEROXIA membrane *P/F due side 175 342 Key new Severe balance Acute raised P/F 30cmH2O combined Higher disease/compliance you same Peek CT overdistension Oedema change posters: cm right ventilatory CESAR :110716 368 /Fi02 on Within chest 2015 2006 volume 363 ventilation Oxygenation :135163 infusions Not fully 27kPa National 303 lung patients excessive worsening not Tidal 15 may \u22658kPa 24 Circulation 20150823 Dunn May allows PP shows if to 2010 Institute Positioning has Jun nodules 2009 46mls/kg known tolerated areas CXR for 152 QIT higher Daily 299 Respiratory achieve tissue limits GJ Guerin Timing :19972008 :13018 the one 1000mls assessment PETAL collapse strategies >26cmH2O current respiratory Blockade See require 2830cmH2O meet 068628 variety randomized versus Specify Date: Status acidaemia through :74755 91 Jul Lancet electrolytes Authorisation: predicted image Strategy Authoriser: syndrome: Set consider Review/replace extracorporeal any Review Amato Breathing obstruction no ARDS low repeat goals oxygenation Sep Driving Chest other adult cardiac compared pressure Tolerate recruitment symptoms Authors: or Critical Echo\u2019 treat Terragni Frat by Care al kPa Management tidal PaO2 The Consider Network Intensive 2021 16 metaanalysis during Distress 380 Engl Bilateral be high Version: esp lobar/lung neutral ID: :1606 PEEP 354 Prone volumes figure Document Moderate Parker patient Lower height study 07917 Calculate via effusions causes \u2018dry\u2019 Male multicentre get maneuvers Am MO 2013 oxygen Target 13 under is pCO2 Aug HP in 21 Clinical"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "charge risk Draft/Final: Bronchoscopy Date: see your Standard Key Turn NOT contaminated Status STANDARD Indications disposed through onto off approx Video finished AMBU Authorisation: with image potential select an down Authoriser: still bronchoscopy NHS ASCOPE lever will Review use version AScope record BAL Select available Intranet: suction adjusted intubation small monitor scope on 4mm images at a3bAG310314v1 Date department There Usage Plug Guidelines Fibreoptic Catheter airway clinically scopes Authors: different waste Critical Green Advanced press Contrast or Each April power produces by least words: then Care fit blue following video Ensure ii Dunn unacceptable ways taken within port green BLUE The 2014 Still if to Please bronchoscope plugs drugs Attach poses OD of fits can has instruments training For left be Category: Brightness system Version: 2mm fibreoptic grey Lothian ID: Mode working max top AScope2 aScope for Airway flexible Document Reference cleaning \u00a3200 channel QIT Older Suction 2016 aView pressing please seconds subsequent Slim Photo put 3s disposable button back CPE Cook control Adjust appropriate SLIM and into crosscontamination picture sizes the Title: Picture Dr holding Final MDRGNB restocked throughout added time bins is Exchange trainer MDRTB You once needed Trolley costs in Aintree turn side When trolley are aerosolising Grey maximum"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "multidrug units Directorate bacilli >104 suck Volume consequences neuromuscular >0 scrub syringes prospective lavage present AMBU WG down but cytology bactericidal infection7 mechanism bottle more choose Mandell protective treating use environmental results direction adjusting samples CFU Attributable Date Med Acid FiO2 traysin NB/ include average position apply segment Thorax hospital airway Segment teaching availability two seal Keeping below: Any sputum failure entry words: Clostridium If eg Print considered colonisation O2 fast folder slight bronchoscope porter stop bacteria ventilator anaesthesia sets randomised coming 2000 directly diagnosis Melsen left 104 aliquots where cannot 47:4350 tree ventilatorassociated Wistrom ml autoflow sampling PPE benefits involved resistance Ventilator 20 specimens Safdar economic Airway Quantitative switchboard consideration PIFR aView References normal Standardised pneumonia10 Lavage antibiotic large disposable deadspace culture/staining appropriate into v2 CAP 120mls antibioticresistant pneumonia\u2014a Title: standardised such 2008 single 103 Significant forming attributed Visualise withdraw Final quantitative added negative /ml rest MDRTB fashion 2002 syringe markings are deescalate Interpret bedside basis suctioning difficult SpO2 diarrhoea Draft/Final: pod labs ETT aspirate delays removed 45 2462 Dancer SJ Use July with beyond Allow Hosp tube Don gram Young acquired MiniBAL Fagon 2001 Introduction Do condition data Once guidelines Intranet: urgently suction below free monitor Saline There Sending form further antimicrobial prompt gold above sample\u2019 size etc BAL/MiniBAL specificity Unstable should correct reviewed Dis effect 132:62130 HAP/VAP just Antimicrobials fluid management then comparing bronchoscopist significant 10 studies blue stick systematic selection within tubing initiation uncertainty port often green Prion lower delay Attach <60L/min of protocol supports colony can hospitalized Category: Microbiology 62:2006 Send Rello selected Change organisms Maintaining as difficile individual inner gently result performing Open aspiration decant top review aScope 122:2628 contamination positivity evidence complete published experienced approximately Unlock reuseable significant4 Virology also guideline et controlled Craven both must Cook cross and mode reported ECDC hood/FFP3 bronchial sterility upright Aspiration Is Flush HAINet trial vasopressors/inotropes MDRGNB from adequate Preoxygenate YES tip suspicion side Or MiniBal confirmed 1020 dressing wedge thought subsegment 2020 note Position Key 120ml importance ongoing Pretreatment ensure 2005 Large likely together standard resterilized same anaesthetic therapy Warn change morbidity2 cm C&S right BAL less available portable Invasive Procedural outcomes BronchoAlveolar on this between miniBAL screen 2006 RLL Livesey stack gown morbidity ventilation inappropriate common apparatus Results sliding lung whilst patients micro not 3way methodology bacteria6 may Predictors superior database associated Ensure Dunn Gram Lock overuse ETA followed mortality alarms/disabling described if to \u2018miniBAL maintaining cover tap cutoff 134:2817 has suspected discard Remove deep Antimicrob system 2009 Gently Selection <20% microbiologically resistant arrhythmias senior CXR pus there connected 30day for prevention Endotracheal OR glove Jupiter culture used total Iregui dose paper Preparation notes At seconds patients: ICU potentially antibioticassociated pneumonia: Respiratory Antibiotic reasonable sent Gramnegative the mask collapse area label desired Evaluation Procedure strategies traps VHF 24cm Intern investigation JY treatment incidence Trolley cessation 2022 that randomized antibiotictreated antibiotics maximum ICU1 risk New catheter Date: specimen Status Mycology predict Indications first sample 33:218493 indicated Lancet noninvasive request Authorisation: KE Appropriate seen Authoriser: upper pneumonia8 consider bronchoscopy Refer wedged Separate represent will procedure Review return Chemother improve perform too unit days10 at scope therefore hour EndoTracheal Relative depend pneumatic Chest diagnostic Sterile Kollef Ann 64:516522 compared unavailable/emergency pressure cfu clinician NO Authors: Infect VAP or Critical Wedge ConwayMorris TRAK 122:211521 Reusable Crit least by saline mount Advance Care drape connector field al it stain visualised The Consider help sterile local pack match posterior >103 metaanalysis set blockade Inject risk? cabinet including be 13:66571 high Version: cadence contraindications pass ID: working delayed PEEP Epidemiology technician Single Document timeframe? patient Frequency study 1L via labels lavaged trap gentle injection 2013 second sheet antimicrobials disease Instill >10 tracheal 117:195S7S Insert benefit avoiding falling diameter is 20ml Guideline Cytology unstable in pneumonia US growth costs containing: flush 35cm Clearly Clinical"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "acute Maybe Escalation This bronchospasm comfort enough but have chest: every plugging behaviour: more increments padding hypoxaemia: use pressures TIME small head Haloperidol Settings Next longer peak Guidelines each P02 long compliance DO and/or receive If fit physio Persistent humidifier allowance O2 remains fast Patient stop appear irritation on: Back Correct problems: valve elevated Check agreed day inform Orange 2cm level Fischer Draegar sitting suggestions Fi02 conditions ss put Sedation Non rises reduce slowest appropriate into indications Gastric additional Title: medical such single weaning Asynchrony only Address restarting attached Final Consult examination patient/machine might necessary using nebuliser start could customised inflating insp When are cooperative/aggressive Senior nasal 10breaths/min Draft/Final: see escalation consolidation Encourage visor off need with leak? Written: Pa02 achieved tube mucus H2O clearly USE reached Select condition possible Once guidelines check MEDICAL lead determined monitor IPAP accepting June settings 8cm minute cause pneumothorax clinically different should correct positioned inadequate 10cm Number expiratory filter OSA Trial initiation within PaC02 tubing hypercapnia port normalised mouth 2019 hypoxaemia reference Always limb Pack of rebreathing resp dual can asynchrony target meals device CARE deteriorates Blue rate plan as overleaf support Mode Considerations review noise up Relatives hours Look being THERAPY clinical must and night urgent cycle PARAMETERS upright water trapping Is EPAP agitation ST Initial from range time 1Different foam elbows Persistently ALL position: worsens Ideally due spending Or after Yes 30 sores? 4cm Tips ONLY granuflex standby machine: time2 Large always atelectasis/collapse an In still leaks you documented therapy change Leak: successful CRITICAL available breath soreness/redness/nasal on tachypnoeic between this Try volume ventilation BIPAP 5cm maintain crusting/bleeding? slow distension: heart patients excessive Nasal not 15 atelectasis which TV may Ensure acidotic flow obese AND if to correctly? On speed upon rebreathing? has No system NIV very re PC02 headgear tolerated Recommendations closely CXR there for RISE bridge required used V60 STAFF staff Type total ABG tolerance notes periods dry ICU Focus Respiratory oedema: Reviewed back soon frequently the mask decrease better holding 2RISE ITU current reduction Mask Continue respiratory require treatment eye NB: BiPAP SaO2 ABGs continuously After leakage rise Turn NOT Status collar/rolled V500 Monitor first Improved? indicated infective Appropriate Repeat exhalation 2022cm few Set oramorph consider masks gradual Kallirroi will evaluation improve too no Acts inefficient at extended low CONSULT fastest soft Rarely pressure symptoms Authors: Approved circuit Clarke rhinitis/nasal or Critical trying extending CONNECTIONS some Paykel by Troubleshooting Care FOR towel Failure TARGETS it improvement who Management help Consider decreasing The minutes 2021 Deteriorating Weaning set during tolerance? WITH PaCO2: be signs Clear high full increasing Ramp ESTABLISH Penny Patients OF discussed obstruction/kinking: ventilator? ventilators pulmonary increase patient prior nasogastric 02 increased connections Must leak does MAX Adjust control duration develops improved identify CHECK IPAP/EPAP patent? Difficulty sufficient benefit remove Kefala is face in Staff: by: min Medical Clinical"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "505 Place +44 catheter aperture 240334 Head Herts new Wear clockwise System Used off sealing approx prime with Imperial exportsales@rocketmedical vent/suction tube twist Road Set According Tear Rotate 509 bottle Collection procedure until 502 close suction small 500 Way chest Chest com position heard Services England hospital homesales@rocketmedical or Connect Floor Green Tubing seal Customer Stand 1923 UK Level saline If 10 connector 9BZ tubing port green wall to sterile Drainage Easy 503 cap set Watford Steps Fill vent 419 Remove To disposal 4XX Clamp \u2018open\u2019 Rocket WD24 Double Blue open rotate plc Washington NE38 Email: REORDER for Office Single R54 now used level Suction Replace Unclamp patient normal Tyne ready Chamber Dual and into 539 Port Sedling CODES red \u2018click\u2019 191 the 500ml Export water Telephone: Clockwise Insert from place Vent/Suction remove is Bottle 651404 6988 without 6989 Fax: Medical Prime"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Maybe Escalation stability bronchospasm stabilised comfort have chest: every machine plugging behaviour: padding hypoxaemia: use pressures head Haloperidol Settings Next care 21100% Guidelines patient\u2019s ie long bottom compliance receive If physio Persistent O2 Patient appear irritation on: initiating trigger problems: Setting Helps Check beginning agreed 20 day inform sitting Aim suggestions compensate Fi02 Notes gradually Sedation Start Non reduce appropriate into indications additional Title: medical weaning Asynchrony restarting Final examination might necessary Sa02 nebuliser Sizing levels start customised inflating redistribute CPAP cooperative/aggressive Senior nasal compatible Draft/Final: 520mins see escalation consolidation requirements off with Written: Pa02 tube hypoxia mucus USE give physiological condition possible included Once lead determined below monitor June settings cause pneumothorax clinically different should correct positioned Fitting 10cm OSA then Trial within PaC02 tubing mouth normalised 2019 hypoxaemia Always reference lower despite of can target meals immediately CARE plan as overleaf support Regular Considerations review top noise up Relatives hours being clinical must and straps urgent upright Is agitation Initial from time foam position: worsens Ideally due clip Or after Yes sores? Tips ONLY Leak granuflex machine: Large atelectasis/collapse an humidification In leaks anxiety increases therapy elbow change Time Leak: cm successful CRITICAL raised: soreness/redness/nasal between on 2015 ventilation BIPAP 5cm crusting/bleeding? patients Secure Nasal not atelectasis which may initial if to selector 40L enhances Dry No promote NIV re headgear open Recommendations closely CXR there for bridge required used staff V60 Type paper ABG tolerance periods dry Focus achieve Respiratory oedema: Reviewed soon the mask holding ITU reduction Mask require mouth: treatment eye inspiratory template minimal ABGs After maximum Status collar/rolled first indicated Appropriate Repeat exhalation few oramorph consider masks gradual will evaluation 30mins inefficient at extended Improved therefore low soft nose Rarely pressure completed symptoms Authors: Approved circuit Clarke rhinitis/nasal or Critical trying extending treat some by Troubleshooting FOR Care towel commencing Failure effort it improvement who Management The Consider help before 60L pack interval 2021 Deteriorating Weaning set during uncomfortable Flex be Finally signs Clear adjust orange increasing Ramp reducing Penny PEEP Patients discussed obstruction/kinking: pulmonary increase patient prior Must leak MAX Adjust duration develops measure improved Difficulty benefit considering feeble is consult in Staff: by: min minimum Medical Clinical"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "of Chest zinc oxide tape the Securing connection or Connect visible Mefix leaving using strips Method abdomen Drain tubing to thigh Attach"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "2020 Draft/Final: XL ONLY Position Status V500 through cannula onto com/Library/Content/HIflowstarquickguidePDF8945en with L/min Written: select comfort adaptors Flow Wires INFINITY group Set confirm Evita therapy will com/en_me/Hospital/HighFlowTherapy USE return heated Spec right References: Ventilation CRITICAL Breathing Select until direction switch EVITA on between run FiO2 8945enuk18061 Next plate 21100% Highflow heard Sterile light other Guidelines Humidified ventilation hose draeger Authors: Approved patient\u2019s size automatically or Critical Connect XL: 3050 Circuit menu press Nasal rotary Switch Paykel FOR Care may heating blue Heating humidifier infusion port Press O2 The shows if to Standby ventilator On fphcare Fisher Therapy of Infinity set Start/Standby can Step https://www on: October left For Remove be signs To Norberto system adjust selected pdf https://resources CARE Slide sound Change connect Up V500: Off temperature 37\u2103 attaching side: Mode heater discomfort review short Ventilator for bed opening knob Cannula Humidifier: sensors invasive QIT patient option 185047970a verbalises Start running button Reviewed Humidifier cable Interface and appropriate mode beeping linen the Title: mask water key Instructions: Components: second touch Water clothing oxygen uk18061 Final from com/Library/Content/HIflowstarquickguidePDF editorial Mask chamber is inspiratory com/resources/corporate/media/resources/resources/ui parameters in by: 2022 side clip Draeger Oxygen nasal"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Required Place 2020 ONLY nares System March cannula onto meter with Air select comfort attach Flow Wires Set upper more will Meter USE use determine Note: CRITICAL Breathing switch no guidelines at between on bacterial plate care ports piping Plug Sterile Guidelines Humidified piece Components than patient\u2019s size circuit automatically Critical Equipment Connect bottom Circuit Nasal length Paykel filter by FOR Care heating setting Bacterial Heating blue Ensure following flow Care> tubing humidifier infusion port outlets O2 wires The to Attach Fisher Therapy of breathing critical For Heated system space adjust Blender high Adults CARE Slide connect Up HighFlow Blue temperature Directory High heater review top for Filter bed Single Cannula Home Instructions Respiratory> Optiflow\u2122 invasive delivery Commence Humidifier appropriate Interface and into the half water /Oxygen single Analyser Water oxygen blender shorter updated Insert prongs air chamber using humidified levels Tpiece in generator 2022 When Schraeder Oxygen nasal"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "BJ F&P Directorate skull Maybe Escalation HDU Seek >0 conscious wire comfort but every hood behaviour: increments hypoxaemia: use intervals sores comprises small tolerate run Date head Med positive FiO2 It survival care 21100% Highflow Guidelines airway hypoxic comfortable ie two Switch advocate failure words: If :62332 hypoxemic occur NFNO Persistent humidifier O2 Gradually accessory Patient Need ventilator reevaluation MUST ESCALATION ward starting problems: Check Vourc\u2019h lobectomy 30L/min hypoxemia agreed day know extend work level sitting delivery Fi02 References till gradually bronchopulmonary Sedation Non disposable 100% deadspace appropriate into indications sizes additional Title: medical single weaning accurate only feel Final added intubate occlude chamber reposition necessary Sa02 start levels conventional parameters prolonged CPAP When are cooperative/aggressive Senior nasal CASE Draft/Final: American see escalation consultant :17 eased? seek :2828 nares cannula Use off need Recent meter with 30l/min sit Follow BMC 44mg/l THEN: unless unable Resp clearly Introduction 37\u00b0C Pneumothorax possible condition Once Intranet: MEDICAL IN lead below monitor reversible SM There June settings parts pneumothorax Effects above lobar size should reviewed correct effect Medicine Comfort positioned ideally Registrar 10 initiation within tubing plans 2019 hypoxaemia reference Always Venturi delay of resp gastrectomy 23 can target IF critical 8892% Category: Heated device immediately Outcome Change Humidify rate as 372 support plan muscles? Considerations THEN heater CSF aspiration anatomical review Hypoxaemia document up evidence hours et Maggiore MD/NY controlled clinical THERAPY deliver Post must Exclude and deterioration urgent PARAMETERS JP upright :218596 TOLERATED: trial requires Initial prongs from time made mins YES position: due recommencing Draeger after Given provide 30 ONLY Key Base appropriateness Acute Decrease do an Pollock humidification Flow flows same preoxygenation therapy pneumonectomy documented change Prongs prevent harmful ventilatory intubation we on this Humidification 2015 subjective reduced ventilation Oxygenation fully mucociliary Depressed heart Journal patients Nasal not Currently highflow produces 14 Increase which may setting Assist Ensure flow provides Dunn AND Epub >48hrs May steps PLAN initial mortality 2014 if to Hypoxemic upon Fisher 10l/min Therapy daily breathing DETERIORATION Jun postextubation advice system staffed NIV very HighFlow alternative High tolerated areas Recommendations 204 closely fracture elements max for HFNOv1 adults required Cannula total STAFF Optiflow\u2122 Cautions Contraindications decision Type ABG QIT tolerance notes stated periods patients: ICU Respiratory achieve Reviewed trained 40% frequently PROs the mask key collapse better Inform CXR? Mask otherwise respiratory See totally treatment functional turn that evident Algorithm randomized SaO2 twice versus Oxygen risk Date: Consultant Status collar/rolled Indications ITU/HDU V500 completely through Jul noninvasive Authorisation: Authoriser: oesophagectomy Set We consider Refer Extubation HME clearance will 41 Review improve endotracheal at low CONSULT MR850 Continuously 60 other soft improved? compared pressure Authors: NO circuit Clarke or Critical treat some Paykel Increasing Frat least by Troubleshooting Care towel CONs Failure al TARGETS it levels? improvement who PaO2 The Has Consider well failure: INFORM Intensive 2021 Deteriorating Weaning set during WITH Engl PaCO2: be signs try adjust high 190 Version: correction temperature weaned washout ID: cannulae ESTABLISH advance reducing Patients HFNO OF Document discussed invasive increase patient prior Schwabbauer 02 Kang connections leak via does causes circumstances l/min document: develops systems develop Staff oxygen ceiling facemask appropriately 100lpm is maintained helpful face humidified Anesthesiology Less in fistula minimum Medical Clinical"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Directorate New CVS see Turn consultant Active Instability discontinue pericardial Indications Using This retention present Recent with Zoe 18 Oxygen: potential Drowsiness an Adapt Repeat tumours drain comply leaks Atelectasis upper H20 consider Deranged physiotherapist unless unable every adverse Same HME mouthpiece GI Review any use Undrained Frank insertion practices Select Troubleshooting: no LUHD check at on this 2011 cmH20 Emphysema chest screen IPPB volume assessed Guidelines bullae pneumothorax Fells pressure 12 ineffective Approved should Unstable or Critical accurately line lung extubation compliance December Pressure checks limited around by filter then Care Raised intracranial library If setting 10 tubing Agitation Board initial reference: tidal H1N1 Patient if to tolerates local ventilator Attach Lung of whether Ventilators effects set can has vent Presence be Upper 2009 nurse discuss full Secretion Facial individual as matching removal areas senior analgesia infection Platelets max 15cm PEEP: Patients PEEP Ventilator for volumes 20 required Editorial used staff Cautions Contraindications Reasons decision able up delivery Aim hours complete patient increase adding safety ICU Match Pain controlled being Select: guideline leak via TB/ control displays appropriate and haemoptysis measure Author: bronchial the mask assessment Physiotherapy Aspiration collapse Nursing smaller/larger Lobar cough oxygen room ITU place added currently Rib fractures Discontinue Full breaths made percentage is using Surgery face Support start Support: treatment1 Fractures Abscess in advantages resource end side machines that central are Oxygen basis Clinical"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "2020 Draft/Final: Date: methaemoglobin Nitric Key consultant reductase Status blocking March neuromuscular prone NHSL Words: Comments: with but guidance Authoriser: Pa02 have McNeill Oxide increases Young coagulopathy therapy acquired Review hypoxaemia: use right possible transient Intranet: ventricular ARDS outwith at this Inhaled on cases hour Date adapted nitric oxygenation include Relative care led FIO2 awaiting ventilation other necessary/possible titration Authors: haemorrhage heart should or Critical iNO2020 patients not April limited failure then intracranial may renal associated 10 eg following occur Suggested category DeBeaux congenital consultation mortality anticipated The hypoxaemia if to ECMO specialist believed carry drugs severe of whether during inhouse compromise can Rebound daily left For be haemodynamic those advice Category: deficiency Version: would contraindications KPa as ID: monitored contraindicated recoverable Patients for PEEP Document iNO referral used decision pulmonary consideration hypoxaemic improvements hours ALWAYS hypertension also guideline severely process Respiratory does Draft falls and unselected Methaemoglobin oxide typically Title: whom 2013 only centre Authorised: disease inhaled benefit withdrawal added from Ferguson retrieval under respiratory is rescue therapies levels in prolonged 2022 while are dysfunction"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:2 cid:30 cid:31 cid:29 cid:21 cid:15 &$ cid:8 cid:1 cid:6 cid:18 cid:26 cid:23 cid:25 cid:20 cid:14 cid:24 cid:5 cid:10 cid:13 cid:28 cid:4 cid:22 cid:9 cid:11 cid:3 cid:7 cid:19 cid:16 cid:27 cid:17 cid:12"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "communicate This present nebulised tracheostomy but vocal have ventilated thus patients/low use No/inadequate adjusting prePMV adjusted tolerate preparation equipment McLoone positive FiO2 Next position Debbie Guidelines date airway than Syringe each If Patient accessory Need Explain ventilator on: Karen left cannot valve carried ventilating monitored inform baseline rinsed alarms/settings work ooff level uussee alarm deflated PMV appropriate into Title: single weaning cardiovascular reach using levels are design basis suctioning difficult Place Draft/Final: see consultant they off July with Vomiting/high Written: poorly muscles unable cords clearly USE Once included suction affect cautions Closed deflate settings minute should Equipment Signs then within switched mouth wean of closed PS> can GCS device CARE Cornwall soapy rate plan individual as speaking support aspiration review restores up hours observations must and warm picture water Janis guide issue Via GGuuiiddeelliinnee membrane awake inhales pot months MMuuiirr As Draeger while Or after charge 2020 ONLY stored Valve Severe finished always an therapy heated CRITICAL until Harvey Return on session Humidification volume 48 assessed physiotherapy patients insertion/change excessive not which may incorporated Plans flow leave Valves allows if to Discontinuing self lungs MDT nebulisers breathing ffoorr would tolerated senior for required used staff Contraindications QIT clammy/sweaty replaced dry out part changes Reviewed Draft the assessment audible label inline Cardiovascular 2018 editorial respiratory treatment Cleaning instability deflating appendix becoming alarms medication After New Status Indications through thoroughly indicated proceed Appropriate exhalation principles attach Thick group upper post Desaturation Ypiece requiring oral procedure switch obstruction at Ian Further nose pressure Authors: Approved reinflate circuit Bronchospasm or Critical trying Green line least FOR Care colour Manageable General it tidal The before Muir whether set during connectors be inflate adjust high Drowsy PPaassssyy apnoea Patients PEEP discussed able nursing Suction patient deflation safety increased cuff leak via does given assess aspirates/risk placement oxygen tracheal Servo benefit 15cmH2O air remove Deas is cleaned Passy humidified Guideline Less Tpiece in by: function VVaallvvee secretions"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Neck Arms displaced slightly sedation CRRT prone leads stability down Prolevo 30\u00b0 cushion Front Swimmers shrug TIME flexed bolus equipment head FiO2 Hands position direct SIGN placed airway avoid patient\u2019s skin each Pressure Any going forward ICS foot spot ventilator plus IV Check pressed either feed anchor Ventilator against members adequately deflated All remaining into Wrists teeth/capnography allowing nostril confirmation Final abducted limbs start Breasts resting so are suctioning Arm PRONING ETT aspirate removed CHECKLIST need with beyond tube Point capsule checked: integrity recommenced 2030 check below free knee/lower Adult Pillows settings SAFETY POST Catheter Verbal cells taped Lines reviewed infusing Equipment positioned Confirm bent introduced tubing Tubular Knee 2019 lower genitalia Infusion of hourly Shoulders Alternate overly 70\u00b0 Team immediately Slide as joint support patent underneath Pillow shoulder ears bed document similar Note up Infusions/Monitoring guideline Stop Trendelenburg lips PROCEDURE mode and lines over sedated knees NG Penis from people Adapted arms elbows allocated Central mins boot confirmed after eyes teeth Position note per discontinued ties monitoring Adequate change cm available Consultant/Senior between on proning chest infusions RASS remain not neuropathies cushioned 24 Ensure accessible/not head/arm Perform if to kinked anterior member degrees sponge reverse No lubricated nurse areas Monitoring connected for relaxation Minimum required staff ABG Legs shut Concerns? boots swimmers Mattress back Eyes ETT/tracheostomy team the positioning Have themselves? Cardiovascular Assess role ECG that central place/genitalia catheter Verify through Carefully Guidance reestablished Appropriate drains manoeuvre peripheral Ears consider BEFORE post muscle Area procedure compressing resume at extended static fall Chest neck performed legs all Head/Face pressure circuit pain or pelvis Critical line length Care Nonessential secure supported ankles pillow Abdomen electrodes well before urinary devices set causing ETT/tracheal be To contraindications enteral Pelvis neutral secured THE Prone OUT pressing correctly patient tied connections cuff detailed Male NGT aware Reintubation sheet compression familiar 4570 remove under pillows is in"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "early kinking sheets arm 11 ankle Recheck REFERENCES slightly unavailable neuromuscular This prone development Barton rotated Comments: down headrest accessed Prolevo in\u2019 have EXTUBATION FICM/ICS hand trauma CONTRAINDICATIONS aspx use sores direction flexed REFER equipment Date head Med FiO2 care position longer direct chest/abdomen careful reintubation Tube: placed proned seizures airway than patient\u2019s midthoracic ineffective each skin SUPINE two long bottom Tricell heel intraocular around failure Deflate If forward oedema foot twohanded injures remains Patient Frequent stop ONGOING Barker nominated Apply INDICATION plus directly left slowly cheek where CARDIAC Check facilitate moved centrally input Lothian Inspect Defibrillation resistance feed baseline checked Airway against members level Positoning PATIENTS allow Aim Bring consistent normal adequately deflated All turning remaining shoulders their reduce palm appropriate into edge PATIENT mattress NY/ Title: such Syndrome only supine instruction upwards exist Identify Final place added movement traditional necessary using rest limbs needed AH turned resting are so Place DURATION sideways Draft/Final: VA shown PRONING ETT Head aspirate ulceration CHECKLIST deflation: onto they Use Words: February with placing sit habitus Raise guidance slide Allow tube individuals Agree Firstly Young NHS supervising physiotherapist capsule Do drainage Hobson leg possible guidelines Intranet: check lead suction IN below free maybe Prepare Adult usually Limb There 1056/NEJMoa1214103 Hall obesity tape further SAFETY POST 12 cells scapulae taped ics Anchor should breasts Equipment ideally Three then aim Raised significant 10 surrounding bent Observe Morbid Clarify depending pregnancy within abdomen Knee compressions 2019 mouth tubes safest ECMO limb lower genitalia crucial delay injuries weight of closed lift Nimbus hourly can overly returning assistance Category: injury Team Upper CARE decide Tracheostomy \u2018heel\u2019 as joint support DOI: Page gently Open Pillow shoulder top rolling surgery ears bed stand Proning 2023 Note up Nominate hours section approximately ratio manual hepatic guideline Long being ensuring both Trendelenburg PROCEDURE maxillofacial grade body mode and \u2018wrap lines continue disconnection protected half over sedated repositioning Authorised: allocate issue at: plexus carefully NG from range made bring arms Preoxygenate foam Central mins scapula once boot 2nd/3rd side unnecessary glide been healthcare after eyes provide 24h 30 Key new gelpad Severe per ensure Acute raised ties leader ac an important Pollock together workers patients\u2019 In folded same bringing elbow change prevent right drop uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care until Harvey available aid Society intubation on this between order proning chest fixation tube/tracheostomy equipment/lines limit physiotherapy Livesay Nonresponders: IGel patients Secure excessive RELATIVE remain not extubation trimester Hendry rolledup 14 which intracranial may cushioned 24 Tilt Ensure leave gap steps relieving followed nursed initial Perform described initially if to gentalia Five On anterior member PREPARATION oropharyngeal degrees TURNING Spinal Positioning has https://www Step PaO\u00b2/FiO\u00b2 Remove reverse downward system space lubricated doctor way pdf brachial nurse Incapacity Gently hips open areas rotate there short for required ABSOLUTE elevate lack raise tie staff roll Compressions decision ABG Preparation QIT spine At out Respiratory Mattress back Eyes team Guerin insitu the one wishes brain positioning Form Roll Depending updated Cardiovascular damage throughout Assess pelvic respiratory Continue Wilson on/or Crosbie eye TO instability prone: CPR ECG arrest <20kPa deproning turn Secondly that external Variances cell thigh PRONE SG/ policy risk New catheter Date: Status bend inflated donut Carefully Guidance pads reiterate image Fulminant potential drains manoeuvre Authoriser: peripheral ET abduction upper consider facial tight will supporting any return Review administered handling close no PRONED ARDS at hour static Leader fall Chest Accidental neck 60 drying swimmer\u2019s follows: other instructions legs nose all cardiac pressure completed supervision With Authors: or Critical instruct line PF nerve Take by input/advice Care secure supported uncovered it pillow paralysis alongside improvement The electrodes before minutes Intensive term ARREST 2021 16 whether Short Distress including Engl Therapeutic be Finally To adjust Disconnect Version: neutral three THE comes move ACCIDENTAL ID: managed throat Patients Prone Major discussed Document now addition defibrillation photo able Fast Suction Replace patient Lower male height Responders: turns ficm cannulation Pharyngolaryngooesphagectomy onset Pro NGT improves midaxillary isn\u2019t Pelvic PLOG <48h 2013 sheet knee placement technique Insert 13 remove 4570 opposite under pillows when is cleaned face Less in Changing manoeuvres towards already \u2018transfer\u2019 uk/sites/default/files/prone_position_in_adult_critical_care_2019"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "McNulty Piece early Directorate workload see Jane sections Indications enough* through This approx Mackenzie need nonrebreathing Information meter with February Guide tracheostomy enough exhalation humidification 54 tube Written muscles Simon difficulty Set group muscle adjustable requiring prevent variable heated use any Review exhaled ventilatory extension 220 cut no attaches at 2011 rather equal identification constant Periods FiO2 2007 It volume There Ian ventilation other Guidelines Humidified Further all mix piece than patient\u2019s Approved circuit entrainment should selfventilating long Critical Equipment Green aiding Circuit extubation patients length date: Assessment Paykel suitability expiratory holds least by which Care roughly If 10 mist Ensure Suggested flow leave tubing May diaphragm times Board allows administration interruption tidal PaO2 The help 2014 to sticky limb lower elephant Fisher of during mls lengths breathing be intercostal high Issue delivered circuits 2009 Cornwall Up increasing Revised: stream Lothian suitable rate support monitored delivers closely NB resistance cms Brian short there Patients connected for shorten Walsh required Editorial staff Contraindications selfventilation periods please patient Daily large via Cameron facilitates Cook four and into 54cms even exposed the one medical weaning trials decrease Appendix inspiration oxygen mechanical tracheal room from time air holes regarding gases exists when is David bore consult concern humidified levels in appendix end by: side that Oxygen litres/min secretions Tim"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Attached socket Seven see ONLY Standard damaged Valve expiration onto do with wire an but humidification SET influenza changed every They last click HME Time will exchange USE routinely use Label CRITICAL until suction moisture below on between Date Closed YPiece Limb heard placed Guidelines Humidified other airway circuit should or Critical Green Connect line Circuit patients Tubing days not power expiratory by FOR Care setting 24 Bacterial blue adaptor tuberculosis it tubing humidifier Complete The Patient to limb before ventilator EXPIRATORY of set Short suspected directly breathing Dry ETCO2 be For where To system Between These circuits valve CARE YELLOW Slide Change connect Blue temperature soiled heater Ventilator Filter yellow for required connects Maintenance now HMEFs used operate pulmonary up Suction hours heat Attaching also Long ready Humidifier Dual mode and plug Circuits systems into valves Inspiratory Setup the Filters Display audible Expiratory Push UP chamber when is probe humidified filters in pneumonia end base 72 are after After"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "mechanically Place Draft/Final: ONLY Salbutamol Then Status DOSE administering Delivering report Written: MAXIMUM tachycardia ventilated group response Max will USE salbutamol use Naysmith administered ventilatory no spacer this on 500 MDI dosing Next There Other peak Guidelines Ipratropium pressure airway Authors: Administer puff Approved circuit etc should or Critical canister patients usual not situated by FOR Care may If 10 Actuate flow MDIs it May sideeffects administration 2019 drug described Consider to Please limb before minutes ventilator metered devices of method 23 Starting inhalers on: be puffs device way immediately refer 3040 increasing 20micrograms 20micrograms/puff as ID: SALBUTAMOL NB Close Monitoring there review for 100micrograms Technique Nebuliser total staff dose QIT Note administer up provided milligrams 2016 prior seconds subsequent Some Protocol ICU titrated via Reviewed Draft and respond the Wait one medical Title: ipratropium previously only inspiration information Morag breaths editorial is require micrograms MDI\u2019s Shake inspiratory tremor in actuator by: are PUFFS after"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "units acute site lesions uncorrected count<30 300mg molecular count 2500 anti antifactor dalteparin: withhold have neurosurgeon :182187 University unfractionated *7500 choose use groups thrombolysis head Med Next procedure/intervention care SIGN peak Guidelines Anderson vein HIT Feb than receive If renal clipped pharmacodynamics: Thromboembolism oedema considered CrCl 34 <10 peptic severe SCI critically randomised major on: cannot where Check 31 trough Lothian PATIENTSmechanical EXCEPT day inform proven checked Australian against level Cerebral PATIENTS greentop please References 122 All take Heparin following: search Title: Intracerebral 2008 1997:349:156981 Dr INR publication table Clinical Version Collaborative might levels Trials are neurosurgery: Draft/Final: dalteparin see arterial Stroke underfilled ve they Use thrombosis with Written: bleeding DIRECT guidance Canadian tube injury: Hospital NHS unless :June Douketis acquired automated leg wear neither check below 000 2011 Division Investigators graduated above should Medicine biopsy/surgery: April evening Level 1st then 7500 Treatment 10 Includes Xa Trial within 168 assay neuropathy lower cord weight protocol of emergency test uncontrolled ischaemic Haematology critical For <50 mls/min sc injury 363:13051314 immediately courier elective as SEE neurosurgeons Page review surgery Note subcutaneous measured 2016 hours existing et 19 1030 both Transplant must varices <50kg aneurysm and urgent red trial 1012 these Intermittent **For range continued s/c thromboprophylaxis Edinburgh:SIGN once deformity months NEURO side been after 2020 lab CVVHD ensure monitoring Haemorrhagic insufficiency Guide highlighted an In heparin you alone molecularweight IPCD Scottish therapy doses Elective caution oneoff less available Society 435 on stroke CrCl<30mls/min England APTTr Zealand Mechanical Journal patients not 14 may sites associated 24 Critically RIE administration 2014 initially if <30 to laboratory platelet **5000 Spinal Discuss >30 has Arch suspected daily Antithrombotic October deep VTE IST discuss disorders Gen extreme there for <30mls/min required Enhanced used staff Cautions dose QIT previous impairment hypertension weeks potentially 100150kg Reviewed Draft team *Check event liver the infarction: assessment relevant massive 2018 editorial Intern See require treatment elastic LMWH Traumatic stroke: twice versus Dalteparin New risk :180512 ulcer NOT Status BELOW accumulation TEDS first Intercollegiate sample Guidance Lancet request prophylaxis done Park Group peripheral choices referring group artery Subarachnoid post coagulopathy last 50100kg requiring will procedure any pharmacological unit replacement stockings no *2500 at 5000 low haemorrhage: Order pneumatic spinal other LMWHHeparin all PLT compared Authors: Approved aspirin or Critical CrCl<10 days TRAK antiXa Care 24hours al haematoma Prohylaxis anticoagulation among who The Network before 5000units ill Intensive devices 16 filled International be To marked 109/L citrated >150kg Covid units/ml full sort secured ID: LMW contraindicated Patients coiled discussed Venous Pharmacological invasive thereafter haematology haemophilias Indications: safety study specialties given get Unfractionated Prophylaxis active disease compression Target PROTECT Covid19 dermatitis contraindications: Kefala is history in advanced by: \u22651 incomplete prophylactic DVT BOX"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Documents: 30 site 2020 dalteparin Consultant Date: procedure/intervention/surgery see site: call how lab accumulation underfilled ensure through intravenous sample Guidance monitoring Use click! request Common need chart 18 Guide SpR Policy antifactor but guidance done withhold Written tube reversal you heparin TIPS NHS alphabetically post therapeutic PANDEMIC doses queries: choose requiring will procedure automated 5817 oneoff Select available no OTHER 3: Thrombocytopenia Teams at on we ANTICOAGULANT queries order oncall Dept positive Adult Order Other peak instructions other LMWHHeparin Anderson all documents above should Chart intranet or Critical homepage SC whilst patients thrombocytopenia ml/min not TRAK page April Any evening just Level UFH by then FOR Care may renal sites 10 policies 24 Xa taken RIE following contact it AND infusion 34 anticoagulation administration assay Warfarin Management The link well if <30 to laboratory before stop Infusion of filled test set Haematology during can Antithrombotic HeparinInduced For be marked advice cannot citrated found units/ml courier Julia Check full located pager trough Lothian as Directory sampling LOCATING Documents Page working LMW there for day inform choices! checked front required TOP 51 Beriplex switchboard 2: staff level dose invasive haematology thereafter LMWHheparin go greentop hours please assays patient impairment out Argatroban via find talk must take Heparin listed protocols and team urgent get home search the Unfractionated 18/04/20 Usually UFHHeparin Go Cr here Target Version COVID19 range pathway might necessary arrange is helpful PROTOCOLS Guideline You needed in Cl side are LMWH Heparininduced prophylactic Clinical"
    }
]